data_2m51_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m51 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.377 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -141.46 166.57 24.39 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.283 1.433 . . . . 0.0 107.384 173.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.0 161.87 37.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -124.46 140.37 53.01 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.88 157.98 35.31 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.14 3.35 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.244 0.475 . . . . 0.0 111.746 164.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 mt -147.29 160.62 38.95 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 126.334 1.854 . . . . 0.0 107.955 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.15 165.4 14.85 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.647 3.565 . . . . 0.0 111.699 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -157.1 125.58 5.68 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.083 0.953 . . . . 0.0 110.517 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 t -82.48 142.2 32.07 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -83.75 154.41 23.61 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.742 -0.599 . . . . 0.0 109.739 163.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.3 151.56 94.34 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 157.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.34 150.08 13.35 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.496 2.797 . . . . 0.0 110.506 165.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 t70 75.48 13.17 3.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.66 1.984 . . . . 0.0 112.569 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.9 p -107.11 177.56 4.82 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.808 1.243 . . . . 0.0 108.704 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -92.43 10.21 31.0 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.987 0.915 . . . . 0.0 109.219 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.88 162.27 28.78 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.746 -1.221 . . . . 0.0 109.92 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 pt -125.02 140.66 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 124.852 1.261 . . . . 0.0 107.619 164.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 p -85.68 160.34 19.59 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -158.35 167.71 28.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.366 0.667 . . . . 0.0 109.369 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 mt -117.43 167.83 10.92 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.574 1.15 . . . . 0.0 108.579 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -60.77 115.01 3.34 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 167.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.8 -16.41 3.74 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 125.754 1.645 . . . . 0.0 112.36 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -76.88 163.4 26.79 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 119.87 1.835 . . . . 0.0 111.968 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.2 mtp -127.85 154.96 44.86 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 128.149 2.58 . . . . 0.0 108.833 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -136.39 160.4 38.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.431 1.092 . . . . 0.0 108.967 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.7 pt -122.74 137.95 54.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.9 t -69.76 134.27 30.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.83 -27.28 2.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.402 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.99 162.54 41.13 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 119.431 1.014 . . . . 0.0 110.788 162.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -107.47 137.35 45.67 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.565 1.946 . . . . 0.0 107.443 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.1 mt -129.36 177.01 7.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.511 1.924 . . . . 0.0 107.101 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -130.32 14.44 5.59 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.188 -0.945 . . . . 0.0 113.033 -152.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -127.59 21.29 6.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.078 1.751 . . . . 0.0 112.103 -170.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.09 10.32 56.26 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.355 1.455 . . . . 0.0 113.018 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -125.9 155.34 41.42 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.658 1.583 . . . . 0.0 110.847 -165.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.4 mtm -145.82 145.99 30.99 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.316 1.447 . . . . 0.0 108.8 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -84.01 137.3 33.67 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 122.838 0.455 . . . . 0.0 110.655 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.6 m -142.38 -171.24 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.834 0.854 . . . . 0.0 111.724 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.1 m -128.07 150.76 49.81 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 156.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -109.54 109.32 20.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.127 1.771 . . . . 0.0 109.413 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 mt -56.04 -12.86 1.62 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.784 2.034 . . . . 0.0 113.612 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -64.47 -33.96 77.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.958 1.254 . . . . 0.0 111.514 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.251 5.1 t -155.31 15.07 0.39 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.085 0.954 . . . . 0.0 110.737 -168.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.3 t70 53.05 32.85 13.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.085 2.154 . . . . 0.0 111.795 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.1 159.28 33.81 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.809 -0.557 . . . . 0.0 110.326 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -140.23 147.2 39.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.38 -157.66 25.69 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -101.67 146.82 27.21 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.174 1.39 . . . . 0.0 112.277 -165.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.43 154.05 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.063 1.745 . . . . 0.0 110.288 168.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.99 144.59 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.709 1.604 . . . . 0.0 110.127 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -78.63 -6.33 55.37 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.58 -19.95 65.96 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.608 1.163 . . . . 0.0 113.108 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.9 mt -129.21 15.78 6.16 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.526 1.13 . . . . 0.0 113.819 -160.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.02 169.65 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 119.102 0.864 . . . . 0.0 113.058 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -125.63 148.1 49.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 127.407 2.283 . . . . 0.0 109.216 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.93 47.58 1.23 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.263 2.225 . . . . 0.0 112.783 -170.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 122.711 1.243 . . . . 0.0 111.756 -173.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -158.67 166.96 30.8 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.279 1.831 . . . . 0.0 109.361 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.46 178.46 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.872 1.669 . . . . 0.0 108.823 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 -140.93 142.32 34.4 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 120.449 -1.407 . . . . 0.0 108.44 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.68 137.06 47.55 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 119.069 0.85 . . . . 0.0 110.45 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.85 -4.84 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 118.218 -0.896 . . . . 0.0 112.335 163.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -149.81 148.66 26.0 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 125.18 1.392 . . . . 0.0 108.612 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.26 167.5 19.48 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 124.632 3.554 . . . . 0.0 111.27 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -154.4 171.43 19.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.18 0.992 . . . . 0.0 108.483 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.6 m -118.79 113.55 21.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.922 1.289 . . . . 0.0 108.585 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -59.81 151.6 25.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.187 0.903 . . . . 0.0 110.456 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.47 148.64 97.93 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 154.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.63 163.93 14.29 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.57 2.847 . . . . 0.0 111.134 170.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 47.03 47.27 16.02 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.918 2.087 . . . . 0.0 110.002 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.62 172.99 14.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.503 2.721 . . . . 0.0 107.845 -172.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -82.0 5.0 20.67 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.055 -1.028 . . . . 0.0 112.052 -170.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.31 162.33 14.65 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.363 1.465 . . . . 0.0 110.881 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 pp -138.37 132.21 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 127.082 2.153 . . . . 0.0 107.181 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.88 151.02 38.99 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.875 -1.14 . . . . 0.0 111.206 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -152.68 154.51 35.43 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.274 -0.891 . . . . 0.0 111.094 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.86 171.37 7.56 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.886 1.274 . . . . 0.0 109.777 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -52.78 134.2 36.76 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 158.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.05 -7.12 81.44 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 117.694 -1.615 . . . . 0.0 114.501 172.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -64.69 159.08 22.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.951 1.876 . . . . 0.0 108.713 166.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.1 ttt -127.66 142.23 51.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.387 1.075 . . . . 0.0 109.884 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -127.6 146.52 50.51 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.493 1.117 . . . . 0.0 111.089 -170.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 pt -110.01 130.95 62.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.39 124.79 26.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -121.04 -47.65 2.27 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.124 0.97 . . . . 0.0 110.794 176.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -138.87 157.44 46.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 119.006 0.821 . . . . 0.0 111.438 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -130.52 119.51 22.69 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -161.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 mt -119.5 145.53 46.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.885 -171.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -87.07 15.96 5.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.552 1.941 . . . . 0.0 113.335 -165.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -125.83 18.24 7.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.733 1.613 . . . . 0.0 112.533 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.66 16.11 50.17 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.24 0.924 . . . . 0.0 111.931 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -123.34 153.29 40.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.33 1.052 . . . . 0.0 110.154 -166.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.6 mtm -143.89 132.46 22.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -79.68 129.18 34.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.128 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.77 176.05 7.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.761 0.824 . . . . 0.0 111.58 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 m -105.91 138.3 42.34 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 153.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -90.83 114.97 27.51 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 168.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.99 -7.61 23.69 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.9 ttp85 -59.79 -45.16 93.17 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.83 1.195 . . . . 0.0 109.8 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -137.72 -3.46 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 117.843 -1.075 . . . . 0.0 113.039 -168.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 75.53 11.06 3.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.292 1.837 . . . . 0.0 111.989 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.04 149.38 37.08 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.972 0.909 . . . . 0.0 109.379 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -133.52 139.1 46.43 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.885 1.274 . . . . 0.0 108.396 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.42 -170.67 36.47 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.34 146.28 31.64 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.746 1.619 . . . . 0.0 111.592 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -143.66 166.43 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 128.365 2.666 . . . . 0.0 108.468 165.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.45 143.45 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.692 1.197 . . . . 0.0 110.932 -167.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.6 -8.61 56.89 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.351 1.06 . . . . 0.0 113.04 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.03 -27.81 67.23 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.531 1.532 . . . . 0.0 112.232 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.53 14.99 8.21 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -161.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.5 164.1 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.976 0.807 . . . . 0.0 112.611 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -120.36 142.9 48.73 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 127.426 2.29 . . . . 0.0 109.669 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -72.43 92.94 1.49 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.325 1.45 . . . . 0.0 107.725 170.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 122.274 1.035 . . . . 0.0 111.284 -166.035 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -125.95 160.99 28.52 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.836 0.854 . . . . 0.0 109.1 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.54 160.65 31.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 124.772 1.229 . . . . 0.0 108.32 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -134.28 127.17 31.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.113 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.98 134.73 44.81 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.871 0.76 . . . . 0.0 109.792 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.272 0.2 OUTLIER -115.54 5.02 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.726 0.81 . . . . 0.0 112.501 176.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 mt -148.14 160.73 36.57 Favored Pre-proline 0 N--CA 1.468 0.467 0 C-N-CA 127.716 2.406 . . . . 0.0 106.834 166.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.17 170.61 9.49 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.095 3.197 . . . . 0.0 111.283 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -145.59 172.08 13.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.586 0.755 . . . . 0.0 109.183 173.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.1 m -131.54 112.17 12.4 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.019 1.328 . . . . 0.0 108.202 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -66.71 158.69 29.52 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.272 -174.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.06 123.54 86.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 161.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.68 153.96 74.64 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.141 1.227 . . . . 0.0 108.92 166.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 t0 73.5 22.63 2.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.047 1.339 . . . . 0.0 111.118 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -130.04 169.99 14.57 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.095 1.358 . . . . 0.0 109.38 168.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -78.64 9.63 3.92 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.247 1.419 . . . . 0.0 110.309 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -74.72 167.69 21.31 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.138 -1.601 . . . . 0.0 110.541 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.3 pt -138.14 139.71 41.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 126.746 2.018 . . . . 0.0 107.446 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.01 137.26 47.09 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.87 -1.144 . . . . 0.0 108.799 172.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -135.34 165.1 26.23 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.807 0.843 . . . . 0.0 111.664 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -111.63 165.13 12.29 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.18 1.392 . . . . 0.0 109.924 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -59.11 128.66 38.27 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 161.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.89 0.42 62.13 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.204 -1.331 . . . . 0.0 113.434 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.24 161.47 29.9 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.847 1.824 . . . . 0.0 109.948 167.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.8 ttp -146.9 144.13 29.03 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.24 1.016 . . . . 0.0 110.455 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -140.53 155.71 46.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.954 -162.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -104.05 133.1 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.181 1.392 . . . . 0.0 108.328 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.01 129.32 30.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -119.12 -34.06 3.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.388 168.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -145.95 162.19 38.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 119.578 1.081 . . . . 0.0 110.066 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -123.75 112.18 17.03 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.584 1.953 . . . . 0.0 105.915 -170.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.73 -172.72 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.725 1.61 . . . . 0.0 108.606 -169.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -134.4 38.84 3.09 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.301 1.048 . . . . 0.0 112.356 -168.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -152.74 47.59 0.72 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.894 166.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.96 3.58 44.44 Favored Glycine 0 CA--C 1.538 1.481 0 O-C-N 121.031 -1.043 . . . . 0.0 115.252 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -97.32 161.41 13.81 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.624 1.169 . . . . 0.0 110.45 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.2 mtm -138.48 144.41 40.03 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.609 1.164 . . . . 0.0 108.695 165.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.455 ' CE3' ' CD2' ' A' ' 51' ' ' LEU . 24.7 t-105 -79.01 131.66 36.37 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.745 0.818 . . . . 0.0 109.322 166.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.44 -173.05 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.758 0.79 . . . . 0.0 112.462 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 m -136.15 131.68 35.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 161.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -86.22 108.98 18.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.732 1.213 . . . . 0.0 108.716 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.9 mt -75.23 -0.29 18.96 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.556 -1.212 . . . . 0.0 112.128 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -63.38 -33.01 74.6 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 120.8 1.636 . . . . 0.0 110.601 168.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 p -143.84 0.25 1.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.167 -160.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.25 0.3 OUTLIER 70.37 0.88 3.37 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.316 2.646 . . . . 0.0 114.195 -166.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -66.88 104.5 1.37 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.026 0.93 . . . . 0.0 111.749 -168.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -79.34 156.55 27.95 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.933 -0.479 . . . . 0.0 109.839 166.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.72 -154.7 25.7 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.455 ' CD2' ' CE3' ' A' ' 40' ' ' TRP . 1.8 mm? -103.03 144.63 31.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.633 1.173 . . . . 0.0 109.903 -167.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -140.66 151.43 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.397 1.879 . . . . 0.0 109.66 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -99.98 144.21 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.95 1.3 . . . . 0.0 109.086 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -81.44 -1.33 45.37 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.26 -23.55 62.47 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.188 0.995 . . . . 0.0 112.982 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.97 13.64 10.61 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -158.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.81 158.69 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.464 1.029 . . . . 0.0 112.863 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -108.1 157.37 18.33 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.956 1.302 . . . . 0.0 110.521 163.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -76.08 68.89 2.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.978 1.311 . . . . 0.0 110.186 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 122.73 1.252 . . . . 0.0 111.16 -176.536 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.857 0 CA-C-O 121.739 0.78 . . . . 0.0 109.912 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -119.91 149.42 42.13 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.842 0.857 . . . . 0.0 110.083 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.07 164.29 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.466 1.106 . . . . 0.0 110.994 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -135.88 130.48 33.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.368 1.067 . . . . 0.0 109.446 -170.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.8 135.71 51.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 174.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.84 2.76 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.986 0.914 . . . . 0.0 111.005 169.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.3 mt -141.08 153.39 66.93 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 124.818 1.247 . . . . 0.0 108.522 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.18 158.15 17.62 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.503 2.802 . . . . 0.0 110.538 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -149.09 120.54 7.93 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.679 -0.638 . . . . 0.0 111.399 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.6 m -78.03 113.13 15.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.518 0.727 . . . . 0.0 109.264 167.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -65.55 156.74 31.7 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.234 168.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.17 146.21 86.76 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 160.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.23 172.23 12.48 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.995 3.13 . . . . 0.0 111.403 165.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t70 64.43 5.87 2.83 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.468 1.507 . . . . 0.0 113.559 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.2 p -119.27 176.11 5.48 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 119.744 -1.848 . . . . 0.0 110.173 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.33 10.46 4.54 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.031 1.332 . . . . 0.0 110.065 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.33 160.77 27.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.645 1.578 . . . . 0.0 110.669 -170.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.8 pt -131.65 132.36 62.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.9 p -75.59 162.21 28.47 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -157.48 166.28 33.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.929 0.892 . . . . 0.0 109.211 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.23 162.5 15.93 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.736 0.814 . . . . 0.0 109.139 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -57.17 125.51 23.05 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 166.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.21 -6.74 58.16 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.044 -1.975 . . . . 0.0 113.388 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.99 160.28 23.96 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.702 2.251 . . . . 0.0 110.19 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.2 mtp -134.99 153.48 52.07 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.805 0.812 . . . . 0.0 111.557 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -146.26 165.55 28.9 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.273 -1.33 . . . . 0.0 111.755 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.87 128.35 75.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.773 1.629 . . . . 0.0 107.933 -170.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.36 131.39 32.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 120.73 1.605 . . . . 0.0 108.637 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -132.75 -30.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -148.99 165.84 30.43 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.172 0.896 . . . . 0.0 109.253 166.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -133.92 124.28 26.13 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 127.987 2.515 . . . . 0.0 105.063 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.3 -178.29 3.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.943 1.297 . . . . 0.0 110.691 -171.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -132.37 79.49 1.86 Allowed 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 125.488 1.515 . . . . 0.0 107.761 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -168.29 -0.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.505 0.722 . . . . 0.0 112.742 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.34 25.9 38.16 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.236 0.922 . . . . 0.0 112.031 -166.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -136.06 160.02 39.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.178 1.791 . . . . 0.0 108.053 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 35.8 mtm -147.79 158.31 43.96 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -95.25 134.84 37.56 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.837 1.199 . . . . 0.0 111.053 170.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 m -142.53 175.1 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.247 1.819 . . . . 0.0 108.971 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.5 m -114.47 135.54 54.0 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 162.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -82.45 120.13 25.07 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.032 0.933 . . . . 0.0 109.261 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.31 -5.48 3.51 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.283 1.033 . . . . 0.0 113.047 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -63.76 -37.59 87.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.546 -1.216 . . . . 0.0 111.138 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 t -164.0 13.93 0.05 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.986 1.266 . . . . 0.0 113.742 -171.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 73.81 5.01 4.79 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.899 1.679 . . . . 0.0 113.463 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -54.5 116.86 2.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.101 1.76 . . . . 0.0 109.244 167.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.76 165.49 11.35 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 166.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.47 -146.62 13.86 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.68 142.02 45.78 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.687 1.195 . . . . 0.0 110.716 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.5 147.9 23.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 129.724 3.209 . . . . 0.0 107.063 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -88.78 144.77 8.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -68.39 -12.84 61.74 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -69.97 -16.19 63.15 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.152 1.381 . . . . 0.0 114.109 -171.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.5 mt -125.51 6.52 7.6 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.378 1.071 . . . . 0.0 112.363 -162.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.8 m -120.03 156.9 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.634 1.174 . . . . 0.0 110.536 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -116.45 153.35 32.27 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.846 1.258 . . . . 0.0 110.257 173.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.6 63.95 2.81 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.043 172.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 C--N 1.319 -0.74 0 O-C-N 120.888 -1.133 . . . . 0.0 111.609 174.18 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.402 ' H ' ' CG1' ' A' ' 30' ' ' VAL . 3.4 ttt85 . . . . . 0 C--O 1.238 0.464 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -134.28 161.53 34.68 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 125.063 1.345 . . . . 0.0 108.872 159.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.3 164.86 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 162.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -128.73 140.9 51.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.87 141.82 51.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 120.004 1.274 . . . . 0.0 109.714 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.97 2.5 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.039 0.936 . . . . 0.0 111.729 170.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 mt -143.4 157.04 60.29 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 126.085 1.754 . . . . 0.0 107.353 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -88.38 167.47 6.38 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.695 2.93 . . . . 0.0 110.795 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -156.74 167.14 31.35 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.934 0.494 . . . . 0.0 111.13 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 m -124.43 115.5 21.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.18 2.192 . . . . 0.0 107.278 171.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -61.15 157.34 16.19 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.888 172.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.02 135.87 79.95 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 162.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 95.1 Cg_endo -70.12 163.9 36.88 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.146 1.898 . . . . 0.0 109.197 171.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.4 t70 63.2 18.27 10.84 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.601 0.715 . . . . 0.0 112.135 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.3 p -130.9 169.41 15.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.675 1.59 . . . . 0.0 108.699 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.42 3.81 38.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.458 1.503 . . . . 0.0 111.428 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -69.97 167.02 18.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.28 1.832 . . . . 0.0 110.184 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.4 pt -140.14 129.31 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 120.885 -1.134 . . . . 0.0 110.057 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -63.82 160.73 16.76 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.785 0.72 . . . . 0.0 110.105 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -161.44 173.53 14.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.276 0.56 . . . . 0.0 110.588 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mt -125.28 159.71 31.03 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.102 1.361 . . . . 0.0 109.773 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -58.29 120.47 8.76 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.29 2.24 59.11 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 117.678 -1.623 . . . . 0.0 113.117 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.84 158.42 35.53 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.893 2.346 . . . . 0.0 108.034 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.4 ttt -120.04 134.24 55.31 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 126.057 1.743 . . . . 0.0 110.986 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -111.66 165.41 12.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.554 1.168 . . . . 0.0 109.045 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 pt -118.92 138.67 48.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 163.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.402 ' CG1' ' H ' ' A' ' 3' ' ' ARG . 2.3 p -73.99 141.43 16.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 170.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.29 -21.07 1.61 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 112.596 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -150.28 160.54 43.63 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.211 1.004 . . . . 0.0 109.87 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -120.55 118.15 29.45 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 127.32 2.248 . . . . 0.0 105.451 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mt -109.82 -169.05 1.4 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.846 1.258 . . . . 0.0 107.876 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.29 14.13 3.51 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -164.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -130.83 34.23 4.12 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.787 1.635 . . . . 0.0 110.54 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.41 13.64 81.49 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.05 1.31 . . . . 0.0 113.709 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -112.65 156.27 23.02 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.119 1.368 . . . . 0.0 110.272 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.5 mtm -144.83 145.93 31.86 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.707 1.203 . . . . 0.0 108.399 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -78.73 141.62 37.72 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 164.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.49 -175.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 122.436 1.112 . . . . 0.0 111.15 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 m -135.51 125.22 25.39 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 160.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -77.05 102.74 6.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.9 -14.29 21.32 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -61.43 -19.15 61.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 117.181 -1.39 . . . . 0.0 112.679 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -164.42 11.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.799 1.181 . . . . 0.0 112.945 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.78 20.44 11.41 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.285 1.402 . . . . 0.0 112.509 -172.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.17 104.58 0.93 Allowed 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -93.81 156.25 16.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.87 -166.53 31.95 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.08 143.55 27.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.495 1.118 . . . . 0.0 109.861 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.38 151.1 31.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.12 1.368 . . . . 0.0 108.702 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.54 137.82 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -64.11 -18.79 64.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.317 1.047 . . . . 0.0 112.679 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.48 -18.27 63.61 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.551 1.14 . . . . 0.0 113.341 -166.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.6 mt -124.07 10.42 8.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.547 1.539 . . . . 0.0 111.652 -164.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.4 m -119.65 171.77 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.565 1.146 . . . . 0.0 110.864 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -130.39 152.47 49.75 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.941 2.496 . . . . 0.0 109.359 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -70.69 73.29 0.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.583 1.153 . . . . 0.0 109.901 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 C--N 1.329 -0.29 0 O-C-N 120.206 -1.558 . . . . 0.0 109.14 172.209 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.276 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -132.27 154.68 49.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.343 -0.848 . . . . 0.0 109.719 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.89 166.54 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.433 0.693 . . . . 0.0 109.147 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -138.01 136.26 36.72 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.857 -1.152 . . . . 0.0 110.402 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.45 120.53 16.23 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.266 1.027 . . . . 0.0 110.06 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.6 -4.02 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.137 172.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.28 2.1 pp -162.57 152.75 13.84 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.398 1.479 . . . . 0.0 108.519 -171.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.67 160.86 21.89 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.684 2.922 . . . . 0.0 112.336 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -143.22 163.01 34.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.371 1.868 . . . . 0.0 109.2 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.8 m -128.77 105.82 8.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.542 1.137 . . . . 0.0 108.439 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.42 157.02 38.42 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.991 0.517 . . . . 0.0 110.571 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.3 t -87.82 141.35 31.62 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -70.68 141.96 42.74 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 O-C-N 118.418 -1.412 . . . . 0.0 109.212 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.9 t70 75.45 33.93 0.64 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.652 1.981 . . . . 0.0 112.753 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.6 p -132.47 167.19 20.41 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.046 -1.034 . . . . 0.0 111.594 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.5 20.39 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 128.941 2.897 . . . . 0.0 111.814 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -110.04 169.3 8.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.27 1.428 . . . . 0.0 110.678 -160.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -140.15 150.55 21.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.243 1.417 . . . . 0.0 109.063 174.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 p -95.77 167.24 11.39 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -161.74 156.59 23.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.78 174.07 6.03 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.417 1.103 . . . . 0.0 108.905 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -57.98 123.54 16.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 168.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.02 1.54 57.13 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-O 118.359 -1.245 . . . . 0.0 114.486 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.39 162.66 22.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.38 1.59 . . . . 0.0 111.249 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.5 ttt -137.14 145.58 43.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.135 1.374 . . . . 0.0 108.822 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.09 175.38 9.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.432 1.093 . . . . 0.0 109.937 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 pt -126.13 138.69 53.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.558 1.543 . . . . 0.0 106.877 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.92 136.13 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 118.684 0.675 . . . . 0.0 109.763 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -139.19 -18.36 1.01 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -155.66 164.88 38.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.363 1.438 . . . . 0.0 108.912 159.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.89 114.07 11.45 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.323 1.849 . . . . 0.0 106.384 -167.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -114.08 154.03 28.43 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.063 0.945 . . . . 0.0 111.384 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -92.91 48.09 1.32 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.575 1.15 . . . . 0.0 110.927 -164.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -161.28 34.78 0.14 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.275 1.03 . . . . 0.0 110.443 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.83 -2.82 58.54 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.441 1.019 . . . . 0.0 114.223 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -87.54 153.6 21.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.516 1.158 . . . . 0.0 110.886 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.1 mtm -143.93 134.61 25.0 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -76.75 138.99 40.26 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.31 -176.35 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 122.332 1.063 . . . . 0.0 111.554 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -127.8 126.51 41.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 155.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.09 116.14 19.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.622 1.969 . . . . 0.0 108.853 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mt -87.28 13.86 8.93 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.542 -0.724 . . . . 0.0 112.391 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.9 ttp85 -79.97 -16.54 55.01 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.328 -1.483 . . . . 0.0 111.058 170.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -163.77 7.35 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.539 0.609 . . . . 0.0 112.233 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 63.23 23.83 14.04 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.055 1.742 . . . . 0.0 112.682 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.8 108.33 2.49 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.658 0.783 . . . . 0.0 109.361 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -87.87 149.38 24.14 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.655 -0.653 . . . . 0.0 110.147 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.71 -171.93 35.49 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.311 1.434 . . . . 0.0 109.965 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.1 mt -89.93 138.83 31.17 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.52 1.128 . . . . 0.0 112.303 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -134.23 162.87 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 127.194 2.197 . . . . 0.0 108.217 166.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 p -109.59 146.19 15.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 123.89 0.876 . . . . 0.0 109.163 -175.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -68.22 -17.33 64.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.278 1.431 . . . . 0.0 112.255 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.22 -29.23 69.7 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.917 0.887 . . . . 0.0 111.705 -177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.2 mt -115.97 5.22 13.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.58 1.152 . . . . 0.0 111.03 -161.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.36 165.84 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.87 1.268 . . . . 0.0 110.882 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -120.66 152.69 37.88 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 125.782 1.633 . . . . 0.0 108.681 172.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -78.7 69.93 4.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.652 1.181 . . . . 0.0 109.573 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 121.586 0.708 . . . . 0.0 109.429 173.199 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -134.19 166.91 21.68 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.01 154.97 37.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.416 1.087 . . . . 0.0 108.688 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -119.12 133.55 55.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . . . -84.7 154.63 22.35 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.505 1.048 . . . . 0.0 109.724 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.21 11.56 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.196 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.59 161.7 32.46 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.455 2.302 . . . . 0.0 107.859 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -86.46 162.27 9.6 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.927 3.085 . . . . 0.0 111.646 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -159.13 132.05 6.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.776 1.231 . . . . 0.0 110.604 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 t -97.07 137.79 35.6 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 172.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -89.16 139.08 30.84 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.342 -177.119 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.46 134.59 94.51 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 120.242 1.383 . . . . 0.0 108.267 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 60.3 Cg_endo -67.58 162.12 40.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.126 1.884 . . . . 0.0 109.773 168.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.48 -11.44 1.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.04 2.136 . . . . 0.0 113.129 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -118.6 169.0 10.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.564 1.146 . . . . 0.0 111.057 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -92.15 21.31 5.19 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.71 1.604 . . . . 0.0 111.358 -167.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -68.35 163.83 22.21 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.492 -1.38 . . . . 0.0 109.749 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 pt -130.74 138.67 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 120.869 -1.144 . . . . 0.0 111.01 169.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.5 m -73.56 156.09 38.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -147.29 165.21 30.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 122.303 1.049 . . . . 0.0 110.635 164.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.19 166.11 11.35 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -64.88 125.97 26.5 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.0 47.93 1.21 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.007 1.289 . . . . 0.0 113.26 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.7 167.14 23.84 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.206 1.802 . . . . 0.0 108.998 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.3 mtp -138.03 149.75 46.33 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.103 0.961 . . . . 0.0 111.032 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -136.33 159.94 40.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.826 1.25 . . . . 0.0 109.701 -173.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.9 pt -110.52 138.4 38.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.27 129.12 33.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -121.17 -32.07 3.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.107 174.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -152.15 162.44 41.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.066 0.848 . . . . 0.0 111.043 167.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -108.54 132.97 53.31 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.632 1.973 . . . . 0.0 106.813 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.3 mt -125.82 -168.53 1.86 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.106 1.762 . . . . 0.0 107.364 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.68 14.04 3.42 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.583 1.083 . . . . 0.0 113.831 -158.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -120.25 16.13 12.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.363 1.465 . . . . 0.0 111.55 -168.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.84 13.59 69.22 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.669 -1.27 . . . . 0.0 111.862 -168.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -125.86 150.27 48.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.685 1.594 . . . . 0.0 109.706 -169.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 56.8 mtm -142.96 144.39 32.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.827 1.251 . . . . 0.0 108.91 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -81.62 135.6 35.55 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.999 0.52 . . . . 0.0 110.302 170.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.39 175.24 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.416 1.086 . . . . 0.0 110.268 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.3 m -112.38 134.86 53.68 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 154.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -76.54 165.08 25.3 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -88.62 -35.11 17.03 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 121.927 2.149 . . . . 0.0 113.213 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -51.89 -29.22 18.98 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -165.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.251 9.5 t -152.96 18.26 0.58 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.224 1.81 . . . . 0.0 112.593 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 52.36 26.89 4.39 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.222 1.809 . . . . 0.0 112.5 -172.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -66.1 148.3 52.02 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.643 -1.286 . . . . 0.0 111.234 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -137.87 144.88 41.59 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.061 0.945 . . . . 0.0 108.457 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.56 -157.51 27.32 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.7 147.01 27.75 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.895 0.878 . . . . 0.0 112.437 -165.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.1 pt -136.01 147.97 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 126.674 1.99 . . . . 0.0 110.909 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.92 138.01 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.025 1.33 . . . . 0.0 109.732 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.75 -0.78 22.13 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.661 1.184 . . . . 0.0 112.849 -172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -24.12 65.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.793 1.637 . . . . 0.0 112.86 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.4 mt -127.94 13.86 6.83 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.36 1.064 . . . . 0.0 112.665 -158.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.4 m -122.66 170.79 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 126.318 1.847 . . . . 0.0 111.489 -176.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -132.23 155.68 47.83 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 127.772 2.429 . . . . 0.0 109.748 172.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -69.8 78.41 0.45 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.72 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.24 0.599 0 O-C-N 120.911 -1.118 . . . . 0.0 108.81 162.93 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . 0.257 0.0 OUTLIER . . . . . 0 C--O 1.234 0.247 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -117.42 173.71 6.55 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 119.553 -1.967 . . . . 0.0 109.876 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.1 160.18 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 120.512 -1.367 . . . . 0.0 110.531 171.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.72 118.51 28.24 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 125.784 1.633 . . . . 0.0 108.974 -170.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.02 127.11 31.96 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.467 0.707 . . . . 0.0 109.433 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.96 -0.16 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.371 0.669 . . . . 0.0 111.762 172.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.4 161.39 29.42 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 125.817 1.647 . . . . 0.0 109.011 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -87.23 160.47 8.43 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 124.243 3.296 . . . . 0.0 111.25 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -151.74 166.2 32.07 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.633 1.173 . . . . 0.0 110.361 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 t -125.74 136.08 52.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -172.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -70.01 150.54 46.54 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 118.806 -1.157 . . . . 0.0 108.776 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.2 t -75.27 137.53 71.83 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.28 146.38 69.18 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 N-CA-C 108.446 -1.405 . . . . 0.0 108.446 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 t70 75.62 4.94 4.01 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.76 2.024 . . . . 0.0 113.408 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.6 p -108.91 -177.17 3.24 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 120.339 -1.475 . . . . 0.0 112.187 -175.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -83.93 -17.47 40.59 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.102 1.361 . . . . 0.0 109.843 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 165.18 18.5 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.369 1.468 . . . . 0.0 111.954 -164.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 pt -127.43 134.15 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.806 1.242 . . . . 0.0 109.68 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.33 160.76 12.63 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.735 0.814 . . . . 0.0 108.948 173.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -157.43 173.33 17.07 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.935 0.874 . . . . 0.0 113.117 170.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.4 mt -127.96 160.98 30.21 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.111 1.364 . . . . 0.0 109.097 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -62.1 141.47 58.11 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.92 -4.78 81.82 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.681 1.134 . . . . 0.0 114.055 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.3 168.51 19.02 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.007 1.404 . . . . 0.0 109.017 171.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 38.1 mtp -135.51 150.66 49.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.89 0.876 . . . . 0.0 109.525 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -136.06 159.06 42.86 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.91 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 pt -112.16 125.19 69.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 p -63.71 112.45 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.21 -38.32 5.79 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.745 0.818 . . . . 0.0 110.047 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -148.08 172.34 14.42 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -133.07 133.52 43.1 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -175.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.1 mt -120.33 -168.82 1.69 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.615 1.166 . . . . 0.0 109.056 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -136.31 57.78 1.76 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.452 1.101 . . . . 0.0 109.094 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -154.06 22.43 0.5 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.214 171.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.98 23.23 69.61 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.145 -1.597 . . . . 0.0 112.296 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -130.34 148.47 52.16 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.759 2.024 . . . . 0.0 108.534 -170.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.0 mtm -144.77 132.63 21.26 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -72.13 134.62 45.85 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.88 178.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 123.349 0.659 . . . . 0.0 111.793 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 5.2 m -115.03 143.59 44.94 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 154.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -86.47 119.6 26.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.384 1.073 . . . . 0.0 110.105 168.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.98 1.31 2.77 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.478 1.111 . . . . 0.0 113.465 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -66.3 -46.45 76.92 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.219 -1.551 . . . . 0.0 110.423 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -146.13 -3.43 0.66 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.254 1.022 . . . . 0.0 112.551 -157.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.4 t70 68.21 11.54 8.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.172 1.789 . . . . 0.0 112.907 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -61.14 118.34 6.69 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.111 0.964 . . . . 0.0 108.744 167.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 9.5 mp0 -81.84 168.67 17.73 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.385 0.612 . . . . 0.0 110.694 166.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.82 -165.45 30.16 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 mt -99.4 143.83 29.2 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.701 0.8 . . . . 0.0 110.825 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.19 151.34 33.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 125.446 1.498 . . . . 0.0 109.035 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 p -88.58 135.84 24.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.952 1.701 . . . . 0.0 107.934 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.34 -10.29 59.43 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -56.65 -18.4 12.07 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.718 2.407 . . . . 0.0 113.717 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -131.11 13.48 5.17 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.024 1.33 . . . . 0.0 113.296 -164.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.75 153.91 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.237 1.015 . . . . 0.0 112.395 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -117.69 148.29 42.13 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.848 1.659 . . . . 0.0 111.076 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.97 100.86 2.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 128.97 2.908 . . . . 0.0 110.139 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 121.873 0.844 . . . . 0.0 111.543 -174.751 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.484 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -119.8 159.51 24.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.631 1.572 . . . . 0.0 108.469 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -137.9 164.83 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 167.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.2 tpp85 -128.08 129.91 47.38 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.458 1.503 . . . . 0.0 107.349 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.28 125.06 25.96 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 120.463 1.483 . . . . 0.0 108.944 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.28 0.2 OUTLIER -113.36 4.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.423 170.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.8 mt -146.28 157.66 48.9 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.833 1.653 . . . . 0.0 109.176 165.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.31 166.77 15.99 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.82 3.68 . . . . 0.0 111.584 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -153.0 163.58 39.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.605 1.162 . . . . 0.0 109.218 173.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -124.31 120.66 32.83 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.528 1.531 . . . . 0.0 109.049 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -61.33 149.14 39.06 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 124.536 1.147 . . . . 0.0 111.22 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.3 135.45 86.73 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -62.55 153.44 71.49 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.1 2.533 . . . . 0.0 110.221 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.36 38.91 22.78 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.078 1.351 . . . . 0.0 111.842 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 p -138.45 166.03 25.31 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.031 0.932 . . . . 0.0 111.84 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.13 -13.55 48.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.867 2.867 . . . . 0.0 113.055 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -63.49 170.11 3.36 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.181 1.793 . . . . 0.0 113.171 -171.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 pt -131.05 136.71 57.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.743 1.217 . . . . 0.0 110.288 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -72.99 149.71 43.06 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.271 1.428 . . . . 0.0 110.9 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -155.11 158.66 39.36 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.689 -1.257 . . . . 0.0 112.806 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.66 170.32 8.0 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.904 0.859 . . . . 0.0 109.458 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -56.98 134.97 56.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 168.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.42 -11.13 56.69 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 118.872 -0.96 . . . . 0.0 114.148 171.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.26 167.74 19.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.673 1.236 . . . . 0.0 108.897 160.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 18.7 ptm -144.67 168.15 20.85 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 124.083 0.953 . . . . 0.0 109.317 170.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -138.42 163.75 31.11 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.608 1.163 . . . . 0.0 109.614 -164.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.5 pt -127.4 130.94 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 125.283 1.433 . . . . 0.0 107.393 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.94 127.8 29.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -127.55 -15.18 5.09 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.715 0.806 . . . . 0.0 113.106 172.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -150.18 166.42 29.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 156.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -121.53 124.68 44.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.51 -167.49 1.26 Allowed 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -138.48 68.58 1.39 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.398 1.479 . . . . 0.0 107.594 -170.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -168.16 15.8 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.395 1.478 . . . . 0.0 112.312 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.96 37.89 88.28 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.13 1.347 . . . . 0.0 111.848 -169.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -137.72 149.17 46.27 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.588 1.955 . . . . 0.0 107.259 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.2 mtm -134.98 142.99 46.6 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.601 1.161 . . . . 0.0 108.689 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -78.1 135.66 37.74 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 165.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.57 -173.34 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 122.361 1.077 . . . . 0.0 110.804 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 m -131.09 147.31 52.6 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 157.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -97.55 132.01 43.62 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 mt -68.01 -10.1 50.99 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.47 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -65.48 -43.13 91.18 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.37 1.441 . . . . 0.0 112.11 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 p -143.7 9.56 1.56 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.405 1.082 . . . . 0.0 111.738 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 t70 58.31 32.67 22.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.002 0.921 . . . . 0.0 111.429 -167.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -72.29 140.8 48.76 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.913 -1.117 . . . . 0.0 109.417 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -126.45 151.86 47.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 146.62 -155.92 26.76 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.6 mt -108.81 141.88 40.18 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.335 1.054 . . . . 0.0 110.54 -164.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.8 150.75 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.791 1.637 . . . . 0.0 109.292 171.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.33 146.59 5.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 125.901 1.68 . . . . 0.0 109.47 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -87.72 10.71 17.36 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.84 -24.45 60.89 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.564 1.146 . . . . 0.0 113.822 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -125.46 16.28 8.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -156.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.93 170.52 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.013 0.925 . . . . 0.0 112.353 -168.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.86 151.94 41.23 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.133 -0.979 . . . . 0.0 109.827 160.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.94 57.58 2.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 128.691 2.797 . . . . 0.0 111.3 -172.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.537 0.465 0 O-C-N 120.525 -1.359 . . . . 0.0 111.769 -176.477 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.28 150.23 51.91 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.464 1.506 . . . . 0.0 108.34 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.74 164.25 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 120.071 1.305 . . . . 0.0 108.82 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -112.17 141.53 45.74 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.52 139.49 30.52 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 119.612 1.097 . . . . 0.0 111.016 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.68 12.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.159 0.984 . . . . 0.0 112.507 -172.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.8 158.61 33.96 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.198 1.399 . . . . 0.0 108.548 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -88.54 163.36 6.56 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.541 3.494 . . . . 0.0 111.635 171.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -158.67 141.29 14.33 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.836 1.254 . . . . 0.0 110.207 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.9 m -103.74 118.12 35.97 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.923 1.289 . . . . 0.0 109.959 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -78.63 160.42 27.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.868 0.867 . . . . 0.0 111.937 175.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.4 t -89.39 130.46 43.66 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 125.698 1.599 . . . . 0.0 108.235 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 8.3 Cg_endo -64.84 159.2 46.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.716 1.611 . . . . 0.0 112.854 173.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.251 2.9 t70 69.61 27.71 4.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.675 1.99 . . . . 0.0 112.306 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.0 p -131.4 -178.78 5.0 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.461 1.105 . . . . 0.0 110.921 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.74 8.65 36.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.313 2.645 . . . . 0.0 109.465 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -84.45 175.59 9.23 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.605 -1.309 . . . . 0.0 109.174 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.9 pt -148.64 144.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.2 2.2 . . . . 0.0 107.676 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.5 p -102.23 169.15 8.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 121.892 2.133 . . . . 0.0 111.205 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -170.18 -171.23 1.09 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.12 0.486 . . . . 0.0 112.234 -174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 mt -128.44 153.22 47.34 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.888 1.675 . . . . 0.0 109.471 -175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -52.31 127.31 21.74 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.522 -0.736 . . . . 0.0 109.079 168.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.72 -10.49 32.48 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 124.725 1.155 . . . . 0.0 114.211 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.38 158.49 35.69 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.363 1.581 . . . . 0.0 110.197 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.5 ttt -114.49 148.94 37.1 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.471 1.108 . . . . 0.0 108.286 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -125.85 162.66 24.64 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.289 1.036 . . . . 0.0 109.992 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.37 127.49 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.357 1.463 . . . . 0.0 108.99 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 68.5 t -68.78 101.22 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 119.362 0.983 . . . . 0.0 109.354 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -95.3 -34.49 12.16 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.199 -0.938 . . . . 0.0 111.108 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -149.3 175.05 11.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.618 1.167 . . . . 0.0 109.021 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -138.93 127.32 22.91 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.851 2.46 . . . . 0.0 104.96 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.1 -163.01 0.85 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.293 1.437 . . . . 0.0 109.508 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -134.46 44.11 2.71 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.296 -1.502 . . . . 0.0 113.282 -168.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.91 1.48 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.888 1.275 . . . . 0.0 112.074 -157.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.55 5.0 90.26 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.1 1.333 . . . . 0.0 113.263 -167.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -112.26 149.55 32.17 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.962 2.105 . . . . 0.0 110.861 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.7 mtm -149.12 143.65 26.13 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.764 -1.21 . . . . 0.0 110.084 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -86.7 136.66 32.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.099 0.409 . . . . 0.0 111.016 174.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 m -147.7 -167.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.835 0.854 . . . . 0.0 111.413 -172.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.3 m -140.05 150.99 45.04 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 159.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.71 107.3 18.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.143 2.177 . . . . 0.0 108.075 -173.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.1 mt -68.7 1.18 3.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.35 -27.13 63.15 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.311 -1.493 . . . . 0.0 113.165 169.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -167.39 13.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -165.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 t0 60.75 32.8 20.24 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 123.509 1.623 . . . . 0.0 111.52 -174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -74.88 99.56 3.83 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 120.797 -1.189 . . . . 0.0 108.366 172.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -81.99 139.53 34.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.57 1.548 . . . . 0.0 109.551 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.99 -169.17 40.13 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.417 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.9 mt -89.95 139.62 30.42 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.916 2.086 . . . . 0.0 112.997 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.31 158.52 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.147 1.779 . . . . 0.0 111.177 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.96 152.86 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 C-N-CA 124.126 0.97 . . . . 0.0 111.646 164.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.53 -22.89 67.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.285 164.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.57 -17.01 59.16 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 122.937 1.351 . . . . 0.0 112.48 -164.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.9 mt -124.83 6.04 8.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.567 1.547 . . . . 0.0 110.885 -160.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -124.94 159.14 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.77 1.228 . . . . 0.0 109.476 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -117.83 153.59 33.24 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.976 1.311 . . . . 0.0 108.28 173.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.307 0.0 OUTLIER -80.51 118.39 22.07 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.694 1.235 . . . . 0.0 108.723 171.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 126.816 2.047 . . . . 0.0 106.344 171.605 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -141.77 141.17 33.2 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.366 1.867 . . . . 0.0 107.733 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -125.73 160.27 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.146 0.978 . . . . 0.0 108.487 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -115.57 129.68 56.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.62 131.44 41.68 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.004 0.82 . . . . 0.0 108.794 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.86 4.29 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.291 0.636 . . . . 0.0 111.43 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 mt -146.72 154.29 47.7 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.058 1.743 . . . . 0.0 107.893 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.86 169.02 20.1 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.693 3.595 . . . . 0.0 111.792 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -154.23 166.36 33.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.586 0.708 . . . . 0.0 112.884 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.4 m -116.6 102.02 9.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.516 2.326 . . . . 0.0 109.916 -170.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HE3' ' HA ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -57.26 143.46 39.34 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 177.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.02 135.49 82.67 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 166.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.72 151.27 79.14 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.704 2.269 . . . . 0.0 109.849 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.0 t70 61.25 30.27 19.11 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.81 0.844 . . . . 0.0 111.573 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -128.35 170.92 12.53 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.92 4.05 18.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.373 0.669 . . . . 0.0 109.359 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 40.2 mt-10 -67.04 161.95 23.25 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.733 1.213 . . . . 0.0 110.432 173.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.5 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 18.9 pt -141.96 148.26 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.182 1.393 . . . . 0.0 107.852 172.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.13 145.15 51.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.29 164.86 29.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.447 0.642 . . . . 0.0 110.859 170.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.46 163.33 15.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.063 0.945 . . . . 0.0 109.702 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -57.97 133.97 55.97 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 163.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.69 -2.1 76.37 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 117.113 -1.937 . . . . 0.0 112.718 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -71.36 167.8 18.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.784 2.292 . . . . 0.0 109.529 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 19.7 ttt -140.6 147.69 39.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.499 1.52 . . . . 0.0 107.516 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -130.85 170.06 14.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.047 0.842 . . . . 0.0 109.958 -175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.4 pt -131.52 133.69 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.319 1.448 . . . . 0.0 107.635 170.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -69.05 116.88 10.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.4 -20.37 11.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.563 0.745 . . . . 0.0 110.786 176.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -152.03 -176.55 5.7 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.408 1.004 . . . . 0.0 110.229 160.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -125.04 130.35 52.11 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.334 1.853 . . . . 0.0 108.271 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -107.18 -163.45 0.91 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 166.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -134.4 14.56 3.78 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.357 0.98 . . . . 0.0 112.236 -170.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -120.13 11.24 11.6 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.033 1.733 . . . . 0.0 111.278 -159.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.68 20.72 65.39 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 127.083 2.278 . . . . 0.0 112.124 -167.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -127.01 150.9 49.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.371 1.086 . . . . 0.0 110.636 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.5 mtm -136.14 135.51 39.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.494 ' CE3' ' CD2' ' A' ' 51' ' ' LEU . 11.9 t-105 -73.46 128.27 35.01 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.29 1.436 . . . . 0.0 108.462 162.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.55 -173.89 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 123.824 0.85 . . . . 0.0 110.928 -174.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.5 m -124.48 132.98 53.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 157.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -86.07 112.17 21.01 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.59 1.156 . . . . 0.0 108.657 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.7 mt -67.33 -9.41 40.86 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.955 -1.022 . . . . 0.0 113.187 -172.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -30.43 70.97 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 120.921 1.692 . . . . 0.0 113.412 173.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.0 p -147.96 -8.86 0.4 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.526 1.141 . . . . 0.0 113.795 -165.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 t0 73.7 10.5 4.77 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.134 1.374 . . . . 0.0 112.349 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -61.55 126.12 26.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.843 1.657 . . . . 0.0 108.216 167.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -93.13 170.23 9.81 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 109.963 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.93 -158.02 21.79 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 118.139 0.427 . . . . 0.0 112.893 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.494 ' CD2' ' CE3' ' A' ' 40' ' ' TRP . 1.8 mm? -98.54 135.24 40.37 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.544 1.138 . . . . 0.0 111.587 -160.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -140.17 146.33 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.945 1.698 . . . . 0.0 108.941 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -85.86 138.83 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 124.366 1.067 . . . . 0.0 108.951 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.88 3.8 9.37 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.77 -20.01 60.61 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.546 -1.346 . . . . 0.0 114.401 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -126.76 21.02 7.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.194 0.997 . . . . 0.0 112.374 -160.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 m -130.76 173.82 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.269 1.428 . . . . 0.0 109.884 -170.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.15 154.47 50.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.672 1.989 . . . . 0.0 109.289 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.04 37.17 0.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.756 2.022 . . . . 0.0 114.471 -170.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.451 -0.396 0 C-N-CA 126.05 1.74 . . . . 0.0 113.83 -165.833 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.155 0.502 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.9 mpp_? -136.92 115.78 12.24 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.204 1.402 . . . . 0.0 109.507 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.32 170.3 3.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.947 0.88 . . . . 0.0 109.604 171.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -134.59 135.32 42.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.798 1.639 . . . . 0.0 107.766 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.91 137.62 37.73 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.825 1.193 . . . . 0.0 109.039 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.275 0.2 OUTLIER -114.92 8.31 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 178.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.39 165.48 17.43 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 126.508 1.923 . . . . 0.0 108.168 169.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -82.36 168.53 14.75 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.24 2.626 . . . . 0.0 110.065 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -147.43 -178.03 6.01 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.921 0.888 . . . . 0.0 110.099 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.9 m -134.49 105.33 6.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.449 2.3 . . . . 0.0 108.083 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -61.93 145.8 51.84 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.286 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -59.87 140.45 90.01 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 167.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -72.85 138.79 29.33 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.464 2.776 . . . . 0.0 111.093 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 73.34 43.83 0.35 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.184 2.193 . . . . 0.0 111.907 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 HG22 ' CG1' ' A' ' 14' ' ' VAL . 28.4 p -143.32 169.55 17.44 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 121.184 -0.947 . . . . 0.0 111.731 -168.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -85.91 -0.66 55.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.914 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -65.66 168.27 7.88 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.545 1.138 . . . . 0.0 111.163 172.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.53 122.76 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.464 1.906 . . . . 0.0 110.146 -176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.51 124.3 19.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.842 0.857 . . . . 0.0 109.998 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -136.4 164.86 27.15 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.1 0.96 . . . . 0.0 111.226 -175.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.12 167.06 11.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.271 1.028 . . . . 0.0 111.218 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -55.4 140.72 38.96 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 158.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.88 5.86 83.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-O 117.701 -1.61 . . . . 0.0 112.751 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -82.85 169.92 15.56 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.94 1.87 . . . . 0.0 110.53 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -143.28 151.44 40.54 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.708 1.203 . . . . 0.0 110.5 -174.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -138.7 173.53 11.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 124.348 1.03 . . . . 0.0 111.432 -168.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.2 pt -135.59 135.18 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 126.093 1.757 . . . . 0.0 107.697 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.21 117.36 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.74 -21.08 10.37 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.345 -0.847 . . . . 0.0 112.736 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -152.86 -177.29 6.18 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -135.88 124.13 23.19 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.743 1.617 . . . . 0.0 107.36 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mt -103.64 -168.9 1.56 Allowed 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.385 1.074 . . . . 0.0 108.648 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -136.65 51.7 1.98 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.536 1.534 . . . . 0.0 109.059 -169.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -159.64 22.65 0.18 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.652 1.181 . . . . 0.0 108.923 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.46 -2.33 7.74 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 119.542 -1.974 . . . . 0.0 114.052 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -86.85 149.97 24.45 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.176 0.991 . . . . 0.0 110.487 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.5 mtm -136.07 136.0 39.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.526 1.13 . . . . 0.0 109.001 172.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.496 ' CE3' ' CD2' ' A' ' 51' ' ' LEU . 14.1 t-105 -80.4 129.83 34.76 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.996 1.719 . . . . 0.0 108.678 167.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.5 m -142.44 -176.55 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.381 1.072 . . . . 0.0 110.984 -173.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.3 m -118.17 136.22 53.76 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 154.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -88.38 114.61 25.17 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.19 1.796 . . . . 0.0 108.073 166.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.81 -3.28 14.93 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -61.72 -31.58 71.75 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.674 1.579 . . . . 0.0 112.792 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -159.85 12.82 0.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.748 0.704 . . . . 0.0 111.259 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 t0 74.03 19.58 2.98 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.725 1.21 . . . . 0.0 112.519 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -61.43 137.26 58.24 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.792 1.637 . . . . 0.0 107.981 168.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -118.87 158.36 25.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.103 0.961 . . . . 0.0 109.408 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.0 -153.48 21.47 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 124.003 0.815 . . . . 0.0 111.491 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.496 ' CD2' ' CE3' ' A' ' 40' ' ' TRP . 2.6 mm? -94.85 141.71 28.31 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.629 0.772 . . . . 0.0 110.978 -160.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.87 156.96 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 127.161 2.184 . . . . 0.0 107.379 170.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.83 145.45 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.782 0.833 . . . . 0.0 109.397 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -68.07 -18.74 64.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 112.935 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.43 -15.57 63.43 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -168.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.5 mt -124.48 7.2 8.3 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.184 1.394 . . . . 0.0 113.415 -160.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.89 172.06 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 119.183 0.901 . . . . 0.0 110.742 -175.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.59 145.12 44.53 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.26 1.824 . . . . 0.0 108.231 167.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.16 113.84 3.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.32 161.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.444 -0.749 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 165.325 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.382 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -146.15 152.14 38.79 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.265 1.026 . . . . 0.0 108.474 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.13 166.23 10.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 121.908 0.861 . . . . 0.0 111.538 165.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -129.59 136.37 49.7 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 127.315 2.246 . . . . 0.0 106.343 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.41 139.89 37.58 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.58 -2.25 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.487 173.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mt -148.43 155.59 42.39 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.312 2.245 . . . . 0.0 108.055 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.14 168.22 15.35 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 124.153 3.235 . . . . 0.0 112.896 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -160.59 150.76 17.94 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.681 1.192 . . . . 0.0 111.425 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 t -116.3 131.81 56.84 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' H ' ' HB3' ' A' ' 21' ' ' SER . 0.7 OUTLIER -92.84 168.65 11.03 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.117 1.367 . . . . 0.0 111.155 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.27 119.09 57.44 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -58.24 167.28 4.83 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.979 1.786 . . . . 0.0 110.788 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.5 -9.06 1.47 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.247 2.219 . . . . 0.0 113.246 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.7 p -108.4 175.6 5.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.486 1.115 . . . . 0.0 111.706 -174.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -81.62 5.93 16.64 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.313 1.045 . . . . 0.0 112.406 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -77.34 175.74 9.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.931 1.692 . . . . 0.0 111.081 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.3 pt -150.98 156.22 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.828 2.051 . . . . 0.0 109.506 174.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.427 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 19.9 p -116.76 152.57 34.07 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.956 1.303 . . . . 0.0 110.261 -171.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.38 170.84 21.37 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 111.401 -165.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.35 163.68 23.47 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.408 0.683 . . . . 0.0 109.238 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -58.44 144.58 41.6 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.02 -8.23 64.02 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.586 -0.563 . . . . 0.0 113.746 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -69.06 170.56 9.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.806 1.289 . . . . 0.0 110.207 168.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.7 mmm -132.44 163.05 29.63 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.116 1.367 . . . . 0.0 108.995 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -137.23 -176.29 4.34 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 112.814 -1.994 . . . . 0.0 108.821 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.9 pt -143.8 150.27 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 125.772 1.629 . . . . 0.0 107.231 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.7 t -76.14 131.51 34.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -120.6 -44.34 2.45 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.512 1.125 . . . . 0.0 109.595 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -143.88 166.82 23.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.775 0.798 . . . . 0.0 110.434 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -141.02 120.77 13.43 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 126.946 2.098 . . . . 0.0 105.811 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mt -108.39 -164.94 0.99 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.377 1.471 . . . . 0.0 108.508 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -134.57 66.78 1.53 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.262 1.425 . . . . 0.0 108.547 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.25 6.37 0.12 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.26 1.024 . . . . 0.0 112.739 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.45 15.55 71.04 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.961 1.743 . . . . 0.0 112.918 -165.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -122.44 145.76 48.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.463 1.905 . . . . 0.0 109.829 -171.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -144.7 144.99 31.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 109.686 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -91.61 136.87 32.81 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.909 0.884 . . . . 0.0 112.105 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.36 -175.49 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.84 1.256 . . . . 0.0 111.042 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.0 m -123.2 132.72 54.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 158.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.66 108.14 17.23 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.435 1.894 . . . . 0.0 108.646 174.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mt -76.06 16.91 0.38 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -66.68 -35.13 79.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.388 163.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 t -169.46 16.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 117.472 -1.251 . . . . 0.0 113.052 -169.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 75.47 18.29 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.12 1.368 . . . . 0.0 113.303 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.19 134.23 54.4 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.596 -0.69 . . . . 0.0 109.336 170.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -124.92 142.85 51.19 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.18 0.992 . . . . 0.0 108.758 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.06 -160.91 28.58 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.37 147.06 23.91 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.507 1.123 . . . . 0.0 112.406 -165.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.2 pt -133.52 157.0 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.876 1.671 . . . . 0.0 109.995 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.22 147.77 7.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 126.119 1.768 . . . . 0.0 107.786 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -75.62 2.03 12.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -80.75 -18.33 48.05 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.427 1.491 . . . . 0.0 113.123 -172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -123.29 14.79 9.7 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.185 -1.572 . . . . 0.0 112.415 -168.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.09 161.67 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.979 1.711 . . . . 0.0 109.159 -167.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -120.51 148.53 43.72 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.684 1.194 . . . . 0.0 109.02 170.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -70.1 125.53 27.04 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 166.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 125.079 1.352 . . . . 0.0 107.635 171.578 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . 0.293 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.9 mtt85 -111.54 175.79 5.28 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 120.9 -1.125 . . . . 0.0 111.24 172.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.74 162.48 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.119 -0.988 . . . . 0.0 109.168 165.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.426 HH21 HG11 ' A' ' 60' ' ' VAL . 6.7 ttp85 -138.33 143.6 39.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.644 0.777 . . . . 0.0 109.574 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.06 132.33 35.95 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.131 0.972 . . . . 0.0 110.109 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.64 -4.6 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.219 1.008 . . . . 0.0 111.963 171.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.47 153.4 51.58 Favored Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 126.443 1.897 . . . . 0.0 108.253 175.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -76.3 157.87 37.24 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.709 2.939 . . . . 0.0 111.743 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -140.0 165.3 27.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.36 1.064 . . . . 0.0 110.564 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.9 m -136.76 112.37 9.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.536 1.534 . . . . 0.0 107.269 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 15' ' ' PRO . 6.6 pttm -70.61 152.06 44.32 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 169.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.3 t -75.75 146.6 80.11 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 156.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 98.2 Cg_endo -81.6 170.76 14.06 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.577 2.851 . . . . 0.0 111.252 172.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 75.4 16.78 2.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.781 2.432 . . . . 0.0 111.548 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.6 p -132.03 168.08 18.57 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.215 1.806 . . . . 0.0 109.855 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -80.41 3.83 20.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.251 1.421 . . . . 0.0 111.587 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.98 172.85 12.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.993 1.717 . . . . 0.0 110.201 -175.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.8 130.83 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.447 1.499 . . . . 0.0 110.588 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.1 150.23 37.29 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.795 1.238 . . . . 0.0 110.066 176.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -154.48 164.05 39.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.369 0.531 . . . . 0.0 111.528 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.44 162.87 14.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.378 1.071 . . . . 0.0 110.922 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.78 132.15 53.08 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 164.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.51 -5.2 54.61 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-O 119.049 -0.862 . . . . 0.0 113.682 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -102.37 154.53 18.98 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.276 1.03 . . . . 0.0 108.435 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.8 ttt -124.25 158.46 32.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.018 0.927 . . . . 0.0 111.179 -164.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.72 177.38 8.94 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.557 1.543 . . . . 0.0 110.599 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.2 pt -131.59 127.65 59.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.631 1.572 . . . . 0.0 109.386 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -75.06 94.41 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.38 0.536 . . . . 0.0 110.083 -177.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -82.74 -56.56 3.77 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -135.79 165.33 25.85 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.355 0.598 . . . . 0.0 110.111 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -129.95 128.46 42.16 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 125.808 1.643 . . . . 0.0 106.743 -172.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 mt -113.21 -170.77 1.75 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -134.65 48.99 2.26 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.123 0.969 . . . . 0.0 108.897 -166.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -156.6 19.11 0.33 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.924 1.29 . . . . 0.0 112.004 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.13 19.61 79.77 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 120.802 -1.186 . . . . 0.0 112.239 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -120.29 153.33 36.54 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.177 1.391 . . . . 0.0 109.206 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.5 mtm -147.46 131.04 16.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -76.12 128.93 35.98 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.42 -165.71 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.504 1.122 . . . . 0.0 110.514 -175.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.1 m -137.02 127.67 27.01 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 162.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -78.47 99.02 6.27 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.526 1.53 . . . . 0.0 108.441 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.08 -2.44 0.43 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.308 1.443 . . . . 0.0 113.909 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -55.91 -48.37 75.8 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 120.554 -1.341 . . . . 0.0 110.136 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -152.53 14.56 0.58 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.4 0.545 . . . . 0.0 111.78 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 t70 74.76 19.68 2.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.922 2.089 . . . . 0.0 111.963 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.6 108.44 0.83 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.035 0.934 . . . . 0.0 108.897 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -73.51 155.88 38.74 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.74 -165.18 28.06 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-O 121.522 0.512 . . . . 0.0 112.508 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 mt -104.72 142.05 35.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.993 1.317 . . . . 0.0 112.503 -168.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.0 153.41 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.709 1.604 . . . . 0.0 109.713 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -86.23 135.84 24.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.736 1.214 . . . . 0.0 108.26 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -77.18 -3.91 41.98 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -172.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.32 -30.25 68.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.707 2.003 . . . . 0.0 113.295 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.36 12.33 13.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.941 1.296 . . . . 0.0 112.911 -160.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 m -130.41 154.24 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.301 1.04 . . . . 0.0 111.001 -171.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -121.13 147.4 45.63 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.748 1.619 . . . . 0.0 110.31 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.81 94.1 1.02 Allowed 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 127.955 2.502 . . . . 0.0 110.828 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG11 HH21 ' A' ' 6' ' ' ARG . 41.7 t . . . . . 0 N--CA 1.448 -0.564 0 O-C-N 121.5 -0.75 . . . . 0.0 109.591 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 121.995 0.902 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.5 mtm-85 -74.2 147.01 42.92 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 119.908 -1.745 . . . . 0.0 109.553 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.8 m -134.0 156.52 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.7 ttm-85 -120.83 125.27 47.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 126.59 1.956 . . . . 0.0 105.75 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.44 151.17 38.11 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 118.386 -1.326 . . . . 0.0 108.567 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.6 3.08 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.951 1.3 . . . . 0.0 111.337 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 mt -142.2 159.05 59.97 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 126.127 1.771 . . . . 0.0 107.608 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.05 170.39 11.02 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.688 2.925 . . . . 0.0 110.983 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -150.77 160.64 43.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.473 1.109 . . . . 0.0 110.474 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -132.19 109.79 10.19 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 172.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.496 ' H ' ' HB3' ' A' ' 21' ' ' SER . 7.7 pttm -65.57 165.54 12.11 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.667 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.8 147.54 58.9 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 150.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 72.0 Cg_endo -73.79 176.87 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.475 2.784 . . . . 0.0 110.911 158.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 66.91 17.48 10.53 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.043 1.737 . . . . 0.0 112.692 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -135.54 171.73 14.03 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.408 1.883 . . . . 0.0 109.345 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.96 -3.5 29.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.991 1.317 . . . . 0.0 111.561 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.39 162.48 12.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.178 1.391 . . . . 0.0 112.025 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.6 pt -136.88 142.43 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.957 2.103 . . . . 0.0 108.179 165.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.496 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -87.39 171.34 10.65 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.422 -1.424 . . . . 0.0 110.693 170.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -162.23 167.43 24.02 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.888 1.675 . . . . 0.0 108.026 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mt -118.86 161.75 19.64 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.577 1.551 . . . . 0.0 107.052 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.73 126.1 26.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.938 1.245 . . . . 0.0 110.152 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.0 52.1 1.04 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 124.681 1.134 . . . . 0.0 111.146 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -138.45 161.59 36.62 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.978 1.711 . . . . 0.0 108.007 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.5 mtp -138.83 140.1 38.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.245 1.018 . . . . 0.0 110.432 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.9 169.1 9.33 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.088 1.755 . . . . 0.0 109.938 -174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.0 pt -122.02 126.35 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 172.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.24 130.36 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -118.92 -44.76 2.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.582 1.153 . . . . 0.0 110.02 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -140.01 170.15 16.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -132.05 138.65 48.26 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 124.939 1.296 . . . . 0.0 107.604 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 mt -123.31 178.47 5.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.985 1.714 . . . . 0.0 109.68 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -120.89 14.55 11.6 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.917 1.341 . . . . 0.0 112.884 -162.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -129.26 20.25 5.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 127.764 2.426 . . . . 0.0 111.23 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.56 9.05 61.86 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.019 1.295 . . . . 0.0 112.922 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -113.67 162.23 16.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.355 1.062 . . . . 0.0 110.971 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.7 mtm -138.97 143.4 38.52 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.38 1.472 . . . . 0.0 107.845 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -78.26 135.95 37.66 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.702 161.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.7 m -140.96 176.8 4.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.163 0.985 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.0 m -115.39 141.21 48.34 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 152.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -93.26 112.45 24.39 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.464 1.106 . . . . 0.0 108.964 169.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.0 5.41 2.7 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -59.01 -41.85 88.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.261 162.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -147.41 -13.27 0.4 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.101 -0.952 . . . . 0.0 113.379 -161.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 t70 75.07 16.61 2.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.559 1.944 . . . . 0.0 111.761 -162.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -60.78 113.92 2.75 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 120.664 -1.273 . . . . 0.0 108.96 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.11 151.13 21.74 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.91 -0.494 . . . . 0.0 109.873 167.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.76 -167.48 35.29 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.613 0.563 . . . . 0.0 111.917 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -89.59 141.14 28.87 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.399 1.08 . . . . 0.0 110.555 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.8 153.27 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.999 2.12 . . . . 0.0 109.104 169.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.88 146.1 7.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.801 0.84 . . . . 0.0 110.428 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -66.94 -17.65 65.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.439 1.496 . . . . 0.0 113.041 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.92 -18.23 59.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.529 1.932 . . . . 0.0 112.109 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -130.56 12.56 5.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.437 1.495 . . . . 0.0 112.712 -163.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.97 154.43 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.661 1.118 . . . . 0.0 112.994 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -128.3 148.91 50.68 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.805 2.042 . . . . 0.0 110.204 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.64 102.25 0.55 Allowed 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 129.359 3.064 . . . . 0.0 110.324 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 123.19 1.471 . . . . 0.0 110.864 175.461 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.515 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 110.541 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -132.54 150.98 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.377 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 m -123.4 171.07 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.536 1.134 . . . . 0.0 108.461 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -144.02 122.84 12.67 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 120.752 -1.217 . . . . 0.0 111.739 -170.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.38 137.85 58.34 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.801 0.728 . . . . 0.0 109.975 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.27 0.2 OUTLIER -119.73 5.22 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.417 169.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.5 mt -147.8 154.94 44.53 Favored Pre-proline 0 N--CA 1.466 0.374 0 C-N-CA 125.639 1.576 . . . . 0.0 108.822 166.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.66 157.54 31.93 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.613 2.875 . . . . 0.0 110.235 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -146.31 -179.4 6.72 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.782 0.833 . . . . 0.0 108.906 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 t -146.39 133.42 20.32 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.586 ' H ' ' HB3' ' A' ' 21' ' ' SER . 17.9 ptmt -69.52 144.66 53.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.107 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.98 139.91 97.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.02 145.86 69.01 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.068 2.512 . . . . 0.0 110.488 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.82 39.14 8.57 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.765 1.626 . . . . 0.0 112.498 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 p -132.33 171.21 14.01 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.497 -0.752 . . . . 0.0 110.434 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.68 -8.18 59.05 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.64 1.976 . . . . 0.0 111.323 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.03 167.88 3.61 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.781 1.633 . . . . 0.0 111.917 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.99 136.48 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.877 1.671 . . . . 0.0 108.69 174.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.586 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -90.51 122.77 33.63 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.85 1.66 . . . . 0.0 110.148 -178.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -146.99 170.65 16.66 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 119.671 1.123 . . . . 0.0 113.288 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.88 -178.64 5.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.014 0.926 . . . . 0.0 111.738 -164.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -63.57 149.58 45.99 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 160.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.99 -4.73 22.06 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.897 -0.946 . . . . 0.0 113.244 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.55 156.31 39.1 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.639 1.22 . . . . 0.0 107.759 164.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.9 ttt -134.17 148.82 50.98 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.866 -1.146 . . . . 0.0 108.814 -173.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -132.98 159.48 39.89 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.436 1.094 . . . . 0.0 109.636 -169.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.7 pt -110.86 135.98 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -69.39 124.5 25.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 171.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.19 -25.32 4.9 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.97 0.908 . . . . 0.0 113.255 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -154.73 160.44 41.34 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 164.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.76 123.03 42.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.09 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 mt -101.81 -169.42 1.68 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.9 29.59 3.77 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.381 1.072 . . . . 0.0 110.853 -166.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -151.79 29.4 0.6 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.702 1.601 . . . . 0.0 111.534 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.09 36.25 64.23 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 120.9 -1.125 . . . . 0.0 112.426 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -134.72 156.18 49.25 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.362 1.081 . . . . 0.0 108.92 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.5 mtm -138.01 141.86 40.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 168.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -75.41 137.9 41.32 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 160.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.81 -178.84 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 122.186 0.993 . . . . 0.0 111.768 -175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.4 m -124.94 146.68 49.24 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 153.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.77 119.46 32.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.437 2.695 . . . . 0.0 108.43 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt -80.11 21.13 0.6 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.844 1.257 . . . . 0.0 112.491 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.3 ttp85 -101.24 -47.53 4.69 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.089 0.956 . . . . 0.0 110.032 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -146.15 20.31 1.4 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.642 0.777 . . . . 0.0 109.511 -169.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.85 24.13 12.73 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.208 1.803 . . . . 0.0 112.356 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -72.32 160.61 32.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.1 -1.0 . . . . 0.0 112.48 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -139.42 149.54 44.2 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.684 0.754 . . . . 0.0 110.928 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.89 -168.55 32.36 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.638 -174.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.0 mt -92.0 143.53 26.38 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.832 1.253 . . . . 0.0 110.489 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.01 145.57 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.274 1.429 . . . . 0.0 109.029 171.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.02 132.23 32.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.31 -10.97 60.63 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -55.48 -26.85 44.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.942 2.097 . . . . 0.0 111.873 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.96 11.29 11.73 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -160.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -118.11 164.68 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.73 1.612 . . . . 0.0 110.859 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -121.31 151.14 40.42 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.568 1.547 . . . . 0.0 110.154 169.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.18 63.18 0.97 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.768 2.427 . . . . 0.0 111.066 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.238 0.481 0 O-C-N 120.741 -1.224 . . . . 0.0 111.331 177.764 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.407 ' H ' HG11 ' A' ' 30' ' ' VAL . 2.8 ttt85 . . . . . 0 C--O 1.236 0.359 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 mmt85 -140.99 156.52 46.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.13 1.372 . . . . 0.0 107.494 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.09 154.63 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.335 0.97 . . . . 0.0 109.806 170.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -121.66 136.57 54.94 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.84 130.78 41.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.149 0.886 . . . . 0.0 109.506 169.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.07 1.47 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.318 0.647 . . . . 0.0 111.305 170.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 mt -141.03 154.56 68.37 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 168.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.91 158.77 34.66 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.971 2.447 . . . . 0.0 110.247 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -150.12 164.61 35.15 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.58 0.752 . . . . 0.0 110.577 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 t -135.31 135.79 41.07 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -63.46 149.75 45.34 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.22 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.7 166.29 19.59 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.624 1.17 . . . . 0.0 109.557 163.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -79.6 161.27 25.02 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.385 2.056 . . . . 0.0 110.41 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t70 45.94 46.86 12.48 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.987 2.515 . . . . 0.0 112.693 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 p -142.96 177.74 8.15 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.459 -0.776 . . . . 0.0 110.122 -170.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.25 11.25 37.09 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.513 1.525 . . . . 0.0 110.412 -172.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -80.36 170.02 16.96 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.653 1.581 . . . . 0.0 111.549 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.3 pt -136.0 152.78 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.227 1.811 . . . . 0.0 109.964 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -88.99 149.87 23.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.545 2.338 . . . . 0.0 110.642 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -158.28 173.19 17.06 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.423 -0.798 . . . . 0.0 111.797 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.41 161.17 22.64 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.804 1.242 . . . . 0.0 110.516 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -57.98 133.63 55.68 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 166.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.31 -6.77 71.96 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 117.887 -1.507 . . . . 0.0 113.005 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -77.18 166.45 23.22 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.271 2.035 . . . . 0.0 108.699 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 34.7 mtp -133.25 140.3 47.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.566 1.146 . . . . 0.0 109.873 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -122.93 169.94 10.63 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.099 1.359 . . . . 0.0 109.779 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 pt -119.52 129.64 75.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.407 HG11 ' H ' ' A' ' 3' ' ' ARG . 2.3 p -68.46 125.98 27.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -116.64 -33.48 4.84 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.929 0.892 . . . . 0.0 111.961 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -146.62 160.45 42.15 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 119.262 0.937 . . . . 0.0 110.497 172.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -118.06 121.55 40.88 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 126.498 1.919 . . . . 0.0 107.289 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -110.2 -172.15 1.98 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.412 1.485 . . . . 0.0 107.851 173.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -120.26 13.73 12.01 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.171 1.789 . . . . 0.0 114.935 -166.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -143.41 23.31 1.81 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.392 1.077 . . . . 0.0 112.218 -154.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.94 7.28 87.43 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 124.456 1.027 . . . . 0.0 112.617 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -118.48 150.61 39.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.576 1.55 . . . . 0.0 108.73 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 mtm -139.39 140.37 37.4 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -77.05 138.88 39.83 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 166.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -142.56 -175.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.774 1.273 . . . . 0.0 111.166 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.2 m -130.76 132.23 45.19 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 152.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -81.39 114.01 19.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.41 -6.81 11.28 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.024 -0.423 . . . . 0.0 111.679 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -57.01 -40.39 76.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 120.396 -1.44 . . . . 0.0 111.389 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -169.75 33.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.025 0.829 . . . . 0.0 111.793 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t70 66.54 -4.91 0.67 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 171.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -53.73 118.4 3.9 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.192 1.797 . . . . 0.0 109.804 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -100.36 157.87 16.3 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 168.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.49 -171.91 32.98 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.3 mt -87.23 144.88 26.61 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.458 1.503 . . . . 0.0 109.561 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.28 152.64 23.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.95 1.7 . . . . 0.0 108.028 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.18 141.31 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.286 0.634 . . . . 0.0 109.832 -173.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -71.82 -9.56 58.49 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.824 0.85 . . . . 0.0 113.25 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.34 -21.16 66.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.819 1.248 . . . . 0.0 112.064 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -126.86 11.42 7.17 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.802 1.241 . . . . 0.0 112.098 -162.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.11 167.57 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.171 0.989 . . . . 0.0 111.343 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -119.06 152.31 36.68 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 127.184 2.194 . . . . 0.0 108.426 167.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 59.76 1.25 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.319 1.448 . . . . 0.0 110.341 174.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.536 0.431 0 O-C-N 120.87 -1.144 . . . . 0.0 110.633 -175.421 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.603 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -124.6 151.55 44.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.94 145.51 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.275 0.943 . . . . 0.0 109.746 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -111.37 144.96 39.73 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 117.584 -1.198 . . . . 0.0 109.922 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.19 136.71 37.86 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 119.767 1.167 . . . . 0.0 111.819 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.69 1.85 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.158 0.983 . . . . 0.0 112.294 168.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mt -151.71 154.48 33.13 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 125.73 1.612 . . . . 0.0 108.755 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.52 134.93 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.009 2.473 . . . . 0.0 108.604 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -84.64 -179.12 7.06 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.931 0.872 . . . . 0.0 109.043 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.4 m -149.71 100.33 2.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 21' ' ' SER . 11.6 pttt -67.66 156.6 36.49 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.413 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 m -85.53 176.25 3.81 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 126.324 1.85 . . . . 0.0 107.912 168.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -95.17 164.02 1.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.174 2.582 . . . . 0.0 111.336 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 59.04 35.78 24.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.492 1.917 . . . . 0.0 111.243 167.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.39 162.59 36.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.127 0.965 . . . . 0.0 111.483 -161.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.4 35.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.477 1.911 . . . . 0.0 109.427 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -109.3 168.29 9.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.296 1.039 . . . . 0.0 109.149 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.2 pt -145.2 144.66 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 127.39 2.276 . . . . 0.0 106.554 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.415 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 93.1 p -124.88 158.94 32.28 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.564 ' HB2' HD22 ' A' ' 43' ' ' ASN . 0.1 OUTLIER -164.93 -175.03 3.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.512 1.525 . . . . 0.0 109.506 176.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.5 172.39 8.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.173 0.989 . . . . 0.0 109.975 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -54.93 157.2 3.32 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.525 -1.359 . . . . 0.0 109.789 161.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.44 12.55 84.2 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.773 -1.015 . . . . 0.0 112.696 172.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -174.59 4.24 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.733 1.267 . . . . 0.0 111.262 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.36 144.67 32.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.338 1.855 . . . . 0.0 108.934 -170.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -133.74 153.92 51.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.159 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.6 pt -112.92 118.53 58.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -63.76 121.78 13.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.1 -36.28 5.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.433 1.093 . . . . 0.0 109.973 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -149.24 169.55 20.5 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.158 0.89 . . . . 0.0 110.062 168.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -130.35 122.7 28.36 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 127.332 2.253 . . . . 0.0 106.122 -171.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.85 -162.79 0.97 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.677 1.191 . . . . 0.0 110.138 -175.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -141.55 76.63 1.55 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.79 2.036 . . . . 0.0 106.934 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 p30 174.2 -0.97 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.532 1.933 . . . . 0.0 114.363 -165.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.43 7.53 85.26 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 120.055 -1.653 . . . . 0.0 113.142 -171.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -95.73 165.44 12.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.377 1.589 . . . . 0.0 109.922 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.4 mtm -134.94 163.54 29.63 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 168.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.2 t-105 -94.34 132.62 38.75 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.406 0.548 . . . . 0.0 109.665 158.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.56 174.89 6.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.132 0.973 . . . . 0.0 110.503 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.415 ' CG2' ' HA ' ' A' ' 47' ' ' ASP . 7.8 m -107.68 141.82 38.6 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 157.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.564 HD22 ' HB2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -82.19 111.48 18.33 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 127.287 2.235 . . . . 0.0 107.958 170.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.6 -9.31 5.77 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.428 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 22.0 ttp85 -53.31 -38.39 63.11 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.984 0.914 . . . . 0.0 111.436 173.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 t -165.67 -1.61 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -161.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.415 ' HA ' ' CG2' ' A' ' 42' ' ' THR . 0.6 OUTLIER 75.3 17.64 2.52 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.661 1.585 . . . . 0.0 112.401 -173.163 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.2 139.48 58.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -126.51 153.78 44.69 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.614 1.166 . . . . 0.0 108.731 -172.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 151.8 -158.47 27.79 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -172.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -101.56 143.01 32.07 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.61 1.964 . . . . 0.0 112.013 -168.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.94 152.97 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 129.813 3.245 . . . . 0.0 107.024 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.33 139.58 19.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -74.7 -14.83 60.78 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.18 -22.0 64.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.621 1.168 . . . . 0.0 112.719 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.4 mt -107.09 3.9 26.33 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.331 1.452 . . . . 0.0 112.286 -170.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.96 171.14 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.224 1.009 . . . . 0.0 110.737 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -131.21 152.96 49.97 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 125.611 1.565 . . . . 0.0 110.618 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -78.05 80.62 4.47 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.6 1.56 . . . . 0.0 111.089 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.321 -0.648 0 O-C-N 120.963 -1.085 . . . . 0.0 109.449 167.872 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . 0.543 ' HE ' ' HE1' ' A' ' 27' ' ' MET . 11.2 mtp180 -151.79 138.84 19.12 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.28 1.832 . . . . 0.0 108.391 -172.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.89 159.04 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.81 0.844 . . . . 0.0 109.118 173.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -130.03 131.57 45.89 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.729 -1.857 . . . . 0.0 106.099 -168.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.57 156.42 26.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.598 1.545 . . . . 0.0 110.566 -173.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.75 9.89 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.921 162.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.71 155.57 29.68 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 120.35 1.432 . . . . 0.0 110.264 167.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -82.81 163.77 15.99 Favored 'Trans proline' 0 CA--C 1.543 0.956 1 C-N-CA 125.972 4.448 . . . . 0.0 111.925 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -153.14 165.69 34.84 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.745 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -119.27 113.73 21.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.545 1.938 . . . . 0.0 107.21 -175.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -67.26 146.81 53.78 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.38 1.446 . . . . 0.0 110.233 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.39 149.3 98.46 Favored Pre-proline 0 CA--C 1.552 1.035 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.18 141.53 39.75 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 124.234 3.289 . . . . 0.0 111.32 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.1 t70 64.47 27.56 13.51 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.819 1.648 . . . . 0.0 112.843 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 p -121.91 173.76 7.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.467 1.031 . . . . 0.0 113.651 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.28 24.9 0.77 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.173 2.189 . . . . 0.0 110.632 -172.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -108.11 175.47 5.47 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.035 2.134 . . . . 0.0 110.844 -173.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 pt -147.24 121.11 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.311 1.445 . . . . 0.0 110.904 -174.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.63 139.11 39.44 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.054 -1.029 . . . . 0.0 111.338 -176.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -156.51 169.25 25.08 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.012 -1.055 . . . . 0.0 112.062 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.8 167.59 10.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.377 1.071 . . . . 0.0 109.729 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -62.38 119.4 9.03 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 169.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.15 -15.88 4.21 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.645 1.593 . . . . 0.0 112.944 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -80.1 162.74 24.61 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.981 1.391 . . . . 0.0 110.002 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.543 ' HE1' ' HE ' ' A' ' 4' ' ' ARG . 14.5 ptm -138.3 158.95 43.28 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.578 1.951 . . . . 0.0 108.406 175.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -132.66 160.87 35.45 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.382 1.073 . . . . 0.0 111.072 -169.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.6 pt -121.09 125.31 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 108.909 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.85 123.48 13.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -126.36 -23.43 3.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.634 1.174 . . . . 0.0 112.963 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -156.0 161.6 40.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.171 0.896 . . . . 0.0 110.822 159.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -118.54 125.68 50.36 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 129.07 2.948 . . . . 0.0 105.767 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 mt -109.46 -165.36 1.01 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.187 0.995 . . . . 0.0 109.213 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -133.52 91.94 2.92 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 t0 175.85 18.91 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.627 2.371 . . . . 0.0 111.667 168.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.46 -1.86 84.21 Favored Glycine 0 CA--C 1.539 1.572 0 O-C-N 120.146 -1.596 . . . . 0.0 113.878 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -97.73 152.02 19.55 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.752 2.021 . . . . 0.0 110.217 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.7 mtm -141.64 143.8 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.363 1.465 . . . . 0.0 108.638 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -84.39 136.69 33.77 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 171.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.17 -163.79 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.511 0.724 . . . . 0.0 111.549 -173.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.3 m -135.83 158.11 45.21 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 151.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -102.79 115.36 30.44 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.637 1.575 . . . . 0.0 109.677 172.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 mt -66.2 -4.54 7.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.799 1.24 . . . . 0.0 113.44 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -69.35 -46.77 66.22 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 117.187 -1.387 . . . . 0.0 111.47 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.5 p -139.29 4.96 2.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.934 1.243 . . . . 0.0 114.025 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.69 19.69 1.97 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.939 1.696 . . . . 0.0 112.204 -174.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -62.25 141.82 58.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.916 1.286 . . . . 0.0 110.385 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -134.51 155.81 49.72 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.836 0.854 . . . . 0.0 109.65 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.89 -158.17 24.07 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -161.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.3 mt -106.16 144.67 32.53 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.271 1.428 . . . . 0.0 113.858 -164.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.63 154.31 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 127.699 2.4 . . . . 0.0 108.582 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.74 147.97 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 127.483 2.313 . . . . 0.0 112.553 168.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -58.89 -21.32 57.21 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.47 165.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.67 -24.62 67.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.763 0.792 . . . . 0.0 112.178 -166.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.1 mt -118.75 7.2 11.58 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.509 1.523 . . . . 0.0 111.271 -157.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.93 161.84 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.02 1.728 . . . . 0.0 109.797 -169.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.5 153.26 26.45 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.363 1.465 . . . . 0.0 109.059 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.87 61.9 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.928 1.291 . . . . 0.0 111.088 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.445 -0.706 0 CA-C-O 122.32 1.057 . . . . 0.0 110.213 -179.194 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.5 mtm180 -134.61 166.8 22.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.991 0.516 . . . . 0.0 110.451 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.69 161.44 23.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 171.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -139.47 129.87 25.55 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.52 121.72 19.18 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.981 0.81 . . . . 0.0 109.595 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.96 -2.34 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.135 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.81 157.48 32.58 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 126.938 2.095 . . . . 0.0 108.171 173.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.08 159.74 30.24 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.93 3.086 . . . . 0.0 111.147 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -143.9 168.07 20.82 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.826 1.651 . . . . 0.0 107.61 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 t -135.66 143.51 45.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.526 ' H ' ' HB3' ' A' ' 21' ' ' SER . 12.9 pttm -84.35 155.88 22.13 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.924 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.46 139.63 96.63 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 161.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.14 146.68 41.39 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.945 1.763 . . . . 0.0 108.837 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t0 62.65 51.32 3.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.686 1.594 . . . . 0.0 112.019 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.1 p -146.07 174.36 11.37 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 125.926 1.69 . . . . 0.0 110.203 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -84.22 -9.15 58.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.185 0.994 . . . . 0.0 110.992 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.08 173.71 4.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.879 2.071 . . . . 0.0 111.337 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 pt -147.18 126.22 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 126.985 2.114 . . . . 0.0 108.734 -172.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.526 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 1.2 p -93.72 125.72 38.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.075 1.75 . . . . 0.0 111.468 -172.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -150.57 168.61 23.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 124.513 2.101 . . . . 0.0 113.95 -172.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mt -90.16 174.54 7.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.525 2.33 . . . . 0.0 110.126 -166.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -60.47 153.25 23.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 156.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.7 7.15 88.72 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.069 -0.851 . . . . 0.0 113.67 167.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.91 157.05 20.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.213 1.507 . . . . 0.0 109.058 166.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.3 ttt -134.01 147.83 51.02 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.097 0.959 . . . . 0.0 109.12 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -134.76 170.97 15.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.384 -167.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.5 pt -128.06 138.72 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.098 1.359 . . . . 0.0 107.899 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.9 t -75.0 116.84 18.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -112.17 -20.52 11.87 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.402 0.681 . . . . 0.0 111.387 174.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -154.84 179.88 8.68 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 163.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -147.09 118.95 8.1 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.748 1.619 . . . . 0.0 107.369 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -104.91 -177.56 3.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.811 2.445 . . . . 0.0 110.222 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -133.96 78.79 1.78 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.448 1.499 . . . . 0.0 109.6 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -169.9 31.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.63 1.572 . . . . 0.0 110.508 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.1 27.74 67.87 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.609 -1.307 . . . . 0.0 112.623 -174.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -134.52 150.37 50.76 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.534 1.167 . . . . 0.0 110.833 -168.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.6 mtm -149.14 137.66 21.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.493 0.717 . . . . 0.0 110.869 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -86.71 130.84 34.32 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.958 1.303 . . . . 0.0 110.405 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -142.1 -177.12 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.504 0.722 . . . . 0.0 111.879 -175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 m -116.78 138.7 51.3 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.945 1.698 . . . . 0.0 107.42 157.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -92.32 120.84 33.25 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.705 1.202 . . . . 0.0 109.466 165.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.87 1.66 3.19 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -71.34 -36.49 71.56 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 121.191 1.814 . . . . 0.0 112.799 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -158.95 23.31 0.21 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.273 0.488 . . . . 0.0 111.635 -171.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.9 t70 58.59 27.24 15.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.411 1.084 . . . . 0.0 111.784 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -68.61 98.86 0.92 Allowed 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.011 -1.056 . . . . 0.0 109.415 171.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -80.42 158.3 25.99 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.721 0.295 . . . . 0.0 110.619 167.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.16 -170.74 29.46 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 173.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -80.03 141.79 35.56 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.426 1.091 . . . . 0.0 110.882 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.81 152.21 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 110.12 167.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.61 140.58 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.283 1.433 . . . . 0.0 108.736 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.92 -9.33 58.44 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.78 -15.45 61.68 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.345 1.858 . . . . 0.0 113.846 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.2 mt -140.79 21.86 2.31 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.739 1.216 . . . . 0.0 113.677 -167.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.75 154.44 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -100.4 149.32 23.76 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.74 1.216 . . . . 0.0 109.554 167.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.4 123.88 24.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.274 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 121.124 0.488 . . . . 0.0 111.288 172.156 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.792 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 45.62 56.13 6.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.853 1.261 . . . . 0.0 111.456 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.98 125.56 37.7 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.973 1.709 . . . . 0.0 106.415 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -141.46 166.57 24.39 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.283 1.433 . . . . 0.0 107.384 173.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -136.0 161.87 37.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -124.46 140.37 53.01 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.88 157.98 35.31 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.14 3.35 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.244 0.475 . . . . 0.0 111.746 164.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 mt -147.29 160.62 38.95 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 126.334 1.854 . . . . 0.0 107.955 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.15 165.4 14.85 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.647 3.565 . . . . 0.0 111.699 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -157.1 125.58 5.68 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.083 0.953 . . . . 0.0 110.517 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 t -82.48 142.2 32.07 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -83.75 154.41 23.61 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.742 -0.599 . . . . 0.0 109.739 163.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.3 151.56 94.34 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 157.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.34 150.08 13.35 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.496 2.797 . . . . 0.0 110.506 165.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 t70 75.48 13.17 3.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.66 1.984 . . . . 0.0 112.569 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.9 p -107.11 177.56 4.82 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.808 1.243 . . . . 0.0 108.704 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -92.43 10.21 31.0 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.987 0.915 . . . . 0.0 109.219 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.88 162.27 28.78 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.746 -1.221 . . . . 0.0 109.92 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 pt -125.02 140.66 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 124.852 1.261 . . . . 0.0 107.619 164.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.1 p -85.68 160.34 19.59 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -158.35 167.71 28.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.366 0.667 . . . . 0.0 109.369 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 mt -117.43 167.83 10.92 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.574 1.15 . . . . 0.0 108.579 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -60.77 115.01 3.34 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 167.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.8 -16.41 3.74 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 125.754 1.645 . . . . 0.0 112.36 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -76.88 163.4 26.79 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 119.87 1.835 . . . . 0.0 111.968 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.2 mtp -127.85 154.96 44.86 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 128.149 2.58 . . . . 0.0 108.833 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -136.39 160.4 38.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.431 1.092 . . . . 0.0 108.967 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.7 pt -122.74 137.95 54.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.9 t -69.76 134.27 30.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.83 -27.28 2.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.402 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.99 162.54 41.13 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 119.431 1.014 . . . . 0.0 110.788 162.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -107.47 137.35 45.67 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.565 1.946 . . . . 0.0 107.443 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.1 mt -129.36 177.01 7.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.511 1.924 . . . . 0.0 107.101 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -130.32 14.44 5.59 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.188 -0.945 . . . . 0.0 113.033 -152.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -127.59 21.29 6.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.078 1.751 . . . . 0.0 112.103 -170.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.09 10.32 56.26 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.355 1.455 . . . . 0.0 113.018 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -125.9 155.34 41.42 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.658 1.583 . . . . 0.0 110.847 -165.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.4 mtm -145.82 145.99 30.99 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.316 1.447 . . . . 0.0 108.8 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -84.01 137.3 33.67 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 122.838 0.455 . . . . 0.0 110.655 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.6 m -142.38 -171.24 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.834 0.854 . . . . 0.0 111.724 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.1 m -128.07 150.76 49.81 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 156.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -109.54 109.32 20.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.127 1.771 . . . . 0.0 109.413 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 mt -56.04 -12.86 1.62 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.784 2.034 . . . . 0.0 113.612 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -64.47 -33.96 77.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.958 1.254 . . . . 0.0 111.514 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.251 5.1 t -155.31 15.07 0.39 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.085 0.954 . . . . 0.0 110.737 -168.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.3 t70 53.05 32.85 13.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.085 2.154 . . . . 0.0 111.795 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.1 159.28 33.81 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.809 -0.557 . . . . 0.0 110.326 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -140.23 147.2 39.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.38 -157.66 25.69 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -101.67 146.82 27.21 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.174 1.39 . . . . 0.0 112.277 -165.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.43 154.05 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.063 1.745 . . . . 0.0 110.288 168.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.99 144.59 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.709 1.604 . . . . 0.0 110.127 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -78.63 -6.33 55.37 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.58 -19.95 65.96 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.608 1.163 . . . . 0.0 113.108 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.9 mt -129.21 15.78 6.16 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.526 1.13 . . . . 0.0 113.819 -160.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.02 169.65 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 119.102 0.864 . . . . 0.0 113.058 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -125.63 148.1 49.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 127.407 2.283 . . . . 0.0 109.216 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.93 47.58 1.23 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.263 2.225 . . . . 0.0 112.783 -170.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 p -58.23 156.91 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 122.711 1.243 . . . . 0.0 111.756 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -107.17 6.99 37.19 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.192 1.377 . . . . 0.0 113.227 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.656 1.582 . . . . 0.0 110.093 179.834 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.904 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -106.16 -75.98 0.62 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 117.755 0.777 . . . . 0.0 109.617 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.95 157.99 30.05 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.742 1.155 . . . . 0.0 108.762 173.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.0 mtt85 -158.67 166.96 30.8 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.279 1.831 . . . . 0.0 109.361 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.46 178.46 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.872 1.669 . . . . 0.0 108.823 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 -140.93 142.32 34.4 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 120.449 -1.407 . . . . 0.0 108.44 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.68 137.06 47.55 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 119.069 0.85 . . . . 0.0 110.45 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.85 -4.84 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 118.218 -0.896 . . . . 0.0 112.335 163.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -149.81 148.66 26.0 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 125.18 1.392 . . . . 0.0 108.612 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.26 167.5 19.48 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 124.632 3.554 . . . . 0.0 111.27 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -154.4 171.43 19.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.18 0.992 . . . . 0.0 108.483 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.6 m -118.79 113.55 21.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.922 1.289 . . . . 0.0 108.585 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -59.81 151.6 25.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.187 0.903 . . . . 0.0 110.456 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.47 148.64 97.93 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 154.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.63 163.93 14.29 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.57 2.847 . . . . 0.0 111.134 170.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 47.03 47.27 16.02 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.918 2.087 . . . . 0.0 110.002 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.62 172.99 14.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.503 2.721 . . . . 0.0 107.845 -172.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -82.0 5.0 20.67 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.055 -1.028 . . . . 0.0 112.052 -170.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.31 162.33 14.65 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.363 1.465 . . . . 0.0 110.881 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.7 pp -138.37 132.21 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 127.082 2.153 . . . . 0.0 107.181 -174.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.88 151.02 38.99 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.875 -1.14 . . . . 0.0 111.206 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -152.68 154.51 35.43 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.274 -0.891 . . . . 0.0 111.094 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.86 171.37 7.56 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.886 1.274 . . . . 0.0 109.777 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -52.78 134.2 36.76 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 158.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.05 -7.12 81.44 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 117.694 -1.615 . . . . 0.0 114.501 172.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -64.69 159.08 22.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.951 1.876 . . . . 0.0 108.713 166.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.1 ttt -127.66 142.23 51.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.387 1.075 . . . . 0.0 109.884 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -127.6 146.52 50.51 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.493 1.117 . . . . 0.0 111.089 -170.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 pt -110.01 130.95 62.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.39 124.79 26.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -121.04 -47.65 2.27 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.124 0.97 . . . . 0.0 110.794 176.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -138.87 157.44 46.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 119.006 0.821 . . . . 0.0 111.438 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -130.52 119.51 22.69 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -161.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 mt -119.5 145.53 46.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.885 -171.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -87.07 15.96 5.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.552 1.941 . . . . 0.0 113.335 -165.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -125.83 18.24 7.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.733 1.613 . . . . 0.0 112.533 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.66 16.11 50.17 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.24 0.924 . . . . 0.0 111.931 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -123.34 153.29 40.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.33 1.052 . . . . 0.0 110.154 -166.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.6 mtm -143.89 132.46 22.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -79.68 129.18 34.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.128 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.77 176.05 7.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.761 0.824 . . . . 0.0 111.58 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 m -105.91 138.3 42.34 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 153.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -90.83 114.97 27.51 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 168.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.99 -7.61 23.69 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.9 ttp85 -59.79 -45.16 93.17 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.83 1.195 . . . . 0.0 109.8 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -137.72 -3.46 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 117.843 -1.075 . . . . 0.0 113.039 -168.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 75.53 11.06 3.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.292 1.837 . . . . 0.0 111.989 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.04 149.38 37.08 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.972 0.909 . . . . 0.0 109.379 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -133.52 139.1 46.43 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.885 1.274 . . . . 0.0 108.396 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.42 -170.67 36.47 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.34 146.28 31.64 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.746 1.619 . . . . 0.0 111.592 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -143.66 166.43 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 128.365 2.666 . . . . 0.0 108.468 165.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.45 143.45 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.692 1.197 . . . . 0.0 110.932 -167.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.6 -8.61 56.89 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.351 1.06 . . . . 0.0 113.04 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.03 -27.81 67.23 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.531 1.532 . . . . 0.0 112.232 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.53 14.99 8.21 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -161.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.5 164.1 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.976 0.807 . . . . 0.0 112.611 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -120.36 142.9 48.73 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 127.426 2.29 . . . . 0.0 109.669 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -72.43 92.94 1.49 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.325 1.45 . . . . 0.0 107.725 170.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.03 114.55 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.274 1.035 . . . . 0.0 111.284 -166.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.05 -2.26 65.35 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 117.898 -1.501 . . . . 0.0 114.082 -173.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 . . . . . 0 C--O 1.248 1.011 0 C-N-CA 125.727 1.611 . . . . 0.0 113.15 -171.223 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.995 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.1 12.11 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.512 1.925 . . . . 0.0 115.381 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.24 120.81 43.14 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -125.95 160.99 28.52 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.836 0.854 . . . . 0.0 109.1 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.54 160.65 31.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 124.772 1.229 . . . . 0.0 108.32 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -134.28 127.17 31.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.113 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.98 134.73 44.81 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.871 0.76 . . . . 0.0 109.792 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.272 0.2 OUTLIER -115.54 5.02 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.726 0.81 . . . . 0.0 112.501 176.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 mt -148.14 160.73 36.57 Favored Pre-proline 0 N--CA 1.468 0.467 0 C-N-CA 127.716 2.406 . . . . 0.0 106.834 166.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.17 170.61 9.49 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.095 3.197 . . . . 0.0 111.283 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -145.59 172.08 13.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.586 0.755 . . . . 0.0 109.183 173.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.1 m -131.54 112.17 12.4 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.019 1.328 . . . . 0.0 108.202 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -66.71 158.69 29.52 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.272 -174.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.06 123.54 86.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 161.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.68 153.96 74.64 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.141 1.227 . . . . 0.0 108.92 166.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 t0 73.5 22.63 2.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.047 1.339 . . . . 0.0 111.118 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -130.04 169.99 14.57 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.095 1.358 . . . . 0.0 109.38 168.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -78.64 9.63 3.92 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.247 1.419 . . . . 0.0 110.309 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -74.72 167.69 21.31 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.138 -1.601 . . . . 0.0 110.541 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.3 pt -138.14 139.71 41.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 126.746 2.018 . . . . 0.0 107.446 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.01 137.26 47.09 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.87 -1.144 . . . . 0.0 108.799 172.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -135.34 165.1 26.23 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.807 0.843 . . . . 0.0 111.664 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -111.63 165.13 12.29 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.18 1.392 . . . . 0.0 109.924 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -59.11 128.66 38.27 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 161.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.89 0.42 62.13 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.204 -1.331 . . . . 0.0 113.434 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.24 161.47 29.9 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.847 1.824 . . . . 0.0 109.948 167.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.8 ttp -146.9 144.13 29.03 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.24 1.016 . . . . 0.0 110.455 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -140.53 155.71 46.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.954 -162.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -104.05 133.1 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.181 1.392 . . . . 0.0 108.328 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.01 129.32 30.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -119.12 -34.06 3.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.388 168.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -145.95 162.19 38.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 119.578 1.081 . . . . 0.0 110.066 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -123.75 112.18 17.03 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.584 1.953 . . . . 0.0 105.915 -170.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.73 -172.72 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.725 1.61 . . . . 0.0 108.606 -169.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -134.4 38.84 3.09 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.301 1.048 . . . . 0.0 112.356 -168.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -152.74 47.59 0.72 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.894 166.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.96 3.58 44.44 Favored Glycine 0 CA--C 1.538 1.481 0 O-C-N 121.031 -1.043 . . . . 0.0 115.252 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -97.32 161.41 13.81 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.624 1.169 . . . . 0.0 110.45 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.2 mtm -138.48 144.41 40.03 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.609 1.164 . . . . 0.0 108.695 165.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.455 ' CE3' ' CD2' ' A' ' 51' ' ' LEU . 24.7 t-105 -79.01 131.66 36.37 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.745 0.818 . . . . 0.0 109.322 166.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.44 -173.05 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.758 0.79 . . . . 0.0 112.462 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 m -136.15 131.68 35.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 161.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -86.22 108.98 18.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.732 1.213 . . . . 0.0 108.716 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.9 mt -75.23 -0.29 18.96 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.556 -1.212 . . . . 0.0 112.128 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -63.38 -33.01 74.6 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 120.8 1.636 . . . . 0.0 110.601 168.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 p -143.84 0.25 1.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.167 -160.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.25 0.3 OUTLIER 70.37 0.88 3.37 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.316 2.646 . . . . 0.0 114.195 -166.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -66.88 104.5 1.37 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.026 0.93 . . . . 0.0 111.749 -168.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -79.34 156.55 27.95 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.933 -0.479 . . . . 0.0 109.839 166.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.72 -154.7 25.7 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.455 ' CD2' ' CE3' ' A' ' 40' ' ' TRP . 1.8 mm? -103.03 144.63 31.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.633 1.173 . . . . 0.0 109.903 -167.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -140.66 151.43 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.397 1.879 . . . . 0.0 109.66 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -99.98 144.21 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.95 1.3 . . . . 0.0 109.086 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -81.44 -1.33 45.37 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.26 -23.55 62.47 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.188 0.995 . . . . 0.0 112.982 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.97 13.64 10.61 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -158.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.81 158.69 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.464 1.029 . . . . 0.0 112.863 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -108.1 157.37 18.33 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.956 1.302 . . . . 0.0 110.521 163.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -76.08 68.89 2.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.978 1.311 . . . . 0.0 110.186 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.51 127.33 21.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 122.73 1.252 . . . . 0.0 111.16 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.79 -23.78 74.0 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.744 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 127.189 2.196 . . . . 0.0 110.08 -178.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.654 0 CA-C-O 118.621 -1.099 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.4 mtt85 56.11 -18.25 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 128.468 2.707 . . . . 0.0 117.919 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -178.35 2.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 127.804 2.442 . . . . 0.0 109.912 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 20.6 mtm-85 -119.91 149.42 42.13 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.842 0.857 . . . . 0.0 110.083 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.6 m -133.07 164.29 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.466 1.106 . . . . 0.0 110.994 -174.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -135.88 130.48 33.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.368 1.067 . . . . 0.0 109.446 -170.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.8 135.71 51.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 174.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.84 2.76 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.986 0.914 . . . . 0.0 111.005 169.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.3 mt -141.08 153.39 66.93 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 124.818 1.247 . . . . 0.0 108.522 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.18 158.15 17.62 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.503 2.802 . . . . 0.0 110.538 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -149.09 120.54 7.93 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.679 -0.638 . . . . 0.0 111.399 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.6 m -78.03 113.13 15.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.518 0.727 . . . . 0.0 109.264 167.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -65.55 156.74 31.7 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.234 168.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.17 146.21 86.76 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 160.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.23 172.23 12.48 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.995 3.13 . . . . 0.0 111.403 165.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t70 64.43 5.87 2.83 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.468 1.507 . . . . 0.0 113.559 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.2 p -119.27 176.11 5.48 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 119.744 -1.848 . . . . 0.0 110.173 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.33 10.46 4.54 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.031 1.332 . . . . 0.0 110.065 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.33 160.77 27.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.645 1.578 . . . . 0.0 110.669 -170.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.8 pt -131.65 132.36 62.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.9 p -75.59 162.21 28.47 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -157.48 166.28 33.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.929 0.892 . . . . 0.0 109.211 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.23 162.5 15.93 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.736 0.814 . . . . 0.0 109.139 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -57.17 125.51 23.05 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 166.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.21 -6.74 58.16 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.044 -1.975 . . . . 0.0 113.388 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.99 160.28 23.96 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.702 2.251 . . . . 0.0 110.19 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.2 mtp -134.99 153.48 52.07 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.805 0.812 . . . . 0.0 111.557 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -146.26 165.55 28.9 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.273 -1.33 . . . . 0.0 111.755 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.4 pt -122.87 128.35 75.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.773 1.629 . . . . 0.0 107.933 -170.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.36 131.39 32.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 120.73 1.605 . . . . 0.0 108.637 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -132.75 -30.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -148.99 165.84 30.43 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.172 0.896 . . . . 0.0 109.253 166.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -133.92 124.28 26.13 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 127.987 2.515 . . . . 0.0 105.063 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.3 -178.29 3.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.943 1.297 . . . . 0.0 110.691 -171.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -132.37 79.49 1.86 Allowed 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 125.488 1.515 . . . . 0.0 107.761 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -168.29 -0.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.505 0.722 . . . . 0.0 112.742 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.34 25.9 38.16 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.236 0.922 . . . . 0.0 112.031 -166.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -136.06 160.02 39.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.178 1.791 . . . . 0.0 108.053 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 35.8 mtm -147.79 158.31 43.96 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -95.25 134.84 37.56 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.837 1.199 . . . . 0.0 111.053 170.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 m -142.53 175.1 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.247 1.819 . . . . 0.0 108.971 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.5 m -114.47 135.54 54.0 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 162.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -82.45 120.13 25.07 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.032 0.933 . . . . 0.0 109.261 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.31 -5.48 3.51 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.283 1.033 . . . . 0.0 113.047 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -63.76 -37.59 87.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.546 -1.216 . . . . 0.0 111.138 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 t -164.0 13.93 0.05 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.986 1.266 . . . . 0.0 113.742 -171.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 73.81 5.01 4.79 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.899 1.679 . . . . 0.0 113.463 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -54.5 116.86 2.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.101 1.76 . . . . 0.0 109.244 167.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.76 165.49 11.35 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 166.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.47 -146.62 13.86 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.68 142.02 45.78 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.687 1.195 . . . . 0.0 110.716 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.5 147.9 23.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 129.724 3.209 . . . . 0.0 107.063 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -88.78 144.77 8.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -68.39 -12.84 61.74 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -69.97 -16.19 63.15 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.152 1.381 . . . . 0.0 114.109 -171.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.5 mt -125.51 6.52 7.6 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.378 1.071 . . . . 0.0 112.363 -162.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.8 m -120.03 156.9 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.634 1.174 . . . . 0.0 110.536 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -116.45 153.35 32.27 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.846 1.258 . . . . 0.0 110.257 173.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.6 63.95 2.81 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.043 172.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.5 p -60.73 151.67 6.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 O-C-N 120.888 -1.133 . . . . 0.0 111.609 174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.21 35.41 2.29 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.122 1.344 . . . . 0.0 113.008 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.259 0 CA-C-O 116.99 -1.481 . . . . 0.0 112.398 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.758 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.7 ttt-85 -150.67 114.94 5.11 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.402 ' H ' ' CG1' ' A' ' 30' ' ' VAL . 3.4 ttt85 -109.56 -164.48 0.94 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.671 1.588 . . . . 0.0 109.78 -170.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -134.28 161.53 34.68 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 125.063 1.345 . . . . 0.0 108.872 159.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.3 164.86 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 162.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -128.73 140.9 51.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.87 141.82 51.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 120.004 1.274 . . . . 0.0 109.714 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.97 2.5 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.039 0.936 . . . . 0.0 111.729 170.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 mt -143.4 157.04 60.29 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 126.085 1.754 . . . . 0.0 107.353 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -88.38 167.47 6.38 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.695 2.93 . . . . 0.0 110.795 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -156.74 167.14 31.35 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.934 0.494 . . . . 0.0 111.13 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 m -124.43 115.5 21.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.18 2.192 . . . . 0.0 107.278 171.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -61.15 157.34 16.19 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.888 172.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.02 135.87 79.95 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 162.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 95.1 Cg_endo -70.12 163.9 36.88 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.146 1.898 . . . . 0.0 109.197 171.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.4 t70 63.2 18.27 10.84 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.601 0.715 . . . . 0.0 112.135 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.3 p -130.9 169.41 15.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.675 1.59 . . . . 0.0 108.699 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.42 3.81 38.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.458 1.503 . . . . 0.0 111.428 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -69.97 167.02 18.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.28 1.832 . . . . 0.0 110.184 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.4 pt -140.14 129.31 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 120.885 -1.134 . . . . 0.0 110.057 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -63.82 160.73 16.76 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.785 0.72 . . . . 0.0 110.105 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -161.44 173.53 14.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.276 0.56 . . . . 0.0 110.588 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mt -125.28 159.71 31.03 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.102 1.361 . . . . 0.0 109.773 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -58.29 120.47 8.76 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.29 2.24 59.11 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 117.678 -1.623 . . . . 0.0 113.117 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.84 158.42 35.53 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.893 2.346 . . . . 0.0 108.034 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.4 ttt -120.04 134.24 55.31 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 126.057 1.743 . . . . 0.0 110.986 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -111.66 165.41 12.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.554 1.168 . . . . 0.0 109.045 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 pt -118.92 138.67 48.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 163.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' CG1' ' H ' ' A' ' 3' ' ' ARG . 2.3 p -73.99 141.43 16.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 170.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.29 -21.07 1.61 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 112.596 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -150.28 160.54 43.63 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.211 1.004 . . . . 0.0 109.87 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -120.55 118.15 29.45 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 127.32 2.248 . . . . 0.0 105.451 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mt -109.82 -169.05 1.4 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.846 1.258 . . . . 0.0 107.876 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.29 14.13 3.51 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -164.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -130.83 34.23 4.12 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.787 1.635 . . . . 0.0 110.54 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.41 13.64 81.49 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.05 1.31 . . . . 0.0 113.709 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -112.65 156.27 23.02 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.119 1.368 . . . . 0.0 110.272 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.5 mtm -144.83 145.93 31.86 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.707 1.203 . . . . 0.0 108.399 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -78.73 141.62 37.72 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 164.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.49 -175.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 122.436 1.112 . . . . 0.0 111.15 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 m -135.51 125.22 25.39 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 160.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -77.05 102.74 6.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.9 -14.29 21.32 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -61.43 -19.15 61.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 117.181 -1.39 . . . . 0.0 112.679 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -164.42 11.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.799 1.181 . . . . 0.0 112.945 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.78 20.44 11.41 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.285 1.402 . . . . 0.0 112.509 -172.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.17 104.58 0.93 Allowed 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -93.81 156.25 16.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.87 -166.53 31.95 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.08 143.55 27.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.495 1.118 . . . . 0.0 109.861 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.38 151.1 31.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.12 1.368 . . . . 0.0 108.702 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.54 137.82 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -64.11 -18.79 64.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.317 1.047 . . . . 0.0 112.679 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.48 -18.27 63.61 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.551 1.14 . . . . 0.0 113.341 -166.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.6 mt -124.07 10.42 8.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.547 1.539 . . . . 0.0 111.652 -164.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.4 m -119.65 171.77 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.565 1.146 . . . . 0.0 110.864 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -130.39 152.47 49.75 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.941 2.496 . . . . 0.0 109.359 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -70.69 73.29 0.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.583 1.153 . . . . 0.0 109.901 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 p -63.71 152.3 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 120.206 -1.558 . . . . 0.0 109.14 172.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.73 17.59 2.61 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.483 1.04 . . . . 0.0 111.722 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.111 -1.423 . . . . 0.0 110.073 -175.637 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.919 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.04 154.1 44.72 Favored 'General case' 0 C--O 1.239 0.545 0 O-C-N 121.428 -1.042 . . . . 0.0 109.018 167.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.23 -164.64 1.27 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.121 1.368 . . . . 0.0 109.271 -170.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -132.27 154.68 49.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.343 -0.848 . . . . 0.0 109.719 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.89 166.54 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.433 0.693 . . . . 0.0 109.147 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -138.01 136.26 36.72 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.857 -1.152 . . . . 0.0 110.402 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.45 120.53 16.23 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.266 1.027 . . . . 0.0 110.06 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.6 -4.02 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.137 172.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.28 2.1 pp -162.57 152.75 13.84 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.398 1.479 . . . . 0.0 108.519 -171.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.67 160.86 21.89 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.684 2.922 . . . . 0.0 112.336 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -143.22 163.01 34.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.371 1.868 . . . . 0.0 109.2 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.8 m -128.77 105.82 8.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.542 1.137 . . . . 0.0 108.439 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.42 157.02 38.42 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.991 0.517 . . . . 0.0 110.571 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.3 t -87.82 141.35 31.62 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -70.68 141.96 42.74 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 O-C-N 118.418 -1.412 . . . . 0.0 109.212 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.9 t70 75.45 33.93 0.64 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.652 1.981 . . . . 0.0 112.753 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.6 p -132.47 167.19 20.41 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.046 -1.034 . . . . 0.0 111.594 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.5 20.39 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 128.941 2.897 . . . . 0.0 111.814 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -110.04 169.3 8.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.27 1.428 . . . . 0.0 110.678 -160.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -140.15 150.55 21.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.243 1.417 . . . . 0.0 109.063 174.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 p -95.77 167.24 11.39 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -161.74 156.59 23.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.78 174.07 6.03 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.417 1.103 . . . . 0.0 108.905 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -57.98 123.54 16.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 168.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.02 1.54 57.13 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-O 118.359 -1.245 . . . . 0.0 114.486 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.39 162.66 22.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.38 1.59 . . . . 0.0 111.249 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.454 ' SD ' ' HD2' ' A' ' 62' ' ' ARG . 25.5 ttt -137.14 145.58 43.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.135 1.374 . . . . 0.0 108.822 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.09 175.38 9.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.432 1.093 . . . . 0.0 109.937 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 pt -126.13 138.69 53.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.558 1.543 . . . . 0.0 106.877 176.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.92 136.13 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 118.684 0.675 . . . . 0.0 109.763 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -139.19 -18.36 1.01 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -155.66 164.88 38.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.363 1.438 . . . . 0.0 108.912 159.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.89 114.07 11.45 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.323 1.849 . . . . 0.0 106.384 -167.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -114.08 154.03 28.43 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.063 0.945 . . . . 0.0 111.384 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -92.91 48.09 1.32 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.575 1.15 . . . . 0.0 110.927 -164.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -161.28 34.78 0.14 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.275 1.03 . . . . 0.0 110.443 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.83 -2.82 58.54 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.441 1.019 . . . . 0.0 114.223 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -87.54 153.6 21.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.516 1.158 . . . . 0.0 110.886 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.1 mtm -143.93 134.61 25.0 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -76.75 138.99 40.26 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.31 -176.35 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 122.332 1.063 . . . . 0.0 111.554 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -127.8 126.51 41.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 155.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.09 116.14 19.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.622 1.969 . . . . 0.0 108.853 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mt -87.28 13.86 8.93 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.542 -0.724 . . . . 0.0 112.391 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.9 ttp85 -79.97 -16.54 55.01 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.328 -1.483 . . . . 0.0 111.058 170.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -163.77 7.35 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.539 0.609 . . . . 0.0 112.233 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 63.23 23.83 14.04 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.055 1.742 . . . . 0.0 112.682 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.8 108.33 2.49 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.658 0.783 . . . . 0.0 109.361 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -87.87 149.38 24.14 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.655 -0.653 . . . . 0.0 110.147 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.71 -171.93 35.49 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.311 1.434 . . . . 0.0 109.965 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.1 mt -89.93 138.83 31.17 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.52 1.128 . . . . 0.0 112.303 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -134.23 162.87 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 127.194 2.197 . . . . 0.0 108.217 166.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 p -109.59 146.19 15.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 123.89 0.876 . . . . 0.0 109.163 -175.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -68.22 -17.33 64.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.278 1.431 . . . . 0.0 112.255 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.22 -29.23 69.7 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.917 0.887 . . . . 0.0 111.705 -177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 50.2 mt -115.97 5.22 13.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.58 1.152 . . . . 0.0 111.03 -161.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.36 165.84 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.87 1.268 . . . . 0.0 110.882 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -120.66 152.69 37.88 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 125.782 1.633 . . . . 0.0 108.681 172.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -78.7 69.93 4.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.652 1.181 . . . . 0.0 109.573 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 p -70.98 165.27 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.586 0.708 . . . . 0.0 109.429 173.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.92 13.52 5.0 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.26 0.934 . . . . 0.0 112.851 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.454 ' HD2' ' SD ' ' A' ' 27' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.959 0 CA-C-O 117.432 -1.271 . . . . 0.0 110.826 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -137.35 -4.89 1.84 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.6 128.05 42.14 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 17.5 mtt180 -134.19 166.91 21.68 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.01 154.97 37.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.416 1.087 . . . . 0.0 108.688 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -119.12 133.55 55.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . . . -84.7 154.63 22.35 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.505 1.048 . . . . 0.0 109.724 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.21 11.56 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.196 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.59 161.7 32.46 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.455 2.302 . . . . 0.0 107.859 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -86.46 162.27 9.6 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.927 3.085 . . . . 0.0 111.646 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -159.13 132.05 6.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.776 1.231 . . . . 0.0 110.604 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 t -97.07 137.79 35.6 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 172.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -89.16 139.08 30.84 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.342 -177.119 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.46 134.59 94.51 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 120.242 1.383 . . . . 0.0 108.267 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 60.3 Cg_endo -67.58 162.12 40.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.126 1.884 . . . . 0.0 109.773 168.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.48 -11.44 1.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.04 2.136 . . . . 0.0 113.129 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -118.6 169.0 10.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.564 1.146 . . . . 0.0 111.057 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -92.15 21.31 5.19 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.71 1.604 . . . . 0.0 111.358 -167.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -68.35 163.83 22.21 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.492 -1.38 . . . . 0.0 109.749 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 pt -130.74 138.67 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 120.869 -1.144 . . . . 0.0 111.01 169.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.5 m -73.56 156.09 38.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -147.29 165.21 30.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 122.303 1.049 . . . . 0.0 110.635 164.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.19 166.11 11.35 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -64.88 125.97 26.5 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.0 47.93 1.21 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.007 1.289 . . . . 0.0 113.26 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.7 167.14 23.84 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.206 1.802 . . . . 0.0 108.998 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.3 mtp -138.03 149.75 46.33 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.103 0.961 . . . . 0.0 111.032 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -136.33 159.94 40.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.826 1.25 . . . . 0.0 109.701 -173.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.9 pt -110.52 138.4 38.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.27 129.12 33.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -121.17 -32.07 3.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.107 174.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -152.15 162.44 41.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.066 0.848 . . . . 0.0 111.043 167.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -108.54 132.97 53.31 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.632 1.973 . . . . 0.0 106.813 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.3 mt -125.82 -168.53 1.86 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.106 1.762 . . . . 0.0 107.364 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.68 14.04 3.42 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.583 1.083 . . . . 0.0 113.831 -158.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -120.25 16.13 12.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.363 1.465 . . . . 0.0 111.55 -168.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.84 13.59 69.22 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.669 -1.27 . . . . 0.0 111.862 -168.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -125.86 150.27 48.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.685 1.594 . . . . 0.0 109.706 -169.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 56.8 mtm -142.96 144.39 32.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.827 1.251 . . . . 0.0 108.91 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -81.62 135.6 35.55 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.999 0.52 . . . . 0.0 110.302 170.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.39 175.24 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.416 1.086 . . . . 0.0 110.268 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.3 m -112.38 134.86 53.68 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 154.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -76.54 165.08 25.3 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -88.62 -35.11 17.03 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 121.927 2.149 . . . . 0.0 113.213 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -51.89 -29.22 18.98 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -165.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.251 9.5 t -152.96 18.26 0.58 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.224 1.81 . . . . 0.0 112.593 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 52.36 26.89 4.39 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.222 1.809 . . . . 0.0 112.5 -172.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -66.1 148.3 52.02 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.643 -1.286 . . . . 0.0 111.234 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -137.87 144.88 41.59 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.061 0.945 . . . . 0.0 108.457 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.56 -157.51 27.32 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.7 147.01 27.75 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.895 0.878 . . . . 0.0 112.437 -165.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.1 pt -136.01 147.97 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 126.674 1.99 . . . . 0.0 110.909 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.92 138.01 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.025 1.33 . . . . 0.0 109.732 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.75 -0.78 22.13 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.661 1.184 . . . . 0.0 112.849 -172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -24.12 65.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.793 1.637 . . . . 0.0 112.86 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.4 mt -127.94 13.86 6.83 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.36 1.064 . . . . 0.0 112.665 -158.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.4 m -122.66 170.79 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 126.318 1.847 . . . . 0.0 111.489 -176.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -132.23 155.68 47.83 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 127.772 2.429 . . . . 0.0 109.748 172.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -69.8 78.41 0.45 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.72 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -68.7 165.53 2.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 O-C-N 120.911 -1.118 . . . . 0.0 108.81 162.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.93 19.13 0.66 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.653 1.597 . . . . 0.0 110.977 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 . . . . . 0 C--O 1.249 1.058 0 C-N-CA 125.715 1.606 . . . . 0.0 108.993 -170.287 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.883 0 CA-C-O 117.816 -1.547 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.9 mtm-85 51.62 61.11 3.39 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.418 1.109 . . . . 0.0 111.316 167.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . 0.257 0.0 OUTLIER -147.74 -162.14 1.48 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.249 1.42 . . . . 0.0 107.279 -167.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -117.42 173.71 6.55 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 119.553 -1.967 . . . . 0.0 109.876 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.1 160.18 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 120.512 -1.367 . . . . 0.0 110.531 171.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.72 118.51 28.24 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 125.784 1.633 . . . . 0.0 108.974 -170.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.02 127.11 31.96 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.467 0.707 . . . . 0.0 109.433 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.96 -0.16 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.371 0.669 . . . . 0.0 111.762 172.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.4 161.39 29.42 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 125.817 1.647 . . . . 0.0 109.011 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -87.23 160.47 8.43 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 124.243 3.296 . . . . 0.0 111.25 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -151.74 166.2 32.07 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.633 1.173 . . . . 0.0 110.361 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 t -125.74 136.08 52.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -172.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -70.01 150.54 46.54 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 118.806 -1.157 . . . . 0.0 108.776 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.2 t -75.27 137.53 71.83 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.28 146.38 69.18 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 N-CA-C 108.446 -1.405 . . . . 0.0 108.446 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 t70 75.62 4.94 4.01 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.76 2.024 . . . . 0.0 113.408 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.6 p -108.91 -177.17 3.24 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 120.339 -1.475 . . . . 0.0 112.187 -175.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -83.93 -17.47 40.59 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.102 1.361 . . . . 0.0 109.843 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 165.18 18.5 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.369 1.468 . . . . 0.0 111.954 -164.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 pt -127.43 134.15 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.806 1.242 . . . . 0.0 109.68 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.33 160.76 12.63 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.735 0.814 . . . . 0.0 108.948 173.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -157.43 173.33 17.07 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.935 0.874 . . . . 0.0 113.117 170.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.4 mt -127.96 160.98 30.21 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.111 1.364 . . . . 0.0 109.097 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -62.1 141.47 58.11 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.92 -4.78 81.82 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.681 1.134 . . . . 0.0 114.055 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.3 168.51 19.02 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.007 1.404 . . . . 0.0 109.017 171.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 38.1 mtp -135.51 150.66 49.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.89 0.876 . . . . 0.0 109.525 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -136.06 159.06 42.86 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.91 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.7 pt -112.16 125.19 69.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.6 p -63.71 112.45 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.21 -38.32 5.79 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.745 0.818 . . . . 0.0 110.047 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -148.08 172.34 14.42 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -133.07 133.52 43.1 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -175.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.1 mt -120.33 -168.82 1.69 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.615 1.166 . . . . 0.0 109.056 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -136.31 57.78 1.76 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.452 1.101 . . . . 0.0 109.094 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -154.06 22.43 0.5 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.214 171.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.98 23.23 69.61 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.145 -1.597 . . . . 0.0 112.296 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -130.34 148.47 52.16 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.759 2.024 . . . . 0.0 108.534 -170.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.0 mtm -144.77 132.63 21.26 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -72.13 134.62 45.85 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.88 178.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 123.349 0.659 . . . . 0.0 111.793 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 5.2 m -115.03 143.59 44.94 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 154.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -86.47 119.6 26.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.384 1.073 . . . . 0.0 110.105 168.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.98 1.31 2.77 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.478 1.111 . . . . 0.0 113.465 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -66.3 -46.45 76.92 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.219 -1.551 . . . . 0.0 110.423 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -146.13 -3.43 0.66 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.254 1.022 . . . . 0.0 112.551 -157.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.4 t70 68.21 11.54 8.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.172 1.789 . . . . 0.0 112.907 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -61.14 118.34 6.69 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.111 0.964 . . . . 0.0 108.744 167.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 9.5 mp0 -81.84 168.67 17.73 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.385 0.612 . . . . 0.0 110.694 166.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.82 -165.45 30.16 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.6 mt -99.4 143.83 29.2 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.701 0.8 . . . . 0.0 110.825 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.19 151.34 33.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 125.446 1.498 . . . . 0.0 109.035 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 p -88.58 135.84 24.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.952 1.701 . . . . 0.0 107.934 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.34 -10.29 59.43 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -56.65 -18.4 12.07 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.718 2.407 . . . . 0.0 113.717 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -131.11 13.48 5.17 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.024 1.33 . . . . 0.0 113.296 -164.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.75 153.91 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.237 1.015 . . . . 0.0 112.395 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -117.69 148.29 42.13 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.848 1.659 . . . . 0.0 111.076 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.97 100.86 2.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 128.97 2.908 . . . . 0.0 110.139 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.55 ' CG2' ' HE ' ' A' ' 62' ' ' ARG . 4.4 p -120.11 147.01 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.873 0.844 . . . . 0.0 111.543 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.13 57.18 0.9 Allowed Glycine 0 CA--C 1.519 0.325 0 C-N-CA 124.572 1.082 . . . . 0.0 111.258 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.55 ' HE ' ' CG2' ' A' ' 60' ' ' VAL . 31.0 mtt-85 . . . . . 0 C--O 1.242 0.679 0 C-N-CA 125.133 1.373 . . . . 0.0 107.783 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.607 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -139.58 133.13 30.31 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.98 113.9 12.66 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -119.8 159.51 24.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.631 1.572 . . . . 0.0 108.469 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -137.9 164.83 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 167.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.2 tpp85 -128.08 129.91 47.38 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.458 1.503 . . . . 0.0 107.349 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.28 125.06 25.96 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 120.463 1.483 . . . . 0.0 108.944 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.28 0.2 OUTLIER -113.36 4.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.423 170.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.8 mt -146.28 157.66 48.9 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.833 1.653 . . . . 0.0 109.176 165.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.31 166.77 15.99 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.82 3.68 . . . . 0.0 111.584 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -153.0 163.58 39.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.605 1.162 . . . . 0.0 109.218 173.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -124.31 120.66 32.83 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.528 1.531 . . . . 0.0 109.049 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -61.33 149.14 39.06 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 124.536 1.147 . . . . 0.0 111.22 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.3 135.45 86.73 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -62.55 153.44 71.49 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.1 2.533 . . . . 0.0 110.221 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.36 38.91 22.78 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.078 1.351 . . . . 0.0 111.842 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 p -138.45 166.03 25.31 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.031 0.932 . . . . 0.0 111.84 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.13 -13.55 48.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.867 2.867 . . . . 0.0 113.055 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -63.49 170.11 3.36 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.181 1.793 . . . . 0.0 113.171 -171.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 pt -131.05 136.71 57.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.743 1.217 . . . . 0.0 110.288 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -72.99 149.71 43.06 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.271 1.428 . . . . 0.0 110.9 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -155.11 158.66 39.36 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.689 -1.257 . . . . 0.0 112.806 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.66 170.32 8.0 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.904 0.859 . . . . 0.0 109.458 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -56.98 134.97 56.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 168.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.42 -11.13 56.69 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 118.872 -0.96 . . . . 0.0 114.148 171.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.26 167.74 19.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.673 1.236 . . . . 0.0 108.897 160.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 18.7 ptm -144.67 168.15 20.85 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 124.083 0.953 . . . . 0.0 109.317 170.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -138.42 163.75 31.11 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.608 1.163 . . . . 0.0 109.614 -164.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.5 pt -127.4 130.94 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 125.283 1.433 . . . . 0.0 107.393 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.94 127.8 29.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -127.55 -15.18 5.09 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.715 0.806 . . . . 0.0 113.106 172.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -150.18 166.42 29.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 156.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -121.53 124.68 44.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.51 -167.49 1.26 Allowed 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -138.48 68.58 1.39 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.398 1.479 . . . . 0.0 107.594 -170.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -168.16 15.8 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.395 1.478 . . . . 0.0 112.312 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.96 37.89 88.28 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.13 1.347 . . . . 0.0 111.848 -169.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -137.72 149.17 46.27 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.588 1.955 . . . . 0.0 107.259 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.2 mtm -134.98 142.99 46.6 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.601 1.161 . . . . 0.0 108.689 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -78.1 135.66 37.74 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 165.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.57 -173.34 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 122.361 1.077 . . . . 0.0 110.804 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 m -131.09 147.31 52.6 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 157.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -97.55 132.01 43.62 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 mt -68.01 -10.1 50.99 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.47 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -65.48 -43.13 91.18 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.37 1.441 . . . . 0.0 112.11 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 p -143.7 9.56 1.56 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.405 1.082 . . . . 0.0 111.738 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 t70 58.31 32.67 22.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.002 0.921 . . . . 0.0 111.429 -167.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -72.29 140.8 48.76 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.913 -1.117 . . . . 0.0 109.417 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -126.45 151.86 47.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 146.62 -155.92 26.76 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.6 mt -108.81 141.88 40.18 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.335 1.054 . . . . 0.0 110.54 -164.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.8 150.75 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.791 1.637 . . . . 0.0 109.292 171.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.33 146.59 5.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 125.901 1.68 . . . . 0.0 109.47 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -87.72 10.71 17.36 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.84 -24.45 60.89 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.564 1.146 . . . . 0.0 113.822 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -125.46 16.28 8.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -156.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.93 170.52 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.013 0.925 . . . . 0.0 112.353 -168.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.86 151.94 41.23 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.133 -0.979 . . . . 0.0 109.827 160.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.94 57.58 2.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 128.691 2.797 . . . . 0.0 111.3 -172.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.14 156.4 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 120.525 -1.359 . . . . 0.0 111.769 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.21 5.58 57.63 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.476 1.512 . . . . 0.0 113.158 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 . . . . . 0 C--O 1.245 0.823 0 C-N-CA 124.581 1.152 . . . . 0.0 112.351 -174.613 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.937 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -84.48 65.44 8.95 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 121.275 -1.132 . . . . 0.0 109.7 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.43 148.45 44.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.28 150.23 51.91 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.464 1.506 . . . . 0.0 108.34 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.74 164.25 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 120.071 1.305 . . . . 0.0 108.82 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -112.17 141.53 45.74 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.52 139.49 30.52 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 119.612 1.097 . . . . 0.0 111.016 175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.68 12.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.159 0.984 . . . . 0.0 112.507 -172.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.8 158.61 33.96 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.198 1.399 . . . . 0.0 108.548 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -88.54 163.36 6.56 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.541 3.494 . . . . 0.0 111.635 171.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -158.67 141.29 14.33 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.836 1.254 . . . . 0.0 110.207 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.9 m -103.74 118.12 35.97 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.923 1.289 . . . . 0.0 109.959 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.417 ' HE3' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -78.63 160.42 27.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.868 0.867 . . . . 0.0 111.937 175.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.4 t -89.39 130.46 43.66 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 125.698 1.599 . . . . 0.0 108.235 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 8.3 Cg_endo -64.84 159.2 46.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.716 1.611 . . . . 0.0 112.854 173.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.251 2.9 t70 69.61 27.71 4.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.675 1.99 . . . . 0.0 112.306 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.0 p -131.4 -178.78 5.0 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.461 1.105 . . . . 0.0 110.921 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.74 8.65 36.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.313 2.645 . . . . 0.0 109.465 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -84.45 175.59 9.23 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.605 -1.309 . . . . 0.0 109.174 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.9 pt -148.64 144.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.2 2.2 . . . . 0.0 107.676 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.5 p -102.23 169.15 8.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 121.892 2.133 . . . . 0.0 111.205 174.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -170.18 -171.23 1.09 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.12 0.486 . . . . 0.0 112.234 -174.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 mt -128.44 153.22 47.34 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.888 1.675 . . . . 0.0 109.471 -175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -52.31 127.31 21.74 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.522 -0.736 . . . . 0.0 109.079 168.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.72 -10.49 32.48 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 124.725 1.155 . . . . 0.0 114.211 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.38 158.49 35.69 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.363 1.581 . . . . 0.0 110.197 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.5 ttt -114.49 148.94 37.1 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.471 1.108 . . . . 0.0 108.286 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -125.85 162.66 24.64 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.289 1.036 . . . . 0.0 109.992 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.37 127.49 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.357 1.463 . . . . 0.0 108.99 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 68.5 t -68.78 101.22 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 119.362 0.983 . . . . 0.0 109.354 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -95.3 -34.49 12.16 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.199 -0.938 . . . . 0.0 111.108 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -149.3 175.05 11.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.618 1.167 . . . . 0.0 109.021 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -138.93 127.32 22.91 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.851 2.46 . . . . 0.0 104.96 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.1 -163.01 0.85 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.293 1.437 . . . . 0.0 109.508 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -134.46 44.11 2.71 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.296 -1.502 . . . . 0.0 113.282 -168.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.91 1.48 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.888 1.275 . . . . 0.0 112.074 -157.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.55 5.0 90.26 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.1 1.333 . . . . 0.0 113.263 -167.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 84.7 m95 -112.26 149.55 32.17 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.962 2.105 . . . . 0.0 110.861 -175.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.7 mtm -149.12 143.65 26.13 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.764 -1.21 . . . . 0.0 110.084 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -86.7 136.66 32.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.099 0.409 . . . . 0.0 111.016 174.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 m -147.7 -167.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.835 0.854 . . . . 0.0 111.413 -172.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.3 m -140.05 150.99 45.04 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 159.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.71 107.3 18.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.143 2.177 . . . . 0.0 108.075 -173.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.1 mt -68.7 1.18 3.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.35 -27.13 63.15 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.311 -1.493 . . . . 0.0 113.165 169.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -167.39 13.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -165.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 t0 60.75 32.8 20.24 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 123.509 1.623 . . . . 0.0 111.52 -174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -74.88 99.56 3.83 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 120.797 -1.189 . . . . 0.0 108.366 172.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -81.99 139.53 34.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.57 1.548 . . . . 0.0 109.551 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.99 -169.17 40.13 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.417 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.9 mt -89.95 139.62 30.42 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.916 2.086 . . . . 0.0 112.997 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.31 158.52 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.147 1.779 . . . . 0.0 111.177 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.96 152.86 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 C-N-CA 124.126 0.97 . . . . 0.0 111.646 164.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.53 -22.89 67.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.285 164.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -62.57 -17.01 59.16 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 122.937 1.351 . . . . 0.0 112.48 -164.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.9 mt -124.83 6.04 8.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.567 1.547 . . . . 0.0 110.885 -160.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -124.94 159.14 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.77 1.228 . . . . 0.0 109.476 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -117.83 153.59 33.24 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.976 1.311 . . . . 0.0 108.28 173.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.307 0.0 OUTLIER -80.51 118.39 22.07 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.694 1.235 . . . . 0.0 108.723 171.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.26 165.63 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.816 2.047 . . . . 0.0 106.344 171.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.68 -93.81 0.73 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 160.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.136 0 C-N-CA 125.519 1.528 . . . . 0.0 107.086 -151.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -139.06 105.49 5.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -130.87 174.18 10.23 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 123.508 0.723 . . . . 0.0 109.923 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -141.77 141.17 33.2 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.366 1.867 . . . . 0.0 107.733 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 m -125.73 160.27 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.146 0.978 . . . . 0.0 108.487 167.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -115.57 129.68 56.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.62 131.44 41.68 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.004 0.82 . . . . 0.0 108.794 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.86 4.29 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.291 0.636 . . . . 0.0 111.43 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 mt -146.72 154.29 47.7 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.058 1.743 . . . . 0.0 107.893 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.86 169.02 20.1 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.693 3.595 . . . . 0.0 111.792 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -154.23 166.36 33.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.586 0.708 . . . . 0.0 112.884 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.4 m -116.6 102.02 9.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.516 2.326 . . . . 0.0 109.916 -170.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HE3' ' HA ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -57.26 143.46 39.34 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 177.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.02 135.49 82.67 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 166.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.72 151.27 79.14 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.704 2.269 . . . . 0.0 109.849 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.0 t70 61.25 30.27 19.11 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.81 0.844 . . . . 0.0 111.573 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -128.35 170.92 12.53 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.92 4.05 18.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.373 0.669 . . . . 0.0 109.359 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 40.2 mt-10 -67.04 161.95 23.25 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.733 1.213 . . . . 0.0 110.432 173.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.5 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 18.9 pt -141.96 148.26 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.182 1.393 . . . . 0.0 107.852 172.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.13 145.15 51.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.29 164.86 29.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.447 0.642 . . . . 0.0 110.859 170.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.46 163.33 15.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.063 0.945 . . . . 0.0 109.702 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -57.97 133.97 55.97 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 163.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.69 -2.1 76.37 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 117.113 -1.937 . . . . 0.0 112.718 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -71.36 167.8 18.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.784 2.292 . . . . 0.0 109.529 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 19.7 ttt -140.6 147.69 39.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.499 1.52 . . . . 0.0 107.516 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -130.85 170.06 14.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.047 0.842 . . . . 0.0 109.958 -175.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.4 pt -131.52 133.69 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.319 1.448 . . . . 0.0 107.635 170.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -69.05 116.88 10.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.4 -20.37 11.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.563 0.745 . . . . 0.0 110.786 176.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -152.03 -176.55 5.7 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.408 1.004 . . . . 0.0 110.229 160.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -125.04 130.35 52.11 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.334 1.853 . . . . 0.0 108.271 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -107.18 -163.45 0.91 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 166.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -134.4 14.56 3.78 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.357 0.98 . . . . 0.0 112.236 -170.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -120.13 11.24 11.6 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.033 1.733 . . . . 0.0 111.278 -159.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.68 20.72 65.39 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 127.083 2.278 . . . . 0.0 112.124 -167.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -127.01 150.9 49.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.371 1.086 . . . . 0.0 110.636 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.5 mtm -136.14 135.51 39.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.494 ' CE3' ' CD2' ' A' ' 51' ' ' LEU . 11.9 t-105 -73.46 128.27 35.01 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.29 1.436 . . . . 0.0 108.462 162.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.55 -173.89 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 123.824 0.85 . . . . 0.0 110.928 -174.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.5 m -124.48 132.98 53.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 157.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -86.07 112.17 21.01 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.59 1.156 . . . . 0.0 108.657 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.7 mt -67.33 -9.41 40.86 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.955 -1.022 . . . . 0.0 113.187 -172.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -30.43 70.97 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 120.921 1.692 . . . . 0.0 113.412 173.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.0 p -147.96 -8.86 0.4 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.526 1.141 . . . . 0.0 113.795 -165.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 t0 73.7 10.5 4.77 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.134 1.374 . . . . 0.0 112.349 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -61.55 126.12 26.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.843 1.657 . . . . 0.0 108.216 167.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -93.13 170.23 9.81 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 109.963 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.93 -158.02 21.79 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 118.139 0.427 . . . . 0.0 112.893 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.494 ' CD2' ' CE3' ' A' ' 40' ' ' TRP . 1.8 mm? -98.54 135.24 40.37 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.544 1.138 . . . . 0.0 111.587 -160.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -140.17 146.33 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.945 1.698 . . . . 0.0 108.941 174.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -85.86 138.83 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 124.366 1.067 . . . . 0.0 108.951 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.88 3.8 9.37 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.77 -20.01 60.61 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.546 -1.346 . . . . 0.0 114.401 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -126.76 21.02 7.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.194 0.997 . . . . 0.0 112.374 -160.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 m -130.76 173.82 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.269 1.428 . . . . 0.0 109.884 -170.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.15 154.47 50.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.672 1.989 . . . . 0.0 109.289 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.04 37.17 0.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.756 2.022 . . . . 0.0 114.471 -170.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 p -45.43 142.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 126.05 1.74 . . . . 0.0 113.83 -165.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.86 -5.01 83.68 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.883 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 . . . . . 0 C--O 1.25 1.081 0 C-N-CA 125.828 1.651 . . . . 0.0 110.963 -161.373 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.881 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.85 43.03 1.58 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.347 1.07 . . . . 0.0 110.451 -173.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -80.21 -176.03 5.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.797 0.839 . . . . 0.0 112.21 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.9 mpp_? -136.92 115.78 12.24 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.204 1.402 . . . . 0.0 109.507 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.32 170.3 3.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.947 0.88 . . . . 0.0 109.604 171.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -134.59 135.32 42.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.798 1.639 . . . . 0.0 107.766 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.91 137.62 37.73 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.825 1.193 . . . . 0.0 109.039 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.275 0.2 OUTLIER -114.92 8.31 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 178.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.39 165.48 17.43 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 126.508 1.923 . . . . 0.0 108.168 169.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -82.36 168.53 14.75 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.24 2.626 . . . . 0.0 110.065 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -147.43 -178.03 6.01 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.921 0.888 . . . . 0.0 110.099 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.9 m -134.49 105.33 6.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.449 2.3 . . . . 0.0 108.083 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -61.93 145.8 51.84 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.286 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -59.87 140.45 90.01 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 167.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -72.85 138.79 29.33 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.464 2.776 . . . . 0.0 111.093 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 73.34 43.83 0.35 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.184 2.193 . . . . 0.0 111.907 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.408 HG22 ' CG1' ' A' ' 14' ' ' VAL . 28.4 p -143.32 169.55 17.44 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 121.184 -0.947 . . . . 0.0 111.731 -168.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -85.91 -0.66 55.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.914 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -65.66 168.27 7.88 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.545 1.138 . . . . 0.0 111.163 172.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.53 122.76 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.464 1.906 . . . . 0.0 110.146 -176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.51 124.3 19.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.842 0.857 . . . . 0.0 109.998 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -136.4 164.86 27.15 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.1 0.96 . . . . 0.0 111.226 -175.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.12 167.06 11.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.271 1.028 . . . . 0.0 111.218 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -55.4 140.72 38.96 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 158.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.88 5.86 83.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-O 117.701 -1.61 . . . . 0.0 112.751 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -82.85 169.92 15.56 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.94 1.87 . . . . 0.0 110.53 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -143.28 151.44 40.54 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.708 1.203 . . . . 0.0 110.5 -174.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -138.7 173.53 11.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 124.348 1.03 . . . . 0.0 111.432 -168.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.2 pt -135.59 135.18 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 126.093 1.757 . . . . 0.0 107.697 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.21 117.36 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.74 -21.08 10.37 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.345 -0.847 . . . . 0.0 112.736 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -152.86 -177.29 6.18 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -135.88 124.13 23.19 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.743 1.617 . . . . 0.0 107.36 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mt -103.64 -168.9 1.56 Allowed 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.385 1.074 . . . . 0.0 108.648 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -136.65 51.7 1.98 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.536 1.534 . . . . 0.0 109.059 -169.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -159.64 22.65 0.18 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.652 1.181 . . . . 0.0 108.923 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.46 -2.33 7.74 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 119.542 -1.974 . . . . 0.0 114.052 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -86.85 149.97 24.45 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.176 0.991 . . . . 0.0 110.487 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.5 mtm -136.07 136.0 39.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.526 1.13 . . . . 0.0 109.001 172.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.496 ' CE3' ' CD2' ' A' ' 51' ' ' LEU . 14.1 t-105 -80.4 129.83 34.76 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.996 1.719 . . . . 0.0 108.678 167.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.5 m -142.44 -176.55 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.381 1.072 . . . . 0.0 110.984 -173.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.3 m -118.17 136.22 53.76 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 154.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -88.38 114.61 25.17 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.19 1.796 . . . . 0.0 108.073 166.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.81 -3.28 14.93 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -61.72 -31.58 71.75 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.674 1.579 . . . . 0.0 112.792 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -159.85 12.82 0.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.748 0.704 . . . . 0.0 111.259 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 t0 74.03 19.58 2.98 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.725 1.21 . . . . 0.0 112.519 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -61.43 137.26 58.24 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.792 1.637 . . . . 0.0 107.981 168.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -118.87 158.36 25.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.103 0.961 . . . . 0.0 109.408 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.0 -153.48 21.47 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 124.003 0.815 . . . . 0.0 111.491 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.496 ' CD2' ' CE3' ' A' ' 40' ' ' TRP . 2.6 mm? -94.85 141.71 28.31 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.629 0.772 . . . . 0.0 110.978 -160.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.87 156.96 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 127.161 2.184 . . . . 0.0 107.379 170.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.83 145.45 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.782 0.833 . . . . 0.0 109.397 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -68.07 -18.74 64.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 112.935 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.43 -15.57 63.43 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -168.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.5 mt -124.48 7.2 8.3 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.184 1.394 . . . . 0.0 113.415 -160.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.89 172.06 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 119.183 0.901 . . . . 0.0 110.742 -175.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.59 145.12 44.53 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.26 1.824 . . . . 0.0 108.231 167.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.16 113.84 3.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.32 161.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 p -116.34 160.91 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 165.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.66 -77.84 1.23 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 106.564 -2.614 . . . . 0.0 106.564 166.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 . . . . . 0 C--O 1.256 1.397 0 C-N-CA 129.041 2.936 . . . . 0.0 111.276 -178.786 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.804 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -73.44 49.89 0.3 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.557 1.943 . . . . 0.0 114.51 -172.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.6 160.14 42.98 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 120.346 -1.472 . . . . 0.0 107.404 166.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -146.15 152.14 38.79 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.265 1.026 . . . . 0.0 108.474 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.13 166.23 10.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 121.908 0.861 . . . . 0.0 111.538 165.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -129.59 136.37 49.7 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 127.315 2.246 . . . . 0.0 106.343 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.41 139.89 37.58 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.58 -2.25 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.487 173.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mt -148.43 155.59 42.39 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.312 2.245 . . . . 0.0 108.055 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.14 168.22 15.35 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 124.153 3.235 . . . . 0.0 112.896 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -160.59 150.76 17.94 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.681 1.192 . . . . 0.0 111.425 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 t -116.3 131.81 56.84 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' H ' ' HB3' ' A' ' 21' ' ' SER . 0.7 OUTLIER -92.84 168.65 11.03 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.117 1.367 . . . . 0.0 111.155 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.27 119.09 57.44 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -58.24 167.28 4.83 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.979 1.786 . . . . 0.0 110.788 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.5 -9.06 1.47 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.247 2.219 . . . . 0.0 113.246 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.7 p -108.4 175.6 5.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.486 1.115 . . . . 0.0 111.706 -174.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -81.62 5.93 16.64 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.313 1.045 . . . . 0.0 112.406 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -77.34 175.74 9.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.931 1.692 . . . . 0.0 111.081 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.3 pt -150.98 156.22 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.828 2.051 . . . . 0.0 109.506 174.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.427 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 19.9 p -116.76 152.57 34.07 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.956 1.303 . . . . 0.0 110.261 -171.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.38 170.84 21.37 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 111.401 -165.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.35 163.68 23.47 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.408 0.683 . . . . 0.0 109.238 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -58.44 144.58 41.6 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.02 -8.23 64.02 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.586 -0.563 . . . . 0.0 113.746 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -69.06 170.56 9.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.806 1.289 . . . . 0.0 110.207 168.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.7 mmm -132.44 163.05 29.63 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.116 1.367 . . . . 0.0 108.995 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -137.23 -176.29 4.34 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 112.814 -1.994 . . . . 0.0 108.821 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.9 pt -143.8 150.27 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 125.772 1.629 . . . . 0.0 107.231 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.7 t -76.14 131.51 34.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -120.6 -44.34 2.45 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.512 1.125 . . . . 0.0 109.595 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -143.88 166.82 23.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.775 0.798 . . . . 0.0 110.434 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -141.02 120.77 13.43 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 126.946 2.098 . . . . 0.0 105.811 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mt -108.39 -164.94 0.99 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.377 1.471 . . . . 0.0 108.508 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -134.57 66.78 1.53 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.262 1.425 . . . . 0.0 108.547 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.25 6.37 0.12 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.26 1.024 . . . . 0.0 112.739 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.45 15.55 71.04 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.961 1.743 . . . . 0.0 112.918 -165.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -122.44 145.76 48.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.463 1.905 . . . . 0.0 109.829 -171.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -144.7 144.99 31.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 109.686 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -91.61 136.87 32.81 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.909 0.884 . . . . 0.0 112.105 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.36 -175.49 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.84 1.256 . . . . 0.0 111.042 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.0 m -123.2 132.72 54.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 158.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.66 108.14 17.23 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.435 1.894 . . . . 0.0 108.646 174.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mt -76.06 16.91 0.38 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -66.68 -35.13 79.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.388 163.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.6 t -169.46 16.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 117.472 -1.251 . . . . 0.0 113.052 -169.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 75.47 18.29 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.12 1.368 . . . . 0.0 113.303 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.19 134.23 54.4 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.596 -0.69 . . . . 0.0 109.336 170.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -124.92 142.85 51.19 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.18 0.992 . . . . 0.0 108.758 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.06 -160.91 28.58 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.37 147.06 23.91 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.507 1.123 . . . . 0.0 112.406 -165.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.2 pt -133.52 157.0 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.876 1.671 . . . . 0.0 109.995 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.22 147.77 7.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 126.119 1.768 . . . . 0.0 107.786 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -75.62 2.03 12.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -80.75 -18.33 48.05 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.427 1.491 . . . . 0.0 113.123 -172.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -123.29 14.79 9.7 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.185 -1.572 . . . . 0.0 112.415 -168.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.09 161.67 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.979 1.711 . . . . 0.0 109.159 -167.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -120.51 148.53 43.72 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.684 1.194 . . . . 0.0 109.02 170.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -70.1 125.53 27.04 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 166.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.86 162.91 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.079 1.352 . . . . 0.0 107.635 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.94 -92.1 0.17 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 164.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.861 0 C-N-CA 126.18 1.792 . . . . 0.0 111.136 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . . . . . . 0 N--CA 1.468 0.821 0 CA-C-O 118.956 -0.913 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -144.85 -63.15 0.35 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.268 1.534 . . . . 0.0 113.429 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . 0.293 0.0 OUTLIER -133.49 -162.54 1.25 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.171 1.388 . . . . 0.0 108.42 -175.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.9 mtt85 -111.54 175.79 5.28 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 120.9 -1.125 . . . . 0.0 111.24 172.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.74 162.48 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.119 -0.988 . . . . 0.0 109.168 165.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.426 HH21 HG11 ' A' ' 60' ' ' VAL . 6.7 ttp85 -138.33 143.6 39.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.644 0.777 . . . . 0.0 109.574 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.06 132.33 35.95 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.131 0.972 . . . . 0.0 110.109 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.64 -4.6 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.219 1.008 . . . . 0.0 111.963 171.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.47 153.4 51.58 Favored Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 126.443 1.897 . . . . 0.0 108.253 175.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -76.3 157.87 37.24 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.709 2.939 . . . . 0.0 111.743 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -140.0 165.3 27.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.36 1.064 . . . . 0.0 110.564 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.9 m -136.76 112.37 9.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.536 1.534 . . . . 0.0 107.269 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HE2' ' HA ' ' A' ' 15' ' ' PRO . 6.6 pttm -70.61 152.06 44.32 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 169.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.3 t -75.75 146.6 80.11 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 156.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 98.2 Cg_endo -81.6 170.76 14.06 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.577 2.851 . . . . 0.0 111.252 172.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 75.4 16.78 2.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.781 2.432 . . . . 0.0 111.548 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.6 p -132.03 168.08 18.57 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.215 1.806 . . . . 0.0 109.855 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -80.41 3.83 20.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.251 1.421 . . . . 0.0 111.587 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.98 172.85 12.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.993 1.717 . . . . 0.0 110.201 -175.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.8 130.83 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.447 1.499 . . . . 0.0 110.588 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.1 150.23 37.29 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.795 1.238 . . . . 0.0 110.066 176.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -154.48 164.05 39.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.369 0.531 . . . . 0.0 111.528 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.44 162.87 14.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.378 1.071 . . . . 0.0 110.922 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.78 132.15 53.08 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 164.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.51 -5.2 54.61 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-O 119.049 -0.862 . . . . 0.0 113.682 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -102.37 154.53 18.98 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.276 1.03 . . . . 0.0 108.435 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.8 ttt -124.25 158.46 32.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.018 0.927 . . . . 0.0 111.179 -164.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.72 177.38 8.94 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.557 1.543 . . . . 0.0 110.599 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.2 pt -131.59 127.65 59.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.631 1.572 . . . . 0.0 109.386 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.412 ' O ' ' HA2' ' A' ' 1' ' ' GLY . 1.7 p -75.06 94.41 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.38 0.536 . . . . 0.0 110.083 -177.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -82.74 -56.56 3.77 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -135.79 165.33 25.85 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.355 0.598 . . . . 0.0 110.111 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -129.95 128.46 42.16 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 125.808 1.643 . . . . 0.0 106.743 -172.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 mt -113.21 -170.77 1.75 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -134.65 48.99 2.26 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.123 0.969 . . . . 0.0 108.897 -166.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -156.6 19.11 0.33 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.924 1.29 . . . . 0.0 112.004 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.13 19.61 79.77 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 120.802 -1.186 . . . . 0.0 112.239 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -120.29 153.33 36.54 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.177 1.391 . . . . 0.0 109.206 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.5 mtm -147.46 131.04 16.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -76.12 128.93 35.98 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.42 -165.71 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.504 1.122 . . . . 0.0 110.514 -175.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.1 m -137.02 127.67 27.01 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 162.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -78.47 99.02 6.27 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.526 1.53 . . . . 0.0 108.441 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.08 -2.44 0.43 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.308 1.443 . . . . 0.0 113.909 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -55.91 -48.37 75.8 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 120.554 -1.341 . . . . 0.0 110.136 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -152.53 14.56 0.58 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.4 0.545 . . . . 0.0 111.78 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 t70 74.76 19.68 2.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.922 2.089 . . . . 0.0 111.963 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.6 108.44 0.83 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.035 0.934 . . . . 0.0 108.897 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -73.51 155.88 38.74 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.74 -165.18 28.06 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-O 121.522 0.512 . . . . 0.0 112.508 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 mt -104.72 142.05 35.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.993 1.317 . . . . 0.0 112.503 -168.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.0 153.41 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.709 1.604 . . . . 0.0 109.713 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -86.23 135.84 24.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.736 1.214 . . . . 0.0 108.26 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -77.18 -3.91 41.98 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -172.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.32 -30.25 68.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.707 2.003 . . . . 0.0 113.295 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.36 12.33 13.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.941 1.296 . . . . 0.0 112.911 -160.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 m -130.41 154.24 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.301 1.04 . . . . 0.0 111.001 -171.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -121.13 147.4 45.63 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.748 1.619 . . . . 0.0 110.31 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.81 94.1 1.02 Allowed 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 127.955 2.502 . . . . 0.0 110.828 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.468 HG12 ' H ' ' A' ' 62' ' ' ARG . 41.7 t -91.38 135.01 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 O-C-N 121.5 -0.75 . . . . 0.0 109.591 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.01 29.55 5.31 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.819 2.152 . . . . 0.0 111.729 173.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.468 ' H ' HG12 ' A' ' 60' ' ' VAL . 6.4 ptm180 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 124.652 1.181 . . . . 0.0 108.338 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.335 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 42.98 59.26 2.95 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.655 1.728 . . . . 0.0 112.659 166.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.86 25.66 9.02 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 127.004 2.122 . . . . 0.0 112.217 -162.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.5 mtm-85 -74.2 147.01 42.92 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 119.908 -1.745 . . . . 0.0 109.553 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.8 m -134.0 156.52 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.7 ttm-85 -120.83 125.27 47.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 126.59 1.956 . . . . 0.0 105.75 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.44 151.17 38.11 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 118.386 -1.326 . . . . 0.0 108.567 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.6 3.08 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.951 1.3 . . . . 0.0 111.337 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 mt -142.2 159.05 59.97 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 126.127 1.771 . . . . 0.0 107.608 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.05 170.39 11.02 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.688 2.925 . . . . 0.0 110.983 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -150.77 160.64 43.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.473 1.109 . . . . 0.0 110.474 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -132.19 109.79 10.19 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 172.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.496 ' H ' ' HB3' ' A' ' 21' ' ' SER . 7.7 pttm -65.57 165.54 12.11 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.667 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.8 147.54 58.9 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 150.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 72.0 Cg_endo -73.79 176.87 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.475 2.784 . . . . 0.0 110.911 158.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 66.91 17.48 10.53 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.043 1.737 . . . . 0.0 112.692 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -135.54 171.73 14.03 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.408 1.883 . . . . 0.0 109.345 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.96 -3.5 29.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.991 1.317 . . . . 0.0 111.561 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.39 162.48 12.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.178 1.391 . . . . 0.0 112.025 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.6 pt -136.88 142.43 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.957 2.103 . . . . 0.0 108.179 165.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.496 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -87.39 171.34 10.65 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.422 -1.424 . . . . 0.0 110.693 170.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -162.23 167.43 24.02 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.888 1.675 . . . . 0.0 108.026 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mt -118.86 161.75 19.64 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.577 1.551 . . . . 0.0 107.052 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.73 126.1 26.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.938 1.245 . . . . 0.0 110.152 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.0 52.1 1.04 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 124.681 1.134 . . . . 0.0 111.146 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -138.45 161.59 36.62 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.978 1.711 . . . . 0.0 108.007 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.5 mtp -138.83 140.1 38.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.245 1.018 . . . . 0.0 110.432 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.9 169.1 9.33 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.088 1.755 . . . . 0.0 109.938 -174.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.0 pt -122.02 126.35 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 172.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.24 130.36 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -118.92 -44.76 2.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.582 1.153 . . . . 0.0 110.02 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -140.01 170.15 16.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -132.05 138.65 48.26 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 124.939 1.296 . . . . 0.0 107.604 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 mt -123.31 178.47 5.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.985 1.714 . . . . 0.0 109.68 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -120.89 14.55 11.6 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.917 1.341 . . . . 0.0 112.884 -162.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -129.26 20.25 5.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 127.764 2.426 . . . . 0.0 111.23 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.56 9.05 61.86 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.019 1.295 . . . . 0.0 112.922 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -113.67 162.23 16.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.355 1.062 . . . . 0.0 110.971 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.7 mtm -138.97 143.4 38.52 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.38 1.472 . . . . 0.0 107.845 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -78.26 135.95 37.66 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.702 161.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.7 m -140.96 176.8 4.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.163 0.985 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.0 m -115.39 141.21 48.34 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 152.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -93.26 112.45 24.39 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.464 1.106 . . . . 0.0 108.964 169.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.0 5.41 2.7 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -59.01 -41.85 88.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.261 162.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -147.41 -13.27 0.4 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.101 -0.952 . . . . 0.0 113.379 -161.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 t70 75.07 16.61 2.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.559 1.944 . . . . 0.0 111.761 -162.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -60.78 113.92 2.75 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 120.664 -1.273 . . . . 0.0 108.96 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -90.11 151.13 21.74 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.91 -0.494 . . . . 0.0 109.873 167.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.76 -167.48 35.29 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.613 0.563 . . . . 0.0 111.917 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -89.59 141.14 28.87 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.399 1.08 . . . . 0.0 110.555 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.8 153.27 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.999 2.12 . . . . 0.0 109.104 169.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.88 146.1 7.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.801 0.84 . . . . 0.0 110.428 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -66.94 -17.65 65.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.439 1.496 . . . . 0.0 113.041 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.92 -18.23 59.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.529 1.932 . . . . 0.0 112.109 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -130.56 12.56 5.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.437 1.495 . . . . 0.0 112.712 -163.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.97 154.43 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.661 1.118 . . . . 0.0 112.994 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -128.3 148.91 50.68 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.805 2.042 . . . . 0.0 110.204 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.64 102.25 0.55 Allowed 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 129.359 3.064 . . . . 0.0 110.324 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 p -110.46 132.75 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 123.19 1.471 . . . . 0.0 110.864 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.36 7.82 80.83 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.25 -1.341 . . . . 0.0 112.701 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 . . . . . 0 C--O 1.253 1.267 0 CA-C-N 118.553 1.177 . . . . 0.0 108.631 -172.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -116.69 131.84 56.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.113 1.365 . . . . 0.0 108.429 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.36 -169.73 2.09 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 121.031 1.741 . . . . 0.0 110.541 174.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 54.4 mtm180 -132.54 150.98 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.377 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 m -123.4 171.07 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.536 1.134 . . . . 0.0 108.461 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -144.02 122.84 12.67 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 120.752 -1.217 . . . . 0.0 111.739 -170.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.38 137.85 58.34 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.801 0.728 . . . . 0.0 109.975 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.27 0.2 OUTLIER -119.73 5.22 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.417 169.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.5 mt -147.8 154.94 44.53 Favored Pre-proline 0 N--CA 1.466 0.374 0 C-N-CA 125.639 1.576 . . . . 0.0 108.822 166.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.66 157.54 31.93 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.613 2.875 . . . . 0.0 110.235 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -146.31 -179.4 6.72 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.782 0.833 . . . . 0.0 108.906 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 t -146.39 133.42 20.32 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.586 ' H ' ' HB3' ' A' ' 21' ' ' SER . 17.9 ptmt -69.52 144.66 53.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.107 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.98 139.91 97.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.02 145.86 69.01 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.068 2.512 . . . . 0.0 110.488 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.82 39.14 8.57 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.765 1.626 . . . . 0.0 112.498 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 p -132.33 171.21 14.01 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.497 -0.752 . . . . 0.0 110.434 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.68 -8.18 59.05 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.64 1.976 . . . . 0.0 111.323 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.03 167.88 3.61 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.781 1.633 . . . . 0.0 111.917 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.99 136.48 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.877 1.671 . . . . 0.0 108.69 174.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.586 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -90.51 122.77 33.63 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.85 1.66 . . . . 0.0 110.148 -178.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -146.99 170.65 16.66 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 119.671 1.123 . . . . 0.0 113.288 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.88 -178.64 5.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.014 0.926 . . . . 0.0 111.738 -164.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -63.57 149.58 45.99 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 160.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.99 -4.73 22.06 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.897 -0.946 . . . . 0.0 113.244 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.55 156.31 39.1 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.639 1.22 . . . . 0.0 107.759 164.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.9 ttt -134.17 148.82 50.98 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.866 -1.146 . . . . 0.0 108.814 -173.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -132.98 159.48 39.89 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.436 1.094 . . . . 0.0 109.636 -169.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.7 pt -110.86 135.98 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -69.39 124.5 25.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 171.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.19 -25.32 4.9 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.97 0.908 . . . . 0.0 113.255 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -154.73 160.44 41.34 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 164.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.76 123.03 42.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.09 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 mt -101.81 -169.42 1.68 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.9 29.59 3.77 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.381 1.072 . . . . 0.0 110.853 -166.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -151.79 29.4 0.6 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.702 1.601 . . . . 0.0 111.534 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.09 36.25 64.23 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 120.9 -1.125 . . . . 0.0 112.426 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -134.72 156.18 49.25 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.362 1.081 . . . . 0.0 108.92 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.5 mtm -138.01 141.86 40.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 168.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -75.41 137.9 41.32 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 160.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.81 -178.84 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 122.186 0.993 . . . . 0.0 111.768 -175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.4 m -124.94 146.68 49.24 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 153.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.77 119.46 32.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.437 2.695 . . . . 0.0 108.43 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt -80.11 21.13 0.6 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.844 1.257 . . . . 0.0 112.491 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.3 ttp85 -101.24 -47.53 4.69 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.089 0.956 . . . . 0.0 110.032 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -146.15 20.31 1.4 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.642 0.777 . . . . 0.0 109.511 -169.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.85 24.13 12.73 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.208 1.803 . . . . 0.0 112.356 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -72.32 160.61 32.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.1 -1.0 . . . . 0.0 112.48 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -139.42 149.54 44.2 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.684 0.754 . . . . 0.0 110.928 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.89 -168.55 32.36 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.638 -174.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.0 mt -92.0 143.53 26.38 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.832 1.253 . . . . 0.0 110.489 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.01 145.57 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.274 1.429 . . . . 0.0 109.029 171.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.02 132.23 32.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.31 -10.97 60.63 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -55.48 -26.85 44.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.942 2.097 . . . . 0.0 111.873 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.96 11.29 11.73 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -160.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -118.11 164.68 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.73 1.612 . . . . 0.0 110.859 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -121.31 151.14 40.42 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.568 1.547 . . . . 0.0 110.154 169.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.18 63.18 0.97 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.768 2.427 . . . . 0.0 111.066 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -57.64 145.61 8.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 O-C-N 120.741 -1.224 . . . . 0.0 111.331 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.96 -53.3 0.8 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 125.129 1.347 . . . . 0.0 110.982 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.384 4.8 ptm180 . . . . . 0 C--O 1.247 0.933 0 C-N-CA 128.93 2.892 . . . . 0.0 114.258 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.407 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.89 152.24 32.32 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.204 1.002 . . . . 0.0 108.361 164.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.407 ' H ' HG11 ' A' ' 30' ' ' VAL . 2.8 ttt85 -138.31 -165.33 1.79 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 167.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 mmt85 -140.99 156.52 46.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.13 1.372 . . . . 0.0 107.494 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.09 154.63 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.335 0.97 . . . . 0.0 109.806 170.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -121.66 136.57 54.94 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.84 130.78 41.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.149 0.886 . . . . 0.0 109.506 169.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.07 1.47 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.318 0.647 . . . . 0.0 111.305 170.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 mt -141.03 154.56 68.37 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 168.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.91 158.77 34.66 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.971 2.447 . . . . 0.0 110.247 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -150.12 164.61 35.15 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.58 0.752 . . . . 0.0 110.577 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 t -135.31 135.79 41.07 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -63.46 149.75 45.34 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.22 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.2 m -66.7 166.29 19.59 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.624 1.17 . . . . 0.0 109.557 163.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -79.6 161.27 25.02 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.385 2.056 . . . . 0.0 110.41 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t70 45.94 46.86 12.48 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.987 2.515 . . . . 0.0 112.693 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 p -142.96 177.74 8.15 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.459 -0.776 . . . . 0.0 110.122 -170.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.25 11.25 37.09 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.513 1.525 . . . . 0.0 110.412 -172.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -80.36 170.02 16.96 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.653 1.581 . . . . 0.0 111.549 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.3 pt -136.0 152.78 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.227 1.811 . . . . 0.0 109.964 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -88.99 149.87 23.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.545 2.338 . . . . 0.0 110.642 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -158.28 173.19 17.06 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.423 -0.798 . . . . 0.0 111.797 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.41 161.17 22.64 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.804 1.242 . . . . 0.0 110.516 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -57.98 133.63 55.68 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 166.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.31 -6.77 71.96 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 117.887 -1.507 . . . . 0.0 113.005 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -77.18 166.45 23.22 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.271 2.035 . . . . 0.0 108.699 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 34.7 mtp -133.25 140.3 47.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.566 1.146 . . . . 0.0 109.873 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -122.93 169.94 10.63 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.099 1.359 . . . . 0.0 109.779 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 pt -119.52 129.64 75.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.407 HG11 ' H ' ' A' ' 3' ' ' ARG . 2.3 p -68.46 125.98 27.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -116.64 -33.48 4.84 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.929 0.892 . . . . 0.0 111.961 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -146.62 160.45 42.15 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 119.262 0.937 . . . . 0.0 110.497 172.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -118.06 121.55 40.88 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 126.498 1.919 . . . . 0.0 107.289 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -110.2 -172.15 1.98 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.412 1.485 . . . . 0.0 107.851 173.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -120.26 13.73 12.01 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.171 1.789 . . . . 0.0 114.935 -166.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -143.41 23.31 1.81 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.392 1.077 . . . . 0.0 112.218 -154.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.94 7.28 87.43 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 124.456 1.027 . . . . 0.0 112.617 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -118.48 150.61 39.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.576 1.55 . . . . 0.0 108.73 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 mtm -139.39 140.37 37.4 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -77.05 138.88 39.83 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 166.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -142.56 -175.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.774 1.273 . . . . 0.0 111.166 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.2 m -130.76 132.23 45.19 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 152.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -81.39 114.01 19.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.41 -6.81 11.28 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.024 -0.423 . . . . 0.0 111.679 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -57.01 -40.39 76.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 120.396 -1.44 . . . . 0.0 111.389 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -169.75 33.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.025 0.829 . . . . 0.0 111.793 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t70 66.54 -4.91 0.67 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 171.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -53.73 118.4 3.9 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.192 1.797 . . . . 0.0 109.804 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -100.36 157.87 16.3 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 168.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.49 -171.91 32.98 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.3 mt -87.23 144.88 26.61 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.458 1.503 . . . . 0.0 109.561 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.28 152.64 23.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.95 1.7 . . . . 0.0 108.028 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.18 141.31 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.286 0.634 . . . . 0.0 109.832 -173.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -71.82 -9.56 58.49 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.824 0.85 . . . . 0.0 113.25 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.34 -21.16 66.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.819 1.248 . . . . 0.0 112.064 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -126.86 11.42 7.17 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.802 1.241 . . . . 0.0 112.098 -162.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.11 167.57 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.171 0.989 . . . . 0.0 111.343 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -119.06 152.31 36.68 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 127.184 2.194 . . . . 0.0 108.426 167.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 59.76 1.25 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.319 1.448 . . . . 0.0 110.341 174.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.18 158.21 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 120.87 -1.144 . . . . 0.0 110.633 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.55 20.62 1.5 Allowed Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.454 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.713 -177.235 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.814 0 CA-C-O 118.485 -1.175 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 60.46 64.29 1.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 123.085 1.422 . . . . 0.0 108.477 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.43 -164.23 0.97 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.819 1.247 . . . . 0.0 108.279 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -124.6 151.55 44.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.94 145.51 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.275 0.943 . . . . 0.0 109.746 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -111.37 144.96 39.73 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 117.584 -1.198 . . . . 0.0 109.922 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.19 136.71 37.86 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 119.767 1.167 . . . . 0.0 111.819 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.69 1.85 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.158 0.983 . . . . 0.0 112.294 168.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mt -151.71 154.48 33.13 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 125.73 1.612 . . . . 0.0 108.755 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.52 134.93 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.009 2.473 . . . . 0.0 108.604 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -84.64 -179.12 7.06 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.931 0.872 . . . . 0.0 109.043 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.4 m -149.71 100.33 2.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' H ' ' HB3' ' A' ' 21' ' ' SER . 11.6 pttt -67.66 156.6 36.49 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.413 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.0 m -85.53 176.25 3.81 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 126.324 1.85 . . . . 0.0 107.912 168.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -95.17 164.02 1.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.174 2.582 . . . . 0.0 111.336 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 59.04 35.78 24.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.492 1.917 . . . . 0.0 111.243 167.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.39 162.59 36.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.127 0.965 . . . . 0.0 111.483 -161.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.4 35.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.477 1.911 . . . . 0.0 109.427 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -109.3 168.29 9.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.296 1.039 . . . . 0.0 109.149 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.2 pt -145.2 144.66 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 127.39 2.276 . . . . 0.0 106.554 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.415 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 93.1 p -124.88 158.94 32.28 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.564 ' HB2' HD22 ' A' ' 43' ' ' ASN . 0.1 OUTLIER -164.93 -175.03 3.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.512 1.525 . . . . 0.0 109.506 176.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.5 172.39 8.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.173 0.989 . . . . 0.0 109.975 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -54.93 157.2 3.32 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.525 -1.359 . . . . 0.0 109.789 161.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.44 12.55 84.2 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.773 -1.015 . . . . 0.0 112.696 172.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -174.59 4.24 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.733 1.267 . . . . 0.0 111.262 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.36 144.67 32.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.338 1.855 . . . . 0.0 108.934 -170.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -133.74 153.92 51.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.159 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.6 pt -112.92 118.53 58.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -63.76 121.78 13.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.1 -36.28 5.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.433 1.093 . . . . 0.0 109.973 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -149.24 169.55 20.5 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.158 0.89 . . . . 0.0 110.062 168.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -130.35 122.7 28.36 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 127.332 2.253 . . . . 0.0 106.122 -171.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.85 -162.79 0.97 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.677 1.191 . . . . 0.0 110.138 -175.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -141.55 76.63 1.55 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.79 2.036 . . . . 0.0 106.934 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 p30 174.2 -0.97 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.532 1.933 . . . . 0.0 114.363 -165.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.43 7.53 85.26 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 120.055 -1.653 . . . . 0.0 113.142 -171.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -95.73 165.44 12.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.377 1.589 . . . . 0.0 109.922 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.4 mtm -134.94 163.54 29.63 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 168.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.2 t-105 -94.34 132.62 38.75 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.406 0.548 . . . . 0.0 109.665 158.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.56 174.89 6.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.132 0.973 . . . . 0.0 110.503 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.415 ' CG2' ' HA ' ' A' ' 47' ' ' ASP . 7.8 m -107.68 141.82 38.6 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 157.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.564 HD22 ' HB2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -82.19 111.48 18.33 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 127.287 2.235 . . . . 0.0 107.958 170.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.6 -9.31 5.77 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.428 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 22.0 ttp85 -53.31 -38.39 63.11 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.984 0.914 . . . . 0.0 111.436 173.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 t -165.67 -1.61 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -161.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.415 ' HA ' ' CG2' ' A' ' 42' ' ' THR . 0.6 OUTLIER 75.3 17.64 2.52 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.661 1.585 . . . . 0.0 112.401 -173.163 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.2 139.48 58.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -126.51 153.78 44.69 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.614 1.166 . . . . 0.0 108.731 -172.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 151.8 -158.47 27.79 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -172.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -101.56 143.01 32.07 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.61 1.964 . . . . 0.0 112.013 -168.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.94 152.97 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 129.813 3.245 . . . . 0.0 107.024 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.33 139.58 19.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -74.7 -14.83 60.78 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.18 -22.0 64.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.621 1.168 . . . . 0.0 112.719 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.4 mt -107.09 3.9 26.33 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.331 1.452 . . . . 0.0 112.286 -170.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.96 171.14 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.224 1.009 . . . . 0.0 110.737 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -131.21 152.96 49.97 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 125.611 1.565 . . . . 0.0 110.618 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -78.05 80.62 4.47 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.6 1.56 . . . . 0.0 111.089 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.77 164.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 120.963 -1.085 . . . . 0.0 109.449 167.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.36 12.93 10.31 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.49 1.519 . . . . 0.0 113.015 167.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.4 mtp85 . . . . . 0 C--O 1.246 0.903 0 CA-C-O 116.473 -1.727 . . . . 0.0 111.45 -179.092 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.405 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 mtt85 -144.24 109.67 5.17 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.59 1.956 . . . . 0.0 106.388 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.3 172.75 8.01 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.088 1.355 . . . . 0.0 109.455 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.543 ' HE ' ' HE1' ' A' ' 27' ' ' MET . 11.2 mtp180 -151.79 138.84 19.12 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.28 1.832 . . . . 0.0 108.391 -172.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.89 159.04 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.81 0.844 . . . . 0.0 109.118 173.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.9 ttm180 -130.03 131.57 45.89 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.729 -1.857 . . . . 0.0 106.099 -168.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.57 156.42 26.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.598 1.545 . . . . 0.0 110.566 -173.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.75 9.89 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.921 162.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.71 155.57 29.68 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 120.35 1.432 . . . . 0.0 110.264 167.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -82.81 163.77 15.99 Favored 'Trans proline' 0 CA--C 1.543 0.956 1 C-N-CA 125.972 4.448 . . . . 0.0 111.925 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -153.14 165.69 34.84 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.745 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -119.27 113.73 21.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.545 1.938 . . . . 0.0 107.21 -175.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -67.26 146.81 53.78 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.38 1.446 . . . . 0.0 110.233 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.39 149.3 98.46 Favored Pre-proline 0 CA--C 1.552 1.035 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.18 141.53 39.75 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 124.234 3.289 . . . . 0.0 111.32 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.1 t70 64.47 27.56 13.51 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.819 1.648 . . . . 0.0 112.843 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 p -121.91 173.76 7.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.467 1.031 . . . . 0.0 113.651 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.28 24.9 0.77 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.173 2.189 . . . . 0.0 110.632 -172.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -108.11 175.47 5.47 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.035 2.134 . . . . 0.0 110.844 -173.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 pt -147.24 121.11 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.311 1.445 . . . . 0.0 110.904 -174.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.63 139.11 39.44 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.054 -1.029 . . . . 0.0 111.338 -176.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -156.51 169.25 25.08 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.012 -1.055 . . . . 0.0 112.062 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.8 167.59 10.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.377 1.071 . . . . 0.0 109.729 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -62.38 119.4 9.03 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 169.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.15 -15.88 4.21 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.645 1.593 . . . . 0.0 112.944 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -80.1 162.74 24.61 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.981 1.391 . . . . 0.0 110.002 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.543 ' HE1' ' HE ' ' A' ' 4' ' ' ARG . 14.5 ptm -138.3 158.95 43.28 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.578 1.951 . . . . 0.0 108.406 175.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -132.66 160.87 35.45 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.382 1.073 . . . . 0.0 111.072 -169.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.6 pt -121.09 125.31 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 108.909 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.85 123.48 13.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -126.36 -23.43 3.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.634 1.174 . . . . 0.0 112.963 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -156.0 161.6 40.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.171 0.896 . . . . 0.0 110.822 159.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -118.54 125.68 50.36 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 129.07 2.948 . . . . 0.0 105.767 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 mt -109.46 -165.36 1.01 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.187 0.995 . . . . 0.0 109.213 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -133.52 91.94 2.92 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 t0 175.85 18.91 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.627 2.371 . . . . 0.0 111.667 168.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.46 -1.86 84.21 Favored Glycine 0 CA--C 1.539 1.572 0 O-C-N 120.146 -1.596 . . . . 0.0 113.878 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -97.73 152.02 19.55 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.752 2.021 . . . . 0.0 110.217 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.7 mtm -141.64 143.8 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.363 1.465 . . . . 0.0 108.638 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -84.39 136.69 33.77 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 171.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.17 -163.79 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.511 0.724 . . . . 0.0 111.549 -173.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.3 m -135.83 158.11 45.21 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 151.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -102.79 115.36 30.44 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.637 1.575 . . . . 0.0 109.677 172.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 mt -66.2 -4.54 7.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.799 1.24 . . . . 0.0 113.44 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -69.35 -46.77 66.22 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 117.187 -1.387 . . . . 0.0 111.47 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.5 p -139.29 4.96 2.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.934 1.243 . . . . 0.0 114.025 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.69 19.69 1.97 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.939 1.696 . . . . 0.0 112.204 -174.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -62.25 141.82 58.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.916 1.286 . . . . 0.0 110.385 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -134.51 155.81 49.72 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.836 0.854 . . . . 0.0 109.65 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.89 -158.17 24.07 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -161.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.3 mt -106.16 144.67 32.53 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.271 1.428 . . . . 0.0 113.858 -164.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.63 154.31 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 127.699 2.4 . . . . 0.0 108.582 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.74 147.97 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 127.483 2.313 . . . . 0.0 112.553 168.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -58.89 -21.32 57.21 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.47 165.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -63.67 -24.62 67.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.763 0.792 . . . . 0.0 112.178 -166.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.1 mt -118.75 7.2 11.58 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.509 1.523 . . . . 0.0 111.271 -157.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.93 161.84 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.02 1.728 . . . . 0.0 109.797 -169.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.5 153.26 26.45 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.363 1.465 . . . . 0.0 109.059 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.87 61.9 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.928 1.291 . . . . 0.0 111.088 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 p -60.65 164.68 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 122.32 1.057 . . . . 0.0 110.213 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.02 -105.63 0.32 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.507 0 CA-C-O 115.06 -2.4 . . . . 0.0 108.207 -169.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.448 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 55.08 53.88 9.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.91 1.284 . . . . 0.0 109.229 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -124.37 125.9 45.09 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -168.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.464 HH21 ' C ' ' A' ' 62' ' ' ARG . 17.5 mtm180 -134.61 166.8 22.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.991 0.516 . . . . 0.0 110.451 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.69 161.44 23.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 171.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -139.47 129.87 25.55 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.52 121.72 19.18 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.981 0.81 . . . . 0.0 109.595 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.96 -2.34 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.135 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.81 157.48 32.58 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 126.938 2.095 . . . . 0.0 108.171 173.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.08 159.74 30.24 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.93 3.086 . . . . 0.0 111.147 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -143.9 168.07 20.82 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.826 1.651 . . . . 0.0 107.61 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 t -135.66 143.51 45.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.526 ' H ' ' HB3' ' A' ' 21' ' ' SER . 12.9 pttm -84.35 155.88 22.13 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.924 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.46 139.63 96.63 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 161.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.14 146.68 41.39 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.945 1.763 . . . . 0.0 108.837 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t0 62.65 51.32 3.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.686 1.594 . . . . 0.0 112.019 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.1 p -146.07 174.36 11.37 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 125.926 1.69 . . . . 0.0 110.203 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -84.22 -9.15 58.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.185 0.994 . . . . 0.0 110.992 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.08 173.71 4.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.879 2.071 . . . . 0.0 111.337 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 pt -147.18 126.22 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 126.985 2.114 . . . . 0.0 108.734 -172.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.526 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 1.2 p -93.72 125.72 38.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.075 1.75 . . . . 0.0 111.468 -172.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -150.57 168.61 23.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 124.513 2.101 . . . . 0.0 113.95 -172.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mt -90.16 174.54 7.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.525 2.33 . . . . 0.0 110.126 -166.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -60.47 153.25 23.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 156.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.7 7.15 88.72 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.069 -0.851 . . . . 0.0 113.67 167.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.91 157.05 20.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.213 1.507 . . . . 0.0 109.058 166.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.3 ttt -134.01 147.83 51.02 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.097 0.959 . . . . 0.0 109.12 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -134.76 170.97 15.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.384 -167.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.5 pt -128.06 138.72 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.098 1.359 . . . . 0.0 107.899 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.9 t -75.0 116.84 18.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -112.17 -20.52 11.87 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.402 0.681 . . . . 0.0 111.387 174.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -154.84 179.88 8.68 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 163.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -147.09 118.95 8.1 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.748 1.619 . . . . 0.0 107.369 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -104.91 -177.56 3.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.811 2.445 . . . . 0.0 110.222 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -133.96 78.79 1.78 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.448 1.499 . . . . 0.0 109.6 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -169.9 31.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.63 1.572 . . . . 0.0 110.508 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.1 27.74 67.87 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.609 -1.307 . . . . 0.0 112.623 -174.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -134.52 150.37 50.76 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.534 1.167 . . . . 0.0 110.833 -168.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.6 mtm -149.14 137.66 21.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.493 0.717 . . . . 0.0 110.869 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -86.71 130.84 34.32 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.958 1.303 . . . . 0.0 110.405 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -142.1 -177.12 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.504 0.722 . . . . 0.0 111.879 -175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 m -116.78 138.7 51.3 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.945 1.698 . . . . 0.0 107.42 157.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -92.32 120.84 33.25 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.705 1.202 . . . . 0.0 109.466 165.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.87 1.66 3.19 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -71.34 -36.49 71.56 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 121.191 1.814 . . . . 0.0 112.799 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.9 t -158.95 23.31 0.21 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.273 0.488 . . . . 0.0 111.635 -171.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.9 t70 58.59 27.24 15.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.411 1.084 . . . . 0.0 111.784 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -68.61 98.86 0.92 Allowed 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.011 -1.056 . . . . 0.0 109.415 171.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -80.42 158.3 25.99 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.721 0.295 . . . . 0.0 110.619 167.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.16 -170.74 29.46 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 173.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -80.03 141.79 35.56 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.426 1.091 . . . . 0.0 110.882 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.81 152.21 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 110.12 167.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.61 140.58 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.283 1.433 . . . . 0.0 108.736 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.92 -9.33 58.44 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.78 -15.45 61.68 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.345 1.858 . . . . 0.0 113.846 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.2 mt -140.79 21.86 2.31 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.739 1.216 . . . . 0.0 113.677 -167.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.75 154.44 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -100.4 149.32 23.76 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.74 1.216 . . . . 0.0 109.554 167.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.4 123.88 24.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.274 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.445 HG12 ' H ' ' A' ' 62' ' ' ARG . 2.6 t -124.36 149.29 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.124 0.488 . . . . 0.0 111.288 172.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.27 15.52 10.05 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.89 1.709 . . . . 0.0 112.349 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.464 ' C ' HH21 ' A' ' 4' ' ' ARG . 63.2 mtt-85 . . . . . 0 C--O 1.246 0.886 0 C-N-CA 125.184 1.394 . . . . 0.0 109.258 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.377 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HD3' HG22 ' A' ' 29' ' ' ILE . 85.0 mtt180 -141.46 166.57 24.39 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.283 1.433 . . . . 0.0 107.384 173.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -136.0 161.87 37.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -124.46 140.37 53.01 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.88 157.98 35.31 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.14 3.35 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.244 0.475 . . . . 0.0 111.746 164.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 mt -147.29 160.62 38.95 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 126.334 1.854 . . . . 0.0 107.955 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.15 165.4 14.85 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.647 3.565 . . . . 0.0 111.699 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -157.1 125.58 5.68 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.083 0.953 . . . . 0.0 110.517 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 t -82.48 142.2 32.07 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.47 ' H ' ' HB3' ' A' ' 21' ' ' SER . 1.1 pttt -83.75 154.41 23.61 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.742 -0.599 . . . . 0.0 109.739 163.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.3 151.56 94.34 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 157.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.34 150.08 13.35 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.496 2.797 . . . . 0.0 110.506 165.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 t70 75.48 13.17 3.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.66 1.984 . . . . 0.0 112.569 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.9 p -107.11 177.56 4.82 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.808 1.243 . . . . 0.0 108.704 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -92.43 10.21 31.0 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.987 0.915 . . . . 0.0 109.219 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.88 162.27 28.78 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.746 -1.221 . . . . 0.0 109.92 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 pt -125.02 140.66 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 124.852 1.261 . . . . 0.0 107.619 164.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 56.1 p -85.68 160.34 19.59 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -158.35 167.71 28.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.366 0.667 . . . . 0.0 109.369 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 mt -117.43 167.83 10.92 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.574 1.15 . . . . 0.0 108.579 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -60.77 115.01 3.34 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 167.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.8 -16.41 3.74 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 125.754 1.645 . . . . 0.0 112.36 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -76.88 163.4 26.79 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 119.87 1.835 . . . . 0.0 111.968 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.2 mtp -127.85 154.96 44.86 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 128.149 2.58 . . . . 0.0 108.833 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -136.39 160.4 38.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.431 1.092 . . . . 0.0 108.967 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 ' HD3' ' A' ' 4' ' ' ARG . 5.7 pt -122.74 137.95 54.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.9 t -69.76 134.27 30.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.83 -27.28 2.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.402 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.99 162.54 41.13 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 119.431 1.014 . . . . 0.0 110.788 162.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -107.47 137.35 45.67 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.565 1.946 . . . . 0.0 107.443 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.1 mt -129.36 177.01 7.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.511 1.924 . . . . 0.0 107.101 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -130.32 14.44 5.59 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.188 -0.945 . . . . 0.0 113.033 -152.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -127.59 21.29 6.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.078 1.751 . . . . 0.0 112.103 -170.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.09 10.32 56.26 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.355 1.455 . . . . 0.0 113.018 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -125.9 155.34 41.42 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.658 1.583 . . . . 0.0 110.847 -165.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.4 mtm -145.82 145.99 30.99 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.316 1.447 . . . . 0.0 108.8 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -84.01 137.3 33.67 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 122.838 0.455 . . . . 0.0 110.655 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.6 m -142.38 -171.24 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.834 0.854 . . . . 0.0 111.724 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.1 m -128.07 150.76 49.81 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 156.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -109.54 109.32 20.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.127 1.771 . . . . 0.0 109.413 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 44' ' ' LEU . 9.0 mt -56.04 -12.86 1.62 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.784 2.034 . . . . 0.0 113.612 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -64.47 -33.96 77.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.958 1.254 . . . . 0.0 111.514 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.251 5.1 t -155.31 15.07 0.39 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.085 0.954 . . . . 0.0 110.737 -168.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.3 t70 53.05 32.85 13.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.085 2.154 . . . . 0.0 111.795 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.1 159.28 33.81 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.809 -0.557 . . . . 0.0 110.326 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -140.23 147.2 39.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.38 -157.66 25.69 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -101.67 146.82 27.21 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.174 1.39 . . . . 0.0 112.277 -165.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.43 154.05 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.063 1.745 . . . . 0.0 110.288 168.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.99 144.59 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.709 1.604 . . . . 0.0 110.127 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -78.63 -6.33 55.37 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.58 -19.95 65.96 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.608 1.163 . . . . 0.0 113.108 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.9 mt -129.21 15.78 6.16 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.526 1.13 . . . . 0.0 113.819 -160.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.02 169.65 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 119.102 0.864 . . . . 0.0 113.058 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -125.63 148.1 49.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 127.407 2.283 . . . . 0.0 109.216 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -82.93 47.58 1.23 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.263 2.225 . . . . 0.0 112.783 -170.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 122.711 1.243 . . . . 0.0 111.756 -173.899 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 3' ' ' ARG . 0.5 OUTLIER . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.4 ' HD3' HG22 ' A' ' 29' ' ' ILE . 11.0 mtt85 -158.67 166.96 30.8 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.279 1.831 . . . . 0.0 109.361 -176.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.46 178.46 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.872 1.669 . . . . 0.0 108.823 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 -140.93 142.32 34.4 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 120.449 -1.407 . . . . 0.0 108.44 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.68 137.06 47.55 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 119.069 0.85 . . . . 0.0 110.45 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.85 -4.84 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 118.218 -0.896 . . . . 0.0 112.335 163.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -149.81 148.66 26.0 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 125.18 1.392 . . . . 0.0 108.612 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.26 167.5 19.48 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 124.632 3.554 . . . . 0.0 111.27 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -154.4 171.43 19.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.18 0.992 . . . . 0.0 108.483 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.6 m -118.79 113.55 21.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.922 1.289 . . . . 0.0 108.585 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -59.81 151.6 25.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.187 0.903 . . . . 0.0 110.456 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.47 148.64 97.93 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 154.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.63 163.93 14.29 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.57 2.847 . . . . 0.0 111.134 170.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 47.03 47.27 16.02 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.918 2.087 . . . . 0.0 110.002 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.62 172.99 14.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.503 2.721 . . . . 0.0 107.845 -172.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -82.0 5.0 20.67 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.055 -1.028 . . . . 0.0 112.052 -170.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.31 162.33 14.65 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.363 1.465 . . . . 0.0 110.881 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.444 HD13 ' HB2' ' A' ' 43' ' ' ASN . 2.7 pp -138.37 132.21 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 127.082 2.153 . . . . 0.0 107.181 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.88 151.02 38.99 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.875 -1.14 . . . . 0.0 111.206 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -152.68 154.51 35.43 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.274 -0.891 . . . . 0.0 111.094 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.86 171.37 7.56 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.886 1.274 . . . . 0.0 109.777 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -52.78 134.2 36.76 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 158.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.05 -7.12 81.44 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 117.694 -1.615 . . . . 0.0 114.501 172.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -64.69 159.08 22.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.951 1.876 . . . . 0.0 108.713 166.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.1 ttt -127.66 142.23 51.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.387 1.075 . . . . 0.0 109.884 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -127.6 146.52 50.51 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.493 1.117 . . . . 0.0 111.089 -170.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.4 HG22 ' HD3' ' A' ' 4' ' ' ARG . 8.9 pt -110.01 130.95 62.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.39 124.79 26.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -121.04 -47.65 2.27 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.124 0.97 . . . . 0.0 110.794 176.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -138.87 157.44 46.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 119.006 0.821 . . . . 0.0 111.438 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -130.52 119.51 22.69 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -161.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 mt -119.5 145.53 46.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.885 -171.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -87.07 15.96 5.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.552 1.941 . . . . 0.0 113.335 -165.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -125.83 18.24 7.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.733 1.613 . . . . 0.0 112.533 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.66 16.11 50.17 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.24 0.924 . . . . 0.0 111.931 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -123.34 153.29 40.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.33 1.052 . . . . 0.0 110.154 -166.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.6 mtm -143.89 132.46 22.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -79.68 129.18 34.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.128 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.77 176.05 7.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.761 0.824 . . . . 0.0 111.58 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 m -105.91 138.3 42.34 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 153.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB2' HD13 ' A' ' 20' ' ' ILE . 64.5 t-20 -90.83 114.97 27.51 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 168.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.99 -7.61 23.69 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.9 ttp85 -59.79 -45.16 93.17 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.83 1.195 . . . . 0.0 109.8 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -137.72 -3.46 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 117.843 -1.075 . . . . 0.0 113.039 -168.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 75.53 11.06 3.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.292 1.837 . . . . 0.0 111.989 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.04 149.38 37.08 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.972 0.909 . . . . 0.0 109.379 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -133.52 139.1 46.43 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.885 1.274 . . . . 0.0 108.396 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.42 -170.67 36.47 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.34 146.28 31.64 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.746 1.619 . . . . 0.0 111.592 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -143.66 166.43 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 128.365 2.666 . . . . 0.0 108.468 165.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.45 143.45 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.692 1.197 . . . . 0.0 110.932 -167.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.6 -8.61 56.89 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.351 1.06 . . . . 0.0 113.04 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.03 -27.81 67.23 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.531 1.532 . . . . 0.0 112.232 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.53 14.99 8.21 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -161.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.5 164.1 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.976 0.807 . . . . 0.0 112.611 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -120.36 142.9 48.73 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 127.426 2.29 . . . . 0.0 109.669 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -72.43 92.94 1.49 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.325 1.45 . . . . 0.0 107.725 170.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 122.274 1.035 . . . . 0.0 111.284 -166.035 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -125.95 160.99 28.52 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.836 0.854 . . . . 0.0 109.1 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.54 160.65 31.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 124.772 1.229 . . . . 0.0 108.32 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -134.28 127.17 31.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.113 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.98 134.73 44.81 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.871 0.76 . . . . 0.0 109.792 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.272 0.2 OUTLIER -115.54 5.02 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.726 0.81 . . . . 0.0 112.501 176.615 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 mt -148.14 160.73 36.57 Favored Pre-proline 0 N--CA 1.468 0.467 0 C-N-CA 127.716 2.406 . . . . 0.0 106.834 166.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.17 170.61 9.49 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.095 3.197 . . . . 0.0 111.283 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -145.59 172.08 13.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.586 0.755 . . . . 0.0 109.183 173.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.1 m -131.54 112.17 12.4 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.019 1.328 . . . . 0.0 108.202 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -66.71 158.69 29.52 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.272 -174.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.06 123.54 86.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 161.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.68 153.96 74.64 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.141 1.227 . . . . 0.0 108.92 166.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 t0 73.5 22.63 2.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.047 1.339 . . . . 0.0 111.118 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -130.04 169.99 14.57 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.095 1.358 . . . . 0.0 109.38 168.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -78.64 9.63 3.92 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.247 1.419 . . . . 0.0 110.309 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -74.72 167.69 21.31 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.138 -1.601 . . . . 0.0 110.541 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.3 pt -138.14 139.71 41.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 126.746 2.018 . . . . 0.0 107.446 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.01 137.26 47.09 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.87 -1.144 . . . . 0.0 108.799 172.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -135.34 165.1 26.23 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.807 0.843 . . . . 0.0 111.664 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -111.63 165.13 12.29 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.18 1.392 . . . . 0.0 109.924 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -59.11 128.66 38.27 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 161.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.89 0.42 62.13 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.204 -1.331 . . . . 0.0 113.434 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.24 161.47 29.9 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.847 1.824 . . . . 0.0 109.948 167.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.8 ttp -146.9 144.13 29.03 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.24 1.016 . . . . 0.0 110.455 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -140.53 155.71 46.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.954 -162.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -104.05 133.1 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.181 1.392 . . . . 0.0 108.328 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.01 129.32 30.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -119.12 -34.06 3.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.388 168.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -145.95 162.19 38.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 119.578 1.081 . . . . 0.0 110.066 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -123.75 112.18 17.03 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.584 1.953 . . . . 0.0 105.915 -170.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.73 -172.72 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.725 1.61 . . . . 0.0 108.606 -169.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -134.4 38.84 3.09 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.301 1.048 . . . . 0.0 112.356 -168.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -152.74 47.59 0.72 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.894 166.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.96 3.58 44.44 Favored Glycine 0 CA--C 1.538 1.481 0 O-C-N 121.031 -1.043 . . . . 0.0 115.252 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -97.32 161.41 13.81 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.624 1.169 . . . . 0.0 110.45 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.2 mtm -138.48 144.41 40.03 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.609 1.164 . . . . 0.0 108.695 165.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.591 ' CE3' HD21 ' A' ' 51' ' ' LEU . 24.7 t-105 -79.01 131.66 36.37 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.745 0.818 . . . . 0.0 109.322 166.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.44 -173.05 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.758 0.79 . . . . 0.0 112.462 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 m -136.15 131.68 35.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 161.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -86.22 108.98 18.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.732 1.213 . . . . 0.0 108.716 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.9 mt -75.23 -0.29 18.96 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.556 -1.212 . . . . 0.0 112.128 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -63.38 -33.01 74.6 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 120.8 1.636 . . . . 0.0 110.601 168.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 p -143.84 0.25 1.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.167 -160.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.25 0.3 OUTLIER 70.37 0.88 3.37 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.316 2.646 . . . . 0.0 114.195 -166.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -66.88 104.5 1.37 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.026 0.93 . . . . 0.0 111.749 -168.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -79.34 156.55 27.95 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.933 -0.479 . . . . 0.0 109.839 166.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.72 -154.7 25.7 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.591 HD21 ' CE3' ' A' ' 40' ' ' TRP . 1.8 mm? -103.03 144.63 31.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.633 1.173 . . . . 0.0 109.903 -167.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -140.66 151.43 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.397 1.879 . . . . 0.0 109.66 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -99.98 144.21 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.95 1.3 . . . . 0.0 109.086 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -81.44 -1.33 45.37 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.26 -23.55 62.47 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.188 0.995 . . . . 0.0 112.982 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.97 13.64 10.61 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -158.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.81 158.69 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.464 1.029 . . . . 0.0 112.863 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -108.1 157.37 18.33 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.956 1.302 . . . . 0.0 110.521 163.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -76.08 68.89 2.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.978 1.311 . . . . 0.0 110.186 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 122.73 1.252 . . . . 0.0 111.16 -176.536 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.857 0 CA-C-O 121.739 0.78 . . . . 0.0 109.912 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.412 ' HD2' HG22 ' A' ' 29' ' ' ILE . 20.6 mtm-85 -119.91 149.42 42.13 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.842 0.857 . . . . 0.0 110.083 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' A' ' 60' ' ' VAL . 12.6 m -133.07 164.29 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.466 1.106 . . . . 0.0 110.994 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.462 ' HB2' HG11 ' A' ' 60' ' ' VAL . 42.6 ttm180 -135.88 130.48 33.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.368 1.067 . . . . 0.0 109.446 -170.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.8 135.71 51.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 174.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.84 2.76 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.986 0.914 . . . . 0.0 111.005 169.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.3 mt -141.08 153.39 66.93 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 124.818 1.247 . . . . 0.0 108.522 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.18 158.15 17.62 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.503 2.802 . . . . 0.0 110.538 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -149.09 120.54 7.93 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.679 -0.638 . . . . 0.0 111.399 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.6 m -78.03 113.13 15.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.518 0.727 . . . . 0.0 109.264 167.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -65.55 156.74 31.7 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.234 168.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.17 146.21 86.76 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 160.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.23 172.23 12.48 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.995 3.13 . . . . 0.0 111.403 165.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t70 64.43 5.87 2.83 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.468 1.507 . . . . 0.0 113.559 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.2 p -119.27 176.11 5.48 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 119.744 -1.848 . . . . 0.0 110.173 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.33 10.46 4.54 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.031 1.332 . . . . 0.0 110.065 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.33 160.77 27.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.645 1.578 . . . . 0.0 110.669 -170.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.8 pt -131.65 132.36 62.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.9 p -75.59 162.21 28.47 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -157.48 166.28 33.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.929 0.892 . . . . 0.0 109.211 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.23 162.5 15.93 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.736 0.814 . . . . 0.0 109.139 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -57.17 125.51 23.05 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 166.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.21 -6.74 58.16 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.044 -1.975 . . . . 0.0 113.388 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.99 160.28 23.96 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.702 2.251 . . . . 0.0 110.19 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.2 mtp -134.99 153.48 52.07 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.805 0.812 . . . . 0.0 111.557 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -146.26 165.55 28.9 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.273 -1.33 . . . . 0.0 111.755 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.412 HG22 ' HD2' ' A' ' 4' ' ' ARG . 4.4 pt -122.87 128.35 75.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.773 1.629 . . . . 0.0 107.933 -170.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.36 131.39 32.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 120.73 1.605 . . . . 0.0 108.637 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -132.75 -30.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -148.99 165.84 30.43 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.172 0.896 . . . . 0.0 109.253 166.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -133.92 124.28 26.13 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 127.987 2.515 . . . . 0.0 105.063 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.3 -178.29 3.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.943 1.297 . . . . 0.0 110.691 -171.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -132.37 79.49 1.86 Allowed 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 125.488 1.515 . . . . 0.0 107.761 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -168.29 -0.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.505 0.722 . . . . 0.0 112.742 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.34 25.9 38.16 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.236 0.922 . . . . 0.0 112.031 -166.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -136.06 160.02 39.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.178 1.791 . . . . 0.0 108.053 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 35.8 mtm -147.79 158.31 43.96 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -95.25 134.84 37.56 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.837 1.199 . . . . 0.0 111.053 170.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 m -142.53 175.1 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.247 1.819 . . . . 0.0 108.971 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.5 m -114.47 135.54 54.0 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 162.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -82.45 120.13 25.07 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.032 0.933 . . . . 0.0 109.261 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.31 -5.48 3.51 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.283 1.033 . . . . 0.0 113.047 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -63.76 -37.59 87.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.546 -1.216 . . . . 0.0 111.138 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 t -164.0 13.93 0.05 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.986 1.266 . . . . 0.0 113.742 -171.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 73.81 5.01 4.79 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.899 1.679 . . . . 0.0 113.463 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -54.5 116.86 2.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.101 1.76 . . . . 0.0 109.244 167.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.76 165.49 11.35 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 166.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.47 -146.62 13.86 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.68 142.02 45.78 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.687 1.195 . . . . 0.0 110.716 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.5 147.9 23.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 129.724 3.209 . . . . 0.0 107.063 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -88.78 144.77 8.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -68.39 -12.84 61.74 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -69.97 -16.19 63.15 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.152 1.381 . . . . 0.0 114.109 -171.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.5 mt -125.51 6.52 7.6 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.378 1.071 . . . . 0.0 112.363 -162.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.8 m -120.03 156.9 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.634 1.174 . . . . 0.0 110.536 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -116.45 153.35 32.27 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.846 1.258 . . . . 0.0 110.257 173.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.6 63.95 2.81 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.043 172.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.462 HG11 ' HB2' ' A' ' 6' ' ' ARG . 6.5 p . . . . . 0 C--N 1.319 -0.74 0 O-C-N 120.888 -1.133 . . . . 0.0 111.609 174.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 . . . . . 0 C--O 1.238 0.464 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -134.28 161.53 34.68 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 125.063 1.345 . . . . 0.0 108.872 159.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.3 164.86 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 162.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -128.73 140.9 51.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.87 141.82 51.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 120.004 1.274 . . . . 0.0 109.714 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.97 2.5 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.039 0.936 . . . . 0.0 111.729 170.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 mt -143.4 157.04 60.29 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 126.085 1.754 . . . . 0.0 107.353 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -88.38 167.47 6.38 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.695 2.93 . . . . 0.0 110.795 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -156.74 167.14 31.35 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.934 0.494 . . . . 0.0 111.13 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 m -124.43 115.5 21.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.18 2.192 . . . . 0.0 107.278 171.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -61.15 157.34 16.19 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.888 172.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.02 135.87 79.95 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 162.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.493 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 95.1 Cg_endo -70.12 163.9 36.88 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.146 1.898 . . . . 0.0 109.197 171.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.4 t70 63.2 18.27 10.84 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.601 0.715 . . . . 0.0 112.135 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.3 p -130.9 169.41 15.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.675 1.59 . . . . 0.0 108.699 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.42 3.81 38.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.458 1.503 . . . . 0.0 111.428 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -69.97 167.02 18.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.28 1.832 . . . . 0.0 110.184 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.4 pt -140.14 129.31 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 120.885 -1.134 . . . . 0.0 110.057 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -63.82 160.73 16.76 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.785 0.72 . . . . 0.0 110.105 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -161.44 173.53 14.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.276 0.56 . . . . 0.0 110.588 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mt -125.28 159.71 31.03 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.102 1.361 . . . . 0.0 109.773 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -58.29 120.47 8.76 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.29 2.24 59.11 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 117.678 -1.623 . . . . 0.0 113.117 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.84 158.42 35.53 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.893 2.346 . . . . 0.0 108.034 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.4 ttt -120.04 134.24 55.31 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 126.057 1.743 . . . . 0.0 110.986 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CE1' HG21 ' A' ' 52' ' ' ILE . 93.3 m-85 -111.66 165.41 12.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.554 1.168 . . . . 0.0 109.045 177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 pt -118.92 138.67 48.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 163.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.99 141.43 16.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 170.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.29 -21.07 1.61 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 112.596 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -150.28 160.54 43.63 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.211 1.004 . . . . 0.0 109.87 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -120.55 118.15 29.45 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 127.32 2.248 . . . . 0.0 105.451 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mt -109.82 -169.05 1.4 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.846 1.258 . . . . 0.0 107.876 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.29 14.13 3.51 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -164.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -130.83 34.23 4.12 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.787 1.635 . . . . 0.0 110.54 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.41 13.64 81.49 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.05 1.31 . . . . 0.0 113.709 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -112.65 156.27 23.02 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.119 1.368 . . . . 0.0 110.272 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.5 mtm -144.83 145.93 31.86 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.707 1.203 . . . . 0.0 108.399 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -78.73 141.62 37.72 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 164.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.49 -175.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 122.436 1.112 . . . . 0.0 111.15 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 m -135.51 125.22 25.39 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 160.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -77.05 102.74 6.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.9 -14.29 21.32 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -61.43 -19.15 61.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 117.181 -1.39 . . . . 0.0 112.679 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -164.42 11.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.799 1.181 . . . . 0.0 112.945 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.78 20.44 11.41 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.285 1.402 . . . . 0.0 112.509 -172.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.17 104.58 0.93 Allowed 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -93.81 156.25 16.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.87 -166.53 31.95 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.08 143.55 27.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.495 1.118 . . . . 0.0 109.861 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.406 HG21 ' CE1' ' A' ' 28' ' ' PHE . 1.9 pp -134.38 151.1 31.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.12 1.368 . . . . 0.0 108.702 169.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.54 137.82 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -64.11 -18.79 64.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.317 1.047 . . . . 0.0 112.679 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.48 -18.27 63.61 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.551 1.14 . . . . 0.0 113.341 -166.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.6 mt -124.07 10.42 8.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.547 1.539 . . . . 0.0 111.652 -164.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.4 m -119.65 171.77 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.565 1.146 . . . . 0.0 110.864 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -130.39 152.47 49.75 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.941 2.496 . . . . 0.0 109.359 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -70.69 73.29 0.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.583 1.153 . . . . 0.0 109.901 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 C--N 1.329 -0.29 0 O-C-N 120.206 -1.558 . . . . 0.0 109.14 172.209 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.276 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HD3' HG22 ' A' ' 29' ' ' ILE . 74.5 mtt180 -132.27 154.68 49.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.343 -0.848 . . . . 0.0 109.719 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.89 166.54 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.433 0.693 . . . . 0.0 109.147 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -138.01 136.26 36.72 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.857 -1.152 . . . . 0.0 110.402 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.45 120.53 16.23 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.266 1.027 . . . . 0.0 110.06 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.6 -4.02 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.137 172.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.676 HD11 HD22 ' A' ' 56' ' ' LEU 0.28 2.1 pp -162.57 152.75 13.84 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.398 1.479 . . . . 0.0 108.519 -171.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.67 160.86 21.89 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.684 2.922 . . . . 0.0 112.336 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -143.22 163.01 34.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.371 1.868 . . . . 0.0 109.2 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.8 m -128.77 105.82 8.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.542 1.137 . . . . 0.0 108.439 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.42 157.02 38.42 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.991 0.517 . . . . 0.0 110.571 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.3 t -87.82 141.35 31.62 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -173.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -70.68 141.96 42.74 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 O-C-N 118.418 -1.412 . . . . 0.0 109.212 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.9 t70 75.45 33.93 0.64 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.652 1.981 . . . . 0.0 112.753 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.6 p -132.47 167.19 20.41 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.046 -1.034 . . . . 0.0 111.594 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.5 20.39 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 128.941 2.897 . . . . 0.0 111.814 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -110.04 169.3 8.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.27 1.428 . . . . 0.0 110.678 -160.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -140.15 150.55 21.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.243 1.417 . . . . 0.0 109.063 174.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 p -95.77 167.24 11.39 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -161.74 156.59 23.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.78 174.07 6.03 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.417 1.103 . . . . 0.0 108.905 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -57.98 123.54 16.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 168.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.02 1.54 57.13 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-O 118.359 -1.245 . . . . 0.0 114.486 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.39 162.66 22.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.38 1.59 . . . . 0.0 111.249 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.5 ttt -137.14 145.58 43.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.135 1.374 . . . . 0.0 108.822 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.09 175.38 9.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.432 1.093 . . . . 0.0 109.937 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 ' HD3' ' A' ' 4' ' ' ARG . 10.8 pt -126.13 138.69 53.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.558 1.543 . . . . 0.0 106.877 176.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.92 136.13 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 118.684 0.675 . . . . 0.0 109.763 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -139.19 -18.36 1.01 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -155.66 164.88 38.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.363 1.438 . . . . 0.0 108.912 159.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.89 114.07 11.45 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.323 1.849 . . . . 0.0 106.384 -167.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -114.08 154.03 28.43 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.063 0.945 . . . . 0.0 111.384 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -92.91 48.09 1.32 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.575 1.15 . . . . 0.0 110.927 -164.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -161.28 34.78 0.14 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.275 1.03 . . . . 0.0 110.443 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.83 -2.82 58.54 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.441 1.019 . . . . 0.0 114.223 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -87.54 153.6 21.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.516 1.158 . . . . 0.0 110.886 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.1 mtm -143.93 134.61 25.0 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -76.75 138.99 40.26 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.31 -176.35 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 122.332 1.063 . . . . 0.0 111.554 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -127.8 126.51 41.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 155.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.09 116.14 19.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.622 1.969 . . . . 0.0 108.853 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mt -87.28 13.86 8.93 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.542 -0.724 . . . . 0.0 112.391 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.9 ttp85 -79.97 -16.54 55.01 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.328 -1.483 . . . . 0.0 111.058 170.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -163.77 7.35 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.539 0.609 . . . . 0.0 112.233 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 63.23 23.83 14.04 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.055 1.742 . . . . 0.0 112.682 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.8 108.33 2.49 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.658 0.783 . . . . 0.0 109.361 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -87.87 149.38 24.14 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.655 -0.653 . . . . 0.0 110.147 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.71 -171.93 35.49 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.311 1.434 . . . . 0.0 109.965 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.1 mt -89.93 138.83 31.17 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.52 1.128 . . . . 0.0 112.303 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -134.23 162.87 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 127.194 2.197 . . . . 0.0 108.217 166.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 p -109.59 146.19 15.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 123.89 0.876 . . . . 0.0 109.163 -175.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -68.22 -17.33 64.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.278 1.431 . . . . 0.0 112.255 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.22 -29.23 69.7 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.917 0.887 . . . . 0.0 111.705 -177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.676 HD22 HD11 ' A' ' 9' ' ' LEU . 50.2 mt -115.97 5.22 13.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.58 1.152 . . . . 0.0 111.03 -161.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.36 165.84 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.87 1.268 . . . . 0.0 110.882 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -120.66 152.69 37.88 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 125.782 1.633 . . . . 0.0 108.681 172.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -78.7 69.93 4.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.652 1.181 . . . . 0.0 109.573 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 121.586 0.708 . . . . 0.0 109.429 173.199 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' HD3' HG22 ' A' ' 29' ' ' ILE . 17.5 mtt180 -134.19 166.91 21.68 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.01 154.97 37.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.416 1.087 . . . . 0.0 108.688 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -119.12 133.55 55.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . . . -84.7 154.63 22.35 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.505 1.048 . . . . 0.0 109.724 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.21 11.56 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.196 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.59 161.7 32.46 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.455 2.302 . . . . 0.0 107.859 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -86.46 162.27 9.6 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.927 3.085 . . . . 0.0 111.646 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -159.13 132.05 6.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.776 1.231 . . . . 0.0 110.604 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 t -97.07 137.79 35.6 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 172.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -89.16 139.08 30.84 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.342 -177.119 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.46 134.59 94.51 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 120.242 1.383 . . . . 0.0 108.267 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 60.3 Cg_endo -67.58 162.12 40.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.126 1.884 . . . . 0.0 109.773 168.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.48 -11.44 1.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.04 2.136 . . . . 0.0 113.129 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -118.6 169.0 10.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.564 1.146 . . . . 0.0 111.057 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -92.15 21.31 5.19 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.71 1.604 . . . . 0.0 111.358 -167.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -68.35 163.83 22.21 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.492 -1.38 . . . . 0.0 109.749 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 pt -130.74 138.67 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 120.869 -1.144 . . . . 0.0 111.01 169.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.5 m -73.56 156.09 38.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -147.29 165.21 30.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 122.303 1.049 . . . . 0.0 110.635 164.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.19 166.11 11.35 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -64.88 125.97 26.5 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.0 47.93 1.21 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.007 1.289 . . . . 0.0 113.26 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.7 167.14 23.84 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.206 1.802 . . . . 0.0 108.998 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.3 mtp -138.03 149.75 46.33 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.103 0.961 . . . . 0.0 111.032 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -136.33 159.94 40.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.826 1.25 . . . . 0.0 109.701 -173.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.517 HG22 ' HD3' ' A' ' 4' ' ' ARG . 15.9 pt -110.52 138.4 38.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.27 129.12 33.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -121.17 -32.07 3.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.107 174.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -152.15 162.44 41.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.066 0.848 . . . . 0.0 111.043 167.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -108.54 132.97 53.31 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.632 1.973 . . . . 0.0 106.813 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.3 mt -125.82 -168.53 1.86 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.106 1.762 . . . . 0.0 107.364 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.68 14.04 3.42 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.583 1.083 . . . . 0.0 113.831 -158.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -120.25 16.13 12.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.363 1.465 . . . . 0.0 111.55 -168.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.84 13.59 69.22 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.669 -1.27 . . . . 0.0 111.862 -168.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -125.86 150.27 48.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.685 1.594 . . . . 0.0 109.706 -169.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 56.8 mtm -142.96 144.39 32.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.827 1.251 . . . . 0.0 108.91 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -81.62 135.6 35.55 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.999 0.52 . . . . 0.0 110.302 170.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.39 175.24 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.416 1.086 . . . . 0.0 110.268 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.3 m -112.38 134.86 53.68 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 154.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -76.54 165.08 25.3 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -88.62 -35.11 17.03 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 121.927 2.149 . . . . 0.0 113.213 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -51.89 -29.22 18.98 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -165.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.251 9.5 t -152.96 18.26 0.58 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.224 1.81 . . . . 0.0 112.593 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 52.36 26.89 4.39 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.222 1.809 . . . . 0.0 112.5 -172.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -66.1 148.3 52.02 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.643 -1.286 . . . . 0.0 111.234 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -137.87 144.88 41.59 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.061 0.945 . . . . 0.0 108.457 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.56 -157.51 27.32 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.7 147.01 27.75 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.895 0.878 . . . . 0.0 112.437 -165.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.1 pt -136.01 147.97 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 126.674 1.99 . . . . 0.0 110.909 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.92 138.01 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.025 1.33 . . . . 0.0 109.732 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.75 -0.78 22.13 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.661 1.184 . . . . 0.0 112.849 -172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -24.12 65.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.793 1.637 . . . . 0.0 112.86 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.4 mt -127.94 13.86 6.83 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.36 1.064 . . . . 0.0 112.665 -158.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.4 m -122.66 170.79 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 126.318 1.847 . . . . 0.0 111.489 -176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -132.23 155.68 47.83 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 127.772 2.429 . . . . 0.0 109.748 172.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -69.8 78.41 0.45 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.72 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.24 0.599 0 O-C-N 120.911 -1.118 . . . . 0.0 108.81 162.93 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.619 ' NH2' HG13 ' A' ' 5' ' ' VAL 0.257 0.0 OUTLIER . . . . . 0 C--O 1.234 0.247 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 . . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -117.42 173.71 6.55 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 119.553 -1.967 . . . . 0.0 109.876 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.619 HG13 ' NH2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -126.1 160.18 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 120.512 -1.367 . . . . 0.0 110.531 171.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.72 118.51 28.24 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 125.784 1.633 . . . . 0.0 108.974 -170.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.02 127.11 31.96 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.467 0.707 . . . . 0.0 109.433 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.96 -0.16 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.371 0.669 . . . . 0.0 111.762 172.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.4 161.39 29.42 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 125.817 1.647 . . . . 0.0 109.011 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -87.23 160.47 8.43 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 124.243 3.296 . . . . 0.0 111.25 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -151.74 166.2 32.07 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.633 1.173 . . . . 0.0 110.361 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 t -125.74 136.08 52.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -172.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -70.01 150.54 46.54 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 118.806 -1.157 . . . . 0.0 108.776 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.2 t -75.27 137.53 71.83 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.28 146.38 69.18 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 N-CA-C 108.446 -1.405 . . . . 0.0 108.446 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 t70 75.62 4.94 4.01 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.76 2.024 . . . . 0.0 113.408 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.6 p -108.91 -177.17 3.24 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 120.339 -1.475 . . . . 0.0 112.187 -175.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -83.93 -17.47 40.59 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.102 1.361 . . . . 0.0 109.843 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 165.18 18.5 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.369 1.468 . . . . 0.0 111.954 -164.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 pt -127.43 134.15 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.806 1.242 . . . . 0.0 109.68 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.33 160.76 12.63 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.735 0.814 . . . . 0.0 108.948 173.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -157.43 173.33 17.07 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.935 0.874 . . . . 0.0 113.117 170.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.4 mt -127.96 160.98 30.21 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.111 1.364 . . . . 0.0 109.097 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -62.1 141.47 58.11 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.92 -4.78 81.82 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.681 1.134 . . . . 0.0 114.055 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.3 168.51 19.02 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.007 1.404 . . . . 0.0 109.017 171.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 38.1 mtp -135.51 150.66 49.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.89 0.876 . . . . 0.0 109.525 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -136.06 159.06 42.86 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.91 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 29' ' ' ILE . 4.7 pt -112.16 125.19 69.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -175.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 3' ' ' ARG . 1.6 p -63.71 112.45 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.21 -38.32 5.79 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.745 0.818 . . . . 0.0 110.047 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -148.08 172.34 14.42 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -133.07 133.52 43.1 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -175.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.405 ' CD1' HD21 ' A' ' 51' ' ' LEU . 38.1 mt -120.33 -168.82 1.69 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.615 1.166 . . . . 0.0 109.056 -176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -136.31 57.78 1.76 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.452 1.101 . . . . 0.0 109.094 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -154.06 22.43 0.5 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.214 171.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.98 23.23 69.61 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.145 -1.597 . . . . 0.0 112.296 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -130.34 148.47 52.16 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.759 2.024 . . . . 0.0 108.534 -170.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.0 mtm -144.77 132.63 21.26 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -72.13 134.62 45.85 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.88 178.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 123.349 0.659 . . . . 0.0 111.793 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 5.2 m -115.03 143.59 44.94 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 154.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -86.47 119.6 26.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.384 1.073 . . . . 0.0 110.105 168.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.98 1.31 2.77 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.478 1.111 . . . . 0.0 113.465 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -66.3 -46.45 76.92 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.219 -1.551 . . . . 0.0 110.423 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -146.13 -3.43 0.66 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.254 1.022 . . . . 0.0 112.551 -157.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.4 t70 68.21 11.54 8.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.172 1.789 . . . . 0.0 112.907 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -61.14 118.34 6.69 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.111 0.964 . . . . 0.0 108.744 167.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 9.5 mp0 -81.84 168.67 17.73 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.385 0.612 . . . . 0.0 110.694 166.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.82 -165.45 30.16 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD21 ' CD1' ' A' ' 34' ' ' LEU . 9.6 mt -99.4 143.83 29.2 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.701 0.8 . . . . 0.0 110.825 -171.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.19 151.34 33.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 125.446 1.498 . . . . 0.0 109.035 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 p -88.58 135.84 24.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.952 1.701 . . . . 0.0 107.934 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.34 -10.29 59.43 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -56.65 -18.4 12.07 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.718 2.407 . . . . 0.0 113.717 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -131.11 13.48 5.17 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.024 1.33 . . . . 0.0 113.296 -164.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.75 153.91 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.237 1.015 . . . . 0.0 112.395 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -117.69 148.29 42.13 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.848 1.659 . . . . 0.0 111.076 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.97 100.86 2.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 128.97 2.908 . . . . 0.0 110.139 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 121.873 0.844 . . . . 0.0 111.543 -174.751 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.484 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -119.8 159.51 24.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.631 1.572 . . . . 0.0 108.469 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -137.9 164.83 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 167.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.2 tpp85 -128.08 129.91 47.38 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.458 1.503 . . . . 0.0 107.349 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.28 125.06 25.96 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 120.463 1.483 . . . . 0.0 108.944 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.28 0.2 OUTLIER -113.36 4.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.423 170.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.8 mt -146.28 157.66 48.9 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.833 1.653 . . . . 0.0 109.176 165.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.31 166.77 15.99 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.82 3.68 . . . . 0.0 111.584 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -153.0 163.58 39.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.605 1.162 . . . . 0.0 109.218 173.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -124.31 120.66 32.83 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.528 1.531 . . . . 0.0 109.049 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -61.33 149.14 39.06 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 124.536 1.147 . . . . 0.0 111.22 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.3 135.45 86.73 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -62.55 153.44 71.49 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.1 2.533 . . . . 0.0 110.221 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.36 38.91 22.78 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.078 1.351 . . . . 0.0 111.842 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 p -138.45 166.03 25.31 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.031 0.932 . . . . 0.0 111.84 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.13 -13.55 48.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.867 2.867 . . . . 0.0 113.055 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -63.49 170.11 3.36 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.181 1.793 . . . . 0.0 113.171 -171.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 pt -131.05 136.71 57.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.743 1.217 . . . . 0.0 110.288 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -72.99 149.71 43.06 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.271 1.428 . . . . 0.0 110.9 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -155.11 158.66 39.36 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.689 -1.257 . . . . 0.0 112.806 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.66 170.32 8.0 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.904 0.859 . . . . 0.0 109.458 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -56.98 134.97 56.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 168.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.42 -11.13 56.69 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 118.872 -0.96 . . . . 0.0 114.148 171.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.26 167.74 19.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.673 1.236 . . . . 0.0 108.897 160.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 18.7 ptm -144.67 168.15 20.85 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 124.083 0.953 . . . . 0.0 109.317 170.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -138.42 163.75 31.11 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.608 1.163 . . . . 0.0 109.614 -164.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.5 pt -127.4 130.94 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 125.283 1.433 . . . . 0.0 107.393 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.94 127.8 29.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -127.55 -15.18 5.09 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.715 0.806 . . . . 0.0 113.106 172.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -150.18 166.42 29.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 156.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -121.53 124.68 44.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.51 -167.49 1.26 Allowed 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -138.48 68.58 1.39 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.398 1.479 . . . . 0.0 107.594 -170.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -168.16 15.8 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.395 1.478 . . . . 0.0 112.312 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.96 37.89 88.28 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.13 1.347 . . . . 0.0 111.848 -169.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -137.72 149.17 46.27 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.588 1.955 . . . . 0.0 107.259 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.2 mtm -134.98 142.99 46.6 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.601 1.161 . . . . 0.0 108.689 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -78.1 135.66 37.74 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 165.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.57 -173.34 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 122.361 1.077 . . . . 0.0 110.804 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 m -131.09 147.31 52.6 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 157.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -97.55 132.01 43.62 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 mt -68.01 -10.1 50.99 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.47 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -65.48 -43.13 91.18 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.37 1.441 . . . . 0.0 112.11 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 p -143.7 9.56 1.56 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.405 1.082 . . . . 0.0 111.738 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 t70 58.31 32.67 22.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.002 0.921 . . . . 0.0 111.429 -167.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -72.29 140.8 48.76 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.913 -1.117 . . . . 0.0 109.417 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -126.45 151.86 47.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 146.62 -155.92 26.76 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.6 mt -108.81 141.88 40.18 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.335 1.054 . . . . 0.0 110.54 -164.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.8 150.75 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.791 1.637 . . . . 0.0 109.292 171.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.33 146.59 5.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 125.901 1.68 . . . . 0.0 109.47 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -87.72 10.71 17.36 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.84 -24.45 60.89 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.564 1.146 . . . . 0.0 113.822 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -125.46 16.28 8.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -156.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.93 170.52 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.013 0.925 . . . . 0.0 112.353 -168.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.86 151.94 41.23 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.133 -0.979 . . . . 0.0 109.827 160.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.94 57.58 2.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 128.691 2.797 . . . . 0.0 111.3 -172.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.537 0.465 0 O-C-N 120.525 -1.359 . . . . 0.0 111.769 -176.477 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.419 ' HB3' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.28 150.23 51.91 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.464 1.506 . . . . 0.0 108.34 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.74 164.25 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 120.071 1.305 . . . . 0.0 108.82 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -112.17 141.53 45.74 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.533 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -92.52 139.49 30.52 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 119.612 1.097 . . . . 0.0 111.016 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.68 12.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.159 0.984 . . . . 0.0 112.507 -172.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.8 158.61 33.96 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.198 1.399 . . . . 0.0 108.548 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -88.54 163.36 6.56 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.541 3.494 . . . . 0.0 111.635 171.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -158.67 141.29 14.33 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.836 1.254 . . . . 0.0 110.207 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.9 m -103.74 118.12 35.97 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.923 1.289 . . . . 0.0 109.959 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -78.63 160.42 27.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.868 0.867 . . . . 0.0 111.937 175.136 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.4 t -89.39 130.46 43.66 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 125.698 1.599 . . . . 0.0 108.235 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 8.3 Cg_endo -64.84 159.2 46.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.716 1.611 . . . . 0.0 112.854 173.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.251 2.9 t70 69.61 27.71 4.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.675 1.99 . . . . 0.0 112.306 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.0 p -131.4 -178.78 5.0 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.461 1.105 . . . . 0.0 110.921 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.74 8.65 36.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.313 2.645 . . . . 0.0 109.465 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -84.45 175.59 9.23 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.605 -1.309 . . . . 0.0 109.174 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.9 pt -148.64 144.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.2 2.2 . . . . 0.0 107.676 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 77.5 p -102.23 169.15 8.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 121.892 2.133 . . . . 0.0 111.205 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.533 ' CE2' ' HB1' ' A' ' 7' ' ' ALA . 9.4 p90 -170.18 -171.23 1.09 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.12 0.486 . . . . 0.0 112.234 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 mt -128.44 153.22 47.34 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.888 1.675 . . . . 0.0 109.471 -175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -52.31 127.31 21.74 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.522 -0.736 . . . . 0.0 109.079 168.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.72 -10.49 32.48 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 124.725 1.155 . . . . 0.0 114.211 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.38 158.49 35.69 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.363 1.581 . . . . 0.0 110.197 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.5 ttt -114.49 148.94 37.1 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.471 1.108 . . . . 0.0 108.286 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -125.85 162.66 24.64 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.289 1.036 . . . . 0.0 109.992 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.37 127.49 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.357 1.463 . . . . 0.0 108.99 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 3' ' ' ARG . 68.5 t -68.78 101.22 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 119.362 0.983 . . . . 0.0 109.354 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -95.3 -34.49 12.16 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.199 -0.938 . . . . 0.0 111.108 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -149.3 175.05 11.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.618 1.167 . . . . 0.0 109.021 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -138.93 127.32 22.91 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.851 2.46 . . . . 0.0 104.96 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.1 -163.01 0.85 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.293 1.437 . . . . 0.0 109.508 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -134.46 44.11 2.71 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.296 -1.502 . . . . 0.0 113.282 -168.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.91 1.48 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.888 1.275 . . . . 0.0 112.074 -157.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.55 5.0 90.26 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.1 1.333 . . . . 0.0 113.263 -167.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.596 ' CZ2' HG13 ' A' ' 53' ' ' VAL . 84.7 m95 -112.26 149.55 32.17 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.962 2.105 . . . . 0.0 110.861 -175.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.7 mtm -149.12 143.65 26.13 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.764 -1.21 . . . . 0.0 110.084 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -86.7 136.66 32.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.099 0.409 . . . . 0.0 111.016 174.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 m -147.7 -167.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.835 0.854 . . . . 0.0 111.413 -172.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.3 m -140.05 150.99 45.04 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 159.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.71 107.3 18.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.143 2.177 . . . . 0.0 108.075 -173.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.1 mt -68.7 1.18 3.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.35 -27.13 63.15 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.311 -1.493 . . . . 0.0 113.165 169.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -167.39 13.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -165.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 t0 60.75 32.8 20.24 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 123.509 1.623 . . . . 0.0 111.52 -174.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -74.88 99.56 3.83 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 120.797 -1.189 . . . . 0.0 108.366 172.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -81.99 139.53 34.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.57 1.548 . . . . 0.0 109.551 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.99 -169.17 40.13 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.417 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.9 mt -89.95 139.62 30.42 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.916 2.086 . . . . 0.0 112.997 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.31 158.52 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.147 1.779 . . . . 0.0 111.177 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.596 HG13 ' CZ2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -89.96 152.86 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 C-N-CA 124.126 0.97 . . . . 0.0 111.646 164.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.53 -22.89 67.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.285 164.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.57 ' H ' ' HB ' ' A' ' 53' ' ' VAL . 23.3 t70 -62.57 -17.01 59.16 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 122.937 1.351 . . . . 0.0 112.48 -164.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.9 mt -124.83 6.04 8.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.567 1.547 . . . . 0.0 110.885 -160.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -124.94 159.14 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.77 1.228 . . . . 0.0 109.476 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -117.83 153.59 33.24 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.976 1.311 . . . . 0.0 108.28 173.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.307 0.0 OUTLIER -80.51 118.39 22.07 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.694 1.235 . . . . 0.0 108.723 171.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 126.816 2.047 . . . . 0.0 106.344 171.605 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -141.77 141.17 33.2 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.366 1.867 . . . . 0.0 107.733 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 59' ' ' GLU . 1.6 m -125.73 160.27 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.146 0.978 . . . . 0.0 108.487 167.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -115.57 129.68 56.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.62 131.44 41.68 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.004 0.82 . . . . 0.0 108.794 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.86 4.29 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.291 0.636 . . . . 0.0 111.43 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 mt -146.72 154.29 47.7 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.058 1.743 . . . . 0.0 107.893 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.86 169.02 20.1 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.693 3.595 . . . . 0.0 111.792 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -154.23 166.36 33.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.586 0.708 . . . . 0.0 112.884 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.4 m -116.6 102.02 9.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.516 2.326 . . . . 0.0 109.916 -170.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -57.26 143.46 39.34 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 177.145 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.02 135.49 82.67 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 166.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.72 151.27 79.14 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.704 2.269 . . . . 0.0 109.849 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.0 t70 61.25 30.27 19.11 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.81 0.844 . . . . 0.0 111.573 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -128.35 170.92 12.53 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.92 4.05 18.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.373 0.669 . . . . 0.0 109.359 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.41 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 40.2 mt-10 -67.04 161.95 23.25 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.733 1.213 . . . . 0.0 110.432 173.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.489 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 18.9 pt -141.96 148.26 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.182 1.393 . . . . 0.0 107.852 172.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.13 145.15 51.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.29 164.86 29.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.447 0.642 . . . . 0.0 110.859 170.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.46 163.33 15.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.063 0.945 . . . . 0.0 109.702 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -57.97 133.97 55.97 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 163.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.69 -2.1 76.37 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 117.113 -1.937 . . . . 0.0 112.718 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -71.36 167.8 18.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.784 2.292 . . . . 0.0 109.529 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 19.7 ttt -140.6 147.69 39.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.499 1.52 . . . . 0.0 107.516 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -130.85 170.06 14.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.047 0.842 . . . . 0.0 109.958 -175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.4 pt -131.52 133.69 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.319 1.448 . . . . 0.0 107.635 170.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -69.05 116.88 10.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.4 -20.37 11.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.563 0.745 . . . . 0.0 110.786 176.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -152.03 -176.55 5.7 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.408 1.004 . . . . 0.0 110.229 160.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -125.04 130.35 52.11 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.334 1.853 . . . . 0.0 108.271 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -107.18 -163.45 0.91 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 166.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -134.4 14.56 3.78 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.357 0.98 . . . . 0.0 112.236 -170.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -120.13 11.24 11.6 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.033 1.733 . . . . 0.0 111.278 -159.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.68 20.72 65.39 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 127.083 2.278 . . . . 0.0 112.124 -167.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -127.01 150.9 49.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.371 1.086 . . . . 0.0 110.636 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.46 ' HE3' HD11 ' A' ' 52' ' ' ILE . 33.5 mtm -136.14 135.51 39.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' A' ' 51' ' ' LEU . 11.9 t-105 -73.46 128.27 35.01 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.29 1.436 . . . . 0.0 108.462 162.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.55 -173.89 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 123.824 0.85 . . . . 0.0 110.928 -174.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.5 m -124.48 132.98 53.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 157.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -86.07 112.17 21.01 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.59 1.156 . . . . 0.0 108.657 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.7 mt -67.33 -9.41 40.86 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.955 -1.022 . . . . 0.0 113.187 -172.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -30.43 70.97 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 120.921 1.692 . . . . 0.0 113.412 173.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.0 p -147.96 -8.86 0.4 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.526 1.141 . . . . 0.0 113.795 -165.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 t0 73.7 10.5 4.77 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.134 1.374 . . . . 0.0 112.349 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -61.55 126.12 26.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.843 1.657 . . . . 0.0 108.216 167.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -93.13 170.23 9.81 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 109.963 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.93 -158.02 21.79 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 118.139 0.427 . . . . 0.0 112.893 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' A' ' 40' ' ' TRP . 1.8 mm? -98.54 135.24 40.37 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.544 1.138 . . . . 0.0 111.587 -160.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.46 HD11 ' HE3' ' A' ' 39' ' ' MET . 1.5 pp -140.17 146.33 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.945 1.698 . . . . 0.0 108.941 174.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -85.86 138.83 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 124.366 1.067 . . . . 0.0 108.951 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.88 3.8 9.37 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.77 -20.01 60.61 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.546 -1.346 . . . . 0.0 114.401 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -126.76 21.02 7.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.194 0.997 . . . . 0.0 112.374 -160.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 m -130.76 173.82 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.269 1.428 . . . . 0.0 109.884 -170.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.15 154.47 50.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.672 1.989 . . . . 0.0 109.289 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.501 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -79.04 37.17 0.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.756 2.022 . . . . 0.0 114.471 -170.135 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.451 -0.396 0 C-N-CA 126.05 1.74 . . . . 0.0 113.83 -165.833 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.155 0.502 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.9 mpp_? -136.92 115.78 12.24 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.204 1.402 . . . . 0.0 109.507 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.32 170.3 3.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.947 0.88 . . . . 0.0 109.604 171.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -134.59 135.32 42.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.798 1.639 . . . . 0.0 107.766 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB2' ' HE2' ' A' ' 28' ' ' PHE . . . -78.91 137.62 37.73 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.825 1.193 . . . . 0.0 109.039 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.275 0.2 OUTLIER -114.92 8.31 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 178.033 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.39 165.48 17.43 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 126.508 1.923 . . . . 0.0 108.168 169.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -82.36 168.53 14.75 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.24 2.626 . . . . 0.0 110.065 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -147.43 -178.03 6.01 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.921 0.888 . . . . 0.0 110.099 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.9 m -134.49 105.33 6.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.449 2.3 . . . . 0.0 108.083 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -61.93 145.8 51.84 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.286 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.614 ' CG1' HG21 ' A' ' 17' ' ' THR . 0.8 OUTLIER -59.87 140.45 90.01 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 167.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -72.85 138.79 29.33 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.464 2.776 . . . . 0.0 111.093 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 73.34 43.83 0.35 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.184 2.193 . . . . 0.0 111.907 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.614 HG21 ' CG1' ' A' ' 14' ' ' VAL . 28.4 p -143.32 169.55 17.44 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 121.184 -0.947 . . . . 0.0 111.731 -168.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -85.91 -0.66 55.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.914 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.456 ' OE1' HG12 ' A' ' 14' ' ' VAL . 9.2 mt-10 -65.66 168.27 7.88 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.545 1.138 . . . . 0.0 111.163 172.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.53 122.76 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.464 1.906 . . . . 0.0 110.146 -176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.51 124.3 19.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.842 0.857 . . . . 0.0 109.998 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -136.4 164.86 27.15 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.1 0.96 . . . . 0.0 111.226 -175.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.12 167.06 11.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.271 1.028 . . . . 0.0 111.218 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -55.4 140.72 38.96 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 158.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.88 5.86 83.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-O 117.701 -1.61 . . . . 0.0 112.751 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -82.85 169.92 15.56 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.94 1.87 . . . . 0.0 110.53 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -143.28 151.44 40.54 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.708 1.203 . . . . 0.0 110.5 -174.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.422 ' HE2' ' HB2' ' A' ' 7' ' ' ALA . 49.2 m-85 -138.7 173.53 11.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 124.348 1.03 . . . . 0.0 111.432 -168.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.2 pt -135.59 135.18 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 126.093 1.757 . . . . 0.0 107.697 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.21 117.36 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.74 -21.08 10.37 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.345 -0.847 . . . . 0.0 112.736 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -152.86 -177.29 6.18 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -135.88 124.13 23.19 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.743 1.617 . . . . 0.0 107.36 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mt -103.64 -168.9 1.56 Allowed 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.385 1.074 . . . . 0.0 108.648 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -136.65 51.7 1.98 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.536 1.534 . . . . 0.0 109.059 -169.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -159.64 22.65 0.18 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.652 1.181 . . . . 0.0 108.923 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.46 -2.33 7.74 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 119.542 -1.974 . . . . 0.0 114.052 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -86.85 149.97 24.45 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.176 0.991 . . . . 0.0 110.487 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.5 mtm -136.07 136.0 39.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.526 1.13 . . . . 0.0 109.001 172.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.505 ' CE3' HD21 ' A' ' 51' ' ' LEU . 14.1 t-105 -80.4 129.83 34.76 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.996 1.719 . . . . 0.0 108.678 167.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.5 m -142.44 -176.55 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.381 1.072 . . . . 0.0 110.984 -173.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.3 m -118.17 136.22 53.76 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 154.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -88.38 114.61 25.17 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.19 1.796 . . . . 0.0 108.073 166.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.81 -3.28 14.93 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -61.72 -31.58 71.75 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.674 1.579 . . . . 0.0 112.792 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -159.85 12.82 0.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.748 0.704 . . . . 0.0 111.259 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 t0 74.03 19.58 2.98 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.725 1.21 . . . . 0.0 112.519 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -61.43 137.26 58.24 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.792 1.637 . . . . 0.0 107.981 168.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -118.87 158.36 25.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.103 0.961 . . . . 0.0 109.408 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.0 -153.48 21.47 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 124.003 0.815 . . . . 0.0 111.491 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.505 HD21 ' CE3' ' A' ' 40' ' ' TRP . 2.6 mm? -94.85 141.71 28.31 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.629 0.772 . . . . 0.0 110.978 -160.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.87 156.96 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 127.161 2.184 . . . . 0.0 107.379 170.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.83 145.45 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.782 0.833 . . . . 0.0 109.397 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -68.07 -18.74 64.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 112.935 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.43 -15.57 63.43 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -168.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.5 mt -124.48 7.2 8.3 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.184 1.394 . . . . 0.0 113.415 -160.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.89 172.06 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 119.183 0.901 . . . . 0.0 110.742 -175.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.59 145.12 44.53 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.26 1.824 . . . . 0.0 108.231 167.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.16 113.84 3.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.32 161.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.444 -0.749 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 165.325 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.522 ' HB3' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.382 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -146.15 152.14 38.79 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.265 1.026 . . . . 0.0 108.474 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.13 166.23 10.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 121.908 0.861 . . . . 0.0 111.538 165.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -129.59 136.37 49.7 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 127.315 2.246 . . . . 0.0 106.343 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.41 139.89 37.58 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.58 -2.25 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.487 173.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mt -148.43 155.59 42.39 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.312 2.245 . . . . 0.0 108.055 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.14 168.22 15.35 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 124.153 3.235 . . . . 0.0 112.896 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -160.59 150.76 17.94 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.681 1.192 . . . . 0.0 111.425 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 t -116.3 131.81 56.84 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.581 ' H ' ' HB3' ' A' ' 21' ' ' SER . 0.7 OUTLIER -92.84 168.65 11.03 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.117 1.367 . . . . 0.0 111.155 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.27 119.09 57.44 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -58.24 167.28 4.83 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.979 1.786 . . . . 0.0 110.788 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.5 -9.06 1.47 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.247 2.219 . . . . 0.0 113.246 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.7 p -108.4 175.6 5.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.486 1.115 . . . . 0.0 111.706 -174.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -81.62 5.93 16.64 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.313 1.045 . . . . 0.0 112.406 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -77.34 175.74 9.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.931 1.692 . . . . 0.0 111.081 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.3 pt -150.98 156.22 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.828 2.051 . . . . 0.0 109.506 174.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.581 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 19.9 p -116.76 152.57 34.07 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.956 1.303 . . . . 0.0 110.261 -171.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.38 170.84 21.37 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 111.401 -165.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.35 163.68 23.47 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.408 0.683 . . . . 0.0 109.238 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -58.44 144.58 41.6 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.02 -8.23 64.02 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.586 -0.563 . . . . 0.0 113.746 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -69.06 170.56 9.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.806 1.289 . . . . 0.0 110.207 168.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.7 mmm -132.44 163.05 29.63 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.116 1.367 . . . . 0.0 108.995 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -137.23 -176.29 4.34 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 112.814 -1.994 . . . . 0.0 108.821 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.9 pt -143.8 150.27 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 125.772 1.629 . . . . 0.0 107.231 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 3' ' ' ARG . 44.7 t -76.14 131.51 34.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -120.6 -44.34 2.45 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.512 1.125 . . . . 0.0 109.595 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -143.88 166.82 23.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.775 0.798 . . . . 0.0 110.434 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -141.02 120.77 13.43 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 126.946 2.098 . . . . 0.0 105.811 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mt -108.39 -164.94 0.99 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.377 1.471 . . . . 0.0 108.508 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -134.57 66.78 1.53 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.262 1.425 . . . . 0.0 108.547 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.25 6.37 0.12 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.26 1.024 . . . . 0.0 112.739 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.45 15.55 71.04 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.961 1.743 . . . . 0.0 112.918 -165.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -122.44 145.76 48.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.463 1.905 . . . . 0.0 109.829 -171.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -144.7 144.99 31.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 109.686 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -91.61 136.87 32.81 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.909 0.884 . . . . 0.0 112.105 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.36 -175.49 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.84 1.256 . . . . 0.0 111.042 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.0 m -123.2 132.72 54.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 158.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.66 108.14 17.23 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.435 1.894 . . . . 0.0 108.646 174.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mt -76.06 16.91 0.38 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.43 ' HG3' HG22 ' A' ' 46' ' ' THR . 3.3 ptm180 -66.68 -35.13 79.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.388 163.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.43 HG22 ' HG3' ' A' ' 45' ' ' ARG . 1.6 t -169.46 16.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 117.472 -1.251 . . . . 0.0 113.052 -169.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 75.47 18.29 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.12 1.368 . . . . 0.0 113.303 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.19 134.23 54.4 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.596 -0.69 . . . . 0.0 109.336 170.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -124.92 142.85 51.19 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.18 0.992 . . . . 0.0 108.758 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.06 -160.91 28.58 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.37 147.06 23.91 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.507 1.123 . . . . 0.0 112.406 -165.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.2 pt -133.52 157.0 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.876 1.671 . . . . 0.0 109.995 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.22 147.77 7.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 126.119 1.768 . . . . 0.0 107.786 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -75.62 2.03 12.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -80.75 -18.33 48.05 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.427 1.491 . . . . 0.0 113.123 -172.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -123.29 14.79 9.7 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.185 -1.572 . . . . 0.0 112.415 -168.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.09 161.67 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.979 1.711 . . . . 0.0 109.159 -167.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -120.51 148.53 43.72 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.684 1.194 . . . . 0.0 109.02 170.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -70.1 125.53 27.04 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 166.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 125.079 1.352 . . . . 0.0 107.635 171.578 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 30' ' ' VAL 0.293 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 . . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.9 mtt85 -111.54 175.79 5.28 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 120.9 -1.125 . . . . 0.0 111.24 172.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.46 HG13 HH21 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -135.74 162.48 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.119 -0.988 . . . . 0.0 109.168 165.545 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 -138.33 143.6 39.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.644 0.777 . . . . 0.0 109.574 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.06 132.33 35.95 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.131 0.972 . . . . 0.0 110.109 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.64 -4.6 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.219 1.008 . . . . 0.0 111.963 171.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.47 153.4 51.58 Favored Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 126.443 1.897 . . . . 0.0 108.253 175.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -76.3 157.87 37.24 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.709 2.939 . . . . 0.0 111.743 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -140.0 165.3 27.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.36 1.064 . . . . 0.0 110.564 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.9 m -136.76 112.37 9.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.536 1.534 . . . . 0.0 107.269 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 15' ' ' PRO . 6.6 pttm -70.61 152.06 44.32 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 169.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.3 t -75.75 146.6 80.11 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 156.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.539 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 98.2 Cg_endo -81.6 170.76 14.06 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.577 2.851 . . . . 0.0 111.252 172.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 75.4 16.78 2.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.781 2.432 . . . . 0.0 111.548 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.6 p -132.03 168.08 18.57 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.215 1.806 . . . . 0.0 109.855 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -80.41 3.83 20.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.251 1.421 . . . . 0.0 111.587 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.98 172.85 12.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.993 1.717 . . . . 0.0 110.201 -175.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.8 130.83 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.447 1.499 . . . . 0.0 110.588 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.1 150.23 37.29 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.795 1.238 . . . . 0.0 110.066 176.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -154.48 164.05 39.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.369 0.531 . . . . 0.0 111.528 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.44 162.87 14.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.378 1.071 . . . . 0.0 110.922 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.78 132.15 53.08 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 164.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.51 -5.2 54.61 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-O 119.049 -0.862 . . . . 0.0 113.682 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -102.37 154.53 18.98 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.276 1.03 . . . . 0.0 108.435 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.8 ttt -124.25 158.46 32.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.018 0.927 . . . . 0.0 111.179 -164.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.72 177.38 8.94 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.557 1.543 . . . . 0.0 110.599 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.2 pt -131.59 127.65 59.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.631 1.572 . . . . 0.0 109.386 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 3' ' ' ARG . 1.7 p -75.06 94.41 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.38 0.536 . . . . 0.0 110.083 -177.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -82.74 -56.56 3.77 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -135.79 165.33 25.85 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.355 0.598 . . . . 0.0 110.111 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -129.95 128.46 42.16 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 125.808 1.643 . . . . 0.0 106.743 -172.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 mt -113.21 -170.77 1.75 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -175.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -134.65 48.99 2.26 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.123 0.969 . . . . 0.0 108.897 -166.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -156.6 19.11 0.33 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.924 1.29 . . . . 0.0 112.004 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.13 19.61 79.77 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 120.802 -1.186 . . . . 0.0 112.239 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -120.29 153.33 36.54 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.177 1.391 . . . . 0.0 109.206 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.5 mtm -147.46 131.04 16.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -76.12 128.93 35.98 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.42 -165.71 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.504 1.122 . . . . 0.0 110.514 -175.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.1 m -137.02 127.67 27.01 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 162.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -78.47 99.02 6.27 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.526 1.53 . . . . 0.0 108.441 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.08 -2.44 0.43 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.308 1.443 . . . . 0.0 113.909 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -55.91 -48.37 75.8 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 120.554 -1.341 . . . . 0.0 110.136 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -152.53 14.56 0.58 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.4 0.545 . . . . 0.0 111.78 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 t70 74.76 19.68 2.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.922 2.089 . . . . 0.0 111.963 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.6 108.44 0.83 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.035 0.934 . . . . 0.0 108.897 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -73.51 155.88 38.74 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.74 -165.18 28.06 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-O 121.522 0.512 . . . . 0.0 112.508 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 mt -104.72 142.05 35.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.993 1.317 . . . . 0.0 112.503 -168.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.0 153.41 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.709 1.604 . . . . 0.0 109.713 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -86.23 135.84 24.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.736 1.214 . . . . 0.0 108.26 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -77.18 -3.91 41.98 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -172.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.32 -30.25 68.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.707 2.003 . . . . 0.0 113.295 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.36 12.33 13.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.941 1.296 . . . . 0.0 112.911 -160.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 m -130.41 154.24 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.301 1.04 . . . . 0.0 111.001 -171.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -121.13 147.4 45.63 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.748 1.619 . . . . 0.0 110.31 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.81 94.1 1.02 Allowed 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 127.955 2.502 . . . . 0.0 110.828 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t . . . . . 0 N--CA 1.448 -0.564 0 O-C-N 121.5 -0.75 . . . . 0.0 109.591 177.163 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 121.995 0.902 . . . . 0.0 112.217 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.5 mtm-85 -74.2 147.01 42.92 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 119.908 -1.745 . . . . 0.0 109.553 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.8 m -134.0 156.52 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.7 ttm-85 -120.83 125.27 47.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 126.59 1.956 . . . . 0.0 105.75 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.44 151.17 38.11 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 118.386 -1.326 . . . . 0.0 108.567 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.6 3.08 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.951 1.3 . . . . 0.0 111.337 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 mt -142.2 159.05 59.97 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 126.127 1.771 . . . . 0.0 107.608 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.05 170.39 11.02 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.688 2.925 . . . . 0.0 110.983 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -150.77 160.64 43.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.473 1.109 . . . . 0.0 110.474 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -132.19 109.79 10.19 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 172.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' H ' ' HB3' ' A' ' 21' ' ' SER . 7.7 pttm -65.57 165.54 12.11 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.667 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.8 147.54 58.9 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 150.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.79 176.87 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.475 2.784 . . . . 0.0 110.911 158.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 66.91 17.48 10.53 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.043 1.737 . . . . 0.0 112.692 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -135.54 171.73 14.03 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.408 1.883 . . . . 0.0 109.345 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.96 -3.5 29.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.991 1.317 . . . . 0.0 111.561 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.39 162.48 12.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.178 1.391 . . . . 0.0 112.025 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.6 pt -136.88 142.43 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.957 2.103 . . . . 0.0 108.179 165.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.53 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -87.39 171.34 10.65 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.422 -1.424 . . . . 0.0 110.693 170.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -162.23 167.43 24.02 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.888 1.675 . . . . 0.0 108.026 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mt -118.86 161.75 19.64 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.577 1.551 . . . . 0.0 107.052 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.73 126.1 26.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.938 1.245 . . . . 0.0 110.152 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.0 52.1 1.04 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 124.681 1.134 . . . . 0.0 111.146 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -138.45 161.59 36.62 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.978 1.711 . . . . 0.0 108.007 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.5 mtp -138.83 140.1 38.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.245 1.018 . . . . 0.0 110.432 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.9 169.1 9.33 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.088 1.755 . . . . 0.0 109.938 -174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.0 pt -122.02 126.35 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 172.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 3' ' ' ARG . 59.5 t -63.24 130.36 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -118.92 -44.76 2.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.582 1.153 . . . . 0.0 110.02 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -140.01 170.15 16.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -132.05 138.65 48.26 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 124.939 1.296 . . . . 0.0 107.604 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 mt -123.31 178.47 5.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.985 1.714 . . . . 0.0 109.68 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -120.89 14.55 11.6 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.917 1.341 . . . . 0.0 112.884 -162.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -129.26 20.25 5.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 127.764 2.426 . . . . 0.0 111.23 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.56 9.05 61.86 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.019 1.295 . . . . 0.0 112.922 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -113.67 162.23 16.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.355 1.062 . . . . 0.0 110.971 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.7 mtm -138.97 143.4 38.52 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.38 1.472 . . . . 0.0 107.845 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -78.26 135.95 37.66 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.702 161.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.7 m -140.96 176.8 4.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.163 0.985 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.0 m -115.39 141.21 48.34 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 152.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -93.26 112.45 24.39 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.464 1.106 . . . . 0.0 108.964 169.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.0 5.41 2.7 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -59.01 -41.85 88.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.261 162.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -147.41 -13.27 0.4 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.101 -0.952 . . . . 0.0 113.379 -161.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 t70 75.07 16.61 2.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.559 1.944 . . . . 0.0 111.761 -162.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -60.78 113.92 2.75 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 120.664 -1.273 . . . . 0.0 108.96 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.11 151.13 21.74 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.91 -0.494 . . . . 0.0 109.873 167.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.76 -167.48 35.29 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.613 0.563 . . . . 0.0 111.917 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -89.59 141.14 28.87 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.399 1.08 . . . . 0.0 110.555 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.8 153.27 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.999 2.12 . . . . 0.0 109.104 169.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.88 146.1 7.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.801 0.84 . . . . 0.0 110.428 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -66.94 -17.65 65.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.439 1.496 . . . . 0.0 113.041 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.92 -18.23 59.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.529 1.932 . . . . 0.0 112.109 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -130.56 12.56 5.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.437 1.495 . . . . 0.0 112.712 -163.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.97 154.43 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.661 1.118 . . . . 0.0 112.994 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -128.3 148.91 50.68 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.805 2.042 . . . . 0.0 110.204 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.64 102.25 0.55 Allowed 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 129.359 3.064 . . . . 0.0 110.324 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 123.19 1.471 . . . . 0.0 110.864 175.461 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.425 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.515 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 110.541 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.466 ' CD ' HG22 ' A' ' 29' ' ' ILE . 54.4 mtm180 -132.54 150.98 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.377 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 m -123.4 171.07 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.536 1.134 . . . . 0.0 108.461 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -144.02 122.84 12.67 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 120.752 -1.217 . . . . 0.0 111.739 -170.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.38 137.85 58.34 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.801 0.728 . . . . 0.0 109.975 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.27 0.2 OUTLIER -119.73 5.22 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.417 169.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.5 mt -147.8 154.94 44.53 Favored Pre-proline 0 N--CA 1.466 0.374 0 C-N-CA 125.639 1.576 . . . . 0.0 108.822 166.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.66 157.54 31.93 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.613 2.875 . . . . 0.0 110.235 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -146.31 -179.4 6.72 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.782 0.833 . . . . 0.0 108.906 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 t -146.39 133.42 20.32 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.571 ' H ' ' HB3' ' A' ' 21' ' ' SER . 17.9 ptmt -69.52 144.66 53.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.107 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.98 139.91 97.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.02 145.86 69.01 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.068 2.512 . . . . 0.0 110.488 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.82 39.14 8.57 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.765 1.626 . . . . 0.0 112.498 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 p -132.33 171.21 14.01 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.497 -0.752 . . . . 0.0 110.434 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.68 -8.18 59.05 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.64 1.976 . . . . 0.0 111.323 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.03 167.88 3.61 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.781 1.633 . . . . 0.0 111.917 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.99 136.48 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.877 1.671 . . . . 0.0 108.69 174.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.571 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -90.51 122.77 33.63 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.85 1.66 . . . . 0.0 110.148 -178.815 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -146.99 170.65 16.66 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 119.671 1.123 . . . . 0.0 113.288 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.88 -178.64 5.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.014 0.926 . . . . 0.0 111.738 -164.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -63.57 149.58 45.99 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 160.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.99 -4.73 22.06 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.897 -0.946 . . . . 0.0 113.244 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.55 156.31 39.1 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.639 1.22 . . . . 0.0 107.759 164.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.9 ttt -134.17 148.82 50.98 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.866 -1.146 . . . . 0.0 108.814 -173.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -132.98 159.48 39.89 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.436 1.094 . . . . 0.0 109.636 -169.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.466 HG22 ' CD ' ' A' ' 4' ' ' ARG . 6.7 pt -110.86 135.98 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 3' ' ' ARG . 1.7 p -69.39 124.5 25.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 171.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.19 -25.32 4.9 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.97 0.908 . . . . 0.0 113.255 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -154.73 160.44 41.34 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 164.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.76 123.03 42.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.09 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 mt -101.81 -169.42 1.68 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.9 29.59 3.77 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.381 1.072 . . . . 0.0 110.853 -166.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -151.79 29.4 0.6 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.702 1.601 . . . . 0.0 111.534 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.09 36.25 64.23 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 120.9 -1.125 . . . . 0.0 112.426 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -134.72 156.18 49.25 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.362 1.081 . . . . 0.0 108.92 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.5 mtm -138.01 141.86 40.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 168.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -75.41 137.9 41.32 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 160.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.81 -178.84 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 122.186 0.993 . . . . 0.0 111.768 -175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.4 m -124.94 146.68 49.24 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 153.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.77 119.46 32.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.437 2.695 . . . . 0.0 108.43 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt -80.11 21.13 0.6 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.844 1.257 . . . . 0.0 112.491 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.3 ttp85 -101.24 -47.53 4.69 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.089 0.956 . . . . 0.0 110.032 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -146.15 20.31 1.4 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.642 0.777 . . . . 0.0 109.511 -169.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.85 24.13 12.73 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.208 1.803 . . . . 0.0 112.356 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -72.32 160.61 32.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.1 -1.0 . . . . 0.0 112.48 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -139.42 149.54 44.2 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.684 0.754 . . . . 0.0 110.928 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.89 -168.55 32.36 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.638 -174.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.0 mt -92.0 143.53 26.38 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.832 1.253 . . . . 0.0 110.489 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.01 145.57 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.274 1.429 . . . . 0.0 109.029 171.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.02 132.23 32.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.31 -10.97 60.63 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -55.48 -26.85 44.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.942 2.097 . . . . 0.0 111.873 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.96 11.29 11.73 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -160.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -118.11 164.68 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.73 1.612 . . . . 0.0 110.859 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -121.31 151.14 40.42 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.568 1.547 . . . . 0.0 110.154 169.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.18 63.18 0.97 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.768 2.427 . . . . 0.0 111.066 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.238 0.481 0 O-C-N 120.741 -1.224 . . . . 0.0 111.331 177.764 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 . . . . . 0 C--O 1.236 0.359 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 mmt85 -140.99 156.52 46.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.13 1.372 . . . . 0.0 107.494 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.09 154.63 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.335 0.97 . . . . 0.0 109.806 170.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -121.66 136.57 54.94 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.84 130.78 41.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.149 0.886 . . . . 0.0 109.506 169.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.07 1.47 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.318 0.647 . . . . 0.0 111.305 170.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 mt -141.03 154.56 68.37 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 168.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.91 158.77 34.66 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.971 2.447 . . . . 0.0 110.247 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -150.12 164.61 35.15 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.58 0.752 . . . . 0.0 110.577 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 t -135.31 135.79 41.07 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -63.46 149.75 45.34 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.22 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.475 HG23 ' OG1' ' A' ' 17' ' ' THR . 21.2 m -66.7 166.29 19.59 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.624 1.17 . . . . 0.0 109.557 163.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -79.6 161.27 25.02 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.385 2.056 . . . . 0.0 110.41 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t70 45.94 46.86 12.48 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.987 2.515 . . . . 0.0 112.693 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.475 ' OG1' HG23 ' A' ' 14' ' ' VAL . 1.8 p -142.96 177.74 8.15 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.459 -0.776 . . . . 0.0 110.122 -170.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.25 11.25 37.09 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.513 1.525 . . . . 0.0 110.412 -172.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -80.36 170.02 16.96 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.653 1.581 . . . . 0.0 111.549 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.3 pt -136.0 152.78 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.227 1.811 . . . . 0.0 109.964 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -88.99 149.87 23.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.545 2.338 . . . . 0.0 110.642 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -158.28 173.19 17.06 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.423 -0.798 . . . . 0.0 111.797 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.41 161.17 22.64 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.804 1.242 . . . . 0.0 110.516 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -57.98 133.63 55.68 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 166.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.31 -6.77 71.96 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 117.887 -1.507 . . . . 0.0 113.005 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -77.18 166.45 23.22 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.271 2.035 . . . . 0.0 108.699 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 34.7 mtp -133.25 140.3 47.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.566 1.146 . . . . 0.0 109.873 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -122.93 169.94 10.63 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.099 1.359 . . . . 0.0 109.779 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 pt -119.52 129.64 75.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.46 125.98 27.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -116.64 -33.48 4.84 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.929 0.892 . . . . 0.0 111.961 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -146.62 160.45 42.15 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 119.262 0.937 . . . . 0.0 110.497 172.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -118.06 121.55 40.88 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 126.498 1.919 . . . . 0.0 107.289 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -110.2 -172.15 1.98 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.412 1.485 . . . . 0.0 107.851 173.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -120.26 13.73 12.01 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.171 1.789 . . . . 0.0 114.935 -166.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -143.41 23.31 1.81 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.392 1.077 . . . . 0.0 112.218 -154.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.94 7.28 87.43 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 124.456 1.027 . . . . 0.0 112.617 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -118.48 150.61 39.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.576 1.55 . . . . 0.0 108.73 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 mtm -139.39 140.37 37.4 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -77.05 138.88 39.83 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 166.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -142.56 -175.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.774 1.273 . . . . 0.0 111.166 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.2 m -130.76 132.23 45.19 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 152.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -81.39 114.01 19.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.41 -6.81 11.28 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.024 -0.423 . . . . 0.0 111.679 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -57.01 -40.39 76.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 120.396 -1.44 . . . . 0.0 111.389 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -169.75 33.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.025 0.829 . . . . 0.0 111.793 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t70 66.54 -4.91 0.67 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 171.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -53.73 118.4 3.9 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.192 1.797 . . . . 0.0 109.804 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -100.36 157.87 16.3 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 168.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.49 -171.91 32.98 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.3 mt -87.23 144.88 26.61 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.458 1.503 . . . . 0.0 109.561 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.28 152.64 23.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.95 1.7 . . . . 0.0 108.028 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.18 141.31 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.286 0.634 . . . . 0.0 109.832 -173.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -71.82 -9.56 58.49 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.824 0.85 . . . . 0.0 113.25 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.34 -21.16 66.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.819 1.248 . . . . 0.0 112.064 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -126.86 11.42 7.17 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.802 1.241 . . . . 0.0 112.098 -162.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.11 167.57 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.171 0.989 . . . . 0.0 111.343 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -119.06 152.31 36.68 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 127.184 2.194 . . . . 0.0 108.426 167.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 59.76 1.25 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.319 1.448 . . . . 0.0 110.341 174.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.536 0.431 0 O-C-N 120.87 -1.144 . . . . 0.0 110.633 -175.421 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.603 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -124.6 151.55 44.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.94 145.51 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.275 0.943 . . . . 0.0 109.746 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -111.37 144.96 39.73 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 117.584 -1.198 . . . . 0.0 109.922 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.19 136.71 37.86 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 119.767 1.167 . . . . 0.0 111.819 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.69 1.85 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.158 0.983 . . . . 0.0 112.294 168.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mt -151.71 154.48 33.13 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 125.73 1.612 . . . . 0.0 108.755 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.52 134.93 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.009 2.473 . . . . 0.0 108.604 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -84.64 -179.12 7.06 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.931 0.872 . . . . 0.0 109.043 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.4 m -149.71 100.33 2.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' H ' ' HB3' ' A' ' 21' ' ' SER . 11.6 pttt -67.66 156.6 36.49 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.413 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 11.0 m -85.53 176.25 3.81 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 126.324 1.85 . . . . 0.0 107.912 168.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 14' ' ' VAL . 89.6 Cg_endo -95.17 164.02 1.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.174 2.582 . . . . 0.0 111.336 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 59.04 35.78 24.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.492 1.917 . . . . 0.0 111.243 167.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.39 162.59 36.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.127 0.965 . . . . 0.0 111.483 -161.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.4 35.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.477 1.911 . . . . 0.0 109.427 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -109.3 168.29 9.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.296 1.039 . . . . 0.0 109.149 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.2 pt -145.2 144.66 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 127.39 2.276 . . . . 0.0 106.554 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.53 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 93.1 p -124.88 158.94 32.28 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.665 ' HB2' HD21 ' A' ' 43' ' ' ASN . 0.1 OUTLIER -164.93 -175.03 3.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.512 1.525 . . . . 0.0 109.506 176.306 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.5 172.39 8.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.173 0.989 . . . . 0.0 109.975 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -54.93 157.2 3.32 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.525 -1.359 . . . . 0.0 109.789 161.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.44 12.55 84.2 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.773 -1.015 . . . . 0.0 112.696 172.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -174.59 4.24 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.733 1.267 . . . . 0.0 111.262 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.36 144.67 32.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.338 1.855 . . . . 0.0 108.934 -170.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -133.74 153.92 51.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.159 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.6 pt -112.92 118.53 58.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -63.76 121.78 13.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.1 -36.28 5.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.433 1.093 . . . . 0.0 109.973 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -149.24 169.55 20.5 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.158 0.89 . . . . 0.0 110.062 168.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -130.35 122.7 28.36 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 127.332 2.253 . . . . 0.0 106.122 -171.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.85 -162.79 0.97 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.677 1.191 . . . . 0.0 110.138 -175.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -141.55 76.63 1.55 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.79 2.036 . . . . 0.0 106.934 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 p30 174.2 -0.97 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.532 1.933 . . . . 0.0 114.363 -165.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.43 7.53 85.26 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 120.055 -1.653 . . . . 0.0 113.142 -171.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -95.73 165.44 12.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.377 1.589 . . . . 0.0 109.922 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.4 mtm -134.94 163.54 29.63 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 168.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.2 t-105 -94.34 132.62 38.75 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.406 0.548 . . . . 0.0 109.665 158.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.56 174.89 6.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.132 0.973 . . . . 0.0 110.503 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.44 ' CG2' ' HA ' ' A' ' 47' ' ' ASP . 7.8 m -107.68 141.82 38.6 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 157.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.665 HD21 ' HB2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -82.19 111.48 18.33 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 127.287 2.235 . . . . 0.0 107.958 170.366 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.6 -9.31 5.77 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 22.0 ttp85 -53.31 -38.39 63.11 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.984 0.914 . . . . 0.0 111.436 173.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 t -165.67 -1.61 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -161.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.44 ' HA ' ' CG2' ' A' ' 42' ' ' THR . 0.6 OUTLIER 75.3 17.64 2.52 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.661 1.585 . . . . 0.0 112.401 -173.163 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.2 139.48 58.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -126.51 153.78 44.69 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.614 1.166 . . . . 0.0 108.731 -172.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 151.8 -158.47 27.79 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -172.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -101.56 143.01 32.07 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.61 1.964 . . . . 0.0 112.013 -168.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.94 152.97 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 129.813 3.245 . . . . 0.0 107.024 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.33 139.58 19.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -74.7 -14.83 60.78 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.18 -22.0 64.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.621 1.168 . . . . 0.0 112.719 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.4 mt -107.09 3.9 26.33 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.331 1.452 . . . . 0.0 112.286 -170.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.96 171.14 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.224 1.009 . . . . 0.0 110.737 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -131.21 152.96 49.97 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 125.611 1.565 . . . . 0.0 110.618 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -78.05 80.62 4.47 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.6 1.56 . . . . 0.0 111.089 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.321 -0.648 0 O-C-N 120.963 -1.085 . . . . 0.0 109.449 167.872 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -151.79 138.84 19.12 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.28 1.832 . . . . 0.0 108.391 -172.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.89 159.04 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.81 0.844 . . . . 0.0 109.118 173.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.532 ' HE ' ' HE3' ' A' ' 27' ' ' MET . 10.9 ttm180 -130.03 131.57 45.89 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.729 -1.857 . . . . 0.0 106.099 -168.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.57 156.42 26.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.598 1.545 . . . . 0.0 110.566 -173.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.75 9.89 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.921 162.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.71 155.57 29.68 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 120.35 1.432 . . . . 0.0 110.264 167.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' A' ' 23' ' ' LEU . 27.8 Cg_endo -82.81 163.77 15.99 Favored 'Trans proline' 0 CA--C 1.543 0.956 1 C-N-CA 125.972 4.448 . . . . 0.0 111.925 177.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -153.14 165.69 34.84 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.745 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -119.27 113.73 21.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.545 1.938 . . . . 0.0 107.21 -175.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -67.26 146.81 53.78 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.38 1.446 . . . . 0.0 110.233 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.39 149.3 98.46 Favored Pre-proline 0 CA--C 1.552 1.035 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.18 141.53 39.75 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 124.234 3.289 . . . . 0.0 111.32 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.1 t70 64.47 27.56 13.51 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.819 1.648 . . . . 0.0 112.843 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 p -121.91 173.76 7.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.467 1.031 . . . . 0.0 113.651 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.28 24.9 0.77 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.173 2.189 . . . . 0.0 110.632 -172.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -108.11 175.47 5.47 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.035 2.134 . . . . 0.0 110.844 -173.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 pt -147.24 121.11 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.311 1.445 . . . . 0.0 110.904 -174.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.63 139.11 39.44 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.054 -1.029 . . . . 0.0 111.338 -176.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -156.51 169.25 25.08 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.012 -1.055 . . . . 0.0 112.062 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 3.5 mm? -109.8 167.59 10.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.377 1.071 . . . . 0.0 109.729 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -62.38 119.4 9.03 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 169.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.15 -15.88 4.21 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.645 1.593 . . . . 0.0 112.944 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -80.1 162.74 24.61 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.981 1.391 . . . . 0.0 110.002 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.532 ' HE3' ' HE ' ' A' ' 6' ' ' ARG . 14.5 ptm -138.3 158.95 43.28 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.578 1.951 . . . . 0.0 108.406 175.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -132.66 160.87 35.45 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.382 1.073 . . . . 0.0 111.072 -169.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.6 pt -121.09 125.31 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 108.909 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.85 123.48 13.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -126.36 -23.43 3.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.634 1.174 . . . . 0.0 112.963 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -156.0 161.6 40.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.171 0.896 . . . . 0.0 110.822 159.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -118.54 125.68 50.36 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 129.07 2.948 . . . . 0.0 105.767 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 mt -109.46 -165.36 1.01 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.187 0.995 . . . . 0.0 109.213 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -133.52 91.94 2.92 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 t0 175.85 18.91 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.627 2.371 . . . . 0.0 111.667 168.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.46 -1.86 84.21 Favored Glycine 0 CA--C 1.539 1.572 0 O-C-N 120.146 -1.596 . . . . 0.0 113.878 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.498 ' CE2' HG13 ' A' ' 53' ' ' VAL . 90.9 m95 -97.73 152.02 19.55 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.752 2.021 . . . . 0.0 110.217 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.7 mtm -141.64 143.8 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.363 1.465 . . . . 0.0 108.638 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -84.39 136.69 33.77 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 171.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.17 -163.79 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.511 0.724 . . . . 0.0 111.549 -173.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.3 m -135.83 158.11 45.21 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 151.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -102.79 115.36 30.44 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.637 1.575 . . . . 0.0 109.677 172.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 mt -66.2 -4.54 7.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.799 1.24 . . . . 0.0 113.44 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -69.35 -46.77 66.22 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 117.187 -1.387 . . . . 0.0 111.47 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.5 p -139.29 4.96 2.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.934 1.243 . . . . 0.0 114.025 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.69 19.69 1.97 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.939 1.696 . . . . 0.0 112.204 -174.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -62.25 141.82 58.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.916 1.286 . . . . 0.0 110.385 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -134.51 155.81 49.72 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.836 0.854 . . . . 0.0 109.65 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.89 -158.17 24.07 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -161.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.3 mt -106.16 144.67 32.53 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.271 1.428 . . . . 0.0 113.858 -164.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.63 154.31 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 127.699 2.4 . . . . 0.0 108.582 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.553 ' HB ' ' H ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -91.74 147.97 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 127.483 2.313 . . . . 0.0 112.553 168.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -58.89 -21.32 57.21 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.47 165.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.553 ' H ' ' HB ' ' A' ' 53' ' ' VAL . 21.6 t70 -63.67 -24.62 67.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.763 0.792 . . . . 0.0 112.178 -166.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.1 mt -118.75 7.2 11.58 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.509 1.523 . . . . 0.0 111.271 -157.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.93 161.84 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.02 1.728 . . . . 0.0 109.797 -169.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.5 153.26 26.45 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.363 1.465 . . . . 0.0 109.059 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.87 61.9 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.928 1.291 . . . . 0.0 111.088 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.445 -0.706 0 CA-C-O 122.32 1.057 . . . . 0.0 110.213 -179.194 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' HD3' HG22 ' A' ' 29' ' ' ILE . 17.5 mtm180 -134.61 166.8 22.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.991 0.516 . . . . 0.0 110.451 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.69 161.44 23.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 171.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -139.47 129.87 25.55 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.52 121.72 19.18 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.981 0.81 . . . . 0.0 109.595 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.96 -2.34 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.135 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.81 157.48 32.58 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 126.938 2.095 . . . . 0.0 108.171 173.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.08 159.74 30.24 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.93 3.086 . . . . 0.0 111.147 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -143.9 168.07 20.82 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.826 1.651 . . . . 0.0 107.61 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 t -135.66 143.51 45.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.579 ' H ' ' HB3' ' A' ' 21' ' ' SER . 12.9 pttm -84.35 155.88 22.13 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.924 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -62.46 139.63 96.63 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 161.053 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.14 146.68 41.39 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.945 1.763 . . . . 0.0 108.837 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t0 62.65 51.32 3.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.686 1.594 . . . . 0.0 112.019 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.1 p -146.07 174.36 11.37 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 125.926 1.69 . . . . 0.0 110.203 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -84.22 -9.15 58.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.185 0.994 . . . . 0.0 110.992 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.08 173.71 4.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.879 2.071 . . . . 0.0 111.337 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 pt -147.18 126.22 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 126.985 2.114 . . . . 0.0 108.734 -172.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.579 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 1.2 p -93.72 125.72 38.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.075 1.75 . . . . 0.0 111.468 -172.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -150.57 168.61 23.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 124.513 2.101 . . . . 0.0 113.95 -172.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mt -90.16 174.54 7.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.525 2.33 . . . . 0.0 110.126 -166.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -60.47 153.25 23.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 156.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.7 7.15 88.72 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.069 -0.851 . . . . 0.0 113.67 167.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.91 157.05 20.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.213 1.507 . . . . 0.0 109.058 166.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.3 ttt -134.01 147.83 51.02 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.097 0.959 . . . . 0.0 109.12 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -134.76 170.97 15.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.384 -167.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.514 HG22 ' HD3' ' A' ' 4' ' ' ARG . 18.5 pt -128.06 138.72 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.098 1.359 . . . . 0.0 107.899 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.9 t -75.0 116.84 18.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -112.17 -20.52 11.87 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.402 0.681 . . . . 0.0 111.387 174.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -154.84 179.88 8.68 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 163.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -147.09 118.95 8.1 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.748 1.619 . . . . 0.0 107.369 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -104.91 -177.56 3.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.811 2.445 . . . . 0.0 110.222 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -133.96 78.79 1.78 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.448 1.499 . . . . 0.0 109.6 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -169.9 31.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.63 1.572 . . . . 0.0 110.508 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.1 27.74 67.87 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.609 -1.307 . . . . 0.0 112.623 -174.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -134.52 150.37 50.76 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.534 1.167 . . . . 0.0 110.833 -168.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.6 mtm -149.14 137.66 21.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.493 0.717 . . . . 0.0 110.869 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -86.71 130.84 34.32 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.958 1.303 . . . . 0.0 110.405 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -142.1 -177.12 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.504 0.722 . . . . 0.0 111.879 -175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 m -116.78 138.7 51.3 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.945 1.698 . . . . 0.0 107.42 157.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -92.32 120.84 33.25 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.705 1.202 . . . . 0.0 109.466 165.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.87 1.66 3.19 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.774 ' HG3' HG22 ' A' ' 46' ' ' THR . 3.5 ptp180 -71.34 -36.49 71.56 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 121.191 1.814 . . . . 0.0 112.799 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.774 HG22 ' HG3' ' A' ' 45' ' ' ARG . 14.9 t -158.95 23.31 0.21 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.273 0.488 . . . . 0.0 111.635 -171.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.9 t70 58.59 27.24 15.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.411 1.084 . . . . 0.0 111.784 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.517 ' HG3' HG23 ' A' ' 46' ' ' THR . 45.4 mt-10 -68.61 98.86 0.92 Allowed 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.011 -1.056 . . . . 0.0 109.415 171.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -80.42 158.3 25.99 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.721 0.295 . . . . 0.0 110.619 167.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.16 -170.74 29.46 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 173.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -80.03 141.79 35.56 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.426 1.091 . . . . 0.0 110.882 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.81 152.21 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 110.12 167.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.61 140.58 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.283 1.433 . . . . 0.0 108.736 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.92 -9.33 58.44 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.78 -15.45 61.68 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.345 1.858 . . . . 0.0 113.846 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.2 mt -140.79 21.86 2.31 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.739 1.216 . . . . 0.0 113.677 -167.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.75 154.44 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -100.4 149.32 23.76 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.74 1.216 . . . . 0.0 109.554 167.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.4 123.88 24.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.274 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 121.124 0.488 . . . . 0.0 111.288 172.156 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.792 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 45.62 56.13 6.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.853 1.261 . . . . 0.0 111.456 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.98 125.56 37.7 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.973 1.709 . . . . 0.0 106.415 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HD3' HG22 ' A' ' 29' ' ' ILE . 85.0 mtt180 -141.46 166.57 24.39 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.283 1.433 . . . . 0.0 107.384 173.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -136.0 161.87 37.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -124.46 140.37 53.01 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.88 157.98 35.31 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.14 3.35 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.244 0.475 . . . . 0.0 111.746 164.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 mt -147.29 160.62 38.95 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 126.334 1.854 . . . . 0.0 107.955 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.15 165.4 14.85 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.647 3.565 . . . . 0.0 111.699 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -157.1 125.58 5.68 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.083 0.953 . . . . 0.0 110.517 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 t -82.48 142.2 32.07 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.47 ' H ' ' HB3' ' A' ' 21' ' ' SER . 1.1 pttt -83.75 154.41 23.61 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.742 -0.599 . . . . 0.0 109.739 163.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.3 151.56 94.34 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 157.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.34 150.08 13.35 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.496 2.797 . . . . 0.0 110.506 165.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 t70 75.48 13.17 3.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.66 1.984 . . . . 0.0 112.569 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.9 p -107.11 177.56 4.82 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.808 1.243 . . . . 0.0 108.704 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -92.43 10.21 31.0 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.987 0.915 . . . . 0.0 109.219 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.88 162.27 28.78 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.746 -1.221 . . . . 0.0 109.92 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 pt -125.02 140.66 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 124.852 1.261 . . . . 0.0 107.619 164.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 56.1 p -85.68 160.34 19.59 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -158.35 167.71 28.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.366 0.667 . . . . 0.0 109.369 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 mt -117.43 167.83 10.92 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.574 1.15 . . . . 0.0 108.579 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -60.77 115.01 3.34 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 167.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.8 -16.41 3.74 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 125.754 1.645 . . . . 0.0 112.36 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -76.88 163.4 26.79 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 119.87 1.835 . . . . 0.0 111.968 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.2 mtp -127.85 154.96 44.86 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 128.149 2.58 . . . . 0.0 108.833 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -136.39 160.4 38.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.431 1.092 . . . . 0.0 108.967 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 ' HD3' ' A' ' 4' ' ' ARG . 5.7 pt -122.74 137.95 54.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.9 t -69.76 134.27 30.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.83 -27.28 2.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.402 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.99 162.54 41.13 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 119.431 1.014 . . . . 0.0 110.788 162.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -107.47 137.35 45.67 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.565 1.946 . . . . 0.0 107.443 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.1 mt -129.36 177.01 7.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.511 1.924 . . . . 0.0 107.101 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -130.32 14.44 5.59 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.188 -0.945 . . . . 0.0 113.033 -152.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -127.59 21.29 6.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.078 1.751 . . . . 0.0 112.103 -170.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.09 10.32 56.26 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.355 1.455 . . . . 0.0 113.018 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -125.9 155.34 41.42 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.658 1.583 . . . . 0.0 110.847 -165.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.4 mtm -145.82 145.99 30.99 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.316 1.447 . . . . 0.0 108.8 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -84.01 137.3 33.67 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 122.838 0.455 . . . . 0.0 110.655 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.6 m -142.38 -171.24 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.834 0.854 . . . . 0.0 111.724 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.1 m -128.07 150.76 49.81 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 156.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -109.54 109.32 20.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.127 1.771 . . . . 0.0 109.413 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 44' ' ' LEU . 9.0 mt -56.04 -12.86 1.62 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.784 2.034 . . . . 0.0 113.612 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -64.47 -33.96 77.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.958 1.254 . . . . 0.0 111.514 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.251 5.1 t -155.31 15.07 0.39 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.085 0.954 . . . . 0.0 110.737 -168.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.3 t70 53.05 32.85 13.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.085 2.154 . . . . 0.0 111.795 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.1 159.28 33.81 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.809 -0.557 . . . . 0.0 110.326 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -140.23 147.2 39.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.38 -157.66 25.69 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -101.67 146.82 27.21 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.174 1.39 . . . . 0.0 112.277 -165.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.43 154.05 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.063 1.745 . . . . 0.0 110.288 168.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.99 144.59 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.709 1.604 . . . . 0.0 110.127 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -78.63 -6.33 55.37 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.58 -19.95 65.96 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.608 1.163 . . . . 0.0 113.108 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.9 mt -129.21 15.78 6.16 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.526 1.13 . . . . 0.0 113.819 -160.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.02 169.65 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 119.102 0.864 . . . . 0.0 113.058 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -125.63 148.1 49.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 127.407 2.283 . . . . 0.0 109.216 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -82.93 47.58 1.23 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.263 2.225 . . . . 0.0 112.783 -170.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 p -58.23 156.91 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 122.711 1.243 . . . . 0.0 111.756 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -107.17 6.99 37.19 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.192 1.377 . . . . 0.0 113.227 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.656 1.582 . . . . 0.0 110.093 179.834 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.904 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -106.16 -75.98 0.62 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 117.755 0.777 . . . . 0.0 109.617 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 3' ' ' ARG . 0.5 OUTLIER -121.95 157.99 30.05 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.742 1.155 . . . . 0.0 108.762 173.043 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.4 ' HD3' HG22 ' A' ' 29' ' ' ILE . 11.0 mtt85 -158.67 166.96 30.8 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.279 1.831 . . . . 0.0 109.361 -176.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.46 178.46 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.872 1.669 . . . . 0.0 108.823 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 -140.93 142.32 34.4 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 120.449 -1.407 . . . . 0.0 108.44 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.68 137.06 47.55 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 119.069 0.85 . . . . 0.0 110.45 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.85 -4.84 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 118.218 -0.896 . . . . 0.0 112.335 163.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -149.81 148.66 26.0 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 125.18 1.392 . . . . 0.0 108.612 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.26 167.5 19.48 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 124.632 3.554 . . . . 0.0 111.27 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -154.4 171.43 19.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.18 0.992 . . . . 0.0 108.483 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.6 m -118.79 113.55 21.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.922 1.289 . . . . 0.0 108.585 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -59.81 151.6 25.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.187 0.903 . . . . 0.0 110.456 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.47 148.64 97.93 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 154.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.63 163.93 14.29 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.57 2.847 . . . . 0.0 111.134 170.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 47.03 47.27 16.02 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.918 2.087 . . . . 0.0 110.002 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.62 172.99 14.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.503 2.721 . . . . 0.0 107.845 -172.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -82.0 5.0 20.67 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.055 -1.028 . . . . 0.0 112.052 -170.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.31 162.33 14.65 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.363 1.465 . . . . 0.0 110.881 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.444 HD13 ' HB2' ' A' ' 43' ' ' ASN . 2.7 pp -138.37 132.21 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 127.082 2.153 . . . . 0.0 107.181 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.88 151.02 38.99 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.875 -1.14 . . . . 0.0 111.206 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -152.68 154.51 35.43 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.274 -0.891 . . . . 0.0 111.094 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.86 171.37 7.56 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.886 1.274 . . . . 0.0 109.777 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -52.78 134.2 36.76 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 158.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.05 -7.12 81.44 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 117.694 -1.615 . . . . 0.0 114.501 172.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -64.69 159.08 22.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.951 1.876 . . . . 0.0 108.713 166.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.1 ttt -127.66 142.23 51.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.387 1.075 . . . . 0.0 109.884 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -127.6 146.52 50.51 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.493 1.117 . . . . 0.0 111.089 -170.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.4 HG22 ' HD3' ' A' ' 4' ' ' ARG . 8.9 pt -110.01 130.95 62.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.39 124.79 26.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -121.04 -47.65 2.27 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.124 0.97 . . . . 0.0 110.794 176.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -138.87 157.44 46.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 119.006 0.821 . . . . 0.0 111.438 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -130.52 119.51 22.69 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -161.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 mt -119.5 145.53 46.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.885 -171.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -87.07 15.96 5.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.552 1.941 . . . . 0.0 113.335 -165.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -125.83 18.24 7.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.733 1.613 . . . . 0.0 112.533 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.66 16.11 50.17 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.24 0.924 . . . . 0.0 111.931 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -123.34 153.29 40.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.33 1.052 . . . . 0.0 110.154 -166.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.6 mtm -143.89 132.46 22.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -79.68 129.18 34.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.128 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.77 176.05 7.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.761 0.824 . . . . 0.0 111.58 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 m -105.91 138.3 42.34 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 153.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB2' HD13 ' A' ' 20' ' ' ILE . 64.5 t-20 -90.83 114.97 27.51 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 168.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.99 -7.61 23.69 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.9 ttp85 -59.79 -45.16 93.17 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.83 1.195 . . . . 0.0 109.8 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -137.72 -3.46 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 117.843 -1.075 . . . . 0.0 113.039 -168.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 75.53 11.06 3.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.292 1.837 . . . . 0.0 111.989 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.04 149.38 37.08 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.972 0.909 . . . . 0.0 109.379 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -133.52 139.1 46.43 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.885 1.274 . . . . 0.0 108.396 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.42 -170.67 36.47 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.34 146.28 31.64 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.746 1.619 . . . . 0.0 111.592 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -143.66 166.43 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 128.365 2.666 . . . . 0.0 108.468 165.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.45 143.45 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.692 1.197 . . . . 0.0 110.932 -167.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.6 -8.61 56.89 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.351 1.06 . . . . 0.0 113.04 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.03 -27.81 67.23 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.531 1.532 . . . . 0.0 112.232 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.53 14.99 8.21 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -161.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.5 164.1 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.976 0.807 . . . . 0.0 112.611 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -120.36 142.9 48.73 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 127.426 2.29 . . . . 0.0 109.669 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -72.43 92.94 1.49 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.325 1.45 . . . . 0.0 107.725 170.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.03 114.55 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.274 1.035 . . . . 0.0 111.284 -166.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.05 -2.26 65.35 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 117.898 -1.501 . . . . 0.0 114.082 -173.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 . . . . . 0 C--O 1.248 1.011 0 C-N-CA 125.727 1.611 . . . . 0.0 113.15 -171.223 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.995 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.1 12.11 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.512 1.925 . . . . 0.0 115.381 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.24 120.81 43.14 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -125.95 160.99 28.52 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.836 0.854 . . . . 0.0 109.1 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.54 160.65 31.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 124.772 1.229 . . . . 0.0 108.32 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -134.28 127.17 31.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.113 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.98 134.73 44.81 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.871 0.76 . . . . 0.0 109.792 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.272 0.2 OUTLIER -115.54 5.02 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.726 0.81 . . . . 0.0 112.501 176.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 mt -148.14 160.73 36.57 Favored Pre-proline 0 N--CA 1.468 0.467 0 C-N-CA 127.716 2.406 . . . . 0.0 106.834 166.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.17 170.61 9.49 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.095 3.197 . . . . 0.0 111.283 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -145.59 172.08 13.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.586 0.755 . . . . 0.0 109.183 173.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.1 m -131.54 112.17 12.4 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.019 1.328 . . . . 0.0 108.202 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -66.71 158.69 29.52 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.272 -174.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.06 123.54 86.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 161.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.68 153.96 74.64 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.141 1.227 . . . . 0.0 108.92 166.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 t0 73.5 22.63 2.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.047 1.339 . . . . 0.0 111.118 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -130.04 169.99 14.57 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.095 1.358 . . . . 0.0 109.38 168.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -78.64 9.63 3.92 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.247 1.419 . . . . 0.0 110.309 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -74.72 167.69 21.31 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.138 -1.601 . . . . 0.0 110.541 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.3 pt -138.14 139.71 41.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 126.746 2.018 . . . . 0.0 107.446 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.01 137.26 47.09 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.87 -1.144 . . . . 0.0 108.799 172.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -135.34 165.1 26.23 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.807 0.843 . . . . 0.0 111.664 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -111.63 165.13 12.29 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.18 1.392 . . . . 0.0 109.924 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -59.11 128.66 38.27 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 161.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.89 0.42 62.13 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.204 -1.331 . . . . 0.0 113.434 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.24 161.47 29.9 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.847 1.824 . . . . 0.0 109.948 167.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.8 ttp -146.9 144.13 29.03 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.24 1.016 . . . . 0.0 110.455 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -140.53 155.71 46.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.954 -162.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -104.05 133.1 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.181 1.392 . . . . 0.0 108.328 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.01 129.32 30.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -119.12 -34.06 3.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.388 168.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -145.95 162.19 38.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 119.578 1.081 . . . . 0.0 110.066 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -123.75 112.18 17.03 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.584 1.953 . . . . 0.0 105.915 -170.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.73 -172.72 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.725 1.61 . . . . 0.0 108.606 -169.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -134.4 38.84 3.09 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.301 1.048 . . . . 0.0 112.356 -168.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -152.74 47.59 0.72 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.894 166.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.96 3.58 44.44 Favored Glycine 0 CA--C 1.538 1.481 0 O-C-N 121.031 -1.043 . . . . 0.0 115.252 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -97.32 161.41 13.81 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.624 1.169 . . . . 0.0 110.45 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.2 mtm -138.48 144.41 40.03 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.609 1.164 . . . . 0.0 108.695 165.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.591 ' CE3' HD21 ' A' ' 51' ' ' LEU . 24.7 t-105 -79.01 131.66 36.37 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.745 0.818 . . . . 0.0 109.322 166.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.44 -173.05 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.758 0.79 . . . . 0.0 112.462 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 m -136.15 131.68 35.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 161.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -86.22 108.98 18.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.732 1.213 . . . . 0.0 108.716 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.9 mt -75.23 -0.29 18.96 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.556 -1.212 . . . . 0.0 112.128 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -63.38 -33.01 74.6 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 120.8 1.636 . . . . 0.0 110.601 168.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 p -143.84 0.25 1.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.167 -160.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.25 0.3 OUTLIER 70.37 0.88 3.37 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.316 2.646 . . . . 0.0 114.195 -166.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -66.88 104.5 1.37 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.026 0.93 . . . . 0.0 111.749 -168.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -79.34 156.55 27.95 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.933 -0.479 . . . . 0.0 109.839 166.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.72 -154.7 25.7 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.591 HD21 ' CE3' ' A' ' 40' ' ' TRP . 1.8 mm? -103.03 144.63 31.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.633 1.173 . . . . 0.0 109.903 -167.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -140.66 151.43 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.397 1.879 . . . . 0.0 109.66 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -99.98 144.21 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.95 1.3 . . . . 0.0 109.086 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -81.44 -1.33 45.37 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.26 -23.55 62.47 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.188 0.995 . . . . 0.0 112.982 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.97 13.64 10.61 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -158.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.81 158.69 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.464 1.029 . . . . 0.0 112.863 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -108.1 157.37 18.33 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.956 1.302 . . . . 0.0 110.521 163.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -76.08 68.89 2.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.978 1.311 . . . . 0.0 110.186 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.51 127.33 21.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 122.73 1.252 . . . . 0.0 111.16 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.79 -23.78 74.0 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.744 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 127.189 2.196 . . . . 0.0 110.08 -178.699 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.654 0 CA-C-O 118.621 -1.099 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.4 mtt85 56.11 -18.25 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 128.468 2.707 . . . . 0.0 117.919 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -178.35 2.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 127.804 2.442 . . . . 0.0 109.912 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.412 ' HD2' HG22 ' A' ' 29' ' ' ILE . 20.6 mtm-85 -119.91 149.42 42.13 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.842 0.857 . . . . 0.0 110.083 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' A' ' 60' ' ' VAL . 12.6 m -133.07 164.29 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.466 1.106 . . . . 0.0 110.994 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.462 ' HB2' HG11 ' A' ' 60' ' ' VAL . 42.6 ttm180 -135.88 130.48 33.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.368 1.067 . . . . 0.0 109.446 -170.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.8 135.71 51.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 174.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.84 2.76 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.986 0.914 . . . . 0.0 111.005 169.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.3 mt -141.08 153.39 66.93 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 124.818 1.247 . . . . 0.0 108.522 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.18 158.15 17.62 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.503 2.802 . . . . 0.0 110.538 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -149.09 120.54 7.93 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.679 -0.638 . . . . 0.0 111.399 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.6 m -78.03 113.13 15.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.518 0.727 . . . . 0.0 109.264 167.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -65.55 156.74 31.7 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.234 168.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.17 146.21 86.76 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 160.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.23 172.23 12.48 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.995 3.13 . . . . 0.0 111.403 165.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t70 64.43 5.87 2.83 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.468 1.507 . . . . 0.0 113.559 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.2 p -119.27 176.11 5.48 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 119.744 -1.848 . . . . 0.0 110.173 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.33 10.46 4.54 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.031 1.332 . . . . 0.0 110.065 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.33 160.77 27.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.645 1.578 . . . . 0.0 110.669 -170.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.8 pt -131.65 132.36 62.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.9 p -75.59 162.21 28.47 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -157.48 166.28 33.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.929 0.892 . . . . 0.0 109.211 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.23 162.5 15.93 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.736 0.814 . . . . 0.0 109.139 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -57.17 125.51 23.05 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 166.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.21 -6.74 58.16 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.044 -1.975 . . . . 0.0 113.388 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.99 160.28 23.96 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.702 2.251 . . . . 0.0 110.19 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.2 mtp -134.99 153.48 52.07 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.805 0.812 . . . . 0.0 111.557 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -146.26 165.55 28.9 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.273 -1.33 . . . . 0.0 111.755 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.412 HG22 ' HD2' ' A' ' 4' ' ' ARG . 4.4 pt -122.87 128.35 75.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.773 1.629 . . . . 0.0 107.933 -170.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.36 131.39 32.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 120.73 1.605 . . . . 0.0 108.637 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -132.75 -30.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -148.99 165.84 30.43 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.172 0.896 . . . . 0.0 109.253 166.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -133.92 124.28 26.13 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 127.987 2.515 . . . . 0.0 105.063 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.3 -178.29 3.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.943 1.297 . . . . 0.0 110.691 -171.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -132.37 79.49 1.86 Allowed 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 125.488 1.515 . . . . 0.0 107.761 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -168.29 -0.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.505 0.722 . . . . 0.0 112.742 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.34 25.9 38.16 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.236 0.922 . . . . 0.0 112.031 -166.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -136.06 160.02 39.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.178 1.791 . . . . 0.0 108.053 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 35.8 mtm -147.79 158.31 43.96 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -95.25 134.84 37.56 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.837 1.199 . . . . 0.0 111.053 170.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 m -142.53 175.1 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.247 1.819 . . . . 0.0 108.971 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.5 m -114.47 135.54 54.0 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 162.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -82.45 120.13 25.07 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.032 0.933 . . . . 0.0 109.261 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.31 -5.48 3.51 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.283 1.033 . . . . 0.0 113.047 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -63.76 -37.59 87.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.546 -1.216 . . . . 0.0 111.138 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 t -164.0 13.93 0.05 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.986 1.266 . . . . 0.0 113.742 -171.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 73.81 5.01 4.79 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.899 1.679 . . . . 0.0 113.463 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -54.5 116.86 2.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.101 1.76 . . . . 0.0 109.244 167.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.76 165.49 11.35 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 166.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.47 -146.62 13.86 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.68 142.02 45.78 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.687 1.195 . . . . 0.0 110.716 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.5 147.9 23.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 129.724 3.209 . . . . 0.0 107.063 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -88.78 144.77 8.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -68.39 -12.84 61.74 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -69.97 -16.19 63.15 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.152 1.381 . . . . 0.0 114.109 -171.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.5 mt -125.51 6.52 7.6 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.378 1.071 . . . . 0.0 112.363 -162.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.8 m -120.03 156.9 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.634 1.174 . . . . 0.0 110.536 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -116.45 153.35 32.27 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.846 1.258 . . . . 0.0 110.257 173.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.6 63.95 2.81 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.043 172.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.462 HG11 ' HB2' ' A' ' 6' ' ' ARG . 6.5 p -60.73 151.67 6.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 O-C-N 120.888 -1.133 . . . . 0.0 111.609 174.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.21 35.41 2.29 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.122 1.344 . . . . 0.0 113.008 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.451 HH11 HG13 ' A' ' 60' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.259 0 CA-C-O 116.99 -1.481 . . . . 0.0 112.398 176.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.758 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.7 ttt-85 -150.67 114.94 5.11 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.471 ' H ' ' CG1' ' A' ' 30' ' ' VAL . 3.4 ttt85 -109.56 -164.48 0.94 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.671 1.588 . . . . 0.0 109.78 -170.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -134.28 161.53 34.68 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 125.063 1.345 . . . . 0.0 108.872 159.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.3 164.86 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 162.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.466 HH21 ' HD3' ' A' ' 62' ' ' ARG . 32.7 ttm180 -128.73 140.9 51.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 174.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.87 141.82 51.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 120.004 1.274 . . . . 0.0 109.714 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.97 2.5 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.039 0.936 . . . . 0.0 111.729 170.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 mt -143.4 157.04 60.29 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 126.085 1.754 . . . . 0.0 107.353 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -88.38 167.47 6.38 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.695 2.93 . . . . 0.0 110.795 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -156.74 167.14 31.35 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.934 0.494 . . . . 0.0 111.13 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 m -124.43 115.5 21.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.18 2.192 . . . . 0.0 107.278 171.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -61.15 157.34 16.19 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.888 172.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.02 135.87 79.95 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 162.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.493 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 95.1 Cg_endo -70.12 163.9 36.88 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.146 1.898 . . . . 0.0 109.197 171.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.4 t70 63.2 18.27 10.84 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.601 0.715 . . . . 0.0 112.135 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.3 p -130.9 169.41 15.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.675 1.59 . . . . 0.0 108.699 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.42 3.81 38.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.458 1.503 . . . . 0.0 111.428 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -69.97 167.02 18.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.28 1.832 . . . . 0.0 110.184 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.4 pt -140.14 129.31 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 120.885 -1.134 . . . . 0.0 110.057 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -63.82 160.73 16.76 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.785 0.72 . . . . 0.0 110.105 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -161.44 173.53 14.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.276 0.56 . . . . 0.0 110.588 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mt -125.28 159.71 31.03 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.102 1.361 . . . . 0.0 109.773 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -58.29 120.47 8.76 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.29 2.24 59.11 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 117.678 -1.623 . . . . 0.0 113.117 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.84 158.42 35.53 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.893 2.346 . . . . 0.0 108.034 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.4 ttt -120.04 134.24 55.31 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 126.057 1.743 . . . . 0.0 110.986 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CE1' HG21 ' A' ' 52' ' ' ILE . 93.3 m-85 -111.66 165.41 12.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.554 1.168 . . . . 0.0 109.045 177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 pt -118.92 138.67 48.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 163.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.471 ' CG1' ' H ' ' A' ' 3' ' ' ARG . 2.3 p -73.99 141.43 16.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 170.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.29 -21.07 1.61 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 112.596 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -150.28 160.54 43.63 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.211 1.004 . . . . 0.0 109.87 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -120.55 118.15 29.45 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 127.32 2.248 . . . . 0.0 105.451 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mt -109.82 -169.05 1.4 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.846 1.258 . . . . 0.0 107.876 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.29 14.13 3.51 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -164.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -130.83 34.23 4.12 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.787 1.635 . . . . 0.0 110.54 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.41 13.64 81.49 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.05 1.31 . . . . 0.0 113.709 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -112.65 156.27 23.02 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.119 1.368 . . . . 0.0 110.272 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.5 mtm -144.83 145.93 31.86 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.707 1.203 . . . . 0.0 108.399 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -78.73 141.62 37.72 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 164.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.49 -175.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 122.436 1.112 . . . . 0.0 111.15 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 m -135.51 125.22 25.39 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 160.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -77.05 102.74 6.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.9 -14.29 21.32 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -61.43 -19.15 61.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 117.181 -1.39 . . . . 0.0 112.679 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -164.42 11.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.799 1.181 . . . . 0.0 112.945 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.78 20.44 11.41 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.285 1.402 . . . . 0.0 112.509 -172.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.17 104.58 0.93 Allowed 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -93.81 156.25 16.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.87 -166.53 31.95 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.08 143.55 27.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.495 1.118 . . . . 0.0 109.861 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.406 HG21 ' CE1' ' A' ' 28' ' ' PHE . 1.9 pp -134.38 151.1 31.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.12 1.368 . . . . 0.0 108.702 169.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.54 137.82 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -64.11 -18.79 64.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.317 1.047 . . . . 0.0 112.679 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.48 -18.27 63.61 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.551 1.14 . . . . 0.0 113.341 -166.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.6 mt -124.07 10.42 8.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.547 1.539 . . . . 0.0 111.652 -164.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.4 m -119.65 171.77 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.565 1.146 . . . . 0.0 110.864 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -130.39 152.47 49.75 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.941 2.496 . . . . 0.0 109.359 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -70.69 73.29 0.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.583 1.153 . . . . 0.0 109.901 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 62' ' ' ARG . 6.7 p -63.71 152.3 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 120.206 -1.558 . . . . 0.0 109.14 172.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.73 17.59 2.61 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.483 1.04 . . . . 0.0 111.722 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.466 ' HD3' HH21 ' A' ' 6' ' ' ARG . 32.5 ptt180 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.111 -1.423 . . . . 0.0 110.073 -175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.919 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.04 154.1 44.72 Favored 'General case' 0 C--O 1.239 0.545 0 O-C-N 121.428 -1.042 . . . . 0.0 109.018 167.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.23 -164.64 1.27 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.121 1.368 . . . . 0.0 109.271 -170.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HD3' HG22 ' A' ' 29' ' ' ILE . 74.5 mtt180 -132.27 154.68 49.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.343 -0.848 . . . . 0.0 109.719 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.89 166.54 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.433 0.693 . . . . 0.0 109.147 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -138.01 136.26 36.72 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.857 -1.152 . . . . 0.0 110.402 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.45 120.53 16.23 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.266 1.027 . . . . 0.0 110.06 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.6 -4.02 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.137 172.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.676 HD11 HD22 ' A' ' 56' ' ' LEU 0.28 2.1 pp -162.57 152.75 13.84 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.398 1.479 . . . . 0.0 108.519 -171.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.67 160.86 21.89 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.684 2.922 . . . . 0.0 112.336 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -143.22 163.01 34.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.371 1.868 . . . . 0.0 109.2 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.8 m -128.77 105.82 8.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.542 1.137 . . . . 0.0 108.439 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.42 157.02 38.42 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.991 0.517 . . . . 0.0 110.571 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.3 t -87.82 141.35 31.62 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -173.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -70.68 141.96 42.74 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 O-C-N 118.418 -1.412 . . . . 0.0 109.212 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.9 t70 75.45 33.93 0.64 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.652 1.981 . . . . 0.0 112.753 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.6 p -132.47 167.19 20.41 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.046 -1.034 . . . . 0.0 111.594 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.5 20.39 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 128.941 2.897 . . . . 0.0 111.814 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -110.04 169.3 8.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.27 1.428 . . . . 0.0 110.678 -160.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -140.15 150.55 21.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.243 1.417 . . . . 0.0 109.063 174.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 p -95.77 167.24 11.39 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -161.74 156.59 23.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.78 174.07 6.03 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.417 1.103 . . . . 0.0 108.905 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -57.98 123.54 16.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 168.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.02 1.54 57.13 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-O 118.359 -1.245 . . . . 0.0 114.486 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.39 162.66 22.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.38 1.59 . . . . 0.0 111.249 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.498 ' SD ' ' HD2' ' A' ' 62' ' ' ARG . 25.5 ttt -137.14 145.58 43.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.135 1.374 . . . . 0.0 108.822 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.09 175.38 9.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.432 1.093 . . . . 0.0 109.937 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 ' HD3' ' A' ' 4' ' ' ARG . 10.8 pt -126.13 138.69 53.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.558 1.543 . . . . 0.0 106.877 176.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.92 136.13 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 118.684 0.675 . . . . 0.0 109.763 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -139.19 -18.36 1.01 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -155.66 164.88 38.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.363 1.438 . . . . 0.0 108.912 159.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.89 114.07 11.45 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.323 1.849 . . . . 0.0 106.384 -167.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -114.08 154.03 28.43 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.063 0.945 . . . . 0.0 111.384 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -92.91 48.09 1.32 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.575 1.15 . . . . 0.0 110.927 -164.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -161.28 34.78 0.14 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.275 1.03 . . . . 0.0 110.443 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.83 -2.82 58.54 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.441 1.019 . . . . 0.0 114.223 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -87.54 153.6 21.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.516 1.158 . . . . 0.0 110.886 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.1 mtm -143.93 134.61 25.0 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -76.75 138.99 40.26 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.31 -176.35 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 122.332 1.063 . . . . 0.0 111.554 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -127.8 126.51 41.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 155.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.09 116.14 19.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.622 1.969 . . . . 0.0 108.853 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mt -87.28 13.86 8.93 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.542 -0.724 . . . . 0.0 112.391 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.9 ttp85 -79.97 -16.54 55.01 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.328 -1.483 . . . . 0.0 111.058 170.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -163.77 7.35 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.539 0.609 . . . . 0.0 112.233 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 63.23 23.83 14.04 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.055 1.742 . . . . 0.0 112.682 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.8 108.33 2.49 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.658 0.783 . . . . 0.0 109.361 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -87.87 149.38 24.14 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.655 -0.653 . . . . 0.0 110.147 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.71 -171.93 35.49 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.311 1.434 . . . . 0.0 109.965 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.1 mt -89.93 138.83 31.17 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.52 1.128 . . . . 0.0 112.303 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -134.23 162.87 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 127.194 2.197 . . . . 0.0 108.217 166.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 p -109.59 146.19 15.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 123.89 0.876 . . . . 0.0 109.163 -175.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -68.22 -17.33 64.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.278 1.431 . . . . 0.0 112.255 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.22 -29.23 69.7 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.917 0.887 . . . . 0.0 111.705 -177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.676 HD22 HD11 ' A' ' 9' ' ' LEU . 50.2 mt -115.97 5.22 13.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.58 1.152 . . . . 0.0 111.03 -161.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.36 165.84 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.87 1.268 . . . . 0.0 110.882 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -120.66 152.69 37.88 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 125.782 1.633 . . . . 0.0 108.681 172.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -78.7 69.93 4.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.652 1.181 . . . . 0.0 109.573 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 62' ' ' ARG . 2.5 p -70.98 165.27 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.586 0.708 . . . . 0.0 109.429 173.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.92 13.52 5.0 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.26 0.934 . . . . 0.0 112.851 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.498 ' HD2' ' SD ' ' A' ' 27' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.959 0 CA-C-O 117.432 -1.271 . . . . 0.0 110.826 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -137.35 -4.89 1.84 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.6 128.05 42.14 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' HD3' HG22 ' A' ' 29' ' ' ILE . 17.5 mtt180 -134.19 166.91 21.68 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.01 154.97 37.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.416 1.087 . . . . 0.0 108.688 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -119.12 133.55 55.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . . . -84.7 154.63 22.35 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.505 1.048 . . . . 0.0 109.724 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.21 11.56 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.196 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.59 161.7 32.46 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.455 2.302 . . . . 0.0 107.859 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -86.46 162.27 9.6 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.927 3.085 . . . . 0.0 111.646 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -159.13 132.05 6.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.776 1.231 . . . . 0.0 110.604 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 t -97.07 137.79 35.6 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 172.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -89.16 139.08 30.84 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.342 -177.119 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.46 134.59 94.51 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 120.242 1.383 . . . . 0.0 108.267 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 60.3 Cg_endo -67.58 162.12 40.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.126 1.884 . . . . 0.0 109.773 168.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.48 -11.44 1.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.04 2.136 . . . . 0.0 113.129 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -118.6 169.0 10.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.564 1.146 . . . . 0.0 111.057 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -92.15 21.31 5.19 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.71 1.604 . . . . 0.0 111.358 -167.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -68.35 163.83 22.21 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.492 -1.38 . . . . 0.0 109.749 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 pt -130.74 138.67 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 120.869 -1.144 . . . . 0.0 111.01 169.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.5 m -73.56 156.09 38.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -147.29 165.21 30.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 122.303 1.049 . . . . 0.0 110.635 164.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.19 166.11 11.35 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -64.88 125.97 26.5 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.0 47.93 1.21 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.007 1.289 . . . . 0.0 113.26 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.7 167.14 23.84 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.206 1.802 . . . . 0.0 108.998 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.3 mtp -138.03 149.75 46.33 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.103 0.961 . . . . 0.0 111.032 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -136.33 159.94 40.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.826 1.25 . . . . 0.0 109.701 -173.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.517 HG22 ' HD3' ' A' ' 4' ' ' ARG . 15.9 pt -110.52 138.4 38.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.27 129.12 33.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -121.17 -32.07 3.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.107 174.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -152.15 162.44 41.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.066 0.848 . . . . 0.0 111.043 167.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -108.54 132.97 53.31 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.632 1.973 . . . . 0.0 106.813 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.3 mt -125.82 -168.53 1.86 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.106 1.762 . . . . 0.0 107.364 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.68 14.04 3.42 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.583 1.083 . . . . 0.0 113.831 -158.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -120.25 16.13 12.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.363 1.465 . . . . 0.0 111.55 -168.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.84 13.59 69.22 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.669 -1.27 . . . . 0.0 111.862 -168.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -125.86 150.27 48.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.685 1.594 . . . . 0.0 109.706 -169.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 56.8 mtm -142.96 144.39 32.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.827 1.251 . . . . 0.0 108.91 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -81.62 135.6 35.55 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.999 0.52 . . . . 0.0 110.302 170.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.39 175.24 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.416 1.086 . . . . 0.0 110.268 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.3 m -112.38 134.86 53.68 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 154.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -76.54 165.08 25.3 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -88.62 -35.11 17.03 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 121.927 2.149 . . . . 0.0 113.213 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -51.89 -29.22 18.98 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -165.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.251 9.5 t -152.96 18.26 0.58 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.224 1.81 . . . . 0.0 112.593 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 52.36 26.89 4.39 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.222 1.809 . . . . 0.0 112.5 -172.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -66.1 148.3 52.02 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.643 -1.286 . . . . 0.0 111.234 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -137.87 144.88 41.59 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.061 0.945 . . . . 0.0 108.457 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.56 -157.51 27.32 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.7 147.01 27.75 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.895 0.878 . . . . 0.0 112.437 -165.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.1 pt -136.01 147.97 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 126.674 1.99 . . . . 0.0 110.909 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.92 138.01 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.025 1.33 . . . . 0.0 109.732 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.75 -0.78 22.13 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.661 1.184 . . . . 0.0 112.849 -172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -24.12 65.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.793 1.637 . . . . 0.0 112.86 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.4 mt -127.94 13.86 6.83 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.36 1.064 . . . . 0.0 112.665 -158.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.4 m -122.66 170.79 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 126.318 1.847 . . . . 0.0 111.489 -176.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -132.23 155.68 47.83 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 127.772 2.429 . . . . 0.0 109.748 172.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -69.8 78.41 0.45 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.72 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -68.7 165.53 2.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 O-C-N 120.911 -1.118 . . . . 0.0 108.81 162.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.93 19.13 0.66 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.653 1.597 . . . . 0.0 110.977 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 . . . . . 0 C--O 1.249 1.058 0 C-N-CA 125.715 1.606 . . . . 0.0 108.993 -170.287 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.883 0 CA-C-O 117.816 -1.547 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.9 mtm-85 51.62 61.11 3.39 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.418 1.109 . . . . 0.0 111.316 167.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.619 ' NH2' HG13 ' A' ' 5' ' ' VAL 0.257 0.0 OUTLIER -147.74 -162.14 1.48 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.249 1.42 . . . . 0.0 107.279 -167.685 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -117.42 173.71 6.55 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 119.553 -1.967 . . . . 0.0 109.876 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.619 HG13 ' NH2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -126.1 160.18 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 120.512 -1.367 . . . . 0.0 110.531 171.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.72 118.51 28.24 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 125.784 1.633 . . . . 0.0 108.974 -170.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.02 127.11 31.96 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.467 0.707 . . . . 0.0 109.433 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.96 -0.16 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.371 0.669 . . . . 0.0 111.762 172.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.4 161.39 29.42 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 125.817 1.647 . . . . 0.0 109.011 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -87.23 160.47 8.43 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 124.243 3.296 . . . . 0.0 111.25 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -151.74 166.2 32.07 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.633 1.173 . . . . 0.0 110.361 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 t -125.74 136.08 52.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -172.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -70.01 150.54 46.54 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 118.806 -1.157 . . . . 0.0 108.776 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.2 t -75.27 137.53 71.83 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.28 146.38 69.18 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 N-CA-C 108.446 -1.405 . . . . 0.0 108.446 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 t70 75.62 4.94 4.01 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.76 2.024 . . . . 0.0 113.408 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.6 p -108.91 -177.17 3.24 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 120.339 -1.475 . . . . 0.0 112.187 -175.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -83.93 -17.47 40.59 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.102 1.361 . . . . 0.0 109.843 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 165.18 18.5 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.369 1.468 . . . . 0.0 111.954 -164.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 pt -127.43 134.15 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.806 1.242 . . . . 0.0 109.68 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.33 160.76 12.63 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.735 0.814 . . . . 0.0 108.948 173.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -157.43 173.33 17.07 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.935 0.874 . . . . 0.0 113.117 170.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.4 mt -127.96 160.98 30.21 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.111 1.364 . . . . 0.0 109.097 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -62.1 141.47 58.11 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.92 -4.78 81.82 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.681 1.134 . . . . 0.0 114.055 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.3 168.51 19.02 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.007 1.404 . . . . 0.0 109.017 171.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 38.1 mtp -135.51 150.66 49.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.89 0.876 . . . . 0.0 109.525 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -136.06 159.06 42.86 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.91 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 29' ' ' ILE . 4.7 pt -112.16 125.19 69.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -175.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 3' ' ' ARG . 1.6 p -63.71 112.45 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.21 -38.32 5.79 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.745 0.818 . . . . 0.0 110.047 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -148.08 172.34 14.42 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -133.07 133.52 43.1 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -175.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.405 ' CD1' HD21 ' A' ' 51' ' ' LEU . 38.1 mt -120.33 -168.82 1.69 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.615 1.166 . . . . 0.0 109.056 -176.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -136.31 57.78 1.76 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.452 1.101 . . . . 0.0 109.094 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -154.06 22.43 0.5 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.214 171.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.98 23.23 69.61 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.145 -1.597 . . . . 0.0 112.296 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -130.34 148.47 52.16 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.759 2.024 . . . . 0.0 108.534 -170.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.0 mtm -144.77 132.63 21.26 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -72.13 134.62 45.85 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.88 178.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 123.349 0.659 . . . . 0.0 111.793 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 5.2 m -115.03 143.59 44.94 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 154.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -86.47 119.6 26.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.384 1.073 . . . . 0.0 110.105 168.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.98 1.31 2.77 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.478 1.111 . . . . 0.0 113.465 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -66.3 -46.45 76.92 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.219 -1.551 . . . . 0.0 110.423 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -146.13 -3.43 0.66 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.254 1.022 . . . . 0.0 112.551 -157.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.4 t70 68.21 11.54 8.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.172 1.789 . . . . 0.0 112.907 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -61.14 118.34 6.69 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.111 0.964 . . . . 0.0 108.744 167.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 9.5 mp0 -81.84 168.67 17.73 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.385 0.612 . . . . 0.0 110.694 166.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.82 -165.45 30.16 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD21 ' CD1' ' A' ' 34' ' ' LEU . 9.6 mt -99.4 143.83 29.2 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.701 0.8 . . . . 0.0 110.825 -171.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.19 151.34 33.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 125.446 1.498 . . . . 0.0 109.035 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 p -88.58 135.84 24.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.952 1.701 . . . . 0.0 107.934 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.34 -10.29 59.43 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -56.65 -18.4 12.07 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.718 2.407 . . . . 0.0 113.717 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -131.11 13.48 5.17 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.024 1.33 . . . . 0.0 113.296 -164.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.75 153.91 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.237 1.015 . . . . 0.0 112.395 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -117.69 148.29 42.13 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.848 1.659 . . . . 0.0 111.076 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.97 100.86 2.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 128.97 2.908 . . . . 0.0 110.139 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.542 ' CG2' ' HE ' ' A' ' 62' ' ' ARG . 4.4 p -120.11 147.01 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.873 0.844 . . . . 0.0 111.543 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.13 57.18 0.9 Allowed Glycine 0 CA--C 1.519 0.325 0 C-N-CA 124.572 1.082 . . . . 0.0 111.258 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.542 ' HE ' ' CG2' ' A' ' 60' ' ' VAL . 31.0 mtt-85 . . . . . 0 C--O 1.242 0.679 0 C-N-CA 125.133 1.373 . . . . 0.0 107.783 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.607 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -139.58 133.13 30.31 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.98 113.9 12.66 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -119.8 159.51 24.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.631 1.572 . . . . 0.0 108.469 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -137.9 164.83 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 167.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.2 tpp85 -128.08 129.91 47.38 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.458 1.503 . . . . 0.0 107.349 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.28 125.06 25.96 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 120.463 1.483 . . . . 0.0 108.944 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.28 0.2 OUTLIER -113.36 4.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.423 170.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.8 mt -146.28 157.66 48.9 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.833 1.653 . . . . 0.0 109.176 165.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.31 166.77 15.99 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.82 3.68 . . . . 0.0 111.584 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -153.0 163.58 39.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.605 1.162 . . . . 0.0 109.218 173.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -124.31 120.66 32.83 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.528 1.531 . . . . 0.0 109.049 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -61.33 149.14 39.06 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 124.536 1.147 . . . . 0.0 111.22 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.3 135.45 86.73 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -62.55 153.44 71.49 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.1 2.533 . . . . 0.0 110.221 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.36 38.91 22.78 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.078 1.351 . . . . 0.0 111.842 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 p -138.45 166.03 25.31 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.031 0.932 . . . . 0.0 111.84 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.13 -13.55 48.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.867 2.867 . . . . 0.0 113.055 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -63.49 170.11 3.36 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.181 1.793 . . . . 0.0 113.171 -171.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 pt -131.05 136.71 57.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.743 1.217 . . . . 0.0 110.288 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -72.99 149.71 43.06 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.271 1.428 . . . . 0.0 110.9 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -155.11 158.66 39.36 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.689 -1.257 . . . . 0.0 112.806 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.66 170.32 8.0 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.904 0.859 . . . . 0.0 109.458 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -56.98 134.97 56.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 168.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.42 -11.13 56.69 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 118.872 -0.96 . . . . 0.0 114.148 171.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.26 167.74 19.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.673 1.236 . . . . 0.0 108.897 160.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 18.7 ptm -144.67 168.15 20.85 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 124.083 0.953 . . . . 0.0 109.317 170.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -138.42 163.75 31.11 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.608 1.163 . . . . 0.0 109.614 -164.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.5 pt -127.4 130.94 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 125.283 1.433 . . . . 0.0 107.393 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.94 127.8 29.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -127.55 -15.18 5.09 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.715 0.806 . . . . 0.0 113.106 172.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -150.18 166.42 29.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 156.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -121.53 124.68 44.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.51 -167.49 1.26 Allowed 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -138.48 68.58 1.39 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.398 1.479 . . . . 0.0 107.594 -170.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -168.16 15.8 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.395 1.478 . . . . 0.0 112.312 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.96 37.89 88.28 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.13 1.347 . . . . 0.0 111.848 -169.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -137.72 149.17 46.27 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.588 1.955 . . . . 0.0 107.259 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.2 mtm -134.98 142.99 46.6 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.601 1.161 . . . . 0.0 108.689 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -78.1 135.66 37.74 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 165.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.57 -173.34 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 122.361 1.077 . . . . 0.0 110.804 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 m -131.09 147.31 52.6 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 157.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -97.55 132.01 43.62 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 mt -68.01 -10.1 50.99 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.47 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -65.48 -43.13 91.18 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.37 1.441 . . . . 0.0 112.11 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 p -143.7 9.56 1.56 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.405 1.082 . . . . 0.0 111.738 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 t70 58.31 32.67 22.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.002 0.921 . . . . 0.0 111.429 -167.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -72.29 140.8 48.76 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.913 -1.117 . . . . 0.0 109.417 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -126.45 151.86 47.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 146.62 -155.92 26.76 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.6 mt -108.81 141.88 40.18 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.335 1.054 . . . . 0.0 110.54 -164.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.8 150.75 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.791 1.637 . . . . 0.0 109.292 171.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.33 146.59 5.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 125.901 1.68 . . . . 0.0 109.47 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -87.72 10.71 17.36 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.84 -24.45 60.89 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.564 1.146 . . . . 0.0 113.822 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -125.46 16.28 8.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -156.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.93 170.52 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.013 0.925 . . . . 0.0 112.353 -168.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.86 151.94 41.23 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.133 -0.979 . . . . 0.0 109.827 160.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.94 57.58 2.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 128.691 2.797 . . . . 0.0 111.3 -172.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.14 156.4 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 120.525 -1.359 . . . . 0.0 111.769 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.21 5.58 57.63 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.476 1.512 . . . . 0.0 113.158 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 . . . . . 0 C--O 1.245 0.823 0 C-N-CA 124.581 1.152 . . . . 0.0 112.351 -174.613 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.937 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -84.48 65.44 8.95 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 121.275 -1.132 . . . . 0.0 109.7 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.419 ' HB3' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -138.43 148.45 44.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.28 150.23 51.91 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.464 1.506 . . . . 0.0 108.34 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.74 164.25 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 120.071 1.305 . . . . 0.0 108.82 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -112.17 141.53 45.74 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.533 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -92.52 139.49 30.52 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 119.612 1.097 . . . . 0.0 111.016 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.68 12.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.159 0.984 . . . . 0.0 112.507 -172.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.8 158.61 33.96 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.198 1.399 . . . . 0.0 108.548 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -88.54 163.36 6.56 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.541 3.494 . . . . 0.0 111.635 171.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -158.67 141.29 14.33 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.836 1.254 . . . . 0.0 110.207 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.9 m -103.74 118.12 35.97 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.923 1.289 . . . . 0.0 109.959 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -78.63 160.42 27.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.868 0.867 . . . . 0.0 111.937 175.136 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.4 t -89.39 130.46 43.66 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 125.698 1.599 . . . . 0.0 108.235 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 8.3 Cg_endo -64.84 159.2 46.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.716 1.611 . . . . 0.0 112.854 173.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.251 2.9 t70 69.61 27.71 4.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.675 1.99 . . . . 0.0 112.306 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.0 p -131.4 -178.78 5.0 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.461 1.105 . . . . 0.0 110.921 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.74 8.65 36.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.313 2.645 . . . . 0.0 109.465 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -84.45 175.59 9.23 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.605 -1.309 . . . . 0.0 109.174 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.9 pt -148.64 144.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.2 2.2 . . . . 0.0 107.676 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 77.5 p -102.23 169.15 8.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 121.892 2.133 . . . . 0.0 111.205 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.533 ' CE2' ' HB1' ' A' ' 7' ' ' ALA . 9.4 p90 -170.18 -171.23 1.09 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.12 0.486 . . . . 0.0 112.234 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 mt -128.44 153.22 47.34 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.888 1.675 . . . . 0.0 109.471 -175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -52.31 127.31 21.74 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.522 -0.736 . . . . 0.0 109.079 168.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.72 -10.49 32.48 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 124.725 1.155 . . . . 0.0 114.211 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.38 158.49 35.69 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.363 1.581 . . . . 0.0 110.197 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.5 ttt -114.49 148.94 37.1 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.471 1.108 . . . . 0.0 108.286 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -125.85 162.66 24.64 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.289 1.036 . . . . 0.0 109.992 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.37 127.49 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.357 1.463 . . . . 0.0 108.99 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 3' ' ' ARG . 68.5 t -68.78 101.22 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 119.362 0.983 . . . . 0.0 109.354 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -95.3 -34.49 12.16 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.199 -0.938 . . . . 0.0 111.108 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -149.3 175.05 11.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.618 1.167 . . . . 0.0 109.021 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -138.93 127.32 22.91 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.851 2.46 . . . . 0.0 104.96 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.1 -163.01 0.85 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.293 1.437 . . . . 0.0 109.508 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -134.46 44.11 2.71 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.296 -1.502 . . . . 0.0 113.282 -168.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.91 1.48 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.888 1.275 . . . . 0.0 112.074 -157.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.55 5.0 90.26 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.1 1.333 . . . . 0.0 113.263 -167.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.596 ' CZ2' HG13 ' A' ' 53' ' ' VAL . 84.7 m95 -112.26 149.55 32.17 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.962 2.105 . . . . 0.0 110.861 -175.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.7 mtm -149.12 143.65 26.13 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.764 -1.21 . . . . 0.0 110.084 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -86.7 136.66 32.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.099 0.409 . . . . 0.0 111.016 174.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 m -147.7 -167.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.835 0.854 . . . . 0.0 111.413 -172.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.3 m -140.05 150.99 45.04 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 159.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.71 107.3 18.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.143 2.177 . . . . 0.0 108.075 -173.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.1 mt -68.7 1.18 3.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.35 -27.13 63.15 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.311 -1.493 . . . . 0.0 113.165 169.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -167.39 13.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -165.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 t0 60.75 32.8 20.24 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 123.509 1.623 . . . . 0.0 111.52 -174.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -74.88 99.56 3.83 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 120.797 -1.189 . . . . 0.0 108.366 172.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -81.99 139.53 34.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.57 1.548 . . . . 0.0 109.551 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.99 -169.17 40.13 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.417 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.9 mt -89.95 139.62 30.42 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.916 2.086 . . . . 0.0 112.997 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.31 158.52 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.147 1.779 . . . . 0.0 111.177 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.596 HG13 ' CZ2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -89.96 152.86 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 C-N-CA 124.126 0.97 . . . . 0.0 111.646 164.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.53 -22.89 67.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.285 164.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.57 ' H ' ' HB ' ' A' ' 53' ' ' VAL . 23.3 t70 -62.57 -17.01 59.16 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 122.937 1.351 . . . . 0.0 112.48 -164.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.9 mt -124.83 6.04 8.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.567 1.547 . . . . 0.0 110.885 -160.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -124.94 159.14 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.77 1.228 . . . . 0.0 109.476 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -117.83 153.59 33.24 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.976 1.311 . . . . 0.0 108.28 173.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.307 0.0 OUTLIER -80.51 118.39 22.07 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.694 1.235 . . . . 0.0 108.723 171.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.26 165.63 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.816 2.047 . . . . 0.0 106.344 171.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.68 -93.81 0.73 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 160.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.136 0 C-N-CA 125.519 1.528 . . . . 0.0 107.086 -151.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -139.06 105.49 5.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -130.87 174.18 10.23 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 123.508 0.723 . . . . 0.0 109.923 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -141.77 141.17 33.2 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.366 1.867 . . . . 0.0 107.733 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 59' ' ' GLU . 1.6 m -125.73 160.27 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.146 0.978 . . . . 0.0 108.487 167.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -115.57 129.68 56.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.62 131.44 41.68 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.004 0.82 . . . . 0.0 108.794 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.86 4.29 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.291 0.636 . . . . 0.0 111.43 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 mt -146.72 154.29 47.7 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.058 1.743 . . . . 0.0 107.893 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.86 169.02 20.1 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.693 3.595 . . . . 0.0 111.792 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -154.23 166.36 33.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.586 0.708 . . . . 0.0 112.884 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.4 m -116.6 102.02 9.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.516 2.326 . . . . 0.0 109.916 -170.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -57.26 143.46 39.34 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 177.145 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.02 135.49 82.67 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 166.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.72 151.27 79.14 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.704 2.269 . . . . 0.0 109.849 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.0 t70 61.25 30.27 19.11 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.81 0.844 . . . . 0.0 111.573 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -128.35 170.92 12.53 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.92 4.05 18.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.373 0.669 . . . . 0.0 109.359 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.41 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 40.2 mt-10 -67.04 161.95 23.25 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.733 1.213 . . . . 0.0 110.432 173.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.489 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 18.9 pt -141.96 148.26 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.182 1.393 . . . . 0.0 107.852 172.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.13 145.15 51.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.29 164.86 29.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.447 0.642 . . . . 0.0 110.859 170.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.46 163.33 15.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.063 0.945 . . . . 0.0 109.702 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -57.97 133.97 55.97 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 163.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.69 -2.1 76.37 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 117.113 -1.937 . . . . 0.0 112.718 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -71.36 167.8 18.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.784 2.292 . . . . 0.0 109.529 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 19.7 ttt -140.6 147.69 39.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.499 1.52 . . . . 0.0 107.516 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -130.85 170.06 14.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.047 0.842 . . . . 0.0 109.958 -175.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.4 pt -131.52 133.69 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.319 1.448 . . . . 0.0 107.635 170.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -69.05 116.88 10.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.4 -20.37 11.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.563 0.745 . . . . 0.0 110.786 176.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -152.03 -176.55 5.7 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.408 1.004 . . . . 0.0 110.229 160.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -125.04 130.35 52.11 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.334 1.853 . . . . 0.0 108.271 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -107.18 -163.45 0.91 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 166.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -134.4 14.56 3.78 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.357 0.98 . . . . 0.0 112.236 -170.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -120.13 11.24 11.6 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.033 1.733 . . . . 0.0 111.278 -159.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.68 20.72 65.39 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 127.083 2.278 . . . . 0.0 112.124 -167.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -127.01 150.9 49.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.371 1.086 . . . . 0.0 110.636 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.46 ' HE3' HD11 ' A' ' 52' ' ' ILE . 33.5 mtm -136.14 135.51 39.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' A' ' 51' ' ' LEU . 11.9 t-105 -73.46 128.27 35.01 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.29 1.436 . . . . 0.0 108.462 162.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.55 -173.89 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 123.824 0.85 . . . . 0.0 110.928 -174.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.5 m -124.48 132.98 53.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 157.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -86.07 112.17 21.01 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.59 1.156 . . . . 0.0 108.657 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.7 mt -67.33 -9.41 40.86 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.955 -1.022 . . . . 0.0 113.187 -172.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -30.43 70.97 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 120.921 1.692 . . . . 0.0 113.412 173.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.0 p -147.96 -8.86 0.4 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.526 1.141 . . . . 0.0 113.795 -165.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 t0 73.7 10.5 4.77 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.134 1.374 . . . . 0.0 112.349 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -61.55 126.12 26.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.843 1.657 . . . . 0.0 108.216 167.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -93.13 170.23 9.81 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 109.963 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.93 -158.02 21.79 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 118.139 0.427 . . . . 0.0 112.893 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' A' ' 40' ' ' TRP . 1.8 mm? -98.54 135.24 40.37 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.544 1.138 . . . . 0.0 111.587 -160.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.46 HD11 ' HE3' ' A' ' 39' ' ' MET . 1.5 pp -140.17 146.33 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.945 1.698 . . . . 0.0 108.941 174.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -85.86 138.83 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 124.366 1.067 . . . . 0.0 108.951 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.88 3.8 9.37 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.77 -20.01 60.61 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.546 -1.346 . . . . 0.0 114.401 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -126.76 21.02 7.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.194 0.997 . . . . 0.0 112.374 -160.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 m -130.76 173.82 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.269 1.428 . . . . 0.0 109.884 -170.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.15 154.47 50.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.672 1.989 . . . . 0.0 109.289 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.501 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -79.04 37.17 0.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.756 2.022 . . . . 0.0 114.471 -170.135 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 p -45.43 142.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 126.05 1.74 . . . . 0.0 113.83 -165.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.86 -5.01 83.68 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.883 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 . . . . . 0 C--O 1.25 1.081 0 C-N-CA 125.828 1.651 . . . . 0.0 110.963 -161.373 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.881 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.85 43.03 1.58 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.347 1.07 . . . . 0.0 110.451 -173.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -80.21 -176.03 5.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.797 0.839 . . . . 0.0 112.21 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.9 mpp_? -136.92 115.78 12.24 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.204 1.402 . . . . 0.0 109.507 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.32 170.3 3.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.947 0.88 . . . . 0.0 109.604 171.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -134.59 135.32 42.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.798 1.639 . . . . 0.0 107.766 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB2' ' HE2' ' A' ' 28' ' ' PHE . . . -78.91 137.62 37.73 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.825 1.193 . . . . 0.0 109.039 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.275 0.2 OUTLIER -114.92 8.31 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 178.033 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.39 165.48 17.43 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 126.508 1.923 . . . . 0.0 108.168 169.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -82.36 168.53 14.75 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.24 2.626 . . . . 0.0 110.065 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -147.43 -178.03 6.01 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.921 0.888 . . . . 0.0 110.099 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.9 m -134.49 105.33 6.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.449 2.3 . . . . 0.0 108.083 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -61.93 145.8 51.84 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.286 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.614 ' CG1' HG21 ' A' ' 17' ' ' THR . 0.8 OUTLIER -59.87 140.45 90.01 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 167.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -72.85 138.79 29.33 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.464 2.776 . . . . 0.0 111.093 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 73.34 43.83 0.35 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.184 2.193 . . . . 0.0 111.907 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.614 HG21 ' CG1' ' A' ' 14' ' ' VAL . 28.4 p -143.32 169.55 17.44 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 121.184 -0.947 . . . . 0.0 111.731 -168.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -85.91 -0.66 55.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.914 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.456 ' OE1' HG12 ' A' ' 14' ' ' VAL . 9.2 mt-10 -65.66 168.27 7.88 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.545 1.138 . . . . 0.0 111.163 172.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.53 122.76 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.464 1.906 . . . . 0.0 110.146 -176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.51 124.3 19.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.842 0.857 . . . . 0.0 109.998 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -136.4 164.86 27.15 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.1 0.96 . . . . 0.0 111.226 -175.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.12 167.06 11.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.271 1.028 . . . . 0.0 111.218 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -55.4 140.72 38.96 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 158.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.88 5.86 83.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-O 117.701 -1.61 . . . . 0.0 112.751 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -82.85 169.92 15.56 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.94 1.87 . . . . 0.0 110.53 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -143.28 151.44 40.54 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.708 1.203 . . . . 0.0 110.5 -174.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.422 ' HE2' ' HB2' ' A' ' 7' ' ' ALA . 49.2 m-85 -138.7 173.53 11.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 124.348 1.03 . . . . 0.0 111.432 -168.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.2 pt -135.59 135.18 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 126.093 1.757 . . . . 0.0 107.697 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.21 117.36 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.74 -21.08 10.37 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.345 -0.847 . . . . 0.0 112.736 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -152.86 -177.29 6.18 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -135.88 124.13 23.19 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.743 1.617 . . . . 0.0 107.36 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mt -103.64 -168.9 1.56 Allowed 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.385 1.074 . . . . 0.0 108.648 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -136.65 51.7 1.98 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.536 1.534 . . . . 0.0 109.059 -169.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -159.64 22.65 0.18 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.652 1.181 . . . . 0.0 108.923 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.46 -2.33 7.74 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 119.542 -1.974 . . . . 0.0 114.052 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -86.85 149.97 24.45 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.176 0.991 . . . . 0.0 110.487 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.5 mtm -136.07 136.0 39.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.526 1.13 . . . . 0.0 109.001 172.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.505 ' CE3' HD21 ' A' ' 51' ' ' LEU . 14.1 t-105 -80.4 129.83 34.76 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.996 1.719 . . . . 0.0 108.678 167.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.5 m -142.44 -176.55 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.381 1.072 . . . . 0.0 110.984 -173.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.3 m -118.17 136.22 53.76 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 154.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -88.38 114.61 25.17 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.19 1.796 . . . . 0.0 108.073 166.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.81 -3.28 14.93 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -61.72 -31.58 71.75 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.674 1.579 . . . . 0.0 112.792 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -159.85 12.82 0.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.748 0.704 . . . . 0.0 111.259 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 t0 74.03 19.58 2.98 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.725 1.21 . . . . 0.0 112.519 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -61.43 137.26 58.24 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.792 1.637 . . . . 0.0 107.981 168.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -118.87 158.36 25.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.103 0.961 . . . . 0.0 109.408 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.0 -153.48 21.47 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 124.003 0.815 . . . . 0.0 111.491 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.505 HD21 ' CE3' ' A' ' 40' ' ' TRP . 2.6 mm? -94.85 141.71 28.31 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.629 0.772 . . . . 0.0 110.978 -160.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.87 156.96 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 127.161 2.184 . . . . 0.0 107.379 170.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.83 145.45 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.782 0.833 . . . . 0.0 109.397 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -68.07 -18.74 64.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 112.935 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.43 -15.57 63.43 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -168.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.5 mt -124.48 7.2 8.3 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.184 1.394 . . . . 0.0 113.415 -160.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.89 172.06 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 119.183 0.901 . . . . 0.0 110.742 -175.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.59 145.12 44.53 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.26 1.824 . . . . 0.0 108.231 167.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.16 113.84 3.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.32 161.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 p -116.34 160.91 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 165.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.66 -77.84 1.23 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 106.564 -2.614 . . . . 0.0 106.564 166.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 . . . . . 0 C--O 1.256 1.397 0 C-N-CA 129.041 2.936 . . . . 0.0 111.276 -178.786 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.804 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -73.44 49.89 0.3 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.557 1.943 . . . . 0.0 114.51 -172.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.522 ' HB3' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -147.6 160.14 42.98 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 120.346 -1.472 . . . . 0.0 107.404 166.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -146.15 152.14 38.79 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.265 1.026 . . . . 0.0 108.474 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.13 166.23 10.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 121.908 0.861 . . . . 0.0 111.538 165.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -129.59 136.37 49.7 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 127.315 2.246 . . . . 0.0 106.343 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.41 139.89 37.58 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.58 -2.25 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.487 173.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mt -148.43 155.59 42.39 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.312 2.245 . . . . 0.0 108.055 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.14 168.22 15.35 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 124.153 3.235 . . . . 0.0 112.896 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -160.59 150.76 17.94 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.681 1.192 . . . . 0.0 111.425 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 t -116.3 131.81 56.84 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.581 ' H ' ' HB3' ' A' ' 21' ' ' SER . 0.7 OUTLIER -92.84 168.65 11.03 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.117 1.367 . . . . 0.0 111.155 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.27 119.09 57.44 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -58.24 167.28 4.83 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.979 1.786 . . . . 0.0 110.788 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.5 -9.06 1.47 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.247 2.219 . . . . 0.0 113.246 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.7 p -108.4 175.6 5.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.486 1.115 . . . . 0.0 111.706 -174.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -81.62 5.93 16.64 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.313 1.045 . . . . 0.0 112.406 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -77.34 175.74 9.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.931 1.692 . . . . 0.0 111.081 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.3 pt -150.98 156.22 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.828 2.051 . . . . 0.0 109.506 174.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.581 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 19.9 p -116.76 152.57 34.07 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.956 1.303 . . . . 0.0 110.261 -171.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.38 170.84 21.37 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 111.401 -165.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.35 163.68 23.47 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.408 0.683 . . . . 0.0 109.238 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -58.44 144.58 41.6 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.02 -8.23 64.02 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.586 -0.563 . . . . 0.0 113.746 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -69.06 170.56 9.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.806 1.289 . . . . 0.0 110.207 168.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.7 mmm -132.44 163.05 29.63 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.116 1.367 . . . . 0.0 108.995 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -137.23 -176.29 4.34 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 112.814 -1.994 . . . . 0.0 108.821 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.9 pt -143.8 150.27 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 125.772 1.629 . . . . 0.0 107.231 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 3' ' ' ARG . 44.7 t -76.14 131.51 34.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -120.6 -44.34 2.45 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.512 1.125 . . . . 0.0 109.595 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -143.88 166.82 23.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.775 0.798 . . . . 0.0 110.434 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -141.02 120.77 13.43 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 126.946 2.098 . . . . 0.0 105.811 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mt -108.39 -164.94 0.99 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.377 1.471 . . . . 0.0 108.508 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -134.57 66.78 1.53 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.262 1.425 . . . . 0.0 108.547 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.25 6.37 0.12 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.26 1.024 . . . . 0.0 112.739 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.45 15.55 71.04 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.961 1.743 . . . . 0.0 112.918 -165.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -122.44 145.76 48.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.463 1.905 . . . . 0.0 109.829 -171.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -144.7 144.99 31.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 109.686 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -91.61 136.87 32.81 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.909 0.884 . . . . 0.0 112.105 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.36 -175.49 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.84 1.256 . . . . 0.0 111.042 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.0 m -123.2 132.72 54.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 158.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.66 108.14 17.23 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.435 1.894 . . . . 0.0 108.646 174.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mt -76.06 16.91 0.38 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.43 ' HG3' HG22 ' A' ' 46' ' ' THR . 3.3 ptm180 -66.68 -35.13 79.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.388 163.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.43 HG22 ' HG3' ' A' ' 45' ' ' ARG . 1.6 t -169.46 16.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 117.472 -1.251 . . . . 0.0 113.052 -169.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 75.47 18.29 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.12 1.368 . . . . 0.0 113.303 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.19 134.23 54.4 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.596 -0.69 . . . . 0.0 109.336 170.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -124.92 142.85 51.19 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.18 0.992 . . . . 0.0 108.758 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.06 -160.91 28.58 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.37 147.06 23.91 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.507 1.123 . . . . 0.0 112.406 -165.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.2 pt -133.52 157.0 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.876 1.671 . . . . 0.0 109.995 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.22 147.77 7.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 126.119 1.768 . . . . 0.0 107.786 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -75.62 2.03 12.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -80.75 -18.33 48.05 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.427 1.491 . . . . 0.0 113.123 -172.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -123.29 14.79 9.7 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.185 -1.572 . . . . 0.0 112.415 -168.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.09 161.67 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.979 1.711 . . . . 0.0 109.159 -167.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -120.51 148.53 43.72 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.684 1.194 . . . . 0.0 109.02 170.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -70.1 125.53 27.04 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 166.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.86 162.91 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.079 1.352 . . . . 0.0 107.635 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.94 -92.1 0.17 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 164.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.861 0 C-N-CA 126.18 1.792 . . . . 0.0 111.136 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . . . . . . 0 N--CA 1.468 0.821 0 CA-C-O 118.956 -0.913 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -144.85 -63.15 0.35 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.268 1.534 . . . . 0.0 113.429 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 30' ' ' VAL 0.293 0.0 OUTLIER -133.49 -162.54 1.25 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.171 1.388 . . . . 0.0 108.42 -175.253 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.9 mtt85 -111.54 175.79 5.28 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 120.9 -1.125 . . . . 0.0 111.24 172.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.46 HG13 HH21 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -135.74 162.48 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.119 -0.988 . . . . 0.0 109.168 165.545 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 -138.33 143.6 39.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.644 0.777 . . . . 0.0 109.574 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.06 132.33 35.95 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.131 0.972 . . . . 0.0 110.109 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.64 -4.6 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.219 1.008 . . . . 0.0 111.963 171.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.47 153.4 51.58 Favored Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 126.443 1.897 . . . . 0.0 108.253 175.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -76.3 157.87 37.24 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.709 2.939 . . . . 0.0 111.743 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -140.0 165.3 27.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.36 1.064 . . . . 0.0 110.564 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.9 m -136.76 112.37 9.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.536 1.534 . . . . 0.0 107.269 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 15' ' ' PRO . 6.6 pttm -70.61 152.06 44.32 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 169.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.3 t -75.75 146.6 80.11 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 156.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.539 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 98.2 Cg_endo -81.6 170.76 14.06 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.577 2.851 . . . . 0.0 111.252 172.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 75.4 16.78 2.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.781 2.432 . . . . 0.0 111.548 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.6 p -132.03 168.08 18.57 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.215 1.806 . . . . 0.0 109.855 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -80.41 3.83 20.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.251 1.421 . . . . 0.0 111.587 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.98 172.85 12.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.993 1.717 . . . . 0.0 110.201 -175.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.8 130.83 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.447 1.499 . . . . 0.0 110.588 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.1 150.23 37.29 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.795 1.238 . . . . 0.0 110.066 176.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -154.48 164.05 39.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.369 0.531 . . . . 0.0 111.528 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.44 162.87 14.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.378 1.071 . . . . 0.0 110.922 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.78 132.15 53.08 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 164.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.51 -5.2 54.61 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-O 119.049 -0.862 . . . . 0.0 113.682 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -102.37 154.53 18.98 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.276 1.03 . . . . 0.0 108.435 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.8 ttt -124.25 158.46 32.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.018 0.927 . . . . 0.0 111.179 -164.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.72 177.38 8.94 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.557 1.543 . . . . 0.0 110.599 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.2 pt -131.59 127.65 59.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.631 1.572 . . . . 0.0 109.386 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 3' ' ' ARG . 1.7 p -75.06 94.41 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.38 0.536 . . . . 0.0 110.083 -177.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -82.74 -56.56 3.77 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -135.79 165.33 25.85 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.355 0.598 . . . . 0.0 110.111 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -129.95 128.46 42.16 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 125.808 1.643 . . . . 0.0 106.743 -172.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 mt -113.21 -170.77 1.75 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -175.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -134.65 48.99 2.26 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.123 0.969 . . . . 0.0 108.897 -166.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -156.6 19.11 0.33 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.924 1.29 . . . . 0.0 112.004 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.13 19.61 79.77 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 120.802 -1.186 . . . . 0.0 112.239 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -120.29 153.33 36.54 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.177 1.391 . . . . 0.0 109.206 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.5 mtm -147.46 131.04 16.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -76.12 128.93 35.98 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.42 -165.71 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.504 1.122 . . . . 0.0 110.514 -175.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.1 m -137.02 127.67 27.01 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 162.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -78.47 99.02 6.27 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.526 1.53 . . . . 0.0 108.441 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.08 -2.44 0.43 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.308 1.443 . . . . 0.0 113.909 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -55.91 -48.37 75.8 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 120.554 -1.341 . . . . 0.0 110.136 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -152.53 14.56 0.58 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.4 0.545 . . . . 0.0 111.78 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 t70 74.76 19.68 2.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.922 2.089 . . . . 0.0 111.963 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.6 108.44 0.83 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.035 0.934 . . . . 0.0 108.897 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -73.51 155.88 38.74 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.74 -165.18 28.06 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-O 121.522 0.512 . . . . 0.0 112.508 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 mt -104.72 142.05 35.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.993 1.317 . . . . 0.0 112.503 -168.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.0 153.41 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.709 1.604 . . . . 0.0 109.713 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -86.23 135.84 24.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.736 1.214 . . . . 0.0 108.26 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -77.18 -3.91 41.98 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -172.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.32 -30.25 68.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.707 2.003 . . . . 0.0 113.295 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.36 12.33 13.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.941 1.296 . . . . 0.0 112.911 -160.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 m -130.41 154.24 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.301 1.04 . . . . 0.0 111.001 -171.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -121.13 147.4 45.63 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.748 1.619 . . . . 0.0 110.31 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.81 94.1 1.02 Allowed 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 127.955 2.502 . . . . 0.0 110.828 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.664 HG12 ' H ' ' A' ' 62' ' ' ARG . 41.7 t -91.38 135.01 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 O-C-N 121.5 -0.75 . . . . 0.0 109.591 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.01 29.55 5.31 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.819 2.152 . . . . 0.0 111.729 173.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.664 ' H ' HG12 ' A' ' 60' ' ' VAL . 6.4 ptm180 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 124.652 1.181 . . . . 0.0 108.338 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.335 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 42.98 59.26 2.95 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.655 1.728 . . . . 0.0 112.659 166.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -102.86 25.66 9.02 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 127.004 2.122 . . . . 0.0 112.217 -162.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.5 mtm-85 -74.2 147.01 42.92 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 119.908 -1.745 . . . . 0.0 109.553 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.8 m -134.0 156.52 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.7 ttm-85 -120.83 125.27 47.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 126.59 1.956 . . . . 0.0 105.75 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.44 151.17 38.11 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 118.386 -1.326 . . . . 0.0 108.567 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.6 3.08 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.951 1.3 . . . . 0.0 111.337 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 mt -142.2 159.05 59.97 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 126.127 1.771 . . . . 0.0 107.608 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.05 170.39 11.02 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.688 2.925 . . . . 0.0 110.983 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -150.77 160.64 43.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.473 1.109 . . . . 0.0 110.474 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -132.19 109.79 10.19 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 172.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' H ' ' HB3' ' A' ' 21' ' ' SER . 7.7 pttm -65.57 165.54 12.11 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.667 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.8 147.54 58.9 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 150.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.79 176.87 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.475 2.784 . . . . 0.0 110.911 158.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 66.91 17.48 10.53 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.043 1.737 . . . . 0.0 112.692 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -135.54 171.73 14.03 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.408 1.883 . . . . 0.0 109.345 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.96 -3.5 29.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.991 1.317 . . . . 0.0 111.561 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.39 162.48 12.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.178 1.391 . . . . 0.0 112.025 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.6 pt -136.88 142.43 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.957 2.103 . . . . 0.0 108.179 165.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.53 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -87.39 171.34 10.65 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.422 -1.424 . . . . 0.0 110.693 170.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -162.23 167.43 24.02 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.888 1.675 . . . . 0.0 108.026 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mt -118.86 161.75 19.64 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.577 1.551 . . . . 0.0 107.052 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.73 126.1 26.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.938 1.245 . . . . 0.0 110.152 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.0 52.1 1.04 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 124.681 1.134 . . . . 0.0 111.146 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -138.45 161.59 36.62 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.978 1.711 . . . . 0.0 108.007 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.5 mtp -138.83 140.1 38.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.245 1.018 . . . . 0.0 110.432 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.9 169.1 9.33 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.088 1.755 . . . . 0.0 109.938 -174.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.0 pt -122.02 126.35 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 172.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 3' ' ' ARG . 59.5 t -63.24 130.36 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -118.92 -44.76 2.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.582 1.153 . . . . 0.0 110.02 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -140.01 170.15 16.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -132.05 138.65 48.26 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 124.939 1.296 . . . . 0.0 107.604 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 mt -123.31 178.47 5.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.985 1.714 . . . . 0.0 109.68 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -120.89 14.55 11.6 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.917 1.341 . . . . 0.0 112.884 -162.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -129.26 20.25 5.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 127.764 2.426 . . . . 0.0 111.23 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.56 9.05 61.86 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.019 1.295 . . . . 0.0 112.922 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -113.67 162.23 16.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.355 1.062 . . . . 0.0 110.971 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.7 mtm -138.97 143.4 38.52 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.38 1.472 . . . . 0.0 107.845 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -78.26 135.95 37.66 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.702 161.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.7 m -140.96 176.8 4.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.163 0.985 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.0 m -115.39 141.21 48.34 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 152.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -93.26 112.45 24.39 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.464 1.106 . . . . 0.0 108.964 169.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.0 5.41 2.7 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -59.01 -41.85 88.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.261 162.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -147.41 -13.27 0.4 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.101 -0.952 . . . . 0.0 113.379 -161.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 t70 75.07 16.61 2.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.559 1.944 . . . . 0.0 111.761 -162.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -60.78 113.92 2.75 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 120.664 -1.273 . . . . 0.0 108.96 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.11 151.13 21.74 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.91 -0.494 . . . . 0.0 109.873 167.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.76 -167.48 35.29 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.613 0.563 . . . . 0.0 111.917 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -89.59 141.14 28.87 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.399 1.08 . . . . 0.0 110.555 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.8 153.27 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.999 2.12 . . . . 0.0 109.104 169.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.88 146.1 7.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.801 0.84 . . . . 0.0 110.428 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -66.94 -17.65 65.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.439 1.496 . . . . 0.0 113.041 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.92 -18.23 59.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.529 1.932 . . . . 0.0 112.109 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -130.56 12.56 5.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.437 1.495 . . . . 0.0 112.712 -163.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.97 154.43 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.661 1.118 . . . . 0.0 112.994 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -128.3 148.91 50.68 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.805 2.042 . . . . 0.0 110.204 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.64 102.25 0.55 Allowed 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 129.359 3.064 . . . . 0.0 110.324 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 p -110.46 132.75 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 123.19 1.471 . . . . 0.0 110.864 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.36 7.82 80.83 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.25 -1.341 . . . . 0.0 112.701 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 . . . . . 0 C--O 1.253 1.267 0 CA-C-N 118.553 1.177 . . . . 0.0 108.631 -172.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -116.69 131.84 56.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.113 1.365 . . . . 0.0 108.429 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.425 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -127.36 -169.73 2.09 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 121.031 1.741 . . . . 0.0 110.541 174.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.466 ' CD ' HG22 ' A' ' 29' ' ' ILE . 54.4 mtm180 -132.54 150.98 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.377 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 m -123.4 171.07 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.536 1.134 . . . . 0.0 108.461 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -144.02 122.84 12.67 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 120.752 -1.217 . . . . 0.0 111.739 -170.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.38 137.85 58.34 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.801 0.728 . . . . 0.0 109.975 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.27 0.2 OUTLIER -119.73 5.22 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.417 169.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.5 mt -147.8 154.94 44.53 Favored Pre-proline 0 N--CA 1.466 0.374 0 C-N-CA 125.639 1.576 . . . . 0.0 108.822 166.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.66 157.54 31.93 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.613 2.875 . . . . 0.0 110.235 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -146.31 -179.4 6.72 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.782 0.833 . . . . 0.0 108.906 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 t -146.39 133.42 20.32 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.571 ' H ' ' HB3' ' A' ' 21' ' ' SER . 17.9 ptmt -69.52 144.66 53.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.107 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.98 139.91 97.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.02 145.86 69.01 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.068 2.512 . . . . 0.0 110.488 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.82 39.14 8.57 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.765 1.626 . . . . 0.0 112.498 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 p -132.33 171.21 14.01 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.497 -0.752 . . . . 0.0 110.434 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.68 -8.18 59.05 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.64 1.976 . . . . 0.0 111.323 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.03 167.88 3.61 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.781 1.633 . . . . 0.0 111.917 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.99 136.48 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.877 1.671 . . . . 0.0 108.69 174.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.571 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -90.51 122.77 33.63 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.85 1.66 . . . . 0.0 110.148 -178.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -146.99 170.65 16.66 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 119.671 1.123 . . . . 0.0 113.288 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.88 -178.64 5.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.014 0.926 . . . . 0.0 111.738 -164.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -63.57 149.58 45.99 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 160.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.99 -4.73 22.06 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.897 -0.946 . . . . 0.0 113.244 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.55 156.31 39.1 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.639 1.22 . . . . 0.0 107.759 164.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.9 ttt -134.17 148.82 50.98 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.866 -1.146 . . . . 0.0 108.814 -173.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -132.98 159.48 39.89 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.436 1.094 . . . . 0.0 109.636 -169.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.466 HG22 ' CD ' ' A' ' 4' ' ' ARG . 6.7 pt -110.86 135.98 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 3' ' ' ARG . 1.7 p -69.39 124.5 25.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 171.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.19 -25.32 4.9 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.97 0.908 . . . . 0.0 113.255 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -154.73 160.44 41.34 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 164.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.76 123.03 42.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.09 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 mt -101.81 -169.42 1.68 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.9 29.59 3.77 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.381 1.072 . . . . 0.0 110.853 -166.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -151.79 29.4 0.6 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.702 1.601 . . . . 0.0 111.534 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.09 36.25 64.23 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 120.9 -1.125 . . . . 0.0 112.426 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -134.72 156.18 49.25 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.362 1.081 . . . . 0.0 108.92 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.5 mtm -138.01 141.86 40.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 168.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -75.41 137.9 41.32 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 160.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.81 -178.84 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 122.186 0.993 . . . . 0.0 111.768 -175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.4 m -124.94 146.68 49.24 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 153.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.77 119.46 32.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.437 2.695 . . . . 0.0 108.43 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt -80.11 21.13 0.6 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.844 1.257 . . . . 0.0 112.491 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.3 ttp85 -101.24 -47.53 4.69 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.089 0.956 . . . . 0.0 110.032 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -146.15 20.31 1.4 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.642 0.777 . . . . 0.0 109.511 -169.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.85 24.13 12.73 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.208 1.803 . . . . 0.0 112.356 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -72.32 160.61 32.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.1 -1.0 . . . . 0.0 112.48 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -139.42 149.54 44.2 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.684 0.754 . . . . 0.0 110.928 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.89 -168.55 32.36 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.638 -174.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.0 mt -92.0 143.53 26.38 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.832 1.253 . . . . 0.0 110.489 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.01 145.57 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.274 1.429 . . . . 0.0 109.029 171.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.02 132.23 32.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.31 -10.97 60.63 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -55.48 -26.85 44.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.942 2.097 . . . . 0.0 111.873 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.96 11.29 11.73 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -160.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -118.11 164.68 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.73 1.612 . . . . 0.0 110.859 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -121.31 151.14 40.42 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.568 1.547 . . . . 0.0 110.154 169.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.18 63.18 0.97 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.768 2.427 . . . . 0.0 111.066 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -57.64 145.61 8.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 O-C-N 120.741 -1.224 . . . . 0.0 111.331 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.96 -53.3 0.8 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 125.129 1.347 . . . . 0.0 110.982 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.384 4.8 ptm180 . . . . . 0 C--O 1.247 0.933 0 C-N-CA 128.93 2.892 . . . . 0.0 114.258 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.407 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.89 152.24 32.32 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.204 1.002 . . . . 0.0 108.361 164.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -138.31 -165.33 1.79 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 167.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 mmt85 -140.99 156.52 46.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.13 1.372 . . . . 0.0 107.494 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.09 154.63 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.335 0.97 . . . . 0.0 109.806 170.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -121.66 136.57 54.94 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.84 130.78 41.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.149 0.886 . . . . 0.0 109.506 169.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.07 1.47 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.318 0.647 . . . . 0.0 111.305 170.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 mt -141.03 154.56 68.37 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 168.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.91 158.77 34.66 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.971 2.447 . . . . 0.0 110.247 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -150.12 164.61 35.15 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.58 0.752 . . . . 0.0 110.577 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 t -135.31 135.79 41.07 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -63.46 149.75 45.34 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.22 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.475 HG23 ' OG1' ' A' ' 17' ' ' THR . 21.2 m -66.7 166.29 19.59 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.624 1.17 . . . . 0.0 109.557 163.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -79.6 161.27 25.02 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.385 2.056 . . . . 0.0 110.41 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t70 45.94 46.86 12.48 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.987 2.515 . . . . 0.0 112.693 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.475 ' OG1' HG23 ' A' ' 14' ' ' VAL . 1.8 p -142.96 177.74 8.15 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.459 -0.776 . . . . 0.0 110.122 -170.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.25 11.25 37.09 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.513 1.525 . . . . 0.0 110.412 -172.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -80.36 170.02 16.96 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.653 1.581 . . . . 0.0 111.549 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.3 pt -136.0 152.78 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.227 1.811 . . . . 0.0 109.964 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -88.99 149.87 23.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.545 2.338 . . . . 0.0 110.642 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -158.28 173.19 17.06 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.423 -0.798 . . . . 0.0 111.797 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.41 161.17 22.64 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.804 1.242 . . . . 0.0 110.516 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -57.98 133.63 55.68 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 166.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.31 -6.77 71.96 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 117.887 -1.507 . . . . 0.0 113.005 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -77.18 166.45 23.22 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.271 2.035 . . . . 0.0 108.699 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 34.7 mtp -133.25 140.3 47.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.566 1.146 . . . . 0.0 109.873 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -122.93 169.94 10.63 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.099 1.359 . . . . 0.0 109.779 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 pt -119.52 129.64 75.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.46 125.98 27.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -116.64 -33.48 4.84 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.929 0.892 . . . . 0.0 111.961 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -146.62 160.45 42.15 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 119.262 0.937 . . . . 0.0 110.497 172.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -118.06 121.55 40.88 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 126.498 1.919 . . . . 0.0 107.289 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -110.2 -172.15 1.98 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.412 1.485 . . . . 0.0 107.851 173.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -120.26 13.73 12.01 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.171 1.789 . . . . 0.0 114.935 -166.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -143.41 23.31 1.81 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.392 1.077 . . . . 0.0 112.218 -154.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.94 7.28 87.43 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 124.456 1.027 . . . . 0.0 112.617 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -118.48 150.61 39.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.576 1.55 . . . . 0.0 108.73 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 mtm -139.39 140.37 37.4 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -77.05 138.88 39.83 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 166.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -142.56 -175.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.774 1.273 . . . . 0.0 111.166 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.2 m -130.76 132.23 45.19 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 152.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -81.39 114.01 19.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.41 -6.81 11.28 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.024 -0.423 . . . . 0.0 111.679 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -57.01 -40.39 76.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 120.396 -1.44 . . . . 0.0 111.389 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -169.75 33.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.025 0.829 . . . . 0.0 111.793 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t70 66.54 -4.91 0.67 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 171.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -53.73 118.4 3.9 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.192 1.797 . . . . 0.0 109.804 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -100.36 157.87 16.3 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 168.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.49 -171.91 32.98 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.3 mt -87.23 144.88 26.61 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.458 1.503 . . . . 0.0 109.561 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.28 152.64 23.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.95 1.7 . . . . 0.0 108.028 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.18 141.31 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.286 0.634 . . . . 0.0 109.832 -173.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -71.82 -9.56 58.49 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.824 0.85 . . . . 0.0 113.25 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.34 -21.16 66.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.819 1.248 . . . . 0.0 112.064 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -126.86 11.42 7.17 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.802 1.241 . . . . 0.0 112.098 -162.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.11 167.57 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.171 0.989 . . . . 0.0 111.343 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -119.06 152.31 36.68 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 127.184 2.194 . . . . 0.0 108.426 167.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 59.76 1.25 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.319 1.448 . . . . 0.0 110.341 174.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.18 158.21 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 120.87 -1.144 . . . . 0.0 110.633 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.55 20.62 1.5 Allowed Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.454 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.713 -177.235 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.814 0 CA-C-O 118.485 -1.175 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 60.46 64.29 1.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 123.085 1.422 . . . . 0.0 108.477 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.43 -164.23 0.97 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.819 1.247 . . . . 0.0 108.279 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -124.6 151.55 44.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.94 145.51 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.275 0.943 . . . . 0.0 109.746 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -111.37 144.96 39.73 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 117.584 -1.198 . . . . 0.0 109.922 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.19 136.71 37.86 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 119.767 1.167 . . . . 0.0 111.819 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.69 1.85 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.158 0.983 . . . . 0.0 112.294 168.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mt -151.71 154.48 33.13 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 125.73 1.612 . . . . 0.0 108.755 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.52 134.93 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.009 2.473 . . . . 0.0 108.604 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -84.64 -179.12 7.06 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.931 0.872 . . . . 0.0 109.043 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.4 m -149.71 100.33 2.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' H ' ' HB3' ' A' ' 21' ' ' SER . 11.6 pttt -67.66 156.6 36.49 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.413 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.424 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 11.0 m -85.53 176.25 3.81 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 126.324 1.85 . . . . 0.0 107.912 168.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 14' ' ' VAL . 89.6 Cg_endo -95.17 164.02 1.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.174 2.582 . . . . 0.0 111.336 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 59.04 35.78 24.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.492 1.917 . . . . 0.0 111.243 167.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.39 162.59 36.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.127 0.965 . . . . 0.0 111.483 -161.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.4 35.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.477 1.911 . . . . 0.0 109.427 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -109.3 168.29 9.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.296 1.039 . . . . 0.0 109.149 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.2 pt -145.2 144.66 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 127.39 2.276 . . . . 0.0 106.554 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.53 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 93.1 p -124.88 158.94 32.28 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.665 ' HB2' HD21 ' A' ' 43' ' ' ASN . 0.1 OUTLIER -164.93 -175.03 3.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.512 1.525 . . . . 0.0 109.506 176.306 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.5 172.39 8.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.173 0.989 . . . . 0.0 109.975 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -54.93 157.2 3.32 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.525 -1.359 . . . . 0.0 109.789 161.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.44 12.55 84.2 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.773 -1.015 . . . . 0.0 112.696 172.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -174.59 4.24 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.733 1.267 . . . . 0.0 111.262 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.36 144.67 32.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.338 1.855 . . . . 0.0 108.934 -170.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -133.74 153.92 51.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.159 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.6 pt -112.92 118.53 58.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -63.76 121.78 13.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.1 -36.28 5.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.433 1.093 . . . . 0.0 109.973 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -149.24 169.55 20.5 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.158 0.89 . . . . 0.0 110.062 168.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -130.35 122.7 28.36 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 127.332 2.253 . . . . 0.0 106.122 -171.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.85 -162.79 0.97 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.677 1.191 . . . . 0.0 110.138 -175.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -141.55 76.63 1.55 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.79 2.036 . . . . 0.0 106.934 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 p30 174.2 -0.97 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.532 1.933 . . . . 0.0 114.363 -165.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.43 7.53 85.26 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 120.055 -1.653 . . . . 0.0 113.142 -171.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -95.73 165.44 12.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.377 1.589 . . . . 0.0 109.922 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.4 mtm -134.94 163.54 29.63 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 168.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.2 t-105 -94.34 132.62 38.75 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.406 0.548 . . . . 0.0 109.665 158.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.56 174.89 6.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.132 0.973 . . . . 0.0 110.503 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.44 ' CG2' ' HA ' ' A' ' 47' ' ' ASP . 7.8 m -107.68 141.82 38.6 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 157.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.665 HD21 ' HB2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -82.19 111.48 18.33 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 127.287 2.235 . . . . 0.0 107.958 170.366 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.6 -9.31 5.77 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 22.0 ttp85 -53.31 -38.39 63.11 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.984 0.914 . . . . 0.0 111.436 173.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 t -165.67 -1.61 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -161.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.44 ' HA ' ' CG2' ' A' ' 42' ' ' THR . 0.6 OUTLIER 75.3 17.64 2.52 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.661 1.585 . . . . 0.0 112.401 -173.163 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.2 139.48 58.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -126.51 153.78 44.69 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.614 1.166 . . . . 0.0 108.731 -172.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 151.8 -158.47 27.79 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -172.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -101.56 143.01 32.07 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.61 1.964 . . . . 0.0 112.013 -168.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.94 152.97 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 129.813 3.245 . . . . 0.0 107.024 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.33 139.58 19.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -74.7 -14.83 60.78 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.18 -22.0 64.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.621 1.168 . . . . 0.0 112.719 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.4 mt -107.09 3.9 26.33 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.331 1.452 . . . . 0.0 112.286 -170.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.96 171.14 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.224 1.009 . . . . 0.0 110.737 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -131.21 152.96 49.97 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 125.611 1.565 . . . . 0.0 110.618 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -78.05 80.62 4.47 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.6 1.56 . . . . 0.0 111.089 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 62' ' ' ARG . 2.0 t -77.77 164.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 120.963 -1.085 . . . . 0.0 109.449 167.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.36 12.93 10.31 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.49 1.519 . . . . 0.0 113.015 167.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.531 ' H ' HG12 ' A' ' 60' ' ' VAL . 55.4 mtp85 . . . . . 0 C--O 1.246 0.903 0 CA-C-O 116.473 -1.727 . . . . 0.0 111.45 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.405 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 mtt85 -144.24 109.67 5.17 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.59 1.956 . . . . 0.0 106.388 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.3 172.75 8.01 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.088 1.355 . . . . 0.0 109.455 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -151.79 138.84 19.12 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.28 1.832 . . . . 0.0 108.391 -172.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.89 159.04 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.81 0.844 . . . . 0.0 109.118 173.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.554 ' HE ' ' HE3' ' A' ' 27' ' ' MET . 10.9 ttm180 -130.03 131.57 45.89 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.729 -1.857 . . . . 0.0 106.099 -168.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.57 156.42 26.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.598 1.545 . . . . 0.0 110.566 -173.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.75 9.89 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.921 162.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.71 155.57 29.68 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 120.35 1.432 . . . . 0.0 110.264 167.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' A' ' 23' ' ' LEU . 27.8 Cg_endo -82.81 163.77 15.99 Favored 'Trans proline' 0 CA--C 1.543 0.956 1 C-N-CA 125.972 4.448 . . . . 0.0 111.925 177.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -153.14 165.69 34.84 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.745 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -119.27 113.73 21.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.545 1.938 . . . . 0.0 107.21 -175.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -67.26 146.81 53.78 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.38 1.446 . . . . 0.0 110.233 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.39 149.3 98.46 Favored Pre-proline 0 CA--C 1.552 1.035 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.18 141.53 39.75 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 124.234 3.289 . . . . 0.0 111.32 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.1 t70 64.47 27.56 13.51 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.819 1.648 . . . . 0.0 112.843 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 p -121.91 173.76 7.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.467 1.031 . . . . 0.0 113.651 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.28 24.9 0.77 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.173 2.189 . . . . 0.0 110.632 -172.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -108.11 175.47 5.47 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.035 2.134 . . . . 0.0 110.844 -173.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 pt -147.24 121.11 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.311 1.445 . . . . 0.0 110.904 -174.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.63 139.11 39.44 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.054 -1.029 . . . . 0.0 111.338 -176.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -156.51 169.25 25.08 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.012 -1.055 . . . . 0.0 112.062 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 3.5 mm? -109.8 167.59 10.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.377 1.071 . . . . 0.0 109.729 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -62.38 119.4 9.03 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 169.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.15 -15.88 4.21 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.645 1.593 . . . . 0.0 112.944 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -80.1 162.74 24.61 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.981 1.391 . . . . 0.0 110.002 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.554 ' HE3' ' HE ' ' A' ' 6' ' ' ARG . 14.5 ptm -138.3 158.95 43.28 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.578 1.951 . . . . 0.0 108.406 175.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -132.66 160.87 35.45 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.382 1.073 . . . . 0.0 111.072 -169.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.6 pt -121.09 125.31 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 108.909 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.85 123.48 13.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -126.36 -23.43 3.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.634 1.174 . . . . 0.0 112.963 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -156.0 161.6 40.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.171 0.896 . . . . 0.0 110.822 159.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -118.54 125.68 50.36 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 129.07 2.948 . . . . 0.0 105.767 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 mt -109.46 -165.36 1.01 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.187 0.995 . . . . 0.0 109.213 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -133.52 91.94 2.92 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 t0 175.85 18.91 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.627 2.371 . . . . 0.0 111.667 168.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.46 -1.86 84.21 Favored Glycine 0 CA--C 1.539 1.572 0 O-C-N 120.146 -1.596 . . . . 0.0 113.878 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.498 ' CE2' HG13 ' A' ' 53' ' ' VAL . 90.9 m95 -97.73 152.02 19.55 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.752 2.021 . . . . 0.0 110.217 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.7 mtm -141.64 143.8 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.363 1.465 . . . . 0.0 108.638 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -84.39 136.69 33.77 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 171.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.17 -163.79 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.511 0.724 . . . . 0.0 111.549 -173.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.3 m -135.83 158.11 45.21 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 151.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -102.79 115.36 30.44 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.637 1.575 . . . . 0.0 109.677 172.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 mt -66.2 -4.54 7.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.799 1.24 . . . . 0.0 113.44 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -69.35 -46.77 66.22 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 117.187 -1.387 . . . . 0.0 111.47 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.5 p -139.29 4.96 2.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.934 1.243 . . . . 0.0 114.025 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.69 19.69 1.97 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.939 1.696 . . . . 0.0 112.204 -174.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -62.25 141.82 58.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.916 1.286 . . . . 0.0 110.385 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -134.51 155.81 49.72 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.836 0.854 . . . . 0.0 109.65 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.89 -158.17 24.07 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -161.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.3 mt -106.16 144.67 32.53 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.271 1.428 . . . . 0.0 113.858 -164.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.63 154.31 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 127.699 2.4 . . . . 0.0 108.582 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.553 ' HB ' ' H ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -91.74 147.97 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 127.483 2.313 . . . . 0.0 112.553 168.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -58.89 -21.32 57.21 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.47 165.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.553 ' H ' ' HB ' ' A' ' 53' ' ' VAL . 21.6 t70 -63.67 -24.62 67.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.763 0.792 . . . . 0.0 112.178 -166.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.1 mt -118.75 7.2 11.58 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.509 1.523 . . . . 0.0 111.271 -157.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.93 161.84 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.02 1.728 . . . . 0.0 109.797 -169.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.5 153.26 26.45 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.363 1.465 . . . . 0.0 109.059 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.87 61.9 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.928 1.291 . . . . 0.0 111.088 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 p -60.65 164.68 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 122.32 1.057 . . . . 0.0 110.213 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.02 -105.63 0.32 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.507 0 CA-C-O 115.06 -2.4 . . . . 0.0 108.207 -169.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.448 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 55.08 53.88 9.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.91 1.284 . . . . 0.0 109.229 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -124.37 125.9 45.09 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -168.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' HD3' HG22 ' A' ' 29' ' ' ILE . 17.5 mtm180 -134.61 166.8 22.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.991 0.516 . . . . 0.0 110.451 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.69 161.44 23.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 171.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -139.47 129.87 25.55 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.52 121.72 19.18 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.981 0.81 . . . . 0.0 109.595 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.96 -2.34 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.135 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.81 157.48 32.58 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 126.938 2.095 . . . . 0.0 108.171 173.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.08 159.74 30.24 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.93 3.086 . . . . 0.0 111.147 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -143.9 168.07 20.82 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.826 1.651 . . . . 0.0 107.61 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 t -135.66 143.51 45.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.579 ' H ' ' HB3' ' A' ' 21' ' ' SER . 12.9 pttm -84.35 155.88 22.13 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.924 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -62.46 139.63 96.63 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 161.053 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.14 146.68 41.39 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.945 1.763 . . . . 0.0 108.837 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t0 62.65 51.32 3.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.686 1.594 . . . . 0.0 112.019 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.1 p -146.07 174.36 11.37 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 125.926 1.69 . . . . 0.0 110.203 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -84.22 -9.15 58.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.185 0.994 . . . . 0.0 110.992 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.08 173.71 4.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.879 2.071 . . . . 0.0 111.337 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 pt -147.18 126.22 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 126.985 2.114 . . . . 0.0 108.734 -172.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.579 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 1.2 p -93.72 125.72 38.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.075 1.75 . . . . 0.0 111.468 -172.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -150.57 168.61 23.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 124.513 2.101 . . . . 0.0 113.95 -172.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mt -90.16 174.54 7.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.525 2.33 . . . . 0.0 110.126 -166.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -60.47 153.25 23.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 156.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.7 7.15 88.72 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.069 -0.851 . . . . 0.0 113.67 167.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.91 157.05 20.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.213 1.507 . . . . 0.0 109.058 166.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.3 ttt -134.01 147.83 51.02 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.097 0.959 . . . . 0.0 109.12 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -134.76 170.97 15.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.384 -167.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.514 HG22 ' HD3' ' A' ' 4' ' ' ARG . 18.5 pt -128.06 138.72 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.098 1.359 . . . . 0.0 107.899 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.9 t -75.0 116.84 18.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -112.17 -20.52 11.87 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.402 0.681 . . . . 0.0 111.387 174.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -154.84 179.88 8.68 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 163.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -147.09 118.95 8.1 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.748 1.619 . . . . 0.0 107.369 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -104.91 -177.56 3.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.811 2.445 . . . . 0.0 110.222 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -133.96 78.79 1.78 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.448 1.499 . . . . 0.0 109.6 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -169.9 31.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.63 1.572 . . . . 0.0 110.508 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.1 27.74 67.87 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.609 -1.307 . . . . 0.0 112.623 -174.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -134.52 150.37 50.76 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.534 1.167 . . . . 0.0 110.833 -168.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.6 mtm -149.14 137.66 21.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.493 0.717 . . . . 0.0 110.869 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -86.71 130.84 34.32 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.958 1.303 . . . . 0.0 110.405 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -142.1 -177.12 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.504 0.722 . . . . 0.0 111.879 -175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 m -116.78 138.7 51.3 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.945 1.698 . . . . 0.0 107.42 157.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -92.32 120.84 33.25 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.705 1.202 . . . . 0.0 109.466 165.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.87 1.66 3.19 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.774 ' HG3' HG22 ' A' ' 46' ' ' THR . 3.5 ptp180 -71.34 -36.49 71.56 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 121.191 1.814 . . . . 0.0 112.799 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.774 HG22 ' HG3' ' A' ' 45' ' ' ARG . 14.9 t -158.95 23.31 0.21 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.273 0.488 . . . . 0.0 111.635 -171.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.9 t70 58.59 27.24 15.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.411 1.084 . . . . 0.0 111.784 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.517 ' HG3' HG23 ' A' ' 46' ' ' THR . 45.4 mt-10 -68.61 98.86 0.92 Allowed 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.011 -1.056 . . . . 0.0 109.415 171.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -80.42 158.3 25.99 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.721 0.295 . . . . 0.0 110.619 167.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.16 -170.74 29.46 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 173.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -80.03 141.79 35.56 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.426 1.091 . . . . 0.0 110.882 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.81 152.21 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 110.12 167.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.61 140.58 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.283 1.433 . . . . 0.0 108.736 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.92 -9.33 58.44 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.78 -15.45 61.68 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.345 1.858 . . . . 0.0 113.846 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.2 mt -140.79 21.86 2.31 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.739 1.216 . . . . 0.0 113.677 -167.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.75 154.44 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -100.4 149.32 23.76 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.74 1.216 . . . . 0.0 109.554 167.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.4 123.88 24.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.274 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 62' ' ' ARG . 2.6 t -124.36 149.29 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.124 0.488 . . . . 0.0 111.288 172.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.27 15.52 10.05 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.89 1.709 . . . . 0.0 112.349 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.553 ' H ' HG12 ' A' ' 60' ' ' VAL . 63.2 mtt-85 . . . . . 0 C--O 1.246 0.886 0 C-N-CA 125.184 1.394 . . . . 0.0 109.258 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.377 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HD3' HG22 ' A' ' 29' ' ' ILE . 85.0 mtt180 -141.46 166.57 24.39 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.283 1.433 . . . . 0.0 107.384 173.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -136.0 161.87 37.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -124.46 140.37 53.01 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.88 157.98 35.31 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.14 3.35 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.244 0.475 . . . . 0.0 111.746 164.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 mt -147.29 160.62 38.95 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 126.334 1.854 . . . . 0.0 107.955 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.15 165.4 14.85 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.647 3.565 . . . . 0.0 111.699 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -157.1 125.58 5.68 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.083 0.953 . . . . 0.0 110.517 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 t -82.48 142.2 32.07 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.47 ' H ' ' HB3' ' A' ' 21' ' ' SER . 1.1 pttt -83.75 154.41 23.61 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.742 -0.599 . . . . 0.0 109.739 163.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.3 151.56 94.34 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 157.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.34 150.08 13.35 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.496 2.797 . . . . 0.0 110.506 165.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 t70 75.48 13.17 3.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.66 1.984 . . . . 0.0 112.569 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.9 p -107.11 177.56 4.82 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.808 1.243 . . . . 0.0 108.704 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -92.43 10.21 31.0 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.987 0.915 . . . . 0.0 109.219 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.88 162.27 28.78 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.746 -1.221 . . . . 0.0 109.92 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 pt -125.02 140.66 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 124.852 1.261 . . . . 0.0 107.619 164.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 56.1 p -85.68 160.34 19.59 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -158.35 167.71 28.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.366 0.667 . . . . 0.0 109.369 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 mt -117.43 167.83 10.92 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.574 1.15 . . . . 0.0 108.579 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -60.77 115.01 3.34 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 167.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.8 -16.41 3.74 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 125.754 1.645 . . . . 0.0 112.36 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -76.88 163.4 26.79 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 119.87 1.835 . . . . 0.0 111.968 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.2 mtp -127.85 154.96 44.86 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 128.149 2.58 . . . . 0.0 108.833 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -136.39 160.4 38.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.431 1.092 . . . . 0.0 108.967 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 ' HD3' ' A' ' 4' ' ' ARG . 5.7 pt -122.74 137.95 54.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.9 t -69.76 134.27 30.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.83 -27.28 2.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.402 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.99 162.54 41.13 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 119.431 1.014 . . . . 0.0 110.788 162.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -107.47 137.35 45.67 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.565 1.946 . . . . 0.0 107.443 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.1 mt -129.36 177.01 7.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.511 1.924 . . . . 0.0 107.101 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -130.32 14.44 5.59 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.188 -0.945 . . . . 0.0 113.033 -152.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -127.59 21.29 6.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.078 1.751 . . . . 0.0 112.103 -170.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.09 10.32 56.26 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.355 1.455 . . . . 0.0 113.018 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -125.9 155.34 41.42 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.658 1.583 . . . . 0.0 110.847 -165.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.4 mtm -145.82 145.99 30.99 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.316 1.447 . . . . 0.0 108.8 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -84.01 137.3 33.67 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 122.838 0.455 . . . . 0.0 110.655 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.6 m -142.38 -171.24 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.834 0.854 . . . . 0.0 111.724 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.1 m -128.07 150.76 49.81 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 156.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -109.54 109.32 20.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.127 1.771 . . . . 0.0 109.413 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 44' ' ' LEU . 9.0 mt -56.04 -12.86 1.62 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.784 2.034 . . . . 0.0 113.612 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -64.47 -33.96 77.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.958 1.254 . . . . 0.0 111.514 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.251 5.1 t -155.31 15.07 0.39 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.085 0.954 . . . . 0.0 110.737 -168.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.3 t70 53.05 32.85 13.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.085 2.154 . . . . 0.0 111.795 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.1 159.28 33.81 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.809 -0.557 . . . . 0.0 110.326 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -140.23 147.2 39.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.38 -157.66 25.69 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -101.67 146.82 27.21 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.174 1.39 . . . . 0.0 112.277 -165.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.43 154.05 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.063 1.745 . . . . 0.0 110.288 168.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.99 144.59 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.709 1.604 . . . . 0.0 110.127 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -78.63 -6.33 55.37 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.58 -19.95 65.96 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.608 1.163 . . . . 0.0 113.108 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.9 mt -129.21 15.78 6.16 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.526 1.13 . . . . 0.0 113.819 -160.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.02 169.65 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 119.102 0.864 . . . . 0.0 113.058 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -125.63 148.1 49.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 127.407 2.283 . . . . 0.0 109.216 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -82.93 47.58 1.23 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.263 2.225 . . . . 0.0 112.783 -170.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 122.711 1.243 . . . . 0.0 111.756 -173.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 3' ' ' ARG . 0.5 OUTLIER . . . . . 0 CA--C 1.52 -0.202 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.4 ' HD3' HG22 ' A' ' 29' ' ' ILE . 11.0 mtt85 -158.67 166.96 30.8 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.279 1.831 . . . . 0.0 109.361 -176.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.46 178.46 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.872 1.669 . . . . 0.0 108.823 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 -140.93 142.32 34.4 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 120.449 -1.407 . . . . 0.0 108.44 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.68 137.06 47.55 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 119.069 0.85 . . . . 0.0 110.45 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.85 -4.84 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 118.218 -0.896 . . . . 0.0 112.335 163.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -149.81 148.66 26.0 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 125.18 1.392 . . . . 0.0 108.612 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.26 167.5 19.48 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 124.632 3.554 . . . . 0.0 111.27 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -154.4 171.43 19.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.18 0.992 . . . . 0.0 108.483 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.6 m -118.79 113.55 21.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.922 1.289 . . . . 0.0 108.585 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -59.81 151.6 25.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.187 0.903 . . . . 0.0 110.456 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.47 148.64 97.93 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 154.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.63 163.93 14.29 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.57 2.847 . . . . 0.0 111.134 170.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 47.03 47.27 16.02 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.918 2.087 . . . . 0.0 110.002 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.62 172.99 14.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.503 2.721 . . . . 0.0 107.845 -172.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -82.0 5.0 20.67 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.055 -1.028 . . . . 0.0 112.052 -170.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.31 162.33 14.65 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.363 1.465 . . . . 0.0 110.881 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.444 HD13 ' HB2' ' A' ' 43' ' ' ASN . 2.7 pp -138.37 132.21 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 127.082 2.153 . . . . 0.0 107.181 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.88 151.02 38.99 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.875 -1.14 . . . . 0.0 111.206 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -152.68 154.51 35.43 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.274 -0.891 . . . . 0.0 111.094 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.86 171.37 7.56 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.886 1.274 . . . . 0.0 109.777 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -52.78 134.2 36.76 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 158.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.05 -7.12 81.44 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 117.694 -1.615 . . . . 0.0 114.501 172.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -64.69 159.08 22.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.951 1.876 . . . . 0.0 108.713 166.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.1 ttt -127.66 142.23 51.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.387 1.075 . . . . 0.0 109.884 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -127.6 146.52 50.51 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.493 1.117 . . . . 0.0 111.089 -170.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.4 HG22 ' HD3' ' A' ' 4' ' ' ARG . 8.9 pt -110.01 130.95 62.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.39 124.79 26.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -121.04 -47.65 2.27 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.124 0.97 . . . . 0.0 110.794 176.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -138.87 157.44 46.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 119.006 0.821 . . . . 0.0 111.438 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -130.52 119.51 22.69 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -161.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 mt -119.5 145.53 46.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.885 -171.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -87.07 15.96 5.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.552 1.941 . . . . 0.0 113.335 -165.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -125.83 18.24 7.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.733 1.613 . . . . 0.0 112.533 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.66 16.11 50.17 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.24 0.924 . . . . 0.0 111.931 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -123.34 153.29 40.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.33 1.052 . . . . 0.0 110.154 -166.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.6 mtm -143.89 132.46 22.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -79.68 129.18 34.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.128 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.77 176.05 7.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.761 0.824 . . . . 0.0 111.58 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 m -105.91 138.3 42.34 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 153.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB2' HD13 ' A' ' 20' ' ' ILE . 64.5 t-20 -90.83 114.97 27.51 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 168.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.99 -7.61 23.69 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.9 ttp85 -59.79 -45.16 93.17 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.83 1.195 . . . . 0.0 109.8 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -137.72 -3.46 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 117.843 -1.075 . . . . 0.0 113.039 -168.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 75.53 11.06 3.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.292 1.837 . . . . 0.0 111.989 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.04 149.38 37.08 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.972 0.909 . . . . 0.0 109.379 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -133.52 139.1 46.43 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.885 1.274 . . . . 0.0 108.396 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.42 -170.67 36.47 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.34 146.28 31.64 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.746 1.619 . . . . 0.0 111.592 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -143.66 166.43 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 128.365 2.666 . . . . 0.0 108.468 165.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.45 143.45 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.692 1.197 . . . . 0.0 110.932 -167.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.6 -8.61 56.89 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.351 1.06 . . . . 0.0 113.04 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.03 -27.81 67.23 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.531 1.532 . . . . 0.0 112.232 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.53 14.99 8.21 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -161.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.5 164.1 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.976 0.807 . . . . 0.0 112.611 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -120.36 142.9 48.73 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 127.426 2.29 . . . . 0.0 109.669 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -72.43 92.94 1.49 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.325 1.45 . . . . 0.0 107.725 170.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.449 -0.49 0 CA-C-O 122.274 1.035 . . . . 0.0 111.284 -166.035 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -125.95 160.99 28.52 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.836 0.854 . . . . 0.0 109.1 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.54 160.65 31.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 124.772 1.229 . . . . 0.0 108.32 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -134.28 127.17 31.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.113 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.98 134.73 44.81 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.871 0.76 . . . . 0.0 109.792 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.272 0.2 OUTLIER -115.54 5.02 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.726 0.81 . . . . 0.0 112.501 176.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 mt -148.14 160.73 36.57 Favored Pre-proline 0 N--CA 1.468 0.467 0 C-N-CA 127.716 2.406 . . . . 0.0 106.834 166.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.17 170.61 9.49 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.095 3.197 . . . . 0.0 111.283 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -145.59 172.08 13.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.586 0.755 . . . . 0.0 109.183 173.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.1 m -131.54 112.17 12.4 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.019 1.328 . . . . 0.0 108.202 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -66.71 158.69 29.52 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.272 -174.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.06 123.54 86.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 161.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.68 153.96 74.64 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.141 1.227 . . . . 0.0 108.92 166.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 t0 73.5 22.63 2.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.047 1.339 . . . . 0.0 111.118 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -130.04 169.99 14.57 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.095 1.358 . . . . 0.0 109.38 168.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -78.64 9.63 3.92 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.247 1.419 . . . . 0.0 110.309 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -74.72 167.69 21.31 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.138 -1.601 . . . . 0.0 110.541 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.3 pt -138.14 139.71 41.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 126.746 2.018 . . . . 0.0 107.446 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.01 137.26 47.09 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.87 -1.144 . . . . 0.0 108.799 172.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -135.34 165.1 26.23 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.807 0.843 . . . . 0.0 111.664 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -111.63 165.13 12.29 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.18 1.392 . . . . 0.0 109.924 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -59.11 128.66 38.27 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 161.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.89 0.42 62.13 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.204 -1.331 . . . . 0.0 113.434 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.24 161.47 29.9 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.847 1.824 . . . . 0.0 109.948 167.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.8 ttp -146.9 144.13 29.03 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.24 1.016 . . . . 0.0 110.455 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -140.53 155.71 46.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.954 -162.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -104.05 133.1 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.181 1.392 . . . . 0.0 108.328 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.01 129.32 30.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -119.12 -34.06 3.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.388 168.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -145.95 162.19 38.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 119.578 1.081 . . . . 0.0 110.066 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -123.75 112.18 17.03 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.584 1.953 . . . . 0.0 105.915 -170.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.73 -172.72 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.725 1.61 . . . . 0.0 108.606 -169.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -134.4 38.84 3.09 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.301 1.048 . . . . 0.0 112.356 -168.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -152.74 47.59 0.72 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.894 166.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.96 3.58 44.44 Favored Glycine 0 CA--C 1.538 1.481 0 O-C-N 121.031 -1.043 . . . . 0.0 115.252 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -97.32 161.41 13.81 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.624 1.169 . . . . 0.0 110.45 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.2 mtm -138.48 144.41 40.03 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.609 1.164 . . . . 0.0 108.695 165.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.591 ' CE3' HD21 ' A' ' 51' ' ' LEU . 24.7 t-105 -79.01 131.66 36.37 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.745 0.818 . . . . 0.0 109.322 166.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.44 -173.05 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.758 0.79 . . . . 0.0 112.462 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 m -136.15 131.68 35.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 161.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -86.22 108.98 18.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.732 1.213 . . . . 0.0 108.716 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.9 mt -75.23 -0.29 18.96 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.556 -1.212 . . . . 0.0 112.128 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -63.38 -33.01 74.6 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 120.8 1.636 . . . . 0.0 110.601 168.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 p -143.84 0.25 1.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.167 -160.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.25 0.3 OUTLIER 70.37 0.88 3.37 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.316 2.646 . . . . 0.0 114.195 -166.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -66.88 104.5 1.37 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.026 0.93 . . . . 0.0 111.749 -168.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -79.34 156.55 27.95 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.933 -0.479 . . . . 0.0 109.839 166.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.72 -154.7 25.7 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.591 HD21 ' CE3' ' A' ' 40' ' ' TRP . 1.8 mm? -103.03 144.63 31.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.633 1.173 . . . . 0.0 109.903 -167.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -140.66 151.43 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.397 1.879 . . . . 0.0 109.66 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -99.98 144.21 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.95 1.3 . . . . 0.0 109.086 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -81.44 -1.33 45.37 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.26 -23.55 62.47 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.188 0.995 . . . . 0.0 112.982 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.97 13.64 10.61 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -158.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.81 158.69 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.464 1.029 . . . . 0.0 112.863 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -108.1 157.37 18.33 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.956 1.302 . . . . 0.0 110.521 163.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -76.08 68.89 2.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.978 1.311 . . . . 0.0 110.186 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 C--N 1.331 -0.238 0 CA-C-O 122.73 1.252 . . . . 0.0 111.16 -176.536 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.857 0 CA-C-O 121.739 0.78 . . . . 0.0 109.912 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.412 ' HD2' HG22 ' A' ' 29' ' ' ILE . 20.6 mtm-85 -119.91 149.42 42.13 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.842 0.857 . . . . 0.0 110.083 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' A' ' 60' ' ' VAL . 12.6 m -133.07 164.29 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.466 1.106 . . . . 0.0 110.994 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.462 ' HB2' HG11 ' A' ' 60' ' ' VAL . 42.6 ttm180 -135.88 130.48 33.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.368 1.067 . . . . 0.0 109.446 -170.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.8 135.71 51.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 174.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.84 2.76 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.986 0.914 . . . . 0.0 111.005 169.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.3 mt -141.08 153.39 66.93 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 124.818 1.247 . . . . 0.0 108.522 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.18 158.15 17.62 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.503 2.802 . . . . 0.0 110.538 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -149.09 120.54 7.93 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.679 -0.638 . . . . 0.0 111.399 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.6 m -78.03 113.13 15.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.518 0.727 . . . . 0.0 109.264 167.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -65.55 156.74 31.7 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.234 168.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.17 146.21 86.76 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 160.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.23 172.23 12.48 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.995 3.13 . . . . 0.0 111.403 165.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t70 64.43 5.87 2.83 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.468 1.507 . . . . 0.0 113.559 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.2 p -119.27 176.11 5.48 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 119.744 -1.848 . . . . 0.0 110.173 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.33 10.46 4.54 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.031 1.332 . . . . 0.0 110.065 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.33 160.77 27.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.645 1.578 . . . . 0.0 110.669 -170.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.8 pt -131.65 132.36 62.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.9 p -75.59 162.21 28.47 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -157.48 166.28 33.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.929 0.892 . . . . 0.0 109.211 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.23 162.5 15.93 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.736 0.814 . . . . 0.0 109.139 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -57.17 125.51 23.05 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 166.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.21 -6.74 58.16 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.044 -1.975 . . . . 0.0 113.388 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.99 160.28 23.96 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.702 2.251 . . . . 0.0 110.19 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.2 mtp -134.99 153.48 52.07 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.805 0.812 . . . . 0.0 111.557 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -146.26 165.55 28.9 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.273 -1.33 . . . . 0.0 111.755 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.412 HG22 ' HD2' ' A' ' 4' ' ' ARG . 4.4 pt -122.87 128.35 75.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.773 1.629 . . . . 0.0 107.933 -170.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.36 131.39 32.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 120.73 1.605 . . . . 0.0 108.637 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -132.75 -30.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -148.99 165.84 30.43 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.172 0.896 . . . . 0.0 109.253 166.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -133.92 124.28 26.13 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 127.987 2.515 . . . . 0.0 105.063 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.3 -178.29 3.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.943 1.297 . . . . 0.0 110.691 -171.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -132.37 79.49 1.86 Allowed 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 125.488 1.515 . . . . 0.0 107.761 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -168.29 -0.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.505 0.722 . . . . 0.0 112.742 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.34 25.9 38.16 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.236 0.922 . . . . 0.0 112.031 -166.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -136.06 160.02 39.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.178 1.791 . . . . 0.0 108.053 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 35.8 mtm -147.79 158.31 43.96 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -95.25 134.84 37.56 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.837 1.199 . . . . 0.0 111.053 170.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 m -142.53 175.1 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.247 1.819 . . . . 0.0 108.971 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.5 m -114.47 135.54 54.0 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 162.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -82.45 120.13 25.07 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.032 0.933 . . . . 0.0 109.261 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.31 -5.48 3.51 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.283 1.033 . . . . 0.0 113.047 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -63.76 -37.59 87.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.546 -1.216 . . . . 0.0 111.138 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 t -164.0 13.93 0.05 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.986 1.266 . . . . 0.0 113.742 -171.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 73.81 5.01 4.79 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.899 1.679 . . . . 0.0 113.463 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -54.5 116.86 2.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.101 1.76 . . . . 0.0 109.244 167.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.76 165.49 11.35 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 166.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.47 -146.62 13.86 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.68 142.02 45.78 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.687 1.195 . . . . 0.0 110.716 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.5 147.9 23.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 129.724 3.209 . . . . 0.0 107.063 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -88.78 144.77 8.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -68.39 -12.84 61.74 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -69.97 -16.19 63.15 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.152 1.381 . . . . 0.0 114.109 -171.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.5 mt -125.51 6.52 7.6 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.378 1.071 . . . . 0.0 112.363 -162.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.8 m -120.03 156.9 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.634 1.174 . . . . 0.0 110.536 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -116.45 153.35 32.27 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.846 1.258 . . . . 0.0 110.257 173.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.6 63.95 2.81 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.043 172.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.462 HG11 ' HB2' ' A' ' 6' ' ' ARG . 6.5 p . . . . . 0 C--N 1.319 -0.74 0 O-C-N 120.888 -1.133 . . . . 0.0 111.609 174.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 . . . . . 0 C--O 1.238 0.464 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -134.28 161.53 34.68 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 125.063 1.345 . . . . 0.0 108.872 159.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.3 164.86 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 162.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -128.73 140.9 51.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 174.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.87 141.82 51.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 120.004 1.274 . . . . 0.0 109.714 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.97 2.5 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.039 0.936 . . . . 0.0 111.729 170.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 mt -143.4 157.04 60.29 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 126.085 1.754 . . . . 0.0 107.353 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -88.38 167.47 6.38 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.695 2.93 . . . . 0.0 110.795 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -156.74 167.14 31.35 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.934 0.494 . . . . 0.0 111.13 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 m -124.43 115.5 21.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.18 2.192 . . . . 0.0 107.278 171.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -61.15 157.34 16.19 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.888 172.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.02 135.87 79.95 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 162.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.493 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 95.1 Cg_endo -70.12 163.9 36.88 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.146 1.898 . . . . 0.0 109.197 171.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.4 t70 63.2 18.27 10.84 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.601 0.715 . . . . 0.0 112.135 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.3 p -130.9 169.41 15.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.675 1.59 . . . . 0.0 108.699 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.42 3.81 38.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.458 1.503 . . . . 0.0 111.428 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -69.97 167.02 18.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.28 1.832 . . . . 0.0 110.184 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.4 pt -140.14 129.31 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 120.885 -1.134 . . . . 0.0 110.057 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -63.82 160.73 16.76 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.785 0.72 . . . . 0.0 110.105 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -161.44 173.53 14.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.276 0.56 . . . . 0.0 110.588 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mt -125.28 159.71 31.03 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.102 1.361 . . . . 0.0 109.773 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -58.29 120.47 8.76 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.29 2.24 59.11 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 117.678 -1.623 . . . . 0.0 113.117 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.84 158.42 35.53 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.893 2.346 . . . . 0.0 108.034 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.4 ttt -120.04 134.24 55.31 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 126.057 1.743 . . . . 0.0 110.986 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CE1' HG21 ' A' ' 52' ' ' ILE . 93.3 m-85 -111.66 165.41 12.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.554 1.168 . . . . 0.0 109.045 177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 pt -118.92 138.67 48.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 163.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -73.99 141.43 16.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 170.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.29 -21.07 1.61 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 112.596 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -150.28 160.54 43.63 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.211 1.004 . . . . 0.0 109.87 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -120.55 118.15 29.45 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 127.32 2.248 . . . . 0.0 105.451 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mt -109.82 -169.05 1.4 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.846 1.258 . . . . 0.0 107.876 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.29 14.13 3.51 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -164.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -130.83 34.23 4.12 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.787 1.635 . . . . 0.0 110.54 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.41 13.64 81.49 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.05 1.31 . . . . 0.0 113.709 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -112.65 156.27 23.02 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.119 1.368 . . . . 0.0 110.272 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.5 mtm -144.83 145.93 31.86 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.707 1.203 . . . . 0.0 108.399 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -78.73 141.62 37.72 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 164.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.49 -175.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 122.436 1.112 . . . . 0.0 111.15 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 m -135.51 125.22 25.39 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 160.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -77.05 102.74 6.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.9 -14.29 21.32 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -61.43 -19.15 61.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 117.181 -1.39 . . . . 0.0 112.679 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -164.42 11.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.799 1.181 . . . . 0.0 112.945 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.78 20.44 11.41 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.285 1.402 . . . . 0.0 112.509 -172.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.17 104.58 0.93 Allowed 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -93.81 156.25 16.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.87 -166.53 31.95 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.08 143.55 27.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.495 1.118 . . . . 0.0 109.861 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.406 HG21 ' CE1' ' A' ' 28' ' ' PHE . 1.9 pp -134.38 151.1 31.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.12 1.368 . . . . 0.0 108.702 169.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.54 137.82 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -64.11 -18.79 64.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.317 1.047 . . . . 0.0 112.679 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.48 -18.27 63.61 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.551 1.14 . . . . 0.0 113.341 -166.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.6 mt -124.07 10.42 8.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.547 1.539 . . . . 0.0 111.652 -164.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.4 m -119.65 171.77 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.565 1.146 . . . . 0.0 110.864 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -130.39 152.47 49.75 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.941 2.496 . . . . 0.0 109.359 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -70.69 73.29 0.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.583 1.153 . . . . 0.0 109.901 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 C--N 1.329 -0.29 0 O-C-N 120.206 -1.558 . . . . 0.0 109.14 172.209 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.276 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HD3' HG22 ' A' ' 29' ' ' ILE . 74.5 mtt180 -132.27 154.68 49.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.343 -0.848 . . . . 0.0 109.719 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.89 166.54 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.433 0.693 . . . . 0.0 109.147 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -138.01 136.26 36.72 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.857 -1.152 . . . . 0.0 110.402 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.45 120.53 16.23 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.266 1.027 . . . . 0.0 110.06 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.6 -4.02 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.137 172.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.676 HD11 HD22 ' A' ' 56' ' ' LEU 0.28 2.1 pp -162.57 152.75 13.84 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.398 1.479 . . . . 0.0 108.519 -171.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.67 160.86 21.89 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.684 2.922 . . . . 0.0 112.336 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -143.22 163.01 34.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.371 1.868 . . . . 0.0 109.2 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.8 m -128.77 105.82 8.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.542 1.137 . . . . 0.0 108.439 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.42 157.02 38.42 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.991 0.517 . . . . 0.0 110.571 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.3 t -87.82 141.35 31.62 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -173.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -70.68 141.96 42.74 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 O-C-N 118.418 -1.412 . . . . 0.0 109.212 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.9 t70 75.45 33.93 0.64 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.652 1.981 . . . . 0.0 112.753 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.6 p -132.47 167.19 20.41 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.046 -1.034 . . . . 0.0 111.594 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.5 20.39 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 128.941 2.897 . . . . 0.0 111.814 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -110.04 169.3 8.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.27 1.428 . . . . 0.0 110.678 -160.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -140.15 150.55 21.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.243 1.417 . . . . 0.0 109.063 174.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 p -95.77 167.24 11.39 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -161.74 156.59 23.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.78 174.07 6.03 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.417 1.103 . . . . 0.0 108.905 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -57.98 123.54 16.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 168.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.02 1.54 57.13 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-O 118.359 -1.245 . . . . 0.0 114.486 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.39 162.66 22.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.38 1.59 . . . . 0.0 111.249 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.5 ttt -137.14 145.58 43.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.135 1.374 . . . . 0.0 108.822 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.09 175.38 9.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.432 1.093 . . . . 0.0 109.937 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 ' HD3' ' A' ' 4' ' ' ARG . 10.8 pt -126.13 138.69 53.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.558 1.543 . . . . 0.0 106.877 176.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.92 136.13 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 118.684 0.675 . . . . 0.0 109.763 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -139.19 -18.36 1.01 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -155.66 164.88 38.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.363 1.438 . . . . 0.0 108.912 159.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.89 114.07 11.45 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.323 1.849 . . . . 0.0 106.384 -167.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -114.08 154.03 28.43 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.063 0.945 . . . . 0.0 111.384 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -92.91 48.09 1.32 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.575 1.15 . . . . 0.0 110.927 -164.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -161.28 34.78 0.14 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.275 1.03 . . . . 0.0 110.443 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.83 -2.82 58.54 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.441 1.019 . . . . 0.0 114.223 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -87.54 153.6 21.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.516 1.158 . . . . 0.0 110.886 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.1 mtm -143.93 134.61 25.0 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -76.75 138.99 40.26 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.31 -176.35 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 122.332 1.063 . . . . 0.0 111.554 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -127.8 126.51 41.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 155.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.09 116.14 19.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.622 1.969 . . . . 0.0 108.853 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mt -87.28 13.86 8.93 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.542 -0.724 . . . . 0.0 112.391 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.9 ttp85 -79.97 -16.54 55.01 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.328 -1.483 . . . . 0.0 111.058 170.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -163.77 7.35 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.539 0.609 . . . . 0.0 112.233 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 63.23 23.83 14.04 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.055 1.742 . . . . 0.0 112.682 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.8 108.33 2.49 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.658 0.783 . . . . 0.0 109.361 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -87.87 149.38 24.14 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.655 -0.653 . . . . 0.0 110.147 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.71 -171.93 35.49 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.311 1.434 . . . . 0.0 109.965 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.1 mt -89.93 138.83 31.17 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.52 1.128 . . . . 0.0 112.303 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -134.23 162.87 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 127.194 2.197 . . . . 0.0 108.217 166.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 p -109.59 146.19 15.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 123.89 0.876 . . . . 0.0 109.163 -175.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -68.22 -17.33 64.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.278 1.431 . . . . 0.0 112.255 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.22 -29.23 69.7 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.917 0.887 . . . . 0.0 111.705 -177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.676 HD22 HD11 ' A' ' 9' ' ' LEU . 50.2 mt -115.97 5.22 13.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.58 1.152 . . . . 0.0 111.03 -161.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.36 165.84 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.87 1.268 . . . . 0.0 110.882 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -120.66 152.69 37.88 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 125.782 1.633 . . . . 0.0 108.681 172.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -78.7 69.93 4.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.652 1.181 . . . . 0.0 109.573 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 121.586 0.708 . . . . 0.0 109.429 173.199 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.517 ' HD3' HG22 ' A' ' 29' ' ' ILE . 17.5 mtt180 -134.19 166.91 21.68 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.01 154.97 37.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.416 1.087 . . . . 0.0 108.688 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -119.12 133.55 55.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . . . -84.7 154.63 22.35 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.505 1.048 . . . . 0.0 109.724 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.21 11.56 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.196 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.59 161.7 32.46 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.455 2.302 . . . . 0.0 107.859 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -86.46 162.27 9.6 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.927 3.085 . . . . 0.0 111.646 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -159.13 132.05 6.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.776 1.231 . . . . 0.0 110.604 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 t -97.07 137.79 35.6 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 172.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -89.16 139.08 30.84 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.342 -177.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.46 134.59 94.51 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 120.242 1.383 . . . . 0.0 108.267 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 60.3 Cg_endo -67.58 162.12 40.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.126 1.884 . . . . 0.0 109.773 168.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.48 -11.44 1.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.04 2.136 . . . . 0.0 113.129 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -118.6 169.0 10.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.564 1.146 . . . . 0.0 111.057 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -92.15 21.31 5.19 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.71 1.604 . . . . 0.0 111.358 -167.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -68.35 163.83 22.21 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.492 -1.38 . . . . 0.0 109.749 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 pt -130.74 138.67 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 120.869 -1.144 . . . . 0.0 111.01 169.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.5 m -73.56 156.09 38.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -147.29 165.21 30.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 122.303 1.049 . . . . 0.0 110.635 164.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.19 166.11 11.35 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -64.88 125.97 26.5 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.0 47.93 1.21 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.007 1.289 . . . . 0.0 113.26 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.7 167.14 23.84 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.206 1.802 . . . . 0.0 108.998 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.3 mtp -138.03 149.75 46.33 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.103 0.961 . . . . 0.0 111.032 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -136.33 159.94 40.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.826 1.25 . . . . 0.0 109.701 -173.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.517 HG22 ' HD3' ' A' ' 4' ' ' ARG . 15.9 pt -110.52 138.4 38.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.27 129.12 33.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -121.17 -32.07 3.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.107 174.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -152.15 162.44 41.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.066 0.848 . . . . 0.0 111.043 167.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -108.54 132.97 53.31 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.632 1.973 . . . . 0.0 106.813 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.3 mt -125.82 -168.53 1.86 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.106 1.762 . . . . 0.0 107.364 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.68 14.04 3.42 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.583 1.083 . . . . 0.0 113.831 -158.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -120.25 16.13 12.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.363 1.465 . . . . 0.0 111.55 -168.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.84 13.59 69.22 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.669 -1.27 . . . . 0.0 111.862 -168.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -125.86 150.27 48.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.685 1.594 . . . . 0.0 109.706 -169.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 56.8 mtm -142.96 144.39 32.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.827 1.251 . . . . 0.0 108.91 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -81.62 135.6 35.55 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.999 0.52 . . . . 0.0 110.302 170.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.39 175.24 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.416 1.086 . . . . 0.0 110.268 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.3 m -112.38 134.86 53.68 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 154.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -76.54 165.08 25.3 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -88.62 -35.11 17.03 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 121.927 2.149 . . . . 0.0 113.213 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -51.89 -29.22 18.98 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -165.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.251 9.5 t -152.96 18.26 0.58 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.224 1.81 . . . . 0.0 112.593 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 52.36 26.89 4.39 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.222 1.809 . . . . 0.0 112.5 -172.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -66.1 148.3 52.02 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.643 -1.286 . . . . 0.0 111.234 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -137.87 144.88 41.59 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.061 0.945 . . . . 0.0 108.457 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.56 -157.51 27.32 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.7 147.01 27.75 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.895 0.878 . . . . 0.0 112.437 -165.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.1 pt -136.01 147.97 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 126.674 1.99 . . . . 0.0 110.909 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.92 138.01 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.025 1.33 . . . . 0.0 109.732 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.75 -0.78 22.13 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.661 1.184 . . . . 0.0 112.849 -172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -24.12 65.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.793 1.637 . . . . 0.0 112.86 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.4 mt -127.94 13.86 6.83 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.36 1.064 . . . . 0.0 112.665 -158.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.4 m -122.66 170.79 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 126.318 1.847 . . . . 0.0 111.489 -176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -132.23 155.68 47.83 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 127.772 2.429 . . . . 0.0 109.748 172.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -69.8 78.41 0.45 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.72 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.24 0.599 0 O-C-N 120.911 -1.118 . . . . 0.0 108.81 162.93 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.619 ' NH2' HG13 ' A' ' 5' ' ' VAL 0.257 0.0 OUTLIER . . . . . 0 C--O 1.234 0.247 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -117.42 173.71 6.55 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 119.553 -1.967 . . . . 0.0 109.876 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.619 HG13 ' NH2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -126.1 160.18 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 120.512 -1.367 . . . . 0.0 110.531 171.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.72 118.51 28.24 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 125.784 1.633 . . . . 0.0 108.974 -170.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.02 127.11 31.96 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.467 0.707 . . . . 0.0 109.433 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.96 -0.16 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.371 0.669 . . . . 0.0 111.762 172.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.4 161.39 29.42 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 125.817 1.647 . . . . 0.0 109.011 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -87.23 160.47 8.43 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 124.243 3.296 . . . . 0.0 111.25 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -151.74 166.2 32.07 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.633 1.173 . . . . 0.0 110.361 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 t -125.74 136.08 52.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -172.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -70.01 150.54 46.54 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 118.806 -1.157 . . . . 0.0 108.776 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.2 t -75.27 137.53 71.83 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.28 146.38 69.18 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 N-CA-C 108.446 -1.405 . . . . 0.0 108.446 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 t70 75.62 4.94 4.01 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.76 2.024 . . . . 0.0 113.408 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.6 p -108.91 -177.17 3.24 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 120.339 -1.475 . . . . 0.0 112.187 -175.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -83.93 -17.47 40.59 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.102 1.361 . . . . 0.0 109.843 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 165.18 18.5 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.369 1.468 . . . . 0.0 111.954 -164.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 pt -127.43 134.15 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.806 1.242 . . . . 0.0 109.68 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.33 160.76 12.63 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.735 0.814 . . . . 0.0 108.948 173.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -157.43 173.33 17.07 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.935 0.874 . . . . 0.0 113.117 170.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.4 mt -127.96 160.98 30.21 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.111 1.364 . . . . 0.0 109.097 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -62.1 141.47 58.11 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.92 -4.78 81.82 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.681 1.134 . . . . 0.0 114.055 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.3 168.51 19.02 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.007 1.404 . . . . 0.0 109.017 171.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 38.1 mtp -135.51 150.66 49.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.89 0.876 . . . . 0.0 109.525 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -136.06 159.06 42.86 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.91 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 29' ' ' ILE . 4.7 pt -112.16 125.19 69.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -175.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 3' ' ' ARG . 1.6 p -63.71 112.45 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.21 -38.32 5.79 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.745 0.818 . . . . 0.0 110.047 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -148.08 172.34 14.42 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -133.07 133.52 43.1 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -175.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.405 ' CD1' HD21 ' A' ' 51' ' ' LEU . 38.1 mt -120.33 -168.82 1.69 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.615 1.166 . . . . 0.0 109.056 -176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -136.31 57.78 1.76 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.452 1.101 . . . . 0.0 109.094 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -154.06 22.43 0.5 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.214 171.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.98 23.23 69.61 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.145 -1.597 . . . . 0.0 112.296 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -130.34 148.47 52.16 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.759 2.024 . . . . 0.0 108.534 -170.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.0 mtm -144.77 132.63 21.26 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -72.13 134.62 45.85 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.88 178.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 123.349 0.659 . . . . 0.0 111.793 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 5.2 m -115.03 143.59 44.94 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 154.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -86.47 119.6 26.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.384 1.073 . . . . 0.0 110.105 168.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.98 1.31 2.77 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.478 1.111 . . . . 0.0 113.465 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -66.3 -46.45 76.92 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.219 -1.551 . . . . 0.0 110.423 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -146.13 -3.43 0.66 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.254 1.022 . . . . 0.0 112.551 -157.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.4 t70 68.21 11.54 8.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.172 1.789 . . . . 0.0 112.907 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -61.14 118.34 6.69 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.111 0.964 . . . . 0.0 108.744 167.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 9.5 mp0 -81.84 168.67 17.73 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.385 0.612 . . . . 0.0 110.694 166.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.82 -165.45 30.16 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD21 ' CD1' ' A' ' 34' ' ' LEU . 9.6 mt -99.4 143.83 29.2 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.701 0.8 . . . . 0.0 110.825 -171.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.19 151.34 33.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 125.446 1.498 . . . . 0.0 109.035 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 p -88.58 135.84 24.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.952 1.701 . . . . 0.0 107.934 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.34 -10.29 59.43 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -56.65 -18.4 12.07 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.718 2.407 . . . . 0.0 113.717 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -131.11 13.48 5.17 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.024 1.33 . . . . 0.0 113.296 -164.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.75 153.91 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.237 1.015 . . . . 0.0 112.395 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -117.69 148.29 42.13 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.848 1.659 . . . . 0.0 111.076 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.97 100.86 2.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 128.97 2.908 . . . . 0.0 110.139 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 121.873 0.844 . . . . 0.0 111.543 -174.751 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.238 0.484 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -119.8 159.51 24.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.631 1.572 . . . . 0.0 108.469 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -137.9 164.83 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 167.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.2 tpp85 -128.08 129.91 47.38 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.458 1.503 . . . . 0.0 107.349 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.28 125.06 25.96 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 120.463 1.483 . . . . 0.0 108.944 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.28 0.2 OUTLIER -113.36 4.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.423 170.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.8 mt -146.28 157.66 48.9 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.833 1.653 . . . . 0.0 109.176 165.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.31 166.77 15.99 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.82 3.68 . . . . 0.0 111.584 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -153.0 163.58 39.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.605 1.162 . . . . 0.0 109.218 173.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -124.31 120.66 32.83 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.528 1.531 . . . . 0.0 109.049 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -61.33 149.14 39.06 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 124.536 1.147 . . . . 0.0 111.22 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.3 135.45 86.73 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -62.55 153.44 71.49 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.1 2.533 . . . . 0.0 110.221 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.36 38.91 22.78 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.078 1.351 . . . . 0.0 111.842 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 p -138.45 166.03 25.31 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.031 0.932 . . . . 0.0 111.84 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.13 -13.55 48.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.867 2.867 . . . . 0.0 113.055 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -63.49 170.11 3.36 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.181 1.793 . . . . 0.0 113.171 -171.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 pt -131.05 136.71 57.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.743 1.217 . . . . 0.0 110.288 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -72.99 149.71 43.06 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.271 1.428 . . . . 0.0 110.9 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -155.11 158.66 39.36 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.689 -1.257 . . . . 0.0 112.806 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.66 170.32 8.0 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.904 0.859 . . . . 0.0 109.458 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -56.98 134.97 56.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 168.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.42 -11.13 56.69 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 118.872 -0.96 . . . . 0.0 114.148 171.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.26 167.74 19.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.673 1.236 . . . . 0.0 108.897 160.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 18.7 ptm -144.67 168.15 20.85 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 124.083 0.953 . . . . 0.0 109.317 170.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -138.42 163.75 31.11 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.608 1.163 . . . . 0.0 109.614 -164.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.5 pt -127.4 130.94 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 125.283 1.433 . . . . 0.0 107.393 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.94 127.8 29.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -127.55 -15.18 5.09 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.715 0.806 . . . . 0.0 113.106 172.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -150.18 166.42 29.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 156.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -121.53 124.68 44.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.51 -167.49 1.26 Allowed 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -138.48 68.58 1.39 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.398 1.479 . . . . 0.0 107.594 -170.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -168.16 15.8 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.395 1.478 . . . . 0.0 112.312 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.96 37.89 88.28 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.13 1.347 . . . . 0.0 111.848 -169.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -137.72 149.17 46.27 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.588 1.955 . . . . 0.0 107.259 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.2 mtm -134.98 142.99 46.6 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.601 1.161 . . . . 0.0 108.689 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -78.1 135.66 37.74 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 165.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.57 -173.34 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 122.361 1.077 . . . . 0.0 110.804 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 m -131.09 147.31 52.6 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 157.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -97.55 132.01 43.62 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 mt -68.01 -10.1 50.99 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.47 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -65.48 -43.13 91.18 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.37 1.441 . . . . 0.0 112.11 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 p -143.7 9.56 1.56 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.405 1.082 . . . . 0.0 111.738 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 t70 58.31 32.67 22.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.002 0.921 . . . . 0.0 111.429 -167.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -72.29 140.8 48.76 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.913 -1.117 . . . . 0.0 109.417 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -126.45 151.86 47.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 146.62 -155.92 26.76 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.6 mt -108.81 141.88 40.18 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.335 1.054 . . . . 0.0 110.54 -164.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.8 150.75 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.791 1.637 . . . . 0.0 109.292 171.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.33 146.59 5.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 125.901 1.68 . . . . 0.0 109.47 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -87.72 10.71 17.36 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.84 -24.45 60.89 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.564 1.146 . . . . 0.0 113.822 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -125.46 16.28 8.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -156.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.93 170.52 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.013 0.925 . . . . 0.0 112.353 -168.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.86 151.94 41.23 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.133 -0.979 . . . . 0.0 109.827 160.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.94 57.58 2.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 128.691 2.797 . . . . 0.0 111.3 -172.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 CA--C 1.537 0.465 0 O-C-N 120.525 -1.359 . . . . 0.0 111.769 -176.477 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.419 ' HB3' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.455 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.28 150.23 51.91 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.464 1.506 . . . . 0.0 108.34 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.74 164.25 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 120.071 1.305 . . . . 0.0 108.82 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -112.17 141.53 45.74 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.533 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -92.52 139.49 30.52 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 119.612 1.097 . . . . 0.0 111.016 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.68 12.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.159 0.984 . . . . 0.0 112.507 -172.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.8 158.61 33.96 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.198 1.399 . . . . 0.0 108.548 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -88.54 163.36 6.56 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.541 3.494 . . . . 0.0 111.635 171.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -158.67 141.29 14.33 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.836 1.254 . . . . 0.0 110.207 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.9 m -103.74 118.12 35.97 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.923 1.289 . . . . 0.0 109.959 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -78.63 160.42 27.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.868 0.867 . . . . 0.0 111.937 175.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.4 t -89.39 130.46 43.66 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 125.698 1.599 . . . . 0.0 108.235 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 8.3 Cg_endo -64.84 159.2 46.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.716 1.611 . . . . 0.0 112.854 173.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.251 2.9 t70 69.61 27.71 4.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.675 1.99 . . . . 0.0 112.306 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.0 p -131.4 -178.78 5.0 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.461 1.105 . . . . 0.0 110.921 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.74 8.65 36.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.313 2.645 . . . . 0.0 109.465 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -84.45 175.59 9.23 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.605 -1.309 . . . . 0.0 109.174 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.9 pt -148.64 144.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.2 2.2 . . . . 0.0 107.676 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 77.5 p -102.23 169.15 8.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 121.892 2.133 . . . . 0.0 111.205 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.533 ' CE2' ' HB1' ' A' ' 7' ' ' ALA . 9.4 p90 -170.18 -171.23 1.09 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.12 0.486 . . . . 0.0 112.234 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 mt -128.44 153.22 47.34 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.888 1.675 . . . . 0.0 109.471 -175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -52.31 127.31 21.74 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.522 -0.736 . . . . 0.0 109.079 168.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.72 -10.49 32.48 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 124.725 1.155 . . . . 0.0 114.211 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.38 158.49 35.69 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.363 1.581 . . . . 0.0 110.197 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.5 ttt -114.49 148.94 37.1 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.471 1.108 . . . . 0.0 108.286 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -125.85 162.66 24.64 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.289 1.036 . . . . 0.0 109.992 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.37 127.49 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.357 1.463 . . . . 0.0 108.99 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 3' ' ' ARG . 68.5 t -68.78 101.22 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 119.362 0.983 . . . . 0.0 109.354 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -95.3 -34.49 12.16 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.199 -0.938 . . . . 0.0 111.108 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -149.3 175.05 11.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.618 1.167 . . . . 0.0 109.021 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -138.93 127.32 22.91 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.851 2.46 . . . . 0.0 104.96 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.1 -163.01 0.85 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.293 1.437 . . . . 0.0 109.508 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -134.46 44.11 2.71 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.296 -1.502 . . . . 0.0 113.282 -168.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.91 1.48 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.888 1.275 . . . . 0.0 112.074 -157.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.55 5.0 90.26 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.1 1.333 . . . . 0.0 113.263 -167.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.596 ' CZ2' HG13 ' A' ' 53' ' ' VAL . 84.7 m95 -112.26 149.55 32.17 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.962 2.105 . . . . 0.0 110.861 -175.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.7 mtm -149.12 143.65 26.13 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.764 -1.21 . . . . 0.0 110.084 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -86.7 136.66 32.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.099 0.409 . . . . 0.0 111.016 174.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 m -147.7 -167.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.835 0.854 . . . . 0.0 111.413 -172.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.3 m -140.05 150.99 45.04 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 159.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.71 107.3 18.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.143 2.177 . . . . 0.0 108.075 -173.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.1 mt -68.7 1.18 3.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.35 -27.13 63.15 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.311 -1.493 . . . . 0.0 113.165 169.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -167.39 13.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -165.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 t0 60.75 32.8 20.24 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 123.509 1.623 . . . . 0.0 111.52 -174.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -74.88 99.56 3.83 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 120.797 -1.189 . . . . 0.0 108.366 172.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -81.99 139.53 34.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.57 1.548 . . . . 0.0 109.551 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.99 -169.17 40.13 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.417 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.9 mt -89.95 139.62 30.42 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.916 2.086 . . . . 0.0 112.997 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.31 158.52 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.147 1.779 . . . . 0.0 111.177 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.596 HG13 ' CZ2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -89.96 152.86 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 C-N-CA 124.126 0.97 . . . . 0.0 111.646 164.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.53 -22.89 67.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.285 164.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.57 ' H ' ' HB ' ' A' ' 53' ' ' VAL . 23.3 t70 -62.57 -17.01 59.16 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 122.937 1.351 . . . . 0.0 112.48 -164.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.9 mt -124.83 6.04 8.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.567 1.547 . . . . 0.0 110.885 -160.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -124.94 159.14 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.77 1.228 . . . . 0.0 109.476 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -117.83 153.59 33.24 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.976 1.311 . . . . 0.0 108.28 173.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.307 0.0 OUTLIER -80.51 118.39 22.07 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.694 1.235 . . . . 0.0 108.723 171.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.9 p . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 126.816 2.047 . . . . 0.0 106.344 171.605 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -141.77 141.17 33.2 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.366 1.867 . . . . 0.0 107.733 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 59' ' ' GLU . 1.6 m -125.73 160.27 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.146 0.978 . . . . 0.0 108.487 167.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -115.57 129.68 56.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.62 131.44 41.68 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.004 0.82 . . . . 0.0 108.794 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.86 4.29 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.291 0.636 . . . . 0.0 111.43 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 mt -146.72 154.29 47.7 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.058 1.743 . . . . 0.0 107.893 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.86 169.02 20.1 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.693 3.595 . . . . 0.0 111.792 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -154.23 166.36 33.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.586 0.708 . . . . 0.0 112.884 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.4 m -116.6 102.02 9.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.516 2.326 . . . . 0.0 109.916 -170.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -57.26 143.46 39.34 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 177.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.02 135.49 82.67 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 166.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.72 151.27 79.14 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.704 2.269 . . . . 0.0 109.849 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.0 t70 61.25 30.27 19.11 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.81 0.844 . . . . 0.0 111.573 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -128.35 170.92 12.53 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.92 4.05 18.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.373 0.669 . . . . 0.0 109.359 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.41 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 40.2 mt-10 -67.04 161.95 23.25 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.733 1.213 . . . . 0.0 110.432 173.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.489 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 18.9 pt -141.96 148.26 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.182 1.393 . . . . 0.0 107.852 172.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.13 145.15 51.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.29 164.86 29.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.447 0.642 . . . . 0.0 110.859 170.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.46 163.33 15.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.063 0.945 . . . . 0.0 109.702 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -57.97 133.97 55.97 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 163.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.69 -2.1 76.37 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 117.113 -1.937 . . . . 0.0 112.718 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -71.36 167.8 18.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.784 2.292 . . . . 0.0 109.529 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 19.7 ttt -140.6 147.69 39.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.499 1.52 . . . . 0.0 107.516 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -130.85 170.06 14.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.047 0.842 . . . . 0.0 109.958 -175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.4 pt -131.52 133.69 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.319 1.448 . . . . 0.0 107.635 170.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -69.05 116.88 10.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.4 -20.37 11.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.563 0.745 . . . . 0.0 110.786 176.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -152.03 -176.55 5.7 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.408 1.004 . . . . 0.0 110.229 160.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -125.04 130.35 52.11 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.334 1.853 . . . . 0.0 108.271 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -107.18 -163.45 0.91 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 166.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -134.4 14.56 3.78 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.357 0.98 . . . . 0.0 112.236 -170.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -120.13 11.24 11.6 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.033 1.733 . . . . 0.0 111.278 -159.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.68 20.72 65.39 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 127.083 2.278 . . . . 0.0 112.124 -167.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -127.01 150.9 49.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.371 1.086 . . . . 0.0 110.636 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.46 ' HE3' HD11 ' A' ' 52' ' ' ILE . 33.5 mtm -136.14 135.51 39.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' A' ' 51' ' ' LEU . 11.9 t-105 -73.46 128.27 35.01 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.29 1.436 . . . . 0.0 108.462 162.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.55 -173.89 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 123.824 0.85 . . . . 0.0 110.928 -174.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.5 m -124.48 132.98 53.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 157.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -86.07 112.17 21.01 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.59 1.156 . . . . 0.0 108.657 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.7 mt -67.33 -9.41 40.86 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.955 -1.022 . . . . 0.0 113.187 -172.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -30.43 70.97 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 120.921 1.692 . . . . 0.0 113.412 173.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.0 p -147.96 -8.86 0.4 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.526 1.141 . . . . 0.0 113.795 -165.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 t0 73.7 10.5 4.77 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.134 1.374 . . . . 0.0 112.349 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -61.55 126.12 26.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.843 1.657 . . . . 0.0 108.216 167.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -93.13 170.23 9.81 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 109.963 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.93 -158.02 21.79 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 118.139 0.427 . . . . 0.0 112.893 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' A' ' 40' ' ' TRP . 1.8 mm? -98.54 135.24 40.37 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.544 1.138 . . . . 0.0 111.587 -160.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.46 HD11 ' HE3' ' A' ' 39' ' ' MET . 1.5 pp -140.17 146.33 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.945 1.698 . . . . 0.0 108.941 174.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -85.86 138.83 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 124.366 1.067 . . . . 0.0 108.951 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.88 3.8 9.37 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.77 -20.01 60.61 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.546 -1.346 . . . . 0.0 114.401 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -126.76 21.02 7.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.194 0.997 . . . . 0.0 112.374 -160.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 m -130.76 173.82 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.269 1.428 . . . . 0.0 109.884 -170.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.15 154.47 50.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.672 1.989 . . . . 0.0 109.289 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.501 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -79.04 37.17 0.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.756 2.022 . . . . 0.0 114.471 -170.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.451 -0.396 0 C-N-CA 126.05 1.74 . . . . 0.0 113.83 -165.833 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.155 0.502 . . . . 0.0 112.21 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.9 mpp_? -136.92 115.78 12.24 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.204 1.402 . . . . 0.0 109.507 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.32 170.3 3.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.947 0.88 . . . . 0.0 109.604 171.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -134.59 135.32 42.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.798 1.639 . . . . 0.0 107.766 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB2' ' HE2' ' A' ' 28' ' ' PHE . . . -78.91 137.62 37.73 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.825 1.193 . . . . 0.0 109.039 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.275 0.2 OUTLIER -114.92 8.31 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 178.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.39 165.48 17.43 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 126.508 1.923 . . . . 0.0 108.168 169.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -82.36 168.53 14.75 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.24 2.626 . . . . 0.0 110.065 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -147.43 -178.03 6.01 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.921 0.888 . . . . 0.0 110.099 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.9 m -134.49 105.33 6.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.449 2.3 . . . . 0.0 108.083 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -61.93 145.8 51.84 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.286 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.614 ' CG1' HG21 ' A' ' 17' ' ' THR . 0.8 OUTLIER -59.87 140.45 90.01 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 167.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -72.85 138.79 29.33 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.464 2.776 . . . . 0.0 111.093 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 73.34 43.83 0.35 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.184 2.193 . . . . 0.0 111.907 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.614 HG21 ' CG1' ' A' ' 14' ' ' VAL . 28.4 p -143.32 169.55 17.44 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 121.184 -0.947 . . . . 0.0 111.731 -168.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -85.91 -0.66 55.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.914 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.456 ' OE1' HG12 ' A' ' 14' ' ' VAL . 9.2 mt-10 -65.66 168.27 7.88 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.545 1.138 . . . . 0.0 111.163 172.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.53 122.76 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.464 1.906 . . . . 0.0 110.146 -176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.51 124.3 19.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.842 0.857 . . . . 0.0 109.998 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -136.4 164.86 27.15 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.1 0.96 . . . . 0.0 111.226 -175.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.12 167.06 11.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.271 1.028 . . . . 0.0 111.218 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -55.4 140.72 38.96 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 158.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.88 5.86 83.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-O 117.701 -1.61 . . . . 0.0 112.751 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -82.85 169.92 15.56 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.94 1.87 . . . . 0.0 110.53 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -143.28 151.44 40.54 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.708 1.203 . . . . 0.0 110.5 -174.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.422 ' HE2' ' HB2' ' A' ' 7' ' ' ALA . 49.2 m-85 -138.7 173.53 11.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 124.348 1.03 . . . . 0.0 111.432 -168.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.2 pt -135.59 135.18 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 126.093 1.757 . . . . 0.0 107.697 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.21 117.36 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.74 -21.08 10.37 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.345 -0.847 . . . . 0.0 112.736 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -152.86 -177.29 6.18 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -135.88 124.13 23.19 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.743 1.617 . . . . 0.0 107.36 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mt -103.64 -168.9 1.56 Allowed 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.385 1.074 . . . . 0.0 108.648 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -136.65 51.7 1.98 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.536 1.534 . . . . 0.0 109.059 -169.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -159.64 22.65 0.18 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.652 1.181 . . . . 0.0 108.923 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.46 -2.33 7.74 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 119.542 -1.974 . . . . 0.0 114.052 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -86.85 149.97 24.45 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.176 0.991 . . . . 0.0 110.487 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.5 mtm -136.07 136.0 39.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.526 1.13 . . . . 0.0 109.001 172.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.505 ' CE3' HD21 ' A' ' 51' ' ' LEU . 14.1 t-105 -80.4 129.83 34.76 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.996 1.719 . . . . 0.0 108.678 167.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.5 m -142.44 -176.55 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.381 1.072 . . . . 0.0 110.984 -173.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.3 m -118.17 136.22 53.76 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 154.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -88.38 114.61 25.17 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.19 1.796 . . . . 0.0 108.073 166.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.81 -3.28 14.93 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -61.72 -31.58 71.75 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.674 1.579 . . . . 0.0 112.792 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -159.85 12.82 0.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.748 0.704 . . . . 0.0 111.259 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 t0 74.03 19.58 2.98 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.725 1.21 . . . . 0.0 112.519 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -61.43 137.26 58.24 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.792 1.637 . . . . 0.0 107.981 168.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -118.87 158.36 25.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.103 0.961 . . . . 0.0 109.408 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.0 -153.48 21.47 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 124.003 0.815 . . . . 0.0 111.491 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.505 HD21 ' CE3' ' A' ' 40' ' ' TRP . 2.6 mm? -94.85 141.71 28.31 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.629 0.772 . . . . 0.0 110.978 -160.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.87 156.96 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 127.161 2.184 . . . . 0.0 107.379 170.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.83 145.45 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.782 0.833 . . . . 0.0 109.397 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -68.07 -18.74 64.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 112.935 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.43 -15.57 63.43 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -168.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.5 mt -124.48 7.2 8.3 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.184 1.394 . . . . 0.0 113.415 -160.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.89 172.06 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 119.183 0.901 . . . . 0.0 110.742 -175.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.59 145.12 44.53 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.26 1.824 . . . . 0.0 108.231 167.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.16 113.84 3.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.32 161.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.444 -0.749 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 165.325 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.522 ' HB3' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.382 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -146.15 152.14 38.79 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.265 1.026 . . . . 0.0 108.474 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.13 166.23 10.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 121.908 0.861 . . . . 0.0 111.538 165.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -129.59 136.37 49.7 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 127.315 2.246 . . . . 0.0 106.343 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.41 139.89 37.58 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.58 -2.25 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.487 173.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mt -148.43 155.59 42.39 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.312 2.245 . . . . 0.0 108.055 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.14 168.22 15.35 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 124.153 3.235 . . . . 0.0 112.896 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -160.59 150.76 17.94 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.681 1.192 . . . . 0.0 111.425 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 t -116.3 131.81 56.84 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.581 ' H ' ' HB3' ' A' ' 21' ' ' SER . 0.7 OUTLIER -92.84 168.65 11.03 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.117 1.367 . . . . 0.0 111.155 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.27 119.09 57.44 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -58.24 167.28 4.83 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.979 1.786 . . . . 0.0 110.788 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.5 -9.06 1.47 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.247 2.219 . . . . 0.0 113.246 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.7 p -108.4 175.6 5.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.486 1.115 . . . . 0.0 111.706 -174.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -81.62 5.93 16.64 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.313 1.045 . . . . 0.0 112.406 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -77.34 175.74 9.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.931 1.692 . . . . 0.0 111.081 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.3 pt -150.98 156.22 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.828 2.051 . . . . 0.0 109.506 174.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.581 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 19.9 p -116.76 152.57 34.07 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.956 1.303 . . . . 0.0 110.261 -171.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.38 170.84 21.37 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 111.401 -165.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.35 163.68 23.47 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.408 0.683 . . . . 0.0 109.238 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -58.44 144.58 41.6 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.02 -8.23 64.02 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.586 -0.563 . . . . 0.0 113.746 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -69.06 170.56 9.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.806 1.289 . . . . 0.0 110.207 168.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.7 mmm -132.44 163.05 29.63 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.116 1.367 . . . . 0.0 108.995 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -137.23 -176.29 4.34 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 112.814 -1.994 . . . . 0.0 108.821 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.9 pt -143.8 150.27 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 125.772 1.629 . . . . 0.0 107.231 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 3' ' ' ARG . 44.7 t -76.14 131.51 34.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -120.6 -44.34 2.45 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.512 1.125 . . . . 0.0 109.595 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -143.88 166.82 23.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.775 0.798 . . . . 0.0 110.434 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -141.02 120.77 13.43 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 126.946 2.098 . . . . 0.0 105.811 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mt -108.39 -164.94 0.99 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.377 1.471 . . . . 0.0 108.508 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -134.57 66.78 1.53 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.262 1.425 . . . . 0.0 108.547 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.25 6.37 0.12 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.26 1.024 . . . . 0.0 112.739 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.45 15.55 71.04 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.961 1.743 . . . . 0.0 112.918 -165.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -122.44 145.76 48.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.463 1.905 . . . . 0.0 109.829 -171.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -144.7 144.99 31.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 109.686 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -91.61 136.87 32.81 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.909 0.884 . . . . 0.0 112.105 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.36 -175.49 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.84 1.256 . . . . 0.0 111.042 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.0 m -123.2 132.72 54.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 158.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.66 108.14 17.23 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.435 1.894 . . . . 0.0 108.646 174.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mt -76.06 16.91 0.38 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.43 ' HG3' HG22 ' A' ' 46' ' ' THR . 3.3 ptm180 -66.68 -35.13 79.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.388 163.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.43 HG22 ' HG3' ' A' ' 45' ' ' ARG . 1.6 t -169.46 16.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 117.472 -1.251 . . . . 0.0 113.052 -169.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 75.47 18.29 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.12 1.368 . . . . 0.0 113.303 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.19 134.23 54.4 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.596 -0.69 . . . . 0.0 109.336 170.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -124.92 142.85 51.19 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.18 0.992 . . . . 0.0 108.758 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.06 -160.91 28.58 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.37 147.06 23.91 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.507 1.123 . . . . 0.0 112.406 -165.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.2 pt -133.52 157.0 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.876 1.671 . . . . 0.0 109.995 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.22 147.77 7.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 126.119 1.768 . . . . 0.0 107.786 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -75.62 2.03 12.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -80.75 -18.33 48.05 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.427 1.491 . . . . 0.0 113.123 -172.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -123.29 14.79 9.7 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.185 -1.572 . . . . 0.0 112.415 -168.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.09 161.67 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.979 1.711 . . . . 0.0 109.159 -167.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -120.51 148.53 43.72 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.684 1.194 . . . . 0.0 109.02 170.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -70.1 125.53 27.04 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 166.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 125.079 1.352 . . . . 0.0 107.635 171.578 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 30' ' ' VAL 0.293 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.538 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.9 mtt85 -111.54 175.79 5.28 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 120.9 -1.125 . . . . 0.0 111.24 172.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.46 HG13 HH21 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -135.74 162.48 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.119 -0.988 . . . . 0.0 109.168 165.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 -138.33 143.6 39.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.644 0.777 . . . . 0.0 109.574 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.06 132.33 35.95 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.131 0.972 . . . . 0.0 110.109 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.64 -4.6 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.219 1.008 . . . . 0.0 111.963 171.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.47 153.4 51.58 Favored Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 126.443 1.897 . . . . 0.0 108.253 175.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -76.3 157.87 37.24 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.709 2.939 . . . . 0.0 111.743 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -140.0 165.3 27.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.36 1.064 . . . . 0.0 110.564 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.9 m -136.76 112.37 9.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.536 1.534 . . . . 0.0 107.269 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 15' ' ' PRO . 6.6 pttm -70.61 152.06 44.32 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 169.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.3 t -75.75 146.6 80.11 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 156.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.539 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 98.2 Cg_endo -81.6 170.76 14.06 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.577 2.851 . . . . 0.0 111.252 172.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 75.4 16.78 2.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.781 2.432 . . . . 0.0 111.548 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.6 p -132.03 168.08 18.57 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.215 1.806 . . . . 0.0 109.855 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -80.41 3.83 20.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.251 1.421 . . . . 0.0 111.587 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.98 172.85 12.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.993 1.717 . . . . 0.0 110.201 -175.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.8 130.83 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.447 1.499 . . . . 0.0 110.588 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.1 150.23 37.29 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.795 1.238 . . . . 0.0 110.066 176.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -154.48 164.05 39.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.369 0.531 . . . . 0.0 111.528 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.44 162.87 14.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.378 1.071 . . . . 0.0 110.922 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.78 132.15 53.08 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 164.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.51 -5.2 54.61 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-O 119.049 -0.862 . . . . 0.0 113.682 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -102.37 154.53 18.98 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.276 1.03 . . . . 0.0 108.435 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.8 ttt -124.25 158.46 32.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.018 0.927 . . . . 0.0 111.179 -164.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.72 177.38 8.94 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.557 1.543 . . . . 0.0 110.599 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.2 pt -131.59 127.65 59.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.631 1.572 . . . . 0.0 109.386 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 3' ' ' ARG . 1.7 p -75.06 94.41 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.38 0.536 . . . . 0.0 110.083 -177.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -82.74 -56.56 3.77 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -135.79 165.33 25.85 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.355 0.598 . . . . 0.0 110.111 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -129.95 128.46 42.16 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 125.808 1.643 . . . . 0.0 106.743 -172.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 mt -113.21 -170.77 1.75 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -175.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -134.65 48.99 2.26 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.123 0.969 . . . . 0.0 108.897 -166.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -156.6 19.11 0.33 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.924 1.29 . . . . 0.0 112.004 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.13 19.61 79.77 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 120.802 -1.186 . . . . 0.0 112.239 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -120.29 153.33 36.54 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.177 1.391 . . . . 0.0 109.206 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.5 mtm -147.46 131.04 16.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -76.12 128.93 35.98 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.42 -165.71 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.504 1.122 . . . . 0.0 110.514 -175.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.1 m -137.02 127.67 27.01 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 162.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -78.47 99.02 6.27 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.526 1.53 . . . . 0.0 108.441 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.08 -2.44 0.43 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.308 1.443 . . . . 0.0 113.909 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -55.91 -48.37 75.8 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 120.554 -1.341 . . . . 0.0 110.136 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -152.53 14.56 0.58 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.4 0.545 . . . . 0.0 111.78 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 t70 74.76 19.68 2.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.922 2.089 . . . . 0.0 111.963 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.6 108.44 0.83 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.035 0.934 . . . . 0.0 108.897 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -73.51 155.88 38.74 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.74 -165.18 28.06 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-O 121.522 0.512 . . . . 0.0 112.508 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 mt -104.72 142.05 35.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.993 1.317 . . . . 0.0 112.503 -168.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.0 153.41 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.709 1.604 . . . . 0.0 109.713 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -86.23 135.84 24.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.736 1.214 . . . . 0.0 108.26 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -77.18 -3.91 41.98 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -172.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.32 -30.25 68.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.707 2.003 . . . . 0.0 113.295 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.36 12.33 13.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.941 1.296 . . . . 0.0 112.911 -160.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 m -130.41 154.24 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.301 1.04 . . . . 0.0 111.001 -171.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -121.13 147.4 45.63 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.748 1.619 . . . . 0.0 110.31 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.81 94.1 1.02 Allowed 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 127.955 2.502 . . . . 0.0 110.828 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.7 t . . . . . 0 N--CA 1.448 -0.564 0 O-C-N 121.5 -0.75 . . . . 0.0 109.591 177.163 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 121.995 0.902 . . . . 0.0 112.217 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.5 mtm-85 -74.2 147.01 42.92 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 119.908 -1.745 . . . . 0.0 109.553 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.8 m -134.0 156.52 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.7 ttm-85 -120.83 125.27 47.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 126.59 1.956 . . . . 0.0 105.75 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.44 151.17 38.11 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 118.386 -1.326 . . . . 0.0 108.567 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.6 3.08 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.951 1.3 . . . . 0.0 111.337 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 mt -142.2 159.05 59.97 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 126.127 1.771 . . . . 0.0 107.608 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.05 170.39 11.02 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.688 2.925 . . . . 0.0 110.983 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -150.77 160.64 43.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.473 1.109 . . . . 0.0 110.474 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -132.19 109.79 10.19 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 172.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' H ' ' HB3' ' A' ' 21' ' ' SER . 7.7 pttm -65.57 165.54 12.11 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.667 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.8 147.54 58.9 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 150.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.79 176.87 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.475 2.784 . . . . 0.0 110.911 158.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 66.91 17.48 10.53 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.043 1.737 . . . . 0.0 112.692 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -135.54 171.73 14.03 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.408 1.883 . . . . 0.0 109.345 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.96 -3.5 29.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.991 1.317 . . . . 0.0 111.561 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.39 162.48 12.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.178 1.391 . . . . 0.0 112.025 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.6 pt -136.88 142.43 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.957 2.103 . . . . 0.0 108.179 165.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.53 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -87.39 171.34 10.65 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.422 -1.424 . . . . 0.0 110.693 170.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -162.23 167.43 24.02 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.888 1.675 . . . . 0.0 108.026 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mt -118.86 161.75 19.64 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.577 1.551 . . . . 0.0 107.052 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.73 126.1 26.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.938 1.245 . . . . 0.0 110.152 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.0 52.1 1.04 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 124.681 1.134 . . . . 0.0 111.146 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -138.45 161.59 36.62 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.978 1.711 . . . . 0.0 108.007 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.5 mtp -138.83 140.1 38.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.245 1.018 . . . . 0.0 110.432 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.9 169.1 9.33 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.088 1.755 . . . . 0.0 109.938 -174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.0 pt -122.02 126.35 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 172.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 3' ' ' ARG . 59.5 t -63.24 130.36 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -118.92 -44.76 2.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.582 1.153 . . . . 0.0 110.02 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -140.01 170.15 16.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -132.05 138.65 48.26 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 124.939 1.296 . . . . 0.0 107.604 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 mt -123.31 178.47 5.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.985 1.714 . . . . 0.0 109.68 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -120.89 14.55 11.6 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.917 1.341 . . . . 0.0 112.884 -162.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -129.26 20.25 5.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 127.764 2.426 . . . . 0.0 111.23 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.56 9.05 61.86 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.019 1.295 . . . . 0.0 112.922 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -113.67 162.23 16.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.355 1.062 . . . . 0.0 110.971 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.7 mtm -138.97 143.4 38.52 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.38 1.472 . . . . 0.0 107.845 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -78.26 135.95 37.66 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.702 161.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.7 m -140.96 176.8 4.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.163 0.985 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.449 HG23 HE21 ' A' ' 49' ' ' GLN . 15.0 m -115.39 141.21 48.34 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 152.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -93.26 112.45 24.39 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.464 1.106 . . . . 0.0 108.964 169.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.0 5.41 2.7 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -59.01 -41.85 88.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.261 162.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -147.41 -13.27 0.4 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.101 -0.952 . . . . 0.0 113.379 -161.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 t70 75.07 16.61 2.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.559 1.944 . . . . 0.0 111.761 -162.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -60.78 113.92 2.75 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 120.664 -1.273 . . . . 0.0 108.96 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.449 HE21 HG23 ' A' ' 42' ' ' THR . 2.1 mp0 -90.11 151.13 21.74 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.91 -0.494 . . . . 0.0 109.873 167.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.76 -167.48 35.29 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.613 0.563 . . . . 0.0 111.917 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -89.59 141.14 28.87 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.399 1.08 . . . . 0.0 110.555 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.8 153.27 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.999 2.12 . . . . 0.0 109.104 169.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.88 146.1 7.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.801 0.84 . . . . 0.0 110.428 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -66.94 -17.65 65.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.439 1.496 . . . . 0.0 113.041 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.92 -18.23 59.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.529 1.932 . . . . 0.0 112.109 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -130.56 12.56 5.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.437 1.495 . . . . 0.0 112.712 -163.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.97 154.43 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.661 1.118 . . . . 0.0 112.994 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -128.3 148.91 50.68 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.805 2.042 . . . . 0.0 110.204 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.64 102.25 0.55 Allowed 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 129.359 3.064 . . . . 0.0 110.324 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 123.19 1.471 . . . . 0.0 110.864 175.461 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.425 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.515 -0.386 0 CA-C-O 120.978 0.418 . . . . 0.0 110.541 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.466 ' CD ' HG22 ' A' ' 29' ' ' ILE . 54.4 mtm180 -132.54 150.98 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.377 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 m -123.4 171.07 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.536 1.134 . . . . 0.0 108.461 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -144.02 122.84 12.67 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 120.752 -1.217 . . . . 0.0 111.739 -170.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.38 137.85 58.34 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.801 0.728 . . . . 0.0 109.975 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.27 0.2 OUTLIER -119.73 5.22 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.417 169.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.5 mt -147.8 154.94 44.53 Favored Pre-proline 0 N--CA 1.466 0.374 0 C-N-CA 125.639 1.576 . . . . 0.0 108.822 166.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.66 157.54 31.93 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.613 2.875 . . . . 0.0 110.235 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -146.31 -179.4 6.72 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.782 0.833 . . . . 0.0 108.906 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 t -146.39 133.42 20.32 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.571 ' H ' ' HB3' ' A' ' 21' ' ' SER . 17.9 ptmt -69.52 144.66 53.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.107 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.98 139.91 97.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.02 145.86 69.01 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.068 2.512 . . . . 0.0 110.488 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.82 39.14 8.57 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.765 1.626 . . . . 0.0 112.498 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 p -132.33 171.21 14.01 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.497 -0.752 . . . . 0.0 110.434 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.68 -8.18 59.05 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.64 1.976 . . . . 0.0 111.323 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.03 167.88 3.61 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.781 1.633 . . . . 0.0 111.917 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.99 136.48 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.877 1.671 . . . . 0.0 108.69 174.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.571 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -90.51 122.77 33.63 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.85 1.66 . . . . 0.0 110.148 -178.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -146.99 170.65 16.66 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 119.671 1.123 . . . . 0.0 113.288 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.88 -178.64 5.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.014 0.926 . . . . 0.0 111.738 -164.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -63.57 149.58 45.99 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 160.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.99 -4.73 22.06 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.897 -0.946 . . . . 0.0 113.244 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.55 156.31 39.1 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.639 1.22 . . . . 0.0 107.759 164.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.9 ttt -134.17 148.82 50.98 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.866 -1.146 . . . . 0.0 108.814 -173.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -132.98 159.48 39.89 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.436 1.094 . . . . 0.0 109.636 -169.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.466 HG22 ' CD ' ' A' ' 4' ' ' ARG . 6.7 pt -110.86 135.98 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 3' ' ' ARG . 1.7 p -69.39 124.5 25.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 171.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.19 -25.32 4.9 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.97 0.908 . . . . 0.0 113.255 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -154.73 160.44 41.34 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 164.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.76 123.03 42.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.09 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 mt -101.81 -169.42 1.68 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.9 29.59 3.77 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.381 1.072 . . . . 0.0 110.853 -166.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -151.79 29.4 0.6 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.702 1.601 . . . . 0.0 111.534 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.09 36.25 64.23 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 120.9 -1.125 . . . . 0.0 112.426 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -134.72 156.18 49.25 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.362 1.081 . . . . 0.0 108.92 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.5 mtm -138.01 141.86 40.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 168.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -75.41 137.9 41.32 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 160.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.81 -178.84 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 122.186 0.993 . . . . 0.0 111.768 -175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.4 m -124.94 146.68 49.24 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 153.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.77 119.46 32.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.437 2.695 . . . . 0.0 108.43 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt -80.11 21.13 0.6 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.844 1.257 . . . . 0.0 112.491 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.3 ttp85 -101.24 -47.53 4.69 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.089 0.956 . . . . 0.0 110.032 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -146.15 20.31 1.4 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.642 0.777 . . . . 0.0 109.511 -169.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.85 24.13 12.73 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.208 1.803 . . . . 0.0 112.356 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -72.32 160.61 32.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.1 -1.0 . . . . 0.0 112.48 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -139.42 149.54 44.2 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.684 0.754 . . . . 0.0 110.928 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.89 -168.55 32.36 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.638 -174.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.0 mt -92.0 143.53 26.38 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.832 1.253 . . . . 0.0 110.489 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.01 145.57 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.274 1.429 . . . . 0.0 109.029 171.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.02 132.23 32.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.31 -10.97 60.63 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -55.48 -26.85 44.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.942 2.097 . . . . 0.0 111.873 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.96 11.29 11.73 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -160.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -118.11 164.68 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.73 1.612 . . . . 0.0 110.859 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -121.31 151.14 40.42 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.568 1.547 . . . . 0.0 110.154 169.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.18 63.18 0.97 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.768 2.427 . . . . 0.0 111.066 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p . . . . . 0 C--O 1.238 0.481 0 O-C-N 120.741 -1.224 . . . . 0.0 111.331 177.764 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 . . . . . 0 C--O 1.236 0.359 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 mmt85 -140.99 156.52 46.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.13 1.372 . . . . 0.0 107.494 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.09 154.63 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.335 0.97 . . . . 0.0 109.806 170.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -121.66 136.57 54.94 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.84 130.78 41.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.149 0.886 . . . . 0.0 109.506 169.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.07 1.47 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.318 0.647 . . . . 0.0 111.305 170.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 mt -141.03 154.56 68.37 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 168.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.91 158.77 34.66 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.971 2.447 . . . . 0.0 110.247 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -150.12 164.61 35.15 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.58 0.752 . . . . 0.0 110.577 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 t -135.31 135.79 41.07 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -63.46 149.75 45.34 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.22 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.475 HG23 ' OG1' ' A' ' 17' ' ' THR . 21.2 m -66.7 166.29 19.59 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.624 1.17 . . . . 0.0 109.557 163.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -79.6 161.27 25.02 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.385 2.056 . . . . 0.0 110.41 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t70 45.94 46.86 12.48 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.987 2.515 . . . . 0.0 112.693 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.475 ' OG1' HG23 ' A' ' 14' ' ' VAL . 1.8 p -142.96 177.74 8.15 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.459 -0.776 . . . . 0.0 110.122 -170.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.25 11.25 37.09 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.513 1.525 . . . . 0.0 110.412 -172.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -80.36 170.02 16.96 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.653 1.581 . . . . 0.0 111.549 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.3 pt -136.0 152.78 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.227 1.811 . . . . 0.0 109.964 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -88.99 149.87 23.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.545 2.338 . . . . 0.0 110.642 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -158.28 173.19 17.06 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.423 -0.798 . . . . 0.0 111.797 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.41 161.17 22.64 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.804 1.242 . . . . 0.0 110.516 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -57.98 133.63 55.68 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 166.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.31 -6.77 71.96 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 117.887 -1.507 . . . . 0.0 113.005 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -77.18 166.45 23.22 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.271 2.035 . . . . 0.0 108.699 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 34.7 mtp -133.25 140.3 47.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.566 1.146 . . . . 0.0 109.873 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -122.93 169.94 10.63 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.099 1.359 . . . . 0.0 109.779 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 pt -119.52 129.64 75.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.46 125.98 27.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -116.64 -33.48 4.84 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.929 0.892 . . . . 0.0 111.961 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -146.62 160.45 42.15 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 119.262 0.937 . . . . 0.0 110.497 172.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -118.06 121.55 40.88 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 126.498 1.919 . . . . 0.0 107.289 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -110.2 -172.15 1.98 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.412 1.485 . . . . 0.0 107.851 173.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -120.26 13.73 12.01 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.171 1.789 . . . . 0.0 114.935 -166.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -143.41 23.31 1.81 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.392 1.077 . . . . 0.0 112.218 -154.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.94 7.28 87.43 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 124.456 1.027 . . . . 0.0 112.617 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -118.48 150.61 39.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.576 1.55 . . . . 0.0 108.73 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 mtm -139.39 140.37 37.4 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -77.05 138.88 39.83 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 166.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -142.56 -175.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.774 1.273 . . . . 0.0 111.166 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.2 m -130.76 132.23 45.19 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 152.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -81.39 114.01 19.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.41 -6.81 11.28 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.024 -0.423 . . . . 0.0 111.679 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -57.01 -40.39 76.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 120.396 -1.44 . . . . 0.0 111.389 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -169.75 33.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.025 0.829 . . . . 0.0 111.793 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t70 66.54 -4.91 0.67 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 171.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -53.73 118.4 3.9 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.192 1.797 . . . . 0.0 109.804 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -100.36 157.87 16.3 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 168.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.49 -171.91 32.98 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.3 mt -87.23 144.88 26.61 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.458 1.503 . . . . 0.0 109.561 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.28 152.64 23.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.95 1.7 . . . . 0.0 108.028 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.18 141.31 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.286 0.634 . . . . 0.0 109.832 -173.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -71.82 -9.56 58.49 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.824 0.85 . . . . 0.0 113.25 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.34 -21.16 66.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.819 1.248 . . . . 0.0 112.064 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -126.86 11.42 7.17 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.802 1.241 . . . . 0.0 112.098 -162.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.11 167.57 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.171 0.989 . . . . 0.0 111.343 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -119.06 152.31 36.68 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 127.184 2.194 . . . . 0.0 108.426 167.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 59.76 1.25 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.319 1.448 . . . . 0.0 110.341 174.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.536 0.431 0 O-C-N 120.87 -1.144 . . . . 0.0 110.633 -175.421 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.24 0.603 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -124.6 151.55 44.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.94 145.51 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.275 0.943 . . . . 0.0 109.746 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -111.37 144.96 39.73 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 117.584 -1.198 . . . . 0.0 109.922 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.19 136.71 37.86 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 119.767 1.167 . . . . 0.0 111.819 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.69 1.85 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.158 0.983 . . . . 0.0 112.294 168.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mt -151.71 154.48 33.13 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 125.73 1.612 . . . . 0.0 108.755 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.52 134.93 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.009 2.473 . . . . 0.0 108.604 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -84.64 -179.12 7.06 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.931 0.872 . . . . 0.0 109.043 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.4 m -149.71 100.33 2.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.53 ' H ' ' HB3' ' A' ' 21' ' ' SER . 11.6 pttt -67.66 156.6 36.49 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.413 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 11.0 m -85.53 176.25 3.81 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 126.324 1.85 . . . . 0.0 107.912 168.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 14' ' ' VAL . 89.6 Cg_endo -95.17 164.02 1.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.174 2.582 . . . . 0.0 111.336 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 59.04 35.78 24.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.492 1.917 . . . . 0.0 111.243 167.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.39 162.59 36.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.127 0.965 . . . . 0.0 111.483 -161.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.4 35.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.477 1.911 . . . . 0.0 109.427 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -109.3 168.29 9.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.296 1.039 . . . . 0.0 109.149 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.2 pt -145.2 144.66 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 127.39 2.276 . . . . 0.0 106.554 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.53 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 93.1 p -124.88 158.94 32.28 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.665 ' HB2' HD21 ' A' ' 43' ' ' ASN . 0.1 OUTLIER -164.93 -175.03 3.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.512 1.525 . . . . 0.0 109.506 176.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.5 172.39 8.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.173 0.989 . . . . 0.0 109.975 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -54.93 157.2 3.32 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.525 -1.359 . . . . 0.0 109.789 161.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.44 12.55 84.2 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.773 -1.015 . . . . 0.0 112.696 172.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -174.59 4.24 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.733 1.267 . . . . 0.0 111.262 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.36 144.67 32.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.338 1.855 . . . . 0.0 108.934 -170.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -133.74 153.92 51.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.159 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.6 pt -112.92 118.53 58.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -63.76 121.78 13.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.1 -36.28 5.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.433 1.093 . . . . 0.0 109.973 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -149.24 169.55 20.5 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.158 0.89 . . . . 0.0 110.062 168.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -130.35 122.7 28.36 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 127.332 2.253 . . . . 0.0 106.122 -171.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.85 -162.79 0.97 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.677 1.191 . . . . 0.0 110.138 -175.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -141.55 76.63 1.55 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.79 2.036 . . . . 0.0 106.934 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 p30 174.2 -0.97 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.532 1.933 . . . . 0.0 114.363 -165.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.43 7.53 85.26 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 120.055 -1.653 . . . . 0.0 113.142 -171.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -95.73 165.44 12.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.377 1.589 . . . . 0.0 109.922 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.4 mtm -134.94 163.54 29.63 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 168.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.2 t-105 -94.34 132.62 38.75 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.406 0.548 . . . . 0.0 109.665 158.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.56 174.89 6.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.132 0.973 . . . . 0.0 110.503 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.44 ' CG2' ' HA ' ' A' ' 47' ' ' ASP . 7.8 m -107.68 141.82 38.6 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 157.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.665 HD21 ' HB2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -82.19 111.48 18.33 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 127.287 2.235 . . . . 0.0 107.958 170.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.6 -9.31 5.77 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 22.0 ttp85 -53.31 -38.39 63.11 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.984 0.914 . . . . 0.0 111.436 173.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 t -165.67 -1.61 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -161.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.44 ' HA ' ' CG2' ' A' ' 42' ' ' THR . 0.6 OUTLIER 75.3 17.64 2.52 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.661 1.585 . . . . 0.0 112.401 -173.163 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.2 139.48 58.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -126.51 153.78 44.69 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.614 1.166 . . . . 0.0 108.731 -172.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 151.8 -158.47 27.79 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -172.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -101.56 143.01 32.07 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.61 1.964 . . . . 0.0 112.013 -168.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.94 152.97 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 129.813 3.245 . . . . 0.0 107.024 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.33 139.58 19.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -74.7 -14.83 60.78 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.18 -22.0 64.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.621 1.168 . . . . 0.0 112.719 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.4 mt -107.09 3.9 26.33 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.331 1.452 . . . . 0.0 112.286 -170.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.96 171.14 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.224 1.009 . . . . 0.0 110.737 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -131.21 152.96 49.97 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 125.611 1.565 . . . . 0.0 110.618 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -78.05 80.62 4.47 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.6 1.56 . . . . 0.0 111.089 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 C--N 1.321 -0.648 0 O-C-N 120.963 -1.085 . . . . 0.0 109.449 167.872 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.444 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -151.79 138.84 19.12 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.28 1.832 . . . . 0.0 108.391 -172.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.89 159.04 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.81 0.844 . . . . 0.0 109.118 173.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.532 ' HE ' ' HE3' ' A' ' 27' ' ' MET . 10.9 ttm180 -130.03 131.57 45.89 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.729 -1.857 . . . . 0.0 106.099 -168.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.57 156.42 26.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.598 1.545 . . . . 0.0 110.566 -173.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.75 9.89 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.921 162.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.71 155.57 29.68 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 120.35 1.432 . . . . 0.0 110.264 167.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' A' ' 23' ' ' LEU . 27.8 Cg_endo -82.81 163.77 15.99 Favored 'Trans proline' 0 CA--C 1.543 0.956 1 C-N-CA 125.972 4.448 . . . . 0.0 111.925 177.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -153.14 165.69 34.84 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.745 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -119.27 113.73 21.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.545 1.938 . . . . 0.0 107.21 -175.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -67.26 146.81 53.78 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.38 1.446 . . . . 0.0 110.233 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.39 149.3 98.46 Favored Pre-proline 0 CA--C 1.552 1.035 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.18 141.53 39.75 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 124.234 3.289 . . . . 0.0 111.32 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.1 t70 64.47 27.56 13.51 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.819 1.648 . . . . 0.0 112.843 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 p -121.91 173.76 7.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.467 1.031 . . . . 0.0 113.651 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.28 24.9 0.77 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.173 2.189 . . . . 0.0 110.632 -172.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -108.11 175.47 5.47 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.035 2.134 . . . . 0.0 110.844 -173.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 pt -147.24 121.11 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.311 1.445 . . . . 0.0 110.904 -174.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.63 139.11 39.44 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.054 -1.029 . . . . 0.0 111.338 -176.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -156.51 169.25 25.08 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.012 -1.055 . . . . 0.0 112.062 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 3.5 mm? -109.8 167.59 10.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.377 1.071 . . . . 0.0 109.729 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -62.38 119.4 9.03 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 169.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.15 -15.88 4.21 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.645 1.593 . . . . 0.0 112.944 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -80.1 162.74 24.61 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.981 1.391 . . . . 0.0 110.002 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.532 ' HE3' ' HE ' ' A' ' 6' ' ' ARG . 14.5 ptm -138.3 158.95 43.28 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.578 1.951 . . . . 0.0 108.406 175.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -132.66 160.87 35.45 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.382 1.073 . . . . 0.0 111.072 -169.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.6 pt -121.09 125.31 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 108.909 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.85 123.48 13.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -126.36 -23.43 3.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.634 1.174 . . . . 0.0 112.963 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -156.0 161.6 40.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.171 0.896 . . . . 0.0 110.822 159.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -118.54 125.68 50.36 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 129.07 2.948 . . . . 0.0 105.767 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 mt -109.46 -165.36 1.01 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.187 0.995 . . . . 0.0 109.213 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -133.52 91.94 2.92 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 t0 175.85 18.91 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.627 2.371 . . . . 0.0 111.667 168.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.46 -1.86 84.21 Favored Glycine 0 CA--C 1.539 1.572 0 O-C-N 120.146 -1.596 . . . . 0.0 113.878 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.498 ' CE2' HG13 ' A' ' 53' ' ' VAL . 90.9 m95 -97.73 152.02 19.55 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.752 2.021 . . . . 0.0 110.217 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.7 mtm -141.64 143.8 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.363 1.465 . . . . 0.0 108.638 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -84.39 136.69 33.77 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 171.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.17 -163.79 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.511 0.724 . . . . 0.0 111.549 -173.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.3 m -135.83 158.11 45.21 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 151.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -102.79 115.36 30.44 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.637 1.575 . . . . 0.0 109.677 172.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 mt -66.2 -4.54 7.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.799 1.24 . . . . 0.0 113.44 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -69.35 -46.77 66.22 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 117.187 -1.387 . . . . 0.0 111.47 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.5 p -139.29 4.96 2.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.934 1.243 . . . . 0.0 114.025 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.69 19.69 1.97 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.939 1.696 . . . . 0.0 112.204 -174.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -62.25 141.82 58.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.916 1.286 . . . . 0.0 110.385 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -134.51 155.81 49.72 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.836 0.854 . . . . 0.0 109.65 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.89 -158.17 24.07 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -161.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.3 mt -106.16 144.67 32.53 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.271 1.428 . . . . 0.0 113.858 -164.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.63 154.31 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 127.699 2.4 . . . . 0.0 108.582 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.553 ' HB ' ' H ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -91.74 147.97 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 127.483 2.313 . . . . 0.0 112.553 168.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -58.89 -21.32 57.21 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.47 165.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.553 ' H ' ' HB ' ' A' ' 53' ' ' VAL . 21.6 t70 -63.67 -24.62 67.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.763 0.792 . . . . 0.0 112.178 -166.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.1 mt -118.75 7.2 11.58 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.509 1.523 . . . . 0.0 111.271 -157.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.93 161.84 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.02 1.728 . . . . 0.0 109.797 -169.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.5 153.26 26.45 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.363 1.465 . . . . 0.0 109.059 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.87 61.9 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.928 1.291 . . . . 0.0 111.088 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.445 -0.706 0 CA-C-O 122.32 1.057 . . . . 0.0 110.213 -179.194 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? . . . . . 0 N--CA 1.447 -0.615 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ARG . . . . . 0.514 ' HD3' HG22 ' A' ' 29' ' ' ILE . 17.5 mtm180 -134.61 166.8 22.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.991 0.516 . . . . 0.0 110.451 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.69 161.44 23.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 171.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -139.47 129.87 25.55 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.52 121.72 19.18 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.981 0.81 . . . . 0.0 109.595 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.96 -2.34 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.135 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.81 157.48 32.58 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 126.938 2.095 . . . . 0.0 108.171 173.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.08 159.74 30.24 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.93 3.086 . . . . 0.0 111.147 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -143.9 168.07 20.82 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.826 1.651 . . . . 0.0 107.61 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 t -135.66 143.51 45.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.579 ' H ' ' HB3' ' A' ' 21' ' ' SER . 12.9 pttm -84.35 155.88 22.13 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.924 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -62.46 139.63 96.63 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 161.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.14 146.68 41.39 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.945 1.763 . . . . 0.0 108.837 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t0 62.65 51.32 3.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.686 1.594 . . . . 0.0 112.019 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.1 p -146.07 174.36 11.37 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 125.926 1.69 . . . . 0.0 110.203 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -84.22 -9.15 58.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.185 0.994 . . . . 0.0 110.992 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.08 173.71 4.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.879 2.071 . . . . 0.0 111.337 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 pt -147.18 126.22 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 126.985 2.114 . . . . 0.0 108.734 -172.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.579 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 1.2 p -93.72 125.72 38.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.075 1.75 . . . . 0.0 111.468 -172.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -150.57 168.61 23.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 124.513 2.101 . . . . 0.0 113.95 -172.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mt -90.16 174.54 7.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.525 2.33 . . . . 0.0 110.126 -166.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -60.47 153.25 23.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 156.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.7 7.15 88.72 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.069 -0.851 . . . . 0.0 113.67 167.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.91 157.05 20.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.213 1.507 . . . . 0.0 109.058 166.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.3 ttt -134.01 147.83 51.02 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.097 0.959 . . . . 0.0 109.12 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -134.76 170.97 15.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.384 -167.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.514 HG22 ' HD3' ' A' ' 4' ' ' ARG . 18.5 pt -128.06 138.72 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.098 1.359 . . . . 0.0 107.899 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.9 t -75.0 116.84 18.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -112.17 -20.52 11.87 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.402 0.681 . . . . 0.0 111.387 174.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -154.84 179.88 8.68 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 163.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -147.09 118.95 8.1 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.748 1.619 . . . . 0.0 107.369 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -104.91 -177.56 3.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.811 2.445 . . . . 0.0 110.222 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -133.96 78.79 1.78 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.448 1.499 . . . . 0.0 109.6 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -169.9 31.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.63 1.572 . . . . 0.0 110.508 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.1 27.74 67.87 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.609 -1.307 . . . . 0.0 112.623 -174.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -134.52 150.37 50.76 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.534 1.167 . . . . 0.0 110.833 -168.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.6 mtm -149.14 137.66 21.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.493 0.717 . . . . 0.0 110.869 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -86.71 130.84 34.32 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.958 1.303 . . . . 0.0 110.405 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -142.1 -177.12 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.504 0.722 . . . . 0.0 111.879 -175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 m -116.78 138.7 51.3 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.945 1.698 . . . . 0.0 107.42 157.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -92.32 120.84 33.25 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.705 1.202 . . . . 0.0 109.466 165.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.87 1.66 3.19 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.774 ' HG3' HG22 ' A' ' 46' ' ' THR . 3.5 ptp180 -71.34 -36.49 71.56 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 121.191 1.814 . . . . 0.0 112.799 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.774 HG22 ' HG3' ' A' ' 45' ' ' ARG . 14.9 t -158.95 23.31 0.21 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.273 0.488 . . . . 0.0 111.635 -171.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.9 t70 58.59 27.24 15.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.411 1.084 . . . . 0.0 111.784 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.517 ' HG3' HG23 ' A' ' 46' ' ' THR . 45.4 mt-10 -68.61 98.86 0.92 Allowed 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.011 -1.056 . . . . 0.0 109.415 171.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -80.42 158.3 25.99 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.721 0.295 . . . . 0.0 110.619 167.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.16 -170.74 29.46 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 173.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -80.03 141.79 35.56 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.426 1.091 . . . . 0.0 110.882 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.81 152.21 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 110.12 167.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.61 140.58 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.283 1.433 . . . . 0.0 108.736 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.92 -9.33 58.44 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.78 -15.45 61.68 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.345 1.858 . . . . 0.0 113.846 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.2 mt -140.79 21.86 2.31 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.739 1.216 . . . . 0.0 113.677 -167.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.75 154.44 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -100.4 149.32 23.76 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.74 1.216 . . . . 0.0 109.554 167.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.4 123.88 24.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.274 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 121.124 0.488 . . . . 0.0 111.288 172.156 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.792 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 45.62 56.13 6.1 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.853 1.261 . . . . 0.0 111.456 -169.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.98 125.56 37.7 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.973 1.709 . . . . 0.0 106.415 177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HD3' HG22 ' A' ' 29' ' ' ILE . 85.0 mtt180 -141.46 166.57 24.39 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.283 1.433 . . . . 0.0 107.384 173.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 59' ' ' GLU . 0.5 OUTLIER -136.0 161.87 37.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 170.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -124.46 140.37 53.01 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.88 157.98 35.31 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.14 3.35 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 118.244 0.475 . . . . 0.0 111.746 164.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.2 mt -147.29 160.62 38.95 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 126.334 1.854 . . . . 0.0 107.955 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -83.15 165.4 14.85 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.647 3.565 . . . . 0.0 111.699 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -157.1 125.58 5.68 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.083 0.953 . . . . 0.0 110.517 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.7 t -82.48 142.2 32.07 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 168.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.47 ' H ' ' HB3' ' A' ' 21' ' ' SER . 1.1 pttt -83.75 154.41 23.61 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 121.742 -0.599 . . . . 0.0 109.739 163.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.2 t -71.3 151.56 94.34 Favored Pre-proline 0 CA--C 1.544 0.723 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 157.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -83.34 150.08 13.35 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.496 2.797 . . . . 0.0 110.506 165.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 t70 75.48 13.17 3.06 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.66 1.984 . . . . 0.0 112.569 -177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.9 p -107.11 177.56 4.82 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.808 1.243 . . . . 0.0 108.704 172.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -92.43 10.21 31.0 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.987 0.915 . . . . 0.0 109.219 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -74.88 162.27 28.78 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.746 -1.221 . . . . 0.0 109.92 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.9 pt -125.02 140.66 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 124.852 1.261 . . . . 0.0 107.619 164.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.47 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 56.1 p -85.68 160.34 19.59 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -158.35 167.71 28.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.366 0.667 . . . . 0.0 109.369 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.9 mt -117.43 167.83 10.92 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.574 1.15 . . . . 0.0 108.579 175.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -60.77 115.01 3.34 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 167.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.8 -16.41 3.74 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 125.754 1.645 . . . . 0.0 112.36 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -76.88 163.4 26.79 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 119.87 1.835 . . . . 0.0 111.968 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.2 mtp -127.85 154.96 44.86 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 128.149 2.58 . . . . 0.0 108.833 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -136.39 160.4 38.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.431 1.092 . . . . 0.0 108.967 -178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 ' HD3' ' A' ' 4' ' ' ARG . 5.7 pt -122.74 137.95 54.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.9 t -69.76 134.27 30.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.83 -27.28 2.57 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.402 171.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.99 162.54 41.13 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-N 119.431 1.014 . . . . 0.0 110.788 162.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -107.47 137.35 45.67 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.565 1.946 . . . . 0.0 107.443 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.1 mt -129.36 177.01 7.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.511 1.924 . . . . 0.0 107.101 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -130.32 14.44 5.59 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 121.188 -0.945 . . . . 0.0 113.033 -152.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -127.59 21.29 6.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.078 1.751 . . . . 0.0 112.103 -170.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.09 10.32 56.26 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.355 1.455 . . . . 0.0 113.018 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -125.9 155.34 41.42 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 125.658 1.583 . . . . 0.0 110.847 -165.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 30.4 mtm -145.82 145.99 30.99 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.316 1.447 . . . . 0.0 108.8 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -84.01 137.3 33.67 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 122.838 0.455 . . . . 0.0 110.655 168.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 28.6 m -142.38 -171.24 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.834 0.854 . . . . 0.0 111.724 -175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 28.1 m -128.07 150.76 49.81 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 156.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -109.54 109.32 20.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 126.127 1.771 . . . . 0.0 109.413 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 44' ' ' LEU . 9.0 mt -56.04 -12.86 1.62 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 126.784 2.034 . . . . 0.0 113.612 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -64.47 -33.96 77.09 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.958 1.254 . . . . 0.0 111.514 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.251 5.1 t -155.31 15.07 0.39 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.085 0.954 . . . . 0.0 110.737 -168.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.3 t70 53.05 32.85 13.67 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 127.085 2.154 . . . . 0.0 111.795 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.1 159.28 33.81 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.809 -0.557 . . . . 0.0 110.326 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -140.23 147.2 39.67 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -171.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.38 -157.66 25.69 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.2 mt -101.67 146.82 27.21 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 125.174 1.39 . . . . 0.0 112.277 -165.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 pp -137.43 154.05 29.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.063 1.745 . . . . 0.0 110.288 168.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.3 p -96.99 144.59 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.709 1.604 . . . . 0.0 110.127 -174.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -78.63 -6.33 55.37 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -64.58 -19.95 65.96 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.608 1.163 . . . . 0.0 113.108 -178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 90.9 mt -129.21 15.78 6.16 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.526 1.13 . . . . 0.0 113.819 -160.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.9 m -124.02 169.65 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 119.102 0.864 . . . . 0.0 113.058 -170.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -125.63 148.1 49.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 127.407 2.283 . . . . 0.0 109.216 170.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -82.93 47.58 1.23 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 127.263 2.225 . . . . 0.0 112.783 -170.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 p -58.23 156.91 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 122.711 1.243 . . . . 0.0 111.756 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -107.17 6.99 37.19 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.192 1.377 . . . . 0.0 113.227 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 125.656 1.582 . . . . 0.0 110.093 179.834 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.904 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -106.16 -75.98 0.62 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 117.755 0.777 . . . . 0.0 109.617 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.476 HH11 ' HG3' ' A' ' 3' ' ' ARG . 0.5 OUTLIER -121.95 157.99 30.05 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 119.742 1.155 . . . . 0.0 108.762 173.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.4 ' HD3' HG22 ' A' ' 29' ' ' ILE . 11.0 mtt85 -158.67 166.96 30.8 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.279 1.831 . . . . 0.0 109.361 -176.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -147.46 178.46 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 125.872 1.669 . . . . 0.0 108.823 169.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.0 ttm-85 -140.93 142.32 34.4 Favored 'General case' 0 C--O 1.221 -0.404 0 O-C-N 120.449 -1.407 . . . . 0.0 108.44 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.68 137.06 47.55 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 119.069 0.85 . . . . 0.0 110.45 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.85 -4.84 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-O 118.218 -0.896 . . . . 0.0 112.335 163.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 14.9 mt -149.81 148.66 26.0 Favored Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 125.18 1.392 . . . . 0.0 108.612 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.26 167.5 19.48 Favored 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 124.632 3.554 . . . . 0.0 111.27 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 62.9 t80 -154.4 171.43 19.33 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.18 0.992 . . . . 0.0 108.483 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.6 m -118.79 113.55 21.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.922 1.289 . . . . 0.0 108.585 176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.4 ptmt -59.81 151.6 25.12 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.187 0.903 . . . . 0.0 110.456 169.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.47 148.64 97.93 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 154.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -83.63 163.93 14.29 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.57 2.847 . . . . 0.0 111.134 170.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 47.03 47.27 16.02 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.918 2.087 . . . . 0.0 110.002 175.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.62 172.99 14.14 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.503 2.721 . . . . 0.0 107.845 -172.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -82.0 5.0 20.67 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.055 -1.028 . . . . 0.0 112.052 -170.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -91.31 162.33 14.65 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.363 1.465 . . . . 0.0 110.881 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.444 HD13 ' HB2' ' A' ' 43' ' ' ASN . 2.7 pp -138.37 132.21 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 127.082 2.153 . . . . 0.0 107.181 -174.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.88 151.02 38.99 Favored 'General case' 0 CA--C 1.533 0.302 0 O-C-N 120.875 -1.14 . . . . 0.0 111.206 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -152.68 154.51 35.43 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 121.274 -0.891 . . . . 0.0 111.094 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -101.86 171.37 7.56 Favored 'General case' 0 C--N 1.333 -0.116 0 C-N-CA 124.886 1.274 . . . . 0.0 109.777 173.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -52.78 134.2 36.76 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 158.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.05 -7.12 81.44 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-O 117.694 -1.615 . . . . 0.0 114.501 172.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -64.69 159.08 22.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.951 1.876 . . . . 0.0 108.713 166.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 9.1 ttt -127.66 142.23 51.4 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.387 1.075 . . . . 0.0 109.884 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -127.6 146.52 50.51 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.493 1.117 . . . . 0.0 111.089 -170.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.4 HG22 ' HD3' ' A' ' 4' ' ' ARG . 8.9 pt -110.01 130.95 62.28 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.159 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.39 124.79 26.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -121.04 -47.65 2.27 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.124 0.97 . . . . 0.0 110.794 176.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -138.87 157.44 46.05 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 119.006 0.821 . . . . 0.0 111.438 172.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -130.52 119.51 22.69 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -161.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 mt -119.5 145.53 46.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.885 -171.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -87.07 15.96 5.53 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.552 1.941 . . . . 0.0 113.335 -165.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -125.83 18.24 7.94 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 125.733 1.613 . . . . 0.0 112.533 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.66 16.11 50.17 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.24 0.924 . . . . 0.0 111.931 175.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -123.34 153.29 40.51 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.33 1.052 . . . . 0.0 110.154 -166.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.6 mtm -143.89 132.46 22.3 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -79.68 129.18 34.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.128 167.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 m -138.77 176.05 7.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.761 0.824 . . . . 0.0 111.58 -176.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 m -105.91 138.3 42.34 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 106.082 -1.822 . . . . 0.0 106.082 153.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.444 ' HB2' HD13 ' A' ' 20' ' ' ILE . 64.5 t-20 -90.83 114.97 27.51 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 168.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 31.4 mt -66.99 -7.61 23.69 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.9 ttp85 -59.79 -45.16 93.17 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 119.83 1.195 . . . . 0.0 109.8 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -137.72 -3.46 1.86 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 117.843 -1.075 . . . . 0.0 113.039 -168.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 75.53 11.06 3.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.292 1.837 . . . . 0.0 111.989 -173.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -61.04 149.38 37.08 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.972 0.909 . . . . 0.0 109.379 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -133.52 139.1 46.43 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.885 1.274 . . . . 0.0 108.396 -174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 160.42 -170.67 36.47 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 -176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.7 mt -80.34 146.28 31.64 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.746 1.619 . . . . 0.0 111.592 -175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -143.66 166.43 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 128.365 2.666 . . . . 0.0 108.468 165.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.45 143.45 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 124.692 1.197 . . . . 0.0 110.932 -167.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -74.6 -8.61 56.89 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.351 1.06 . . . . 0.0 113.04 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.03 -27.81 67.23 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.531 1.532 . . . . 0.0 112.232 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.53 14.99 8.21 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -161.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.4 m -122.5 164.1 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 118.976 0.807 . . . . 0.0 112.611 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -120.36 142.9 48.73 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 127.426 2.29 . . . . 0.0 109.669 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -72.43 92.94 1.49 Allowed 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.325 1.45 . . . . 0.0 107.725 170.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.7 p -83.03 114.55 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 122.274 1.035 . . . . 0.0 111.284 -166.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -75.05 -2.26 65.35 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 117.898 -1.501 . . . . 0.0 114.082 -173.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 . . . . . 0 C--O 1.248 1.011 0 C-N-CA 125.727 1.611 . . . . 0.0 113.15 -171.223 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.995 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.1 12.11 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.512 1.925 . . . . 0.0 115.381 -178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.24 120.81 43.14 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 176.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -125.95 160.99 28.52 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 123.836 0.854 . . . . 0.0 109.1 174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.6 m -138.54 160.65 31.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 124.772 1.229 . . . . 0.0 108.32 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -134.28 127.17 31.27 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.113 -173.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.98 134.73 44.81 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 118.871 0.76 . . . . 0.0 109.792 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.272 0.2 OUTLIER -115.54 5.02 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.726 0.81 . . . . 0.0 112.501 176.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.4 mt -148.14 160.73 36.57 Favored Pre-proline 0 N--CA 1.468 0.467 0 C-N-CA 127.716 2.406 . . . . 0.0 106.834 166.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -85.17 170.61 9.49 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.095 3.197 . . . . 0.0 111.283 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -145.59 172.08 13.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.586 0.755 . . . . 0.0 109.183 173.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.1 m -131.54 112.17 12.4 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.019 1.328 . . . . 0.0 108.202 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -66.71 158.69 29.52 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.272 -174.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.06 123.54 86.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 161.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.68 153.96 74.64 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.141 1.227 . . . . 0.0 108.92 166.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.8 t0 73.5 22.63 2.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.047 1.339 . . . . 0.0 111.118 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -130.04 169.99 14.57 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.095 1.358 . . . . 0.0 109.38 168.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -78.64 9.63 3.92 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.247 1.419 . . . . 0.0 110.309 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -74.72 167.69 21.31 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 120.138 -1.601 . . . . 0.0 110.541 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.3 pt -138.14 139.71 41.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 126.746 2.018 . . . . 0.0 107.446 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.01 137.26 47.09 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 120.87 -1.144 . . . . 0.0 108.799 172.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -135.34 165.1 26.23 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.807 0.843 . . . . 0.0 111.664 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -111.63 165.13 12.29 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.18 1.392 . . . . 0.0 109.924 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -59.11 128.66 38.27 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 161.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.89 0.42 62.13 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.204 -1.331 . . . . 0.0 113.434 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -74.24 161.47 29.9 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 119.847 1.824 . . . . 0.0 109.948 167.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.8 ttp -146.9 144.13 29.03 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.24 1.016 . . . . 0.0 110.455 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -140.53 155.71 46.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.954 -162.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.8 pt -104.05 133.1 48.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 125.181 1.392 . . . . 0.0 108.328 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.6 t -66.01 129.32 30.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 170.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -119.12 -34.06 3.98 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 118.123 -0.942 . . . . 0.0 112.388 168.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -145.95 162.19 38.35 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 119.578 1.081 . . . . 0.0 110.066 169.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -123.75 112.18 17.03 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 126.584 1.953 . . . . 0.0 105.915 -170.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 18.3 mt -103.73 -172.72 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.725 1.61 . . . . 0.0 108.606 -169.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -134.4 38.84 3.09 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 122.301 1.048 . . . . 0.0 112.356 -168.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -152.74 47.59 0.72 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.894 166.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.96 3.58 44.44 Favored Glycine 0 CA--C 1.538 1.481 0 O-C-N 121.031 -1.043 . . . . 0.0 115.252 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -97.32 161.41 13.81 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.624 1.169 . . . . 0.0 110.45 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 38.2 mtm -138.48 144.41 40.03 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.609 1.164 . . . . 0.0 108.695 165.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.591 ' CE3' HD21 ' A' ' 51' ' ' LEU . 24.7 t-105 -79.01 131.66 36.37 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.745 0.818 . . . . 0.0 109.322 166.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.8 m -141.44 -173.05 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.758 0.79 . . . . 0.0 112.462 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 m -136.15 131.68 35.01 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 161.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -86.22 108.98 18.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.732 1.213 . . . . 0.0 108.716 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.9 mt -75.23 -0.29 18.96 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.556 -1.212 . . . . 0.0 112.128 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 52.1 ttp85 -63.38 -33.01 74.6 Favored 'General case' 0 C--N 1.347 0.462 0 CA-C-N 120.8 1.636 . . . . 0.0 110.601 168.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.1 p -143.84 0.25 1.08 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 118.857 -0.592 . . . . 0.0 112.167 -160.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.25 0.3 OUTLIER 70.37 0.88 3.37 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 128.316 2.646 . . . . 0.0 114.195 -166.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -66.88 104.5 1.37 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.026 0.93 . . . . 0.0 111.749 -168.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -79.34 156.55 27.95 Favored 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 121.933 -0.479 . . . . 0.0 109.839 166.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.72 -154.7 25.7 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.591 HD21 ' CE3' ' A' ' 40' ' ' TRP . 1.8 mm? -103.03 144.63 31.03 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.633 1.173 . . . . 0.0 109.903 -167.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -140.66 151.43 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 126.397 1.879 . . . . 0.0 109.66 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 p -99.98 144.21 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 124.95 1.3 . . . . 0.0 109.086 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -81.44 -1.33 45.37 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -175.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.26 -23.55 62.47 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 124.188 0.995 . . . . 0.0 112.982 174.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.1 mt -121.97 13.64 10.61 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 -158.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.81 158.69 39.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.464 1.029 . . . . 0.0 112.863 -169.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -108.1 157.37 18.33 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 124.956 1.302 . . . . 0.0 110.521 163.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -76.08 68.89 2.6 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.978 1.311 . . . . 0.0 110.186 173.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.8 p -61.51 127.33 21.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 122.73 1.252 . . . . 0.0 111.16 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.79 -23.78 74.0 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 114.505 -1.225 . . . . 0.0 112.744 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 127.189 2.196 . . . . 0.0 110.08 -178.699 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.654 0 CA-C-O 118.621 -1.099 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.4 mtt85 56.11 -18.25 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 128.468 2.707 . . . . 0.0 117.919 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -178.35 2.61 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 127.804 2.442 . . . . 0.0 109.912 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.412 ' HD2' HG22 ' A' ' 29' ' ' ILE . 20.6 mtm-85 -119.91 149.42 42.13 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.842 0.857 . . . . 0.0 110.083 -178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' A' ' 60' ' ' VAL . 12.6 m -133.07 164.29 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 124.466 1.106 . . . . 0.0 110.994 -174.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.462 ' HB2' HG11 ' A' ' 60' ' ' VAL . 42.6 ttm180 -135.88 130.48 33.91 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.368 1.067 . . . . 0.0 109.446 -170.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.8 135.71 51.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 174.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.84 2.76 8.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 123.986 0.914 . . . . 0.0 111.005 169.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 23.3 mt -141.08 153.39 66.93 Favored Pre-proline 0 CA--C 1.53 0.179 0 C-N-CA 124.818 1.247 . . . . 0.0 108.522 172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -82.18 158.15 17.62 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.503 2.802 . . . . 0.0 110.538 175.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -149.09 120.54 7.93 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 121.679 -0.638 . . . . 0.0 111.399 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.6 m -78.03 113.13 15.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.518 0.727 . . . . 0.0 109.264 167.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 pttm -65.55 156.74 31.7 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 121.115 -0.234 . . . . 0.0 111.234 168.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.8 t -73.17 146.21 86.76 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 160.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.23 172.23 12.48 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 123.995 3.13 . . . . 0.0 111.403 165.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t70 64.43 5.87 2.83 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.468 1.507 . . . . 0.0 113.559 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 34.2 p -119.27 176.11 5.48 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 119.744 -1.848 . . . . 0.0 110.173 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -80.33 10.46 4.54 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.031 1.332 . . . . 0.0 110.065 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -78.33 160.77 27.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.645 1.578 . . . . 0.0 110.669 -170.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.8 pt -131.65 132.36 62.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 171.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 70.9 p -75.59 162.21 28.47 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 170.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -157.48 166.28 33.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.929 0.892 . . . . 0.0 109.211 174.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -113.23 162.5 15.93 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.736 0.814 . . . . 0.0 109.139 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -57.17 125.51 23.05 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 166.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.21 -6.74 58.16 Favored Glycine 0 CA--C 1.525 0.681 0 CA-C-O 117.044 -1.975 . . . . 0.0 113.388 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -65.99 160.28 23.96 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.702 2.251 . . . . 0.0 110.19 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 2.2 mtp -134.99 153.48 52.07 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.805 0.812 . . . . 0.0 111.557 178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -146.26 165.55 28.9 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.273 -1.33 . . . . 0.0 111.755 -168.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.412 HG22 ' HD2' ' A' ' 4' ' ' ARG . 4.4 pt -122.87 128.35 75.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.773 1.629 . . . . 0.0 107.933 -170.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.2 t -67.36 131.39 32.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 120.73 1.605 . . . . 0.0 108.637 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -132.75 -30.16 1.44 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -148.99 165.84 30.43 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 119.172 0.896 . . . . 0.0 109.253 166.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -133.92 124.28 26.13 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 127.987 2.515 . . . . 0.0 105.063 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.3 -178.29 3.84 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.943 1.297 . . . . 0.0 110.691 -171.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -132.37 79.49 1.86 Allowed 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 125.488 1.515 . . . . 0.0 107.761 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -168.29 -0.74 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.505 0.722 . . . . 0.0 112.742 176.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.34 25.9 38.16 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.236 0.922 . . . . 0.0 112.031 -166.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -136.06 160.02 39.93 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.178 1.791 . . . . 0.0 108.053 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 35.8 mtm -147.79 158.31 43.96 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.4 t-105 -95.25 134.84 37.56 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 119.837 1.199 . . . . 0.0 111.053 170.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.4 m -142.53 175.1 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 126.247 1.819 . . . . 0.0 108.971 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.5 m -114.47 135.54 54.0 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 162.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -82.45 120.13 25.07 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.032 0.933 . . . . 0.0 109.261 172.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.31 -5.48 3.51 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.283 1.033 . . . . 0.0 113.047 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 ttp180 -63.76 -37.59 87.95 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 117.546 -1.216 . . . . 0.0 111.138 172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.3 t -164.0 13.93 0.05 Allowed 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 119.986 1.266 . . . . 0.0 113.742 -171.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.6 t70 73.81 5.01 4.79 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.899 1.679 . . . . 0.0 113.463 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -54.5 116.86 2.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.101 1.76 . . . . 0.0 109.244 167.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.76 165.49 11.35 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 166.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 157.47 -146.62 13.86 Favored Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.68 142.02 45.78 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 124.687 1.195 . . . . 0.0 110.716 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -139.5 147.9 23.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.601 0 C-N-CA 129.724 3.209 . . . . 0.0 107.063 176.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.6 p -88.78 144.77 8.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -68.39 -12.84 61.74 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -69.97 -16.19 63.15 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.152 1.381 . . . . 0.0 114.109 -171.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.5 mt -125.51 6.52 7.6 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.378 1.071 . . . . 0.0 112.363 -162.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.8 m -120.03 156.9 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 124.634 1.174 . . . . 0.0 110.536 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -116.45 153.35 32.27 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.846 1.258 . . . . 0.0 110.257 173.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -77.6 63.95 2.81 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.043 172.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.462 HG11 ' HB2' ' A' ' 6' ' ' ARG . 6.5 p -60.73 151.67 6.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 O-C-N 120.888 -1.133 . . . . 0.0 111.609 174.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -133.21 35.41 2.29 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.122 1.344 . . . . 0.0 113.008 179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.451 HH11 HG13 ' A' ' 60' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.259 0 CA-C-O 116.99 -1.481 . . . . 0.0 112.398 176.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.758 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.7 ttt-85 -150.67 114.94 5.11 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.471 ' H ' ' CG1' ' A' ' 30' ' ' VAL . 3.4 ttt85 -109.56 -164.48 0.94 Allowed 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.671 1.588 . . . . 0.0 109.78 -170.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -134.28 161.53 34.68 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 125.063 1.345 . . . . 0.0 108.872 159.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.6 m -131.3 164.86 33.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 162.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.466 HH21 ' HD3' ' A' ' 62' ' ' ARG . 32.7 ttm180 -128.73 140.9 51.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.606 -1.628 . . . . 0.0 106.606 174.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.87 141.82 51.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 120.004 1.274 . . . . 0.0 109.714 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.97 2.5 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 124.039 0.936 . . . . 0.0 111.729 170.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.2 mt -143.4 157.04 60.29 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 126.085 1.754 . . . . 0.0 107.353 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -88.38 167.47 6.38 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.695 2.93 . . . . 0.0 110.795 176.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -156.74 167.14 31.35 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.934 0.494 . . . . 0.0 111.13 173.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.3 m -124.43 115.5 21.03 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.18 2.192 . . . . 0.0 107.278 171.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HE2' ' HA ' ' A' ' 15' ' ' PRO . 0.9 OUTLIER -61.15 157.34 16.19 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.888 172.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 t -73.02 135.87 79.95 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 162.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.493 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 95.1 Cg_endo -70.12 163.9 36.88 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.146 1.898 . . . . 0.0 109.197 171.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.4 t70 63.2 18.27 10.84 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.601 0.715 . . . . 0.0 112.135 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.3 p -130.9 169.41 15.82 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.675 1.59 . . . . 0.0 108.699 172.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -85.42 3.81 38.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.458 1.503 . . . . 0.0 111.428 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -69.97 167.02 18.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.28 1.832 . . . . 0.0 110.184 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.4 pt -140.14 129.31 27.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 120.885 -1.134 . . . . 0.0 110.057 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 69.5 m -63.82 160.73 16.76 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.785 0.72 . . . . 0.0 110.105 177.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -161.44 173.53 14.76 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.276 0.56 . . . . 0.0 110.588 175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mt -125.28 159.71 31.03 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.102 1.361 . . . . 0.0 109.773 -175.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -58.29 120.47 8.76 Favored 'General case' 0 N--CA 1.457 -0.093 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.29 2.24 59.11 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-O 117.678 -1.623 . . . . 0.0 113.117 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -69.84 158.42 35.53 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 120.893 2.346 . . . . 0.0 108.034 168.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 11.4 ttt -120.04 134.24 55.31 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 126.057 1.743 . . . . 0.0 110.986 176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CE1' HG21 ' A' ' 52' ' ' ILE . 93.3 m-85 -111.66 165.41 12.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 122.554 1.168 . . . . 0.0 109.045 177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 11.9 pt -118.92 138.67 48.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 163.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.471 ' CG1' ' H ' ' A' ' 3' ' ' ARG . 2.3 p -73.99 141.43 16.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 170.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.29 -21.07 1.61 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.767 1.227 . . . . 0.0 112.596 177.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -150.28 160.54 43.63 Favored 'General case' 0 CA--C 1.513 -0.463 0 C-N-CA 124.211 1.004 . . . . 0.0 109.87 169.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -120.55 118.15 29.45 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 127.32 2.248 . . . . 0.0 105.451 -176.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mt -109.82 -169.05 1.4 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.846 1.258 . . . . 0.0 107.876 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -135.29 14.13 3.51 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -164.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -130.83 34.23 4.12 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 125.787 1.635 . . . . 0.0 110.54 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.41 13.64 81.49 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.05 1.31 . . . . 0.0 113.709 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -112.65 156.27 23.02 Favored 'General case' 0 C--O 1.232 0.133 0 C-N-CA 125.119 1.368 . . . . 0.0 110.272 -176.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.5 mtm -144.83 145.93 31.86 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.707 1.203 . . . . 0.0 108.399 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -78.73 141.62 37.72 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 164.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.49 -175.56 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-O 122.436 1.112 . . . . 0.0 111.15 -175.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 m -135.51 125.22 25.39 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 160.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -77.05 102.74 6.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.9 -14.29 21.32 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.5 ttp180 -61.43 -19.15 61.64 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 117.181 -1.39 . . . . 0.0 112.679 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.8 t -164.42 11.14 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 119.799 1.181 . . . . 0.0 112.945 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 61.78 20.44 11.41 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.285 1.402 . . . . 0.0 112.509 -172.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -65.17 104.58 0.93 Allowed 'General case' 0 C--O 1.232 0.142 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -93.81 156.25 16.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.87 -166.53 31.95 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -174.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -97.08 143.55 27.8 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 124.495 1.118 . . . . 0.0 109.861 -178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.406 HG21 ' CE1' ' A' ' 28' ' ' PHE . 1.9 pp -134.38 151.1 31.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 125.12 1.368 . . . . 0.0 108.702 169.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.1 p -85.54 137.82 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.5 pt-20 -64.11 -18.79 64.75 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.317 1.047 . . . . 0.0 112.679 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.48 -18.27 63.61 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.551 1.14 . . . . 0.0 113.341 -166.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.6 mt -124.07 10.42 8.78 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.547 1.539 . . . . 0.0 111.652 -164.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.4 m -119.65 171.77 7.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.565 1.146 . . . . 0.0 110.864 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -130.39 152.47 49.75 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 127.941 2.496 . . . . 0.0 109.359 176.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -70.69 73.29 0.55 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.583 1.153 . . . . 0.0 109.901 174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 62' ' ' ARG . 6.7 p -63.71 152.3 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 120.206 -1.558 . . . . 0.0 109.14 172.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -141.73 17.59 2.61 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 124.483 1.04 . . . . 0.0 111.722 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.466 ' HD3' HH21 ' A' ' 6' ' ' ARG . 32.5 ptt180 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 117.111 -1.423 . . . . 0.0 110.073 -175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.919 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.04 154.1 44.72 Favored 'General case' 0 C--O 1.239 0.545 0 O-C-N 121.428 -1.042 . . . . 0.0 109.018 167.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.23 -164.64 1.27 Allowed 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.121 1.368 . . . . 0.0 109.271 -170.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.405 ' HD3' HG22 ' A' ' 29' ' ' ILE . 74.5 mtt180 -132.27 154.68 49.43 Favored 'General case' 0 CA--C 1.517 -0.293 0 O-C-N 121.343 -0.848 . . . . 0.0 109.719 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.8 m -130.89 166.54 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.433 0.693 . . . . 0.0 109.147 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 ttp85 -138.01 136.26 36.72 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 120.857 -1.152 . . . . 0.0 110.402 -177.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.45 120.53 16.23 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.266 1.027 . . . . 0.0 110.06 173.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -88.6 -4.02 9.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.137 172.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.676 HD11 HD22 ' A' ' 56' ' ' LEU 0.28 2.1 pp -162.57 152.75 13.84 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.398 1.479 . . . . 0.0 108.519 -171.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -80.67 160.86 21.89 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 123.684 2.922 . . . . 0.0 112.336 -174.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -143.22 163.01 34.12 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.371 1.868 . . . . 0.0 109.2 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.8 m -128.77 105.82 8.51 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.542 1.137 . . . . 0.0 108.439 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.42 157.02 38.42 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.991 0.517 . . . . 0.0 110.571 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.3 t -87.82 141.35 31.62 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -173.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -70.68 141.96 42.74 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 O-C-N 118.418 -1.412 . . . . 0.0 109.212 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.9 t70 75.45 33.93 0.64 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.652 1.981 . . . . 0.0 112.753 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.6 p -132.47 167.19 20.41 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.046 -1.034 . . . . 0.0 111.594 176.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.5 20.39 0.07 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 128.941 2.897 . . . . 0.0 111.814 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -110.04 169.3 8.82 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.27 1.428 . . . . 0.0 110.678 -160.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -140.15 150.55 21.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 125.243 1.417 . . . . 0.0 109.063 174.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 p -95.77 167.24 11.39 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -161.74 156.59 23.08 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -108.78 174.07 6.03 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.417 1.103 . . . . 0.0 108.905 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.3 tttt -57.98 123.54 16.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 168.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.02 1.54 57.13 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-O 118.359 -1.245 . . . . 0.0 114.486 176.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.39 162.66 22.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.38 1.59 . . . . 0.0 111.249 174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.498 ' SD ' ' HD2' ' A' ' 62' ' ' ARG . 25.5 ttt -137.14 145.58 43.99 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.135 1.374 . . . . 0.0 108.822 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -138.09 175.38 9.63 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.432 1.093 . . . . 0.0 109.937 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.405 HG22 ' HD3' ' A' ' 4' ' ' ARG . 10.8 pt -126.13 138.69 53.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 125.558 1.543 . . . . 0.0 106.877 176.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -76.92 136.13 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 118.684 0.675 . . . . 0.0 109.763 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -139.19 -18.36 1.01 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -155.66 164.88 38.03 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.363 1.438 . . . . 0.0 108.912 159.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -135.89 114.07 11.45 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.323 1.849 . . . . 0.0 106.384 -167.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -114.08 154.03 28.43 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.063 0.945 . . . . 0.0 111.384 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -92.91 48.09 1.32 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.575 1.15 . . . . 0.0 110.927 -164.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -161.28 34.78 0.14 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.275 1.03 . . . . 0.0 110.443 173.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.83 -2.82 58.54 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.441 1.019 . . . . 0.0 114.223 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -87.54 153.6 21.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.516 1.158 . . . . 0.0 110.886 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.1 mtm -143.93 134.61 25.0 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -76.75 138.99 40.26 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 167.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.0 m -143.31 -176.35 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 122.332 1.063 . . . . 0.0 111.554 -174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.4 m -127.8 126.51 41.85 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 155.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -79.09 116.14 19.19 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.622 1.969 . . . . 0.0 108.853 169.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mt -87.28 13.86 8.93 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.542 -0.724 . . . . 0.0 112.391 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 28.9 ttp85 -79.97 -16.54 55.01 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 120.328 -1.483 . . . . 0.0 111.058 170.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -163.77 7.35 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 118.539 0.609 . . . . 0.0 112.233 -173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 63.23 23.83 14.04 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 126.055 1.742 . . . . 0.0 112.682 -172.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -66.8 108.33 2.49 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.658 0.783 . . . . 0.0 109.361 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.9 mp0 -87.87 149.38 24.14 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.655 -0.653 . . . . 0.0 110.147 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 158.71 -171.93 35.49 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 125.311 1.434 . . . . 0.0 109.965 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.1 mt -89.93 138.83 31.17 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.52 1.128 . . . . 0.0 112.303 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -134.23 162.87 38.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 127.194 2.197 . . . . 0.0 108.217 166.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.7 p -109.59 146.19 15.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 123.89 0.876 . . . . 0.0 109.163 -175.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -68.22 -17.33 64.29 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.278 1.431 . . . . 0.0 112.255 -177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -61.22 -29.23 69.7 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 123.917 0.887 . . . . 0.0 111.705 -177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.676 HD22 HD11 ' A' ' 9' ' ' LEU . 50.2 mt -115.97 5.22 13.91 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.58 1.152 . . . . 0.0 111.03 -161.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 29.1 m -119.36 165.84 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 124.87 1.268 . . . . 0.0 110.882 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -120.66 152.69 37.88 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 125.782 1.633 . . . . 0.0 108.681 172.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -78.7 69.93 4.96 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 124.652 1.181 . . . . 0.0 109.573 175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 62' ' ' ARG . 2.5 p -70.98 165.27 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.586 0.708 . . . . 0.0 109.429 173.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -132.92 13.52 5.0 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 124.26 0.934 . . . . 0.0 112.851 171.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.498 ' HD2' ' SD ' ' A' ' 27' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.959 0 CA-C-O 117.432 -1.271 . . . . 0.0 110.826 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.718 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 36.6 ptt180 -137.35 -4.89 1.84 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.6 128.05 42.14 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.517 ' HD3' HG22 ' A' ' 29' ' ' ILE . 17.5 mtt180 -134.19 166.91 21.68 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 170.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.01 154.97 37.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.416 1.087 . . . . 0.0 108.688 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -119.12 133.55 55.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 57' ' ' VAL . . . -84.7 154.63 22.35 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.505 1.048 . . . . 0.0 109.724 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.21 11.56 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.196 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.59 161.7 32.46 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.455 2.302 . . . . 0.0 107.859 173.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -86.46 162.27 9.6 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.927 3.085 . . . . 0.0 111.646 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -159.13 132.05 6.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.776 1.231 . . . . 0.0 110.604 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 t -97.07 137.79 35.6 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 172.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -89.16 139.08 30.84 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 117.826 -1.083 . . . . 0.0 110.342 -177.119 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.1 t -66.46 134.59 94.51 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 120.242 1.383 . . . . 0.0 108.267 175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 60.3 Cg_endo -67.58 162.12 40.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.126 1.884 . . . . 0.0 109.773 168.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 75.48 -11.44 1.1 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.04 2.136 . . . . 0.0 113.129 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.9 p -118.6 169.0 10.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.564 1.146 . . . . 0.0 111.057 175.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -92.15 21.31 5.19 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.71 1.604 . . . . 0.0 111.358 -167.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 -68.35 163.83 22.21 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 120.492 -1.38 . . . . 0.0 109.749 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.3 pt -130.74 138.67 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 O-C-N 120.869 -1.144 . . . . 0.0 111.01 169.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 62.5 m -73.56 156.09 38.46 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -147.29 165.21 30.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 122.303 1.049 . . . . 0.0 110.635 164.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.19 166.11 11.35 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.9 tttm -64.88 125.97 26.5 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.0 47.93 1.21 Allowed Glycine 0 CA--C 1.527 0.832 0 C-N-CA 125.007 1.289 . . . . 0.0 113.26 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -145.7 167.14 23.84 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 126.206 1.802 . . . . 0.0 108.998 177.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.3 mtp -138.03 149.75 46.33 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 124.103 0.961 . . . . 0.0 111.032 -173.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -136.33 159.94 40.24 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.826 1.25 . . . . 0.0 109.701 -173.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.517 HG22 ' HD3' ' A' ' 4' ' ' ARG . 15.9 pt -110.52 138.4 38.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.27 129.12 33.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -121.17 -32.07 3.99 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 118.544 -0.741 . . . . 0.0 111.107 174.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -152.15 162.44 41.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 119.066 0.848 . . . . 0.0 111.043 167.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -108.54 132.97 53.31 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 126.632 1.973 . . . . 0.0 106.813 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.3 mt -125.82 -168.53 1.86 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.106 1.762 . . . . 0.0 107.364 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -135.68 14.04 3.42 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.583 1.083 . . . . 0.0 113.831 -158.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -120.25 16.13 12.29 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 125.363 1.465 . . . . 0.0 111.55 -168.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.84 13.59 69.22 Favored Glycine 0 CA--C 1.527 0.819 0 O-C-N 120.669 -1.27 . . . . 0.0 111.862 -168.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -125.86 150.27 48.01 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.685 1.594 . . . . 0.0 109.706 -169.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 56.8 mtm -142.96 144.39 32.33 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.827 1.251 . . . . 0.0 108.91 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.8 t-105 -81.62 135.6 35.55 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 122.999 0.52 . . . . 0.0 110.302 170.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.9 m -142.39 175.24 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 124.416 1.086 . . . . 0.0 110.268 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.3 m -112.38 134.86 53.68 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 104.343 -2.466 . . . . 0.0 104.343 154.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -76.54 165.08 25.3 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 166.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 20.4 mt -88.62 -35.11 17.03 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 121.927 2.149 . . . . 0.0 113.213 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -51.89 -29.22 18.98 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 117.22 2.304 . . . . 0.0 117.22 -165.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . 0.251 9.5 t -152.96 18.26 0.58 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.224 1.81 . . . . 0.0 112.593 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 52.36 26.89 4.39 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.222 1.809 . . . . 0.0 112.5 -172.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -66.1 148.3 52.02 Favored 'General case' 0 N--CA 1.468 0.43 0 O-C-N 120.643 -1.286 . . . . 0.0 111.234 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -137.87 144.88 41.59 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.061 0.945 . . . . 0.0 108.457 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 148.56 -157.51 27.32 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -175.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.7 147.01 27.75 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.895 0.878 . . . . 0.0 112.437 -165.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.1 pt -136.01 147.97 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 126.674 1.99 . . . . 0.0 110.909 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 p -91.92 138.01 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.025 1.33 . . . . 0.0 109.732 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.75 -0.78 22.13 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.661 1.184 . . . . 0.0 112.849 -172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.04 -24.12 65.96 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.793 1.637 . . . . 0.0 112.86 179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.4 mt -127.94 13.86 6.83 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.36 1.064 . . . . 0.0 112.665 -158.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 2.4 m -122.66 170.79 12.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 126.318 1.847 . . . . 0.0 111.489 -176.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -132.23 155.68 47.83 Favored 'General case' 0 C--O 1.242 0.691 0 C-N-CA 127.772 2.429 . . . . 0.0 109.748 172.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -69.8 78.41 0.45 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.72 168.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.6 p -68.7 165.53 2.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 O-C-N 120.911 -1.118 . . . . 0.0 108.81 162.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -153.93 19.13 0.66 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.653 1.597 . . . . 0.0 110.977 175.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.6 mtt-85 . . . . . 0 C--O 1.249 1.058 0 C-N-CA 125.715 1.606 . . . . 0.0 108.993 -170.287 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.883 0 CA-C-O 117.816 -1.547 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.9 mtm-85 51.62 61.11 3.39 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.418 1.109 . . . . 0.0 111.316 167.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.619 ' NH2' HG13 ' A' ' 5' ' ' VAL 0.257 0.0 OUTLIER -147.74 -162.14 1.48 Allowed 'General case' 0 C--O 1.234 0.247 0 C-N-CA 125.249 1.42 . . . . 0.0 107.279 -167.685 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 28.0 mtm180 -117.42 173.71 6.55 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 119.553 -1.967 . . . . 0.0 109.876 174.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.619 HG13 ' NH2' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -126.1 160.18 33.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 120.512 -1.367 . . . . 0.0 110.531 171.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -122.72 118.51 28.24 Favored 'General case' 0 C--O 1.226 -0.168 0 C-N-CA 125.784 1.633 . . . . 0.0 108.974 -170.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.02 127.11 31.96 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 123.467 0.707 . . . . 0.0 109.433 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.96 -0.16 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 123.371 0.669 . . . . 0.0 111.762 172.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.4 161.39 29.42 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 125.817 1.647 . . . . 0.0 109.011 175.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -87.23 160.47 8.43 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 124.243 3.296 . . . . 0.0 111.25 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -151.74 166.2 32.07 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 124.633 1.173 . . . . 0.0 110.361 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 t -125.74 136.08 52.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.742 -1.947 . . . . 0.0 105.742 -172.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -70.01 150.54 46.54 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 118.806 -1.157 . . . . 0.0 108.776 171.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.2 t -75.27 137.53 71.83 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 172.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.28 146.38 69.18 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 N-CA-C 108.446 -1.405 . . . . 0.0 108.446 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.5 t70 75.62 4.94 4.01 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.76 2.024 . . . . 0.0 113.408 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.6 p -108.91 -177.17 3.24 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 120.339 -1.475 . . . . 0.0 112.187 -175.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -83.93 -17.47 40.59 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.102 1.361 . . . . 0.0 109.843 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.03 165.18 18.5 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 125.369 1.468 . . . . 0.0 111.954 -164.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.1 pt -127.43 134.15 66.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 124.806 1.242 . . . . 0.0 109.68 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.33 160.76 12.63 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.735 0.814 . . . . 0.0 108.948 173.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -157.43 173.33 17.07 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 121.935 0.874 . . . . 0.0 113.117 170.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.4 mt -127.96 160.98 30.21 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.111 1.364 . . . . 0.0 109.097 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -62.1 141.47 58.11 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 173.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.92 -4.78 81.82 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 124.681 1.134 . . . . 0.0 114.055 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.3 168.51 19.02 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 119.007 1.404 . . . . 0.0 109.017 171.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 38.1 mtp -135.51 150.66 49.83 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.89 0.876 . . . . 0.0 109.525 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -136.06 159.06 42.86 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.91 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 29' ' ' ILE . 4.7 pt -112.16 125.19 69.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -175.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.521 HG12 ' O ' ' A' ' 3' ' ' ARG . 1.6 p -63.71 112.45 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.21 -38.32 5.79 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.745 0.818 . . . . 0.0 110.047 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -148.08 172.34 14.42 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 171.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -133.07 133.52 43.1 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -175.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.405 ' CD1' HD21 ' A' ' 51' ' ' LEU . 38.1 mt -120.33 -168.82 1.69 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.615 1.166 . . . . 0.0 109.056 -176.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -136.31 57.78 1.76 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.452 1.101 . . . . 0.0 109.094 -173.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -154.06 22.43 0.5 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.214 171.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.98 23.23 69.61 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 120.145 -1.597 . . . . 0.0 112.296 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 72.3 m95 -130.34 148.47 52.16 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.759 2.024 . . . . 0.0 108.534 -170.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 32.0 mtm -144.77 132.63 21.26 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 26.1 t-105 -72.13 134.62 45.85 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.5 m -143.88 178.88 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 123.349 0.659 . . . . 0.0 111.793 -177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 5.2 m -115.03 143.59 44.94 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 154.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -86.47 119.6 26.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.384 1.073 . . . . 0.0 110.105 168.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.98 1.31 2.77 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.478 1.111 . . . . 0.0 113.465 178.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -66.3 -46.45 76.92 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 120.219 -1.551 . . . . 0.0 110.423 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -146.13 -3.43 0.66 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.254 1.022 . . . . 0.0 112.551 -157.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.4 t70 68.21 11.54 8.4 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.172 1.789 . . . . 0.0 112.907 -174.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -61.14 118.34 6.69 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.111 0.964 . . . . 0.0 108.744 167.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 42' ' ' THR . 9.5 mp0 -81.84 168.67 17.73 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.385 0.612 . . . . 0.0 110.694 166.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 150.82 -165.45 30.16 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 108.177 -1.969 . . . . 0.0 108.177 171.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD21 ' CD1' ' A' ' 34' ' ' LEU . 9.6 mt -99.4 143.83 29.2 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.701 0.8 . . . . 0.0 110.825 -171.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.19 151.34 33.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 C-N-CA 125.446 1.498 . . . . 0.0 109.035 169.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.2 p -88.58 135.84 24.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 125.952 1.701 . . . . 0.0 107.934 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.34 -10.29 59.43 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -175.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -56.65 -18.4 12.07 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.718 2.407 . . . . 0.0 113.717 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -131.11 13.48 5.17 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.024 1.33 . . . . 0.0 113.296 -164.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.75 153.91 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 124.237 1.015 . . . . 0.0 112.395 -175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -117.69 148.29 42.13 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.848 1.659 . . . . 0.0 111.076 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.97 100.86 2.05 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 128.97 2.908 . . . . 0.0 110.139 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.542 ' CG2' ' HE ' ' A' ' 62' ' ' ARG . 4.4 p -120.11 147.01 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.873 0.844 . . . . 0.0 111.543 -174.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -99.13 57.18 0.9 Allowed Glycine 0 CA--C 1.519 0.325 0 C-N-CA 124.572 1.082 . . . . 0.0 111.258 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.542 ' HE ' ' CG2' ' A' ' 60' ' ' VAL . 31.0 mtt-85 . . . . . 0 C--O 1.242 0.679 0 C-N-CA 125.133 1.373 . . . . 0.0 107.783 -177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.607 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -139.58 133.13 30.31 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.98 113.9 12.66 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -119.8 159.51 24.41 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.631 1.572 . . . . 0.0 108.469 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.3 m -137.9 164.83 27.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 167.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.2 tpp85 -128.08 129.91 47.38 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.458 1.503 . . . . 0.0 107.349 -173.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.28 125.06 25.96 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 120.463 1.483 . . . . 0.0 108.944 171.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.28 0.2 OUTLIER -113.36 4.05 8.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 118.836 -0.602 . . . . 0.0 111.423 170.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 11.8 mt -146.28 157.66 48.9 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 125.833 1.653 . . . . 0.0 109.176 165.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -82.31 166.77 15.99 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 124.82 3.68 . . . . 0.0 111.584 -178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -153.0 163.58 39.58 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.605 1.162 . . . . 0.0 109.218 173.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -124.31 120.66 32.83 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 125.528 1.531 . . . . 0.0 109.049 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -61.33 149.14 39.06 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 124.536 1.147 . . . . 0.0 111.22 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.7 t -70.3 135.45 86.73 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 167.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -62.55 153.44 71.49 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.1 2.533 . . . . 0.0 110.221 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t0 59.36 38.91 22.78 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.078 1.351 . . . . 0.0 111.842 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.4 p -138.45 166.03 25.31 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.031 0.932 . . . . 0.0 111.84 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.13 -13.55 48.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 128.867 2.867 . . . . 0.0 113.055 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -63.49 170.11 3.36 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.181 1.793 . . . . 0.0 113.171 -171.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 pt -131.05 136.71 57.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 124.743 1.217 . . . . 0.0 110.288 171.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -72.99 149.71 43.06 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.271 1.428 . . . . 0.0 110.9 174.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -155.11 158.66 39.36 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 120.689 -1.257 . . . . 0.0 112.806 171.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -106.66 170.32 8.0 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.904 0.859 . . . . 0.0 109.458 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.7 tttm -56.98 134.97 56.17 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 168.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.42 -11.13 56.69 Favored Glycine 0 CA--C 1.525 0.718 0 CA-C-O 118.872 -0.96 . . . . 0.0 114.148 171.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.26 167.74 19.76 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.673 1.236 . . . . 0.0 108.897 160.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 18.7 ptm -144.67 168.15 20.85 Favored 'General case' 0 N--CA 1.423 -1.781 0 C-N-CA 124.083 0.953 . . . . 0.0 109.317 170.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -138.42 163.75 31.11 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.608 1.163 . . . . 0.0 109.614 -164.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.5 pt -127.4 130.94 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 125.283 1.433 . . . . 0.0 107.393 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.0 t -66.94 127.8 29.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -127.55 -15.18 5.09 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 123.715 0.806 . . . . 0.0 113.106 172.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -150.18 166.42 29.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 156.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -121.53 124.68 44.98 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 mt -115.51 -167.49 1.26 Allowed 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -138.48 68.58 1.39 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.398 1.479 . . . . 0.0 107.594 -170.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -168.16 15.8 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.395 1.478 . . . . 0.0 112.312 174.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.96 37.89 88.28 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.13 1.347 . . . . 0.0 111.848 -169.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -137.72 149.17 46.27 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.588 1.955 . . . . 0.0 107.259 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 36.2 mtm -134.98 142.99 46.6 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 124.601 1.161 . . . . 0.0 108.689 177.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -78.1 135.66 37.74 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 165.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.57 -173.34 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 122.361 1.077 . . . . 0.0 110.804 -174.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 20.7 m -131.09 147.31 52.6 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 157.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -97.55 132.01 43.62 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.5 mt -68.01 -10.1 50.99 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 118.372 -0.823 . . . . 0.0 112.47 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 -65.48 -43.13 91.18 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 120.37 1.441 . . . . 0.0 112.11 -176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 58.2 p -143.7 9.56 1.56 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.405 1.082 . . . . 0.0 111.738 -171.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.1 t70 58.31 32.67 22.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.002 0.921 . . . . 0.0 111.429 -167.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -72.29 140.8 48.76 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 120.913 -1.117 . . . . 0.0 109.417 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -126.45 151.86 47.17 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 146.62 -155.92 26.76 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 39.6 mt -108.81 141.88 40.18 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.335 1.054 . . . . 0.0 110.54 -164.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -134.8 150.75 30.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.791 1.637 . . . . 0.0 109.292 171.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.4 p -89.33 146.59 5.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 125.901 1.68 . . . . 0.0 109.47 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -87.72 10.71 17.36 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.84 -24.45 60.89 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.564 1.146 . . . . 0.0 113.822 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -125.46 16.28 8.25 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -156.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.93 170.52 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.013 0.925 . . . . 0.0 112.353 -168.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -122.86 151.94 41.23 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 121.133 -0.979 . . . . 0.0 109.827 160.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.94 57.58 2.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 128.691 2.797 . . . . 0.0 111.3 -172.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.6 p -63.14 156.4 4.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 120.525 -1.359 . . . . 0.0 111.769 -176.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.21 5.58 57.63 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 125.476 1.512 . . . . 0.0 113.158 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 . . . . . 0 C--O 1.245 0.823 0 C-N-CA 124.581 1.152 . . . . 0.0 112.351 -174.613 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.937 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.3 mtt85 -84.48 65.44 8.95 Favored 'General case' 0 C--N 1.332 -0.175 0 O-C-N 121.275 -1.132 . . . . 0.0 109.7 177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.419 ' HB3' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -138.43 148.45 44.43 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 179.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -133.28 150.23 51.91 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.464 1.506 . . . . 0.0 108.34 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.74 164.25 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 120.071 1.305 . . . . 0.0 108.82 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.9 tpp180 -112.17 141.53 45.74 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.533 ' HB1' ' CE2' ' A' ' 22' ' ' PHE . . . -92.52 139.49 30.52 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 119.612 1.097 . . . . 0.0 111.016 175.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.68 12.77 6.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 C-N-CA 124.159 0.984 . . . . 0.0 112.507 -172.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.8 158.61 33.96 Favored Pre-proline 0 N--CA 1.478 0.954 0 C-N-CA 125.198 1.399 . . . . 0.0 108.548 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -88.54 163.36 6.56 Favored 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.541 3.494 . . . . 0.0 111.635 171.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -158.67 141.29 14.33 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.836 1.254 . . . . 0.0 110.207 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.9 m -103.74 118.12 35.97 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.923 1.289 . . . . 0.0 109.959 174.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' A' ' 15' ' ' PRO . 0.0 OUTLIER -78.63 160.42 27.56 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.868 0.867 . . . . 0.0 111.937 175.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.4 t -89.39 130.46 43.66 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 125.698 1.599 . . . . 0.0 108.235 176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 8.3 Cg_endo -64.84 159.2 46.96 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.716 1.611 . . . . 0.0 112.854 173.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . 0.251 2.9 t70 69.61 27.71 4.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.675 1.99 . . . . 0.0 112.306 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.0 p -131.4 -178.78 5.0 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.461 1.105 . . . . 0.0 110.921 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.74 8.65 36.05 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.313 2.645 . . . . 0.0 109.465 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -84.45 175.59 9.23 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.605 -1.309 . . . . 0.0 109.174 -178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.9 pt -148.64 144.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 127.2 2.2 . . . . 0.0 107.676 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 77.5 p -102.23 169.15 8.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 121.892 2.133 . . . . 0.0 111.205 174.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.533 ' CE2' ' HB1' ' A' ' 7' ' ' ALA . 9.4 p90 -170.18 -171.23 1.09 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.12 0.486 . . . . 0.0 112.234 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.1 mt -128.44 153.22 47.34 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.888 1.675 . . . . 0.0 109.471 -175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -52.31 127.31 21.74 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.522 -0.736 . . . . 0.0 109.079 168.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.72 -10.49 32.48 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 124.725 1.155 . . . . 0.0 114.211 177.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.38 158.49 35.69 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.363 1.581 . . . . 0.0 110.197 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.5 ttt -114.49 148.94 37.1 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.471 1.108 . . . . 0.0 108.286 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -125.85 162.66 24.64 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.289 1.036 . . . . 0.0 109.992 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 pt -128.37 127.49 67.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 C-N-CA 125.357 1.463 . . . . 0.0 108.99 -175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' A' ' 3' ' ' ARG . 68.5 t -68.78 101.22 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 119.362 0.983 . . . . 0.0 109.354 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -95.3 -34.49 12.16 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 121.199 -0.938 . . . . 0.0 111.108 177.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -149.3 175.05 11.76 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.618 1.167 . . . . 0.0 109.021 169.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -138.93 127.32 22.91 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.851 2.46 . . . . 0.0 104.96 -174.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.7 mt -115.1 -163.01 0.85 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.293 1.437 . . . . 0.0 109.508 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -134.46 44.11 2.71 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.296 -1.502 . . . . 0.0 113.282 -168.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.91 1.48 0.24 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.888 1.275 . . . . 0.0 112.074 -157.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.55 5.0 90.26 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.1 1.333 . . . . 0.0 113.263 -167.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.596 ' CZ2' HG13 ' A' ' 53' ' ' VAL . 84.7 m95 -112.26 149.55 32.17 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.962 2.105 . . . . 0.0 110.861 -175.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 61.7 mtm -149.12 143.65 26.13 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 120.764 -1.21 . . . . 0.0 110.084 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.8 t-105 -86.7 136.66 32.94 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 118.099 0.409 . . . . 0.0 111.016 174.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.5 m -147.7 -167.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 123.835 0.854 . . . . 0.0 111.413 -172.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 45.3 m -140.05 150.99 45.04 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 159.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.71 107.3 18.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.143 2.177 . . . . 0.0 108.075 -173.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.1 mt -68.7 1.18 3.43 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -71.35 -27.13 63.15 Favored 'General case' 0 C--O 1.235 0.323 0 O-C-N 120.311 -1.493 . . . . 0.0 113.165 169.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 t -167.39 13.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 -165.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 t0 60.75 32.8 20.24 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 123.509 1.623 . . . . 0.0 111.52 -174.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -74.88 99.56 3.83 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 120.797 -1.189 . . . . 0.0 108.366 172.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -81.99 139.53 34.49 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 125.57 1.548 . . . . 0.0 109.551 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 165.99 -169.17 40.13 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.417 179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 30.9 mt -89.95 139.62 30.42 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.916 2.086 . . . . 0.0 112.997 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.31 158.52 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.147 1.779 . . . . 0.0 111.177 174.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.596 HG13 ' CZ2' ' A' ' 38' ' ' TRP . 0.0 OUTLIER -89.96 152.86 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 C-N-CA 124.126 0.97 . . . . 0.0 111.646 164.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.53 -22.89 67.15 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 114.521 -1.218 . . . . 0.0 112.285 164.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.57 ' H ' ' HB ' ' A' ' 53' ' ' VAL . 23.3 t70 -62.57 -17.01 59.16 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 122.937 1.351 . . . . 0.0 112.48 -164.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.9 mt -124.83 6.04 8.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.567 1.547 . . . . 0.0 110.885 -160.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.2 m -124.94 159.14 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.77 1.228 . . . . 0.0 109.476 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -117.83 153.59 33.24 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.976 1.311 . . . . 0.0 108.28 173.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . 0.307 0.0 OUTLIER -80.51 118.39 22.07 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-O 122.694 1.235 . . . . 0.0 108.723 171.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.9 p -136.26 165.63 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 126.816 2.047 . . . . 0.0 106.344 171.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.68 -93.81 0.73 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 160.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.136 0 C-N-CA 125.519 1.528 . . . . 0.0 107.086 -151.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.691 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -139.06 105.49 5.29 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -130.87 174.18 10.23 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 123.508 0.723 . . . . 0.0 109.923 -176.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.3 mtt85 -141.77 141.17 33.2 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.366 1.867 . . . . 0.0 107.733 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 59' ' ' GLU . 1.6 m -125.73 160.27 32.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.146 0.978 . . . . 0.0 108.487 167.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -115.57 129.68 56.6 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.62 131.44 41.68 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 119.004 0.82 . . . . 0.0 108.794 175.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.86 4.29 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.291 0.636 . . . . 0.0 111.43 174.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.9 mt -146.72 154.29 47.7 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 126.058 1.743 . . . . 0.0 107.893 172.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -78.86 169.02 20.1 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.693 3.595 . . . . 0.0 111.792 172.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -154.23 166.36 33.38 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.586 0.708 . . . . 0.0 112.884 172.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.4 m -116.6 102.02 9.1 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.516 2.326 . . . . 0.0 109.916 -170.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -57.26 143.46 39.34 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 177.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -72.02 135.49 82.67 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 166.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -67.72 151.27 79.14 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.704 2.269 . . . . 0.0 109.849 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.0 t70 61.25 30.27 19.11 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.81 0.844 . . . . 0.0 111.573 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -128.35 170.92 12.53 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 170.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -79.92 4.05 18.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.373 0.669 . . . . 0.0 109.359 -177.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.41 ' O ' ' HE3' ' A' ' 13' ' ' LYS . 40.2 mt-10 -67.04 161.95 23.25 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 124.733 1.213 . . . . 0.0 110.432 173.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.489 ' HA ' ' HE3' ' A' ' 13' ' ' LYS . 18.9 pt -141.96 148.26 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 125.182 1.393 . . . . 0.0 107.852 172.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.13 145.15 51.75 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.29 164.86 29.0 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.447 0.642 . . . . 0.0 110.859 170.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.46 163.33 15.89 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.063 0.945 . . . . 0.0 109.702 -173.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -57.97 133.97 55.97 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 163.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.69 -2.1 76.37 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 117.113 -1.937 . . . . 0.0 112.718 178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -71.36 167.8 18.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 120.784 2.292 . . . . 0.0 109.529 167.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 19.7 ttt -140.6 147.69 39.78 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.499 1.52 . . . . 0.0 107.516 -176.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -130.85 170.06 14.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.047 0.842 . . . . 0.0 109.958 -175.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.4 pt -131.52 133.69 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 125.319 1.448 . . . . 0.0 107.635 170.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 33.6 t -69.05 116.88 10.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -113.4 -20.37 11.35 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.563 0.745 . . . . 0.0 110.786 176.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -152.03 -176.55 5.7 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 119.408 1.004 . . . . 0.0 110.229 160.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -125.04 130.35 52.11 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 126.334 1.853 . . . . 0.0 108.271 172.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.0 mt -107.18 -163.45 0.91 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.244 -1.762 . . . . 0.0 106.244 166.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -134.4 14.56 3.78 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 119.357 0.98 . . . . 0.0 112.236 -170.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -120.13 11.24 11.6 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 126.033 1.733 . . . . 0.0 111.278 -159.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.68 20.72 65.39 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 127.083 2.278 . . . . 0.0 112.124 -167.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -127.01 150.9 49.22 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 118.371 1.086 . . . . 0.0 110.636 -172.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.46 ' HE3' HD11 ' A' ' 52' ' ' ILE . 33.5 mtm -136.14 135.51 39.29 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' A' ' 51' ' ' LEU . 11.9 t-105 -73.46 128.27 35.01 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.29 1.436 . . . . 0.0 108.462 162.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.55 -173.89 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 123.824 0.85 . . . . 0.0 110.928 -174.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 35.5 m -124.48 132.98 53.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 157.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -86.07 112.17 21.01 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 124.59 1.156 . . . . 0.0 108.657 175.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.7 mt -67.33 -9.41 40.86 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 117.955 -1.022 . . . . 0.0 113.187 -172.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -30.43 70.97 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 120.921 1.692 . . . . 0.0 113.412 173.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.0 p -147.96 -8.86 0.4 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.526 1.141 . . . . 0.0 113.795 -165.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.0 t0 73.7 10.5 4.77 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.134 1.374 . . . . 0.0 112.349 -175.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -61.55 126.12 26.24 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.843 1.657 . . . . 0.0 108.216 167.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -93.13 170.23 9.81 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.723 0.809 . . . . 0.0 109.963 175.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 128.93 -158.02 21.79 Favored Glycine 0 C--N 1.334 0.467 0 CA-C-N 118.139 0.427 . . . . 0.0 112.893 170.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' A' ' 40' ' ' TRP . 1.8 mm? -98.54 135.24 40.37 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 124.544 1.138 . . . . 0.0 111.587 -160.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.46 HD11 ' HE3' ' A' ' 39' ' ' MET . 1.5 pp -140.17 146.33 24.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.945 1.698 . . . . 0.0 108.941 174.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -85.86 138.83 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 124.366 1.067 . . . . 0.0 108.951 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.88 3.8 9.37 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -73.77 -20.01 60.61 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 120.546 -1.346 . . . . 0.0 114.401 -177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -126.76 21.02 7.05 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.194 0.997 . . . . 0.0 112.374 -160.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.6 m -130.76 173.82 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 125.269 1.428 . . . . 0.0 109.884 -170.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -133.15 154.47 50.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.672 1.989 . . . . 0.0 109.289 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.501 ' HA ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -79.04 37.17 0.3 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.756 2.022 . . . . 0.0 114.471 -170.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 p -45.43 142.55 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 126.05 1.74 . . . . 0.0 113.83 -165.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -76.86 -5.01 83.68 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 114.611 -1.177 . . . . 0.0 113.883 -175.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 . . . . . 0 C--O 1.25 1.081 0 C-N-CA 125.828 1.651 . . . . 0.0 110.963 -161.373 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.881 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.85 43.03 1.58 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.347 1.07 . . . . 0.0 110.451 -173.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 31.7 mmm-85 -80.21 -176.03 5.37 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 123.797 0.839 . . . . 0.0 112.21 -175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 5.9 mpp_? -136.92 115.78 12.24 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.204 1.402 . . . . 0.0 109.507 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.32 170.3 3.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-O 121.947 0.88 . . . . 0.0 109.604 171.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.8 ttm-85 -134.59 135.32 42.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.798 1.639 . . . . 0.0 107.766 -175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB2' ' HE2' ' A' ' 28' ' ' PHE . . . -78.91 137.62 37.73 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 119.825 1.193 . . . . 0.0 109.039 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.275 0.2 OUTLIER -114.92 8.31 7.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 178.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.39 165.48 17.43 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 126.508 1.923 . . . . 0.0 108.168 169.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -82.36 168.53 14.75 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.24 2.626 . . . . 0.0 110.065 168.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -147.43 -178.03 6.01 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.921 0.888 . . . . 0.0 110.099 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.9 m -134.49 105.33 6.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 127.449 2.3 . . . . 0.0 108.083 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.1 ptmt -61.93 145.8 51.84 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 118.819 -0.61 . . . . 0.0 111.286 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.614 ' CG1' HG21 ' A' ' 17' ' ' THR . 0.8 OUTLIER -59.87 140.45 90.01 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 167.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -72.85 138.79 29.33 Favored 'Trans proline' 0 CA--C 1.533 0.449 0 C-N-CA 123.464 2.776 . . . . 0.0 111.093 174.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.0 t70 73.34 43.83 0.35 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 127.184 2.193 . . . . 0.0 111.907 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.614 HG21 ' CG1' ' A' ' 14' ' ' VAL . 28.4 p -143.32 169.55 17.44 Favored 'General case' 0 C--O 1.241 0.623 0 O-C-N 121.184 -0.947 . . . . 0.0 111.731 -168.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -85.91 -0.66 55.99 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.115 -1.402 . . . . 0.0 109.914 -176.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.456 ' OE1' HG12 ' A' ' 14' ' ' VAL . 9.2 mt-10 -65.66 168.27 7.88 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.545 1.138 . . . . 0.0 111.163 172.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.6 pt -141.53 122.76 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.464 1.906 . . . . 0.0 110.146 -176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.51 124.3 19.96 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.842 0.857 . . . . 0.0 109.998 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -136.4 164.86 27.15 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.1 0.96 . . . . 0.0 111.226 -175.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.12 167.06 11.0 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.271 1.028 . . . . 0.0 111.218 -176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -55.4 140.72 38.96 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 158.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.88 5.86 83.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-O 117.701 -1.61 . . . . 0.0 112.751 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -82.85 169.92 15.56 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 119.94 1.87 . . . . 0.0 110.53 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -143.28 151.44 40.54 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.708 1.203 . . . . 0.0 110.5 -174.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.422 ' HE2' ' HB2' ' A' ' 7' ' ' ALA . 49.2 m-85 -138.7 173.53 11.49 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 124.348 1.03 . . . . 0.0 111.432 -168.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.2 pt -135.59 135.18 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 126.093 1.757 . . . . 0.0 107.697 174.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.6 t -69.21 117.36 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.74 -21.08 10.37 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.345 -0.847 . . . . 0.0 112.736 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -152.86 -177.29 6.18 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -135.88 124.13 23.19 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.743 1.617 . . . . 0.0 107.36 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mt -103.64 -168.9 1.56 Allowed 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.385 1.074 . . . . 0.0 108.648 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -136.65 51.7 1.98 Allowed 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.536 1.534 . . . . 0.0 109.059 -169.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -159.64 22.65 0.18 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.652 1.181 . . . . 0.0 108.923 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.46 -2.33 7.74 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 119.542 -1.974 . . . . 0.0 114.052 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -86.85 149.97 24.45 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.176 0.991 . . . . 0.0 110.487 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.5 mtm -136.07 136.0 39.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.526 1.13 . . . . 0.0 109.001 172.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.505 ' CE3' HD21 ' A' ' 51' ' ' LEU . 14.1 t-105 -80.4 129.83 34.76 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.996 1.719 . . . . 0.0 108.678 167.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.5 m -142.44 -176.55 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.381 1.072 . . . . 0.0 110.984 -173.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.3 m -118.17 136.22 53.76 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 154.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -88.38 114.61 25.17 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 126.19 1.796 . . . . 0.0 108.073 166.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.3 mt -69.81 -3.28 14.93 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.2 ptt180 -61.72 -31.58 71.75 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 120.674 1.579 . . . . 0.0 112.792 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -159.85 12.82 0.13 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.748 0.704 . . . . 0.0 111.259 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.8 t0 74.03 19.58 2.98 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.725 1.21 . . . . 0.0 112.519 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -61.43 137.26 58.24 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.792 1.637 . . . . 0.0 107.981 168.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -118.87 158.36 25.82 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.103 0.961 . . . . 0.0 109.408 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.0 -153.48 21.47 Favored Glycine 0 N--CA 1.45 -0.429 0 O-C-N 124.003 0.815 . . . . 0.0 111.491 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.505 HD21 ' CE3' ' A' ' 40' ' ' TRP . 2.6 mm? -94.85 141.71 28.31 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.629 0.772 . . . . 0.0 110.978 -160.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -143.87 156.96 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 C-N-CA 127.161 2.184 . . . . 0.0 107.379 170.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.1 p -102.83 145.45 12.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.782 0.833 . . . . 0.0 109.397 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 24.9 pt-20 -68.07 -18.74 64.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 112.935 -178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -66.43 -15.57 63.43 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -168.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.5 mt -124.48 7.2 8.3 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.184 1.394 . . . . 0.0 113.415 -160.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.89 172.06 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 119.183 0.901 . . . . 0.0 110.742 -175.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.59 145.12 44.53 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 126.26 1.824 . . . . 0.0 108.231 167.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.16 113.84 3.4 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 113.724 -1.58 . . . . 0.0 107.32 161.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 p -116.34 160.91 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 165.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.66 -77.84 1.23 Allowed Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 106.564 -2.614 . . . . 0.0 106.564 166.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 . . . . . 0 C--O 1.256 1.397 0 C-N-CA 129.041 2.936 . . . . 0.0 111.276 -178.786 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.804 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -73.44 49.89 0.3 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.557 1.943 . . . . 0.0 114.51 -172.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.522 ' HB3' HG21 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -147.6 160.14 42.98 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 120.346 -1.472 . . . . 0.0 107.404 166.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 52.4 mtt180 -146.15 152.14 38.79 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.265 1.026 . . . . 0.0 108.474 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.13 166.23 10.47 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 121.908 0.861 . . . . 0.0 111.538 165.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.4 ttm-85 -129.59 136.37 49.7 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 127.315 2.246 . . . . 0.0 106.343 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.41 139.89 37.58 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -114.58 -2.25 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.487 173.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.0 mt -148.43 155.59 42.39 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 127.312 2.245 . . . . 0.0 108.055 -179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -82.14 168.22 15.35 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 C-N-CA 124.153 3.235 . . . . 0.0 112.896 170.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -160.59 150.76 17.94 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.681 1.192 . . . . 0.0 111.425 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.4 t -116.3 131.81 56.84 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 166.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.581 ' H ' ' HB3' ' A' ' 21' ' ' SER . 0.7 OUTLIER -92.84 168.65 11.03 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 125.117 1.367 . . . . 0.0 111.155 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.8 t -102.27 119.09 57.44 Favored Pre-proline 0 C--N 1.327 -0.377 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -176.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -58.24 167.28 4.83 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 121.979 1.786 . . . . 0.0 110.788 174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.5 -9.06 1.47 Allowed 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 127.247 2.219 . . . . 0.0 113.246 -175.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.7 p -108.4 175.6 5.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.486 1.115 . . . . 0.0 111.706 -174.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -81.62 5.93 16.64 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.313 1.045 . . . . 0.0 112.406 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -77.34 175.74 9.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 125.931 1.692 . . . . 0.0 111.081 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 8.3 pt -150.98 156.22 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 126.828 2.051 . . . . 0.0 109.506 174.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.581 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 19.9 p -116.76 152.57 34.07 Favored 'General case' 0 CA--C 1.523 -0.093 0 C-N-CA 124.956 1.303 . . . . 0.0 110.261 -171.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.38 170.84 21.37 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.779 0.323 . . . . 0.0 111.401 -165.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.35 163.68 23.47 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.408 0.683 . . . . 0.0 109.238 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -58.44 144.58 41.6 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.02 -8.23 64.02 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 119.586 -0.563 . . . . 0.0 113.746 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -69.06 170.56 9.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 122.806 1.289 . . . . 0.0 110.207 168.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.7 mmm -132.44 163.05 29.63 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.116 1.367 . . . . 0.0 108.995 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -137.23 -176.29 4.34 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 112.814 -1.994 . . . . 0.0 108.821 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 16.9 pt -143.8 150.27 17.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 125.772 1.629 . . . . 0.0 107.231 170.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 3' ' ' ARG . 44.7 t -76.14 131.51 34.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 175.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -120.6 -44.34 2.45 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.512 1.125 . . . . 0.0 109.595 170.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -143.88 166.82 23.85 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.775 0.798 . . . . 0.0 110.434 173.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -141.02 120.77 13.43 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 126.946 2.098 . . . . 0.0 105.811 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mt -108.39 -164.94 0.99 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.377 1.471 . . . . 0.0 108.508 -175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -134.57 66.78 1.53 Allowed 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.262 1.425 . . . . 0.0 108.547 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.25 6.37 0.12 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.26 1.024 . . . . 0.0 112.739 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.45 15.55 71.04 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.961 1.743 . . . . 0.0 112.918 -165.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 76.6 m95 -122.44 145.76 48.0 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.463 1.905 . . . . 0.0 109.829 -171.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -144.7 144.99 31.49 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.92 0.888 . . . . 0.0 109.686 -177.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -91.61 136.87 32.81 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.909 0.884 . . . . 0.0 112.105 174.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.36 -175.49 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 124.84 1.256 . . . . 0.0 111.042 -170.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 25.0 m -123.2 132.72 54.15 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 158.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.66 108.14 17.23 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.435 1.894 . . . . 0.0 108.646 174.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.1 mt -76.06 16.91 0.38 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.43 ' HG3' HG22 ' A' ' 46' ' ' THR . 3.3 ptm180 -66.68 -35.13 79.42 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.388 163.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.43 HG22 ' HG3' ' A' ' 45' ' ' ARG . 1.6 t -169.46 16.29 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 117.472 -1.251 . . . . 0.0 113.052 -169.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 75.47 18.29 2.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.12 1.368 . . . . 0.0 113.303 177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -64.19 134.23 54.4 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.596 -0.69 . . . . 0.0 109.336 170.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -124.92 142.85 51.19 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.18 0.992 . . . . 0.0 108.758 -173.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.06 -160.91 28.58 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -173.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -95.37 147.06 23.91 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.507 1.123 . . . . 0.0 112.406 -165.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.2 pt -133.52 157.0 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.876 1.671 . . . . 0.0 109.995 170.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.22 147.77 7.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 126.119 1.768 . . . . 0.0 107.786 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -75.62 2.03 12.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -80.75 -18.33 48.05 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.427 1.491 . . . . 0.0 113.123 -172.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -123.29 14.79 9.7 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 120.185 -1.572 . . . . 0.0 112.415 -168.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.09 161.67 40.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.979 1.711 . . . . 0.0 109.159 -167.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -120.51 148.53 43.72 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.684 1.194 . . . . 0.0 109.02 170.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -70.1 125.53 27.04 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 166.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.86 162.91 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.079 1.352 . . . . 0.0 107.635 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -74.94 -92.1 0.17 Allowed Glycine 0 CA--C 1.521 0.43 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 164.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.245 0.861 0 C-N-CA 126.18 1.792 . . . . 0.0 111.136 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . . . . . . 0 N--CA 1.468 0.821 0 CA-C-O 118.956 -0.913 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -144.85 -63.15 0.35 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.268 1.534 . . . . 0.0 113.429 172.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 30' ' ' VAL 0.293 0.0 OUTLIER -133.49 -162.54 1.25 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.171 1.388 . . . . 0.0 108.42 -175.253 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 19.9 mtt85 -111.54 175.79 5.28 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 120.9 -1.125 . . . . 0.0 111.24 172.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.46 HG13 HH21 ' A' ' 3' ' ' ARG . 0.0 OUTLIER -135.74 162.48 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 O-C-N 121.119 -0.988 . . . . 0.0 109.168 165.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 ttp85 -138.33 143.6 39.98 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.644 0.777 . . . . 0.0 109.574 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -80.06 132.33 35.95 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.131 0.972 . . . . 0.0 110.109 -177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -104.64 -4.6 9.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 124.219 1.008 . . . . 0.0 111.963 171.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -145.47 153.4 51.58 Favored Pre-proline 0 N--CA 1.465 0.283 0 C-N-CA 126.443 1.897 . . . . 0.0 108.253 175.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -76.3 157.87 37.24 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.709 2.939 . . . . 0.0 111.743 175.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -140.0 165.3 27.69 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.36 1.064 . . . . 0.0 110.564 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.9 m -136.76 112.37 9.38 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.536 1.534 . . . . 0.0 107.269 177.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 15' ' ' PRO . 6.6 pttm -70.61 152.06 44.32 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 169.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.3 t -75.75 146.6 80.11 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 156.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.539 ' HA ' ' HE2' ' A' ' 13' ' ' LYS . 98.2 Cg_endo -81.6 170.76 14.06 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.577 2.851 . . . . 0.0 111.252 172.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.3 t70 75.4 16.78 2.6 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.781 2.432 . . . . 0.0 111.548 -179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 65.6 p -132.03 168.08 18.57 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 126.215 1.806 . . . . 0.0 109.855 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -80.41 3.83 20.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.251 1.421 . . . . 0.0 111.587 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.98 172.85 12.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.993 1.717 . . . . 0.0 110.201 -175.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 pt -146.8 130.83 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.447 1.499 . . . . 0.0 110.588 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.1 150.23 37.29 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.795 1.238 . . . . 0.0 110.066 176.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -154.48 164.05 39.26 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.369 0.531 . . . . 0.0 111.528 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -110.44 162.87 14.24 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.378 1.071 . . . . 0.0 110.922 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -59.78 132.15 53.08 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 164.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.51 -5.2 54.61 Favored Glycine 0 CA--C 1.523 0.55 0 CA-C-O 119.049 -0.862 . . . . 0.0 113.682 178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -102.37 154.53 18.98 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.276 1.03 . . . . 0.0 108.435 -174.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 10.8 ttt -124.25 158.46 32.45 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.018 0.927 . . . . 0.0 111.179 -164.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.72 177.38 8.94 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.557 1.543 . . . . 0.0 110.599 -178.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 17.2 pt -131.59 127.65 59.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 C-N-CA 125.631 1.572 . . . . 0.0 109.386 -174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 3' ' ' ARG . 1.7 p -75.06 94.41 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.38 0.536 . . . . 0.0 110.083 -177.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -82.74 -56.56 3.77 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -135.79 165.33 25.85 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.355 0.598 . . . . 0.0 110.111 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -129.95 128.46 42.16 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 125.808 1.643 . . . . 0.0 106.743 -172.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.1 mt -113.21 -170.77 1.75 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -175.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -134.65 48.99 2.26 Favored 'General case' 0 N--CA 1.463 0.194 0 C-N-CA 124.123 0.969 . . . . 0.0 108.897 -166.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -156.6 19.11 0.33 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.924 1.29 . . . . 0.0 112.004 -177.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.13 19.61 79.77 Favored Glycine 0 CA--C 1.527 0.787 0 O-C-N 120.802 -1.186 . . . . 0.0 112.239 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -120.29 153.33 36.54 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 125.177 1.391 . . . . 0.0 109.206 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 40.5 mtm -147.46 131.04 16.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 17.5 t-105 -76.12 128.93 35.98 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.42 -165.71 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.504 1.122 . . . . 0.0 110.514 -175.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 23.1 m -137.02 127.67 27.01 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 162.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -78.47 99.02 6.27 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.526 1.53 . . . . 0.0 108.441 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.08 -2.44 0.43 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.308 1.443 . . . . 0.0 113.909 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -55.91 -48.37 75.8 Favored 'General case' 0 N--CA 1.461 0.104 0 O-C-N 120.554 -1.341 . . . . 0.0 110.136 168.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 t -152.53 14.56 0.58 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 118.4 0.545 . . . . 0.0 111.78 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 t70 74.76 19.68 2.47 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.922 2.089 . . . . 0.0 111.963 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.6 108.44 0.83 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.035 0.934 . . . . 0.0 108.897 171.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -73.51 155.88 38.74 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 171.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 145.74 -165.18 28.06 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-O 121.522 0.512 . . . . 0.0 112.508 176.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 mt -104.72 142.05 35.38 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.993 1.317 . . . . 0.0 112.503 -168.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -133.0 153.41 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.709 1.604 . . . . 0.0 109.713 172.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.0 p -86.23 135.84 24.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.736 1.214 . . . . 0.0 108.26 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -77.18 -3.91 41.98 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -172.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -59.32 -30.25 68.23 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.707 2.003 . . . . 0.0 113.295 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.36 12.33 13.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.941 1.296 . . . . 0.0 112.911 -160.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.9 m -130.41 154.24 40.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 124.301 1.04 . . . . 0.0 111.001 -171.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -121.13 147.4 45.63 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 125.748 1.619 . . . . 0.0 110.31 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.81 94.1 1.02 Allowed 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 127.955 2.502 . . . . 0.0 110.828 177.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.664 HG12 ' H ' ' A' ' 62' ' ' ARG . 41.7 t -91.38 135.01 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 O-C-N 121.5 -0.75 . . . . 0.0 109.591 177.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -123.01 29.55 5.31 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.819 2.152 . . . . 0.0 111.729 173.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.664 ' H ' HG12 ' A' ' 60' ' ' VAL . 6.4 ptm180 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 124.652 1.181 . . . . 0.0 108.338 173.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.335 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 42.98 59.26 2.95 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 119.655 1.728 . . . . 0.0 112.659 166.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 30' ' ' VAL . 0.0 OUTLIER -102.86 25.66 9.02 Favored 'General case' 0 C--O 1.221 -0.436 0 C-N-CA 127.004 2.122 . . . . 0.0 112.217 -162.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 71.5 mtm-85 -74.2 147.01 42.92 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 119.908 -1.745 . . . . 0.0 109.553 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.8 m -134.0 156.52 41.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.7 ttm-85 -120.83 125.27 47.1 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 126.59 1.956 . . . . 0.0 105.75 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.44 151.17 38.11 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 118.386 -1.326 . . . . 0.0 108.567 173.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.6 3.08 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 124.951 1.3 . . . . 0.0 111.337 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 mt -142.2 159.05 59.97 Favored Pre-proline 0 CA--C 1.532 0.262 0 C-N-CA 126.127 1.771 . . . . 0.0 107.608 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -84.05 170.39 11.02 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.688 2.925 . . . . 0.0 110.983 174.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -150.77 160.64 43.73 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.473 1.109 . . . . 0.0 110.474 177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.1 m -132.19 109.79 10.19 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 172.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' H ' ' HB3' ' A' ' 21' ' ' SER . 7.7 pttm -65.57 165.54 12.11 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.667 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.8 147.54 58.9 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 150.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -73.79 176.87 8.82 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 123.475 2.784 . . . . 0.0 110.911 158.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.5 t70 66.91 17.48 10.53 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.043 1.737 . . . . 0.0 112.692 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.4 p -135.54 171.73 14.03 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 126.408 1.883 . . . . 0.0 109.345 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.96 -3.5 29.5 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.991 1.317 . . . . 0.0 111.561 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.39 162.48 12.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.178 1.391 . . . . 0.0 112.025 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.6 pt -136.88 142.43 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.957 2.103 . . . . 0.0 108.179 165.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.53 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 0.5 OUTLIER -87.39 171.34 10.65 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 120.422 -1.424 . . . . 0.0 110.693 170.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -162.23 167.43 24.02 Favored 'General case' 0 C--O 1.226 -0.138 0 C-N-CA 125.888 1.675 . . . . 0.0 108.026 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mt -118.86 161.75 19.64 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.577 1.551 . . . . 0.0 107.052 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -59.73 126.1 26.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 119.938 1.245 . . . . 0.0 110.152 175.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.0 52.1 1.04 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 124.681 1.134 . . . . 0.0 111.146 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -138.45 161.59 36.62 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.978 1.711 . . . . 0.0 108.007 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 12.5 mtp -138.83 140.1 38.4 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.245 1.018 . . . . 0.0 110.432 -178.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.9 169.1 9.33 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.088 1.755 . . . . 0.0 109.938 -174.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.0 pt -122.02 126.35 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 172.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 3' ' ' ARG . 59.5 t -63.24 130.36 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 172.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -118.92 -44.76 2.6 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.582 1.153 . . . . 0.0 110.02 176.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -140.01 170.15 16.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -132.05 138.65 48.26 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 124.939 1.296 . . . . 0.0 107.604 -176.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.3 mt -123.31 178.47 5.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.985 1.714 . . . . 0.0 109.68 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -120.89 14.55 11.6 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 122.917 1.341 . . . . 0.0 112.884 -162.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -129.26 20.25 5.79 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 127.764 2.426 . . . . 0.0 111.23 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.56 9.05 61.86 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.019 1.295 . . . . 0.0 112.922 175.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -113.67 162.23 16.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.355 1.062 . . . . 0.0 110.971 -173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 34.7 mtm -138.97 143.4 38.52 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.38 1.472 . . . . 0.0 107.845 173.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -78.26 135.95 37.66 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.428 -0.509 . . . . 0.0 109.702 161.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.7 m -140.96 176.8 4.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 C-N-CA 124.163 0.985 . . . . 0.0 110.995 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.449 HG23 HE21 ' A' ' 49' ' ' GLN . 15.0 m -115.39 141.21 48.34 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 152.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -93.26 112.45 24.39 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.464 1.106 . . . . 0.0 108.964 169.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.0 5.41 2.7 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -59.01 -41.85 88.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.261 162.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -147.41 -13.27 0.4 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 118.101 -0.952 . . . . 0.0 113.379 -161.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.3 t70 75.07 16.61 2.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.559 1.944 . . . . 0.0 111.761 -162.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -60.78 113.92 2.75 Favored 'General case' 0 C--O 1.232 0.159 0 O-C-N 120.664 -1.273 . . . . 0.0 108.96 168.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.449 HE21 HG23 ' A' ' 42' ' ' THR . 2.1 mp0 -90.11 151.13 21.74 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 121.91 -0.494 . . . . 0.0 109.873 167.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.76 -167.48 35.29 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-O 121.613 0.563 . . . . 0.0 111.917 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.6 mt -89.59 141.14 28.87 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.399 1.08 . . . . 0.0 110.555 -176.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -136.8 153.27 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 126.999 2.12 . . . . 0.0 109.104 169.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.88 146.1 7.94 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 123.801 0.84 . . . . 0.0 110.428 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -66.94 -17.65 65.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.439 1.496 . . . . 0.0 113.041 178.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.92 -18.23 59.54 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.529 1.932 . . . . 0.0 112.109 -171.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.4 mt -130.56 12.56 5.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.437 1.495 . . . . 0.0 112.712 -163.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.6 m -128.97 154.43 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.661 1.118 . . . . 0.0 112.994 -173.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -128.3 148.91 50.68 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 126.805 2.042 . . . . 0.0 110.204 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.64 102.25 0.55 Allowed 'General case' 0 N--CA 1.427 -1.589 0 C-N-CA 129.359 3.064 . . . . 0.0 110.324 176.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 p -110.46 132.75 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 CA-C-O 123.19 1.471 . . . . 0.0 110.864 175.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -90.36 7.82 80.83 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 114.25 -1.341 . . . . 0.0 112.701 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 . . . . . 0 C--O 1.253 1.267 0 CA-C-N 118.553 1.177 . . . . 0.0 108.631 -172.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -116.69 131.84 56.85 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.113 1.365 . . . . 0.0 108.429 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.425 ' O ' HG12 ' A' ' 30' ' ' VAL . 0.4 OUTLIER -127.36 -169.73 2.09 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-N 121.031 1.741 . . . . 0.0 110.541 174.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.466 ' CD ' HG22 ' A' ' 29' ' ' ILE . 54.4 mtm180 -132.54 150.98 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.395 -0.812 . . . . 0.0 110.377 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.5 m -123.4 171.07 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 124.536 1.134 . . . . 0.0 108.461 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.1 ttm-85 -144.02 122.84 12.67 Favored 'General case' 0 C--O 1.222 -0.353 0 O-C-N 120.752 -1.217 . . . . 0.0 111.739 -170.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.38 137.85 58.34 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.801 0.728 . . . . 0.0 109.975 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.27 0.2 OUTLIER -119.73 5.22 6.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.417 169.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.5 mt -147.8 154.94 44.53 Favored Pre-proline 0 N--CA 1.466 0.374 0 C-N-CA 125.639 1.576 . . . . 0.0 108.822 166.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.66 157.54 31.93 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.613 2.875 . . . . 0.0 110.235 174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -146.31 -179.4 6.72 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.782 0.833 . . . . 0.0 108.906 177.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 t -146.39 133.42 20.32 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -175.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.571 ' H ' ' HB3' ' A' ' 21' ' ' SER . 17.9 ptmt -69.52 144.66 53.09 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.107 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.98 139.91 97.95 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 165.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.02 145.86 69.01 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.068 2.512 . . . . 0.0 110.488 174.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.82 39.14 8.57 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.765 1.626 . . . . 0.0 112.498 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 p -132.33 171.21 14.01 Favored 'General case' 0 C--O 1.238 0.495 0 O-C-N 121.497 -0.752 . . . . 0.0 110.434 176.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.68 -8.18 59.05 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.64 1.976 . . . . 0.0 111.323 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -62.03 167.88 3.61 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.781 1.633 . . . . 0.0 111.917 -177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.6 pt -134.99 136.48 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 125.877 1.671 . . . . 0.0 108.69 174.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.571 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 0.2 OUTLIER -90.51 122.77 33.63 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.85 1.66 . . . . 0.0 110.148 -178.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -146.99 170.65 16.66 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 119.671 1.123 . . . . 0.0 113.288 174.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.88 -178.64 5.08 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.014 0.926 . . . . 0.0 111.738 -164.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -63.57 149.58 45.99 Favored 'General case' 0 C--N 1.337 0.064 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 160.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 72.99 -4.73 22.06 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 118.897 -0.946 . . . . 0.0 113.244 174.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.55 156.31 39.1 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.639 1.22 . . . . 0.0 107.759 164.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 20.9 ttt -134.17 148.82 50.98 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 120.866 -1.146 . . . . 0.0 108.814 -173.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -132.98 159.48 39.89 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 124.436 1.094 . . . . 0.0 109.636 -169.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.466 HG22 ' CD ' ' A' ' 4' ' ' ARG . 6.7 pt -110.86 135.98 48.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 170.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 3' ' ' ARG . 1.7 p -69.39 124.5 25.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 171.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.19 -25.32 4.9 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.97 0.908 . . . . 0.0 113.255 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -154.73 160.44 41.34 Favored 'General case' 0 CA--C 1.51 -0.559 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 164.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -119.76 123.03 42.72 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.517 -1.219 . . . . 0.0 108.09 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.6 mt -101.81 -169.42 1.68 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -133.9 29.59 3.77 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.381 1.072 . . . . 0.0 110.853 -166.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -151.79 29.4 0.6 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.702 1.601 . . . . 0.0 111.534 -172.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.09 36.25 64.23 Favored Glycine 0 CA--C 1.532 1.127 0 O-C-N 120.9 -1.125 . . . . 0.0 112.426 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -134.72 156.18 49.25 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.362 1.081 . . . . 0.0 108.92 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 33.5 mtm -138.01 141.86 40.41 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 168.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -75.41 137.9 41.32 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 160.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.0 m -139.81 -178.84 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 122.186 0.993 . . . . 0.0 111.768 -175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 42.4 m -124.94 146.68 49.24 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 153.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -93.77 119.46 32.77 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.437 2.695 . . . . 0.0 108.43 -177.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.9 mt -80.11 21.13 0.6 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.844 1.257 . . . . 0.0 112.491 -177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 49.3 ttp85 -101.24 -47.53 4.69 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.089 0.956 . . . . 0.0 110.032 176.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 t -146.15 20.31 1.4 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.642 0.777 . . . . 0.0 109.511 -169.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.85 24.13 12.73 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.208 1.803 . . . . 0.0 112.356 177.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -72.32 160.61 32.09 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 121.1 -1.0 . . . . 0.0 112.48 -176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -139.42 149.54 44.2 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.684 0.754 . . . . 0.0 110.928 -178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 153.89 -168.55 32.36 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.638 -174.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.0 mt -92.0 143.53 26.38 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.832 1.253 . . . . 0.0 110.489 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.01 145.57 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.274 1.429 . . . . 0.0 109.029 171.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.02 132.23 32.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -71.31 -10.97 60.63 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -55.48 -26.85 44.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.942 2.097 . . . . 0.0 111.873 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.96 11.29 11.73 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -160.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 m -118.11 164.68 14.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 125.73 1.612 . . . . 0.0 110.859 -175.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -121.31 151.14 40.42 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.568 1.547 . . . . 0.0 110.154 169.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -74.18 63.18 0.97 Allowed 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 127.768 2.427 . . . . 0.0 111.066 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.3 p -57.64 145.61 8.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 O-C-N 120.741 -1.224 . . . . 0.0 111.331 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.96 -53.3 0.8 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 125.129 1.347 . . . . 0.0 110.982 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.384 4.8 ptm180 . . . . . 0 C--O 1.247 0.933 0 C-N-CA 128.93 2.892 . . . . 0.0 114.258 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.407 0 N-CA-C 109.061 -1.616 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.89 152.24 32.32 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.204 1.002 . . . . 0.0 108.361 164.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.8 ttt85 -138.31 -165.33 1.79 Allowed 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 167.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.2 mmt85 -140.99 156.52 46.03 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.13 1.372 . . . . 0.0 107.494 174.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.09 154.63 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 119.335 0.97 . . . . 0.0 109.806 170.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.9 ttp85 -121.66 136.57 54.94 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.84 130.78 41.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 119.149 0.886 . . . . 0.0 109.506 169.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -111.07 1.47 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.318 0.647 . . . . 0.0 111.305 170.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 12.4 mt -141.03 154.56 68.37 Favored Pre-proline 0 CA--C 1.532 0.277 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 168.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.91 158.77 34.66 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 122.971 2.447 . . . . 0.0 110.247 177.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -150.12 164.61 35.15 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 123.58 0.752 . . . . 0.0 110.577 170.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.4 t -135.31 135.79 41.07 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.6 ptmt -63.46 149.75 45.34 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.22 178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.475 HG23 ' OG1' ' A' ' 17' ' ' THR . 21.2 m -66.7 166.29 19.59 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.624 1.17 . . . . 0.0 109.557 163.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -79.6 161.27 25.02 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.385 2.056 . . . . 0.0 110.41 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.5 t70 45.94 46.86 12.48 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 127.987 2.515 . . . . 0.0 112.693 170.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.475 ' OG1' HG23 ' A' ' 14' ' ' VAL . 1.8 p -142.96 177.74 8.15 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.459 -0.776 . . . . 0.0 110.122 -170.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -97.25 11.25 37.09 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.513 1.525 . . . . 0.0 110.412 -172.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -80.36 170.02 16.96 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.653 1.581 . . . . 0.0 111.549 174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.3 pt -136.0 152.78 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.227 1.811 . . . . 0.0 109.964 170.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 p -88.99 149.87 23.07 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.545 2.338 . . . . 0.0 110.642 175.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -158.28 173.19 17.06 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 121.423 -0.798 . . . . 0.0 111.797 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.41 161.17 22.64 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 124.804 1.242 . . . . 0.0 110.516 -175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 46.9 tttm -57.98 133.63 55.68 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 166.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.31 -6.77 71.96 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-O 117.887 -1.507 . . . . 0.0 113.005 177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -77.18 166.45 23.22 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 120.271 2.035 . . . . 0.0 108.699 175.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 34.7 mtp -133.25 140.3 47.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.566 1.146 . . . . 0.0 109.873 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -122.93 169.94 10.63 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.099 1.359 . . . . 0.0 109.779 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.9 pt -119.52 129.64 75.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 p -68.46 125.98 27.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 175.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -116.64 -33.48 4.84 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 123.929 0.892 . . . . 0.0 111.961 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -146.62 160.45 42.15 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 119.262 0.937 . . . . 0.0 110.497 172.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -118.06 121.55 40.88 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 126.498 1.919 . . . . 0.0 107.289 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 mt -110.2 -172.15 1.98 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.412 1.485 . . . . 0.0 107.851 173.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -120.26 13.73 12.01 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.171 1.789 . . . . 0.0 114.935 -166.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -143.41 23.31 1.81 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.392 1.077 . . . . 0.0 112.218 -154.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.94 7.28 87.43 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 124.456 1.027 . . . . 0.0 112.617 177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -118.48 150.61 39.31 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.576 1.55 . . . . 0.0 108.73 -174.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 14.9 mtm -139.39 140.37 37.4 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 175.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -77.05 138.88 39.83 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 166.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 m -142.56 -175.89 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 122.774 1.273 . . . . 0.0 111.166 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.2 m -130.76 132.23 45.19 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 152.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -81.39 114.01 19.86 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.5 mt -65.41 -6.81 11.28 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.024 -0.423 . . . . 0.0 111.679 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 ttp85 -57.01 -40.39 76.53 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 120.396 -1.44 . . . . 0.0 111.389 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.6 t -169.75 33.51 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.025 0.829 . . . . 0.0 111.793 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.4 t70 66.54 -4.91 0.67 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 171.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -53.73 118.4 3.9 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.192 1.797 . . . . 0.0 109.804 176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.5 mp0 -100.36 157.87 16.3 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 168.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 154.49 -171.91 32.98 Favored Glycine 0 N--CA 1.439 -1.159 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.3 mt -87.23 144.88 26.61 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.458 1.503 . . . . 0.0 109.561 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -139.28 152.64 23.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 C-N-CA 125.95 1.7 . . . . 0.0 108.028 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.3 p -95.18 141.31 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 123.286 0.634 . . . . 0.0 109.832 -173.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -71.82 -9.56 58.49 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.824 0.85 . . . . 0.0 113.25 -178.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.34 -21.16 66.52 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.819 1.248 . . . . 0.0 112.064 -174.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -126.86 11.42 7.17 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.802 1.241 . . . . 0.0 112.098 -162.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.11 167.57 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 124.171 0.989 . . . . 0.0 111.343 -175.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -119.06 152.31 36.68 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 127.184 2.194 . . . . 0.0 108.426 167.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 59.76 1.25 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.319 1.448 . . . . 0.0 110.341 174.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.18 158.21 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 O-C-N 120.87 -1.144 . . . . 0.0 110.633 -175.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -147.55 20.62 1.5 Allowed Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.209 -0.905 . . . . 0.0 112.454 176.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 ptt85 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 117.496 -1.24 . . . . 0.0 109.713 -177.235 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.814 0 CA-C-O 118.485 -1.175 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 60.46 64.29 1.22 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 123.085 1.422 . . . . 0.0 108.477 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.43 -164.23 0.97 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.819 1.247 . . . . 0.0 108.279 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 -124.6 151.55 44.68 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.94 145.51 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 119.275 0.943 . . . . 0.0 109.746 170.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 30.2 ttm-85 -111.37 144.96 39.73 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 117.584 -1.198 . . . . 0.0 109.922 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -78.19 136.71 37.86 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 119.767 1.167 . . . . 0.0 111.819 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.69 1.85 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.158 0.983 . . . . 0.0 112.294 168.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 mt -151.71 154.48 33.13 Favored Pre-proline 0 N--CA 1.469 0.493 0 C-N-CA 125.73 1.612 . . . . 0.0 108.755 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.52 134.93 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.009 2.473 . . . . 0.0 108.604 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -84.64 -179.12 7.06 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.931 0.872 . . . . 0.0 109.043 168.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.4 m -149.71 100.33 2.96 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.53 ' H ' ' HB3' ' A' ' 21' ' ' SER . 11.6 pttt -67.66 156.6 36.49 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.413 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.424 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 11.0 m -85.53 176.25 3.81 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 126.324 1.85 . . . . 0.0 107.912 168.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.424 ' HD2' ' HB ' ' A' ' 14' ' ' VAL . 89.6 Cg_endo -95.17 164.02 1.6 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.174 2.582 . . . . 0.0 111.336 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 59.04 35.78 24.07 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.492 1.917 . . . . 0.0 111.243 167.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.39 162.59 36.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 122.127 0.965 . . . . 0.0 111.483 -161.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -83.4 35.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 126.477 1.911 . . . . 0.0 109.427 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -109.3 168.29 9.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.296 1.039 . . . . 0.0 109.149 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.2 pt -145.2 144.66 21.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 127.39 2.276 . . . . 0.0 106.554 -175.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.53 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 93.1 p -124.88 158.94 32.28 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.665 ' HB2' HD21 ' A' ' 43' ' ' ASN . 0.1 OUTLIER -164.93 -175.03 3.56 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.512 1.525 . . . . 0.0 109.506 176.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -94.5 172.39 8.22 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.173 0.989 . . . . 0.0 109.975 -176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -54.93 157.2 3.32 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.525 -1.359 . . . . 0.0 109.789 161.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 76.44 12.55 84.2 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 118.773 -1.015 . . . . 0.0 112.696 172.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -90.21 -174.59 4.24 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.733 1.267 . . . . 0.0 111.262 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.36 144.67 32.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.338 1.855 . . . . 0.0 108.934 -170.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -133.74 153.92 51.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.541 -1.663 . . . . 0.0 111.159 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.6 pt -112.92 118.53 58.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 177.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 p -63.76 121.78 13.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -113.1 -36.28 5.12 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 124.433 1.093 . . . . 0.0 109.973 177.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -149.24 169.55 20.5 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 119.158 0.89 . . . . 0.0 110.062 168.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -130.35 122.7 28.36 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 127.332 2.253 . . . . 0.0 106.122 -171.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.85 -162.79 0.97 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.677 1.191 . . . . 0.0 110.138 -175.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -141.55 76.63 1.55 Allowed 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.79 2.036 . . . . 0.0 106.934 -177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.3 p30 174.2 -0.97 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 126.532 1.933 . . . . 0.0 114.363 -165.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.43 7.53 85.26 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 120.055 -1.653 . . . . 0.0 113.142 -171.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -95.73 165.44 12.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 119.377 1.589 . . . . 0.0 109.922 169.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.4 mtm -134.94 163.54 29.63 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 168.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.2 t-105 -94.34 132.62 38.75 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.406 0.548 . . . . 0.0 109.665 158.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.4 m -141.56 174.89 6.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 C-N-CA 124.132 0.973 . . . . 0.0 110.503 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.44 ' CG2' ' HA ' ' A' ' 47' ' ' ASP . 7.8 m -107.68 141.82 38.6 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 157.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.665 HD21 ' HB2' ' A' ' 22' ' ' PHE . 0.5 OUTLIER -82.19 111.48 18.33 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 127.287 2.235 . . . . 0.0 107.958 170.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.3 mt -61.6 -9.31 5.77 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.432 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 22.0 ttp85 -53.31 -38.39 63.11 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 123.984 0.914 . . . . 0.0 111.436 173.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.8 t -165.67 -1.61 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 -161.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.44 ' HA ' ' CG2' ' A' ' 42' ' ' THR . 0.6 OUTLIER 75.3 17.64 2.52 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.661 1.585 . . . . 0.0 112.401 -173.163 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -65.2 139.48 58.66 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -126.51 153.78 44.69 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.614 1.166 . . . . 0.0 108.731 -172.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 151.8 -158.47 27.79 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -172.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt -101.56 143.01 32.07 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.61 1.964 . . . . 0.0 112.013 -168.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.94 152.97 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 129.813 3.245 . . . . 0.0 107.024 175.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.6 p -96.33 139.58 19.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -74.7 -14.83 60.78 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -174.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -61.18 -22.0 64.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.621 1.168 . . . . 0.0 112.719 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 87.4 mt -107.09 3.9 26.33 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.331 1.452 . . . . 0.0 112.286 -170.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.96 171.14 14.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.224 1.009 . . . . 0.0 110.737 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -131.21 152.96 49.97 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 125.611 1.565 . . . . 0.0 110.618 -179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -78.05 80.62 4.47 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.6 1.56 . . . . 0.0 111.089 177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 62' ' ' ARG . 2.0 t -77.77 164.93 3.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 O-C-N 120.963 -1.085 . . . . 0.0 109.449 167.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.36 12.93 10.31 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 125.49 1.519 . . . . 0.0 113.015 167.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.531 ' H ' HG12 ' A' ' 60' ' ' VAL . 55.4 mtp85 . . . . . 0 C--O 1.246 0.903 0 CA-C-O 116.473 -1.727 . . . . 0.0 111.45 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.405 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 56.6 mtt85 -144.24 109.67 5.17 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 126.59 1.956 . . . . 0.0 106.388 173.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.3 172.75 8.01 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 125.088 1.355 . . . . 0.0 109.455 172.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -151.79 138.84 19.12 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.28 1.832 . . . . 0.0 108.391 -172.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.89 159.04 37.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 123.81 0.844 . . . . 0.0 109.118 173.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.554 ' HE ' ' HE3' ' A' ' 27' ' ' MET . 10.9 ttm180 -130.03 131.57 45.89 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 119.729 -1.857 . . . . 0.0 106.099 -168.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.57 156.42 26.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.598 1.545 . . . . 0.0 110.566 -173.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.75 9.89 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-O 118.299 -0.858 . . . . 0.0 111.921 162.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.71 155.57 29.68 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-N 120.35 1.432 . . . . 0.0 110.264 167.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HB3' ' HA ' ' A' ' 23' ' ' LEU . 27.8 Cg_endo -82.81 163.77 15.99 Favored 'Trans proline' 0 CA--C 1.543 0.956 1 C-N-CA 125.972 4.448 . . . . 0.0 111.925 177.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -153.14 165.69 34.84 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.209 -0.932 . . . . 0.0 109.745 -175.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.3 m -119.27 113.73 21.3 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 126.545 1.938 . . . . 0.0 107.21 -175.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.1 ptmt -67.26 146.81 53.78 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 120.38 1.446 . . . . 0.0 110.233 171.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -67.39 149.3 98.46 Favored Pre-proline 0 CA--C 1.552 1.035 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.18 141.53 39.75 Favored 'Trans proline' 0 N--CA 1.461 -0.417 0 C-N-CA 124.234 3.289 . . . . 0.0 111.32 174.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.1 t70 64.47 27.56 13.51 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.819 1.648 . . . . 0.0 112.843 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.1 p -121.91 173.76 7.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.467 1.031 . . . . 0.0 113.651 -177.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -83.28 24.9 0.77 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.173 2.189 . . . . 0.0 110.632 -172.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -108.11 175.47 5.47 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.035 2.134 . . . . 0.0 110.844 -173.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 pt -147.24 121.11 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.311 1.445 . . . . 0.0 110.904 -174.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.63 139.11 39.44 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.054 -1.029 . . . . 0.0 111.338 -176.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -156.51 169.25 25.08 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.012 -1.055 . . . . 0.0 112.062 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 3.5 mm? -109.8 167.59 10.04 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.377 1.071 . . . . 0.0 109.729 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -62.38 119.4 9.03 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 169.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.15 -15.88 4.21 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.645 1.593 . . . . 0.0 112.944 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -80.1 162.74 24.61 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.981 1.391 . . . . 0.0 110.002 174.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.554 ' HE3' ' HE ' ' A' ' 6' ' ' ARG . 14.5 ptm -138.3 158.95 43.28 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.578 1.951 . . . . 0.0 108.406 175.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -132.66 160.87 35.45 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.382 1.073 . . . . 0.0 111.072 -169.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.6 pt -121.09 125.31 73.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 124.536 1.134 . . . . 0.0 108.909 -175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 82.9 t -60.85 123.48 13.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -126.36 -23.43 3.82 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.634 1.174 . . . . 0.0 112.963 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -156.0 161.6 40.45 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.171 0.896 . . . . 0.0 110.822 159.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -118.54 125.68 50.36 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 129.07 2.948 . . . . 0.0 105.767 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.6 mt -109.46 -165.36 1.01 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.187 0.995 . . . . 0.0 109.213 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -133.52 91.94 2.92 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 170.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.9 t0 175.85 18.91 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 127.627 2.371 . . . . 0.0 111.667 168.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.46 -1.86 84.21 Favored Glycine 0 CA--C 1.539 1.572 0 O-C-N 120.146 -1.596 . . . . 0.0 113.878 -175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.498 ' CE2' HG13 ' A' ' 53' ' ' VAL . 90.9 m95 -97.73 152.02 19.55 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 126.752 2.021 . . . . 0.0 110.217 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 49.7 mtm -141.64 143.8 33.82 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.363 1.465 . . . . 0.0 108.638 178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -84.39 136.69 33.77 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 171.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 m -141.17 -163.79 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 123.511 0.724 . . . . 0.0 111.549 -173.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 34.3 m -135.83 158.11 45.21 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 151.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -102.79 115.36 30.44 Favored 'General case' 0 C--O 1.231 0.1 0 C-N-CA 125.637 1.575 . . . . 0.0 109.677 172.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.2 mt -66.2 -4.54 7.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.799 1.24 . . . . 0.0 113.44 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -69.35 -46.77 66.22 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 117.187 -1.387 . . . . 0.0 111.47 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.5 p -139.29 4.96 2.25 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 119.934 1.243 . . . . 0.0 114.025 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.69 19.69 1.97 Allowed 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.939 1.696 . . . . 0.0 112.204 -174.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -62.25 141.82 58.03 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.916 1.286 . . . . 0.0 110.385 174.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -134.51 155.81 49.72 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.836 0.854 . . . . 0.0 109.65 -173.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 136.89 -158.17 24.07 Favored Glycine 0 CA--C 1.532 1.095 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 -161.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.3 mt -106.16 144.67 32.53 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 125.271 1.428 . . . . 0.0 113.858 -164.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.0 pp -135.63 154.31 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 127.699 2.4 . . . . 0.0 108.582 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.553 ' HB ' ' H ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -91.74 147.97 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 127.483 2.313 . . . . 0.0 112.553 168.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -58.89 -21.32 57.21 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.47 165.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.553 ' H ' ' HB ' ' A' ' 53' ' ' VAL . 21.6 t70 -63.67 -24.62 67.86 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.763 0.792 . . . . 0.0 112.178 -166.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 58.1 mt -118.75 7.2 11.58 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.509 1.523 . . . . 0.0 111.271 -157.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.5 m -134.93 161.84 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 126.02 1.728 . . . . 0.0 109.797 -169.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.5 153.26 26.45 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.363 1.465 . . . . 0.0 109.059 170.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -81.87 61.9 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 124.928 1.291 . . . . 0.0 111.088 -177.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.4 p -60.65 164.68 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 CA-C-O 122.32 1.057 . . . . 0.0 110.213 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.02 -105.63 0.32 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 169.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.507 0 CA-C-O 115.06 -2.4 . . . . 0.0 108.207 -169.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.448 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 55.08 53.88 9.64 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.91 1.284 . . . . 0.0 109.229 -173.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.0 tpm_? -124.37 125.9 45.09 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 -168.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' HD3' HG22 ' A' ' 29' ' ' ILE . 17.5 mtm180 -134.61 166.8 22.07 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.991 0.516 . . . . 0.0 110.451 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.69 161.44 23.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 171.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.6 ttm180 -139.47 129.87 25.55 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -175.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -71.52 121.72 19.18 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.981 0.81 . . . . 0.0 109.595 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -95.96 -2.34 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 118.506 -0.759 . . . . 0.0 112.135 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.81 157.48 32.58 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 126.938 2.095 . . . . 0.0 108.171 173.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -78.08 159.74 30.24 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.93 3.086 . . . . 0.0 111.147 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -143.9 168.07 20.82 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.826 1.651 . . . . 0.0 107.61 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 t -135.66 143.51 45.52 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.579 ' H ' ' HB3' ' A' ' 21' ' ' SER . 12.9 pttm -84.35 155.88 22.13 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.924 -177.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.406 HG12 ' H ' ' A' ' 14' ' ' VAL . 0.1 OUTLIER -62.46 139.63 96.63 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 161.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -73.14 146.68 41.39 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.945 1.763 . . . . 0.0 108.837 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.3 t0 62.65 51.32 3.17 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.686 1.594 . . . . 0.0 112.019 177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.1 p -146.07 174.36 11.37 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 125.926 1.69 . . . . 0.0 110.203 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -84.22 -9.15 58.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.185 0.994 . . . . 0.0 110.992 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -68.08 173.71 4.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.879 2.071 . . . . 0.0 111.337 178.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.9 pt -147.18 126.22 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 126.985 2.114 . . . . 0.0 108.734 -172.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.579 ' HB3' ' H ' ' A' ' 13' ' ' LYS . 1.2 p -93.72 125.72 38.5 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.075 1.75 . . . . 0.0 111.468 -172.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -150.57 168.61 23.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 124.513 2.101 . . . . 0.0 113.95 -172.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mt -90.16 174.54 7.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.525 2.33 . . . . 0.0 110.126 -166.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -60.47 153.25 23.65 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 156.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.7 7.15 88.72 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.069 -0.851 . . . . 0.0 113.67 167.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.91 157.05 20.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 119.213 1.507 . . . . 0.0 109.058 166.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 25.3 ttt -134.01 147.83 51.02 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.097 0.959 . . . . 0.0 109.12 -176.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -134.76 170.97 15.04 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.384 -167.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.514 HG22 ' HD3' ' A' ' 4' ' ' ARG . 18.5 pt -128.06 138.72 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 125.098 1.359 . . . . 0.0 107.899 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 53.9 t -75.0 116.84 18.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -112.17 -20.52 11.87 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.402 0.681 . . . . 0.0 111.387 174.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -154.84 179.88 8.68 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 163.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -147.09 118.95 8.1 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.748 1.619 . . . . 0.0 107.369 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.8 mt -104.91 -177.56 3.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 127.811 2.445 . . . . 0.0 110.222 -177.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -133.96 78.79 1.78 Allowed 'General case' 0 C--O 1.238 0.467 0 C-N-CA 125.448 1.499 . . . . 0.0 109.6 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -169.9 31.03 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.63 1.572 . . . . 0.0 110.508 169.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.1 27.74 67.87 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.609 -1.307 . . . . 0.0 112.623 -174.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -134.52 150.37 50.76 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-N 118.534 1.167 . . . . 0.0 110.833 -168.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 70.6 mtm -149.14 137.66 21.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.493 0.717 . . . . 0.0 110.869 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -86.71 130.84 34.32 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.958 1.303 . . . . 0.0 110.405 173.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 m -142.1 -177.12 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 123.504 0.722 . . . . 0.0 111.879 -175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 24.3 m -116.78 138.7 51.3 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.945 1.698 . . . . 0.0 107.42 157.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -92.32 120.84 33.25 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.705 1.202 . . . . 0.0 109.466 165.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.87 1.66 3.19 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.774 ' HG3' HG22 ' A' ' 46' ' ' THR . 3.5 ptp180 -71.34 -36.49 71.56 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 121.191 1.814 . . . . 0.0 112.799 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.774 HG22 ' HG3' ' A' ' 45' ' ' ARG . 14.9 t -158.95 23.31 0.21 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.273 0.488 . . . . 0.0 111.635 -171.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.9 t70 58.59 27.24 15.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.411 1.084 . . . . 0.0 111.784 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.517 ' HG3' HG23 ' A' ' 46' ' ' THR . 45.4 mt-10 -68.61 98.86 0.92 Allowed 'General case' 0 C--O 1.233 0.234 0 O-C-N 121.011 -1.056 . . . . 0.0 109.415 171.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -80.42 158.3 25.99 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 120.721 0.295 . . . . 0.0 110.619 167.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 149.16 -170.74 29.46 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 173.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -80.03 141.79 35.56 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.426 1.091 . . . . 0.0 110.882 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -133.81 152.21 34.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 126.138 1.775 . . . . 0.0 110.12 167.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -85.61 140.58 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 125.283 1.433 . . . . 0.0 108.736 -176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -74.92 -9.33 58.44 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.78 -15.45 61.68 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.345 1.858 . . . . 0.0 113.846 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.2 mt -140.79 21.86 2.31 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 124.739 1.216 . . . . 0.0 113.677 -167.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 16.3 m -120.75 154.44 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -100.4 149.32 23.76 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.74 1.216 . . . . 0.0 109.554 167.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.4 123.88 24.7 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.274 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 62' ' ' ARG . 2.6 t -124.36 149.29 28.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 CA-C-O 121.124 0.488 . . . . 0.0 111.288 172.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.27 15.52 10.05 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.89 1.709 . . . . 0.0 112.349 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.553 ' H ' HG12 ' A' ' 60' ' ' VAL . 63.2 mtt-85 . . . . . 0 C--O 1.246 0.886 0 C-N-CA 125.184 1.394 . . . . 0.0 109.258 176.518 . . . . . . . . 1 1 . 1 stop_ save_